<SEC-DOCUMENT>0001999371-25-011457.txt : 20250815
<SEC-HEADER>0001999371-25-011457.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815150448
ACCESSION NUMBER:		0001999371-25-011457
CONFORMED SUBMISSION TYPE:	N-2/A
PUBLIC DOCUMENT COUNT:		28
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuveen Global High Income Fund
		CENTRAL INDEX KEY:			0001615905
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-22988
		FILM NUMBER:		251224224

	BUSINESS ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-917-8146

	MAIL ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuveen Global High Income Fund
		CENTRAL INDEX KEY:			0001615905
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287584
		FILM NUMBER:		251224223

	BUSINESS ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-917-8146

	MAIL ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2/A
<SEQUENCE>1
<FILENAME>jgh-n2a_052725.htm
<DESCRIPTION>AMENDMENT TO FORM N-2
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:jgh="http://nuveen.com/20250815">
<head>
     <title>Nuveen Municipal Credit Opportunities Fund</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_CEF%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_jgh_nuveen.com_20250815 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250815_20250815 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentType_N%2D2/A -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001615905 -->
<!-- Field: Set; Name: xdx; ID: xdx_07E_XDX_jgh%2Dn2a__052725.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="line-height: normal">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000004" name="dei:DocumentType">N-2/A</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000005" name="dei:EntityCentralIndexKey">0001615905</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-15" id="xdx2ixbrl0048" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="jgh-20250815.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-15</xbrli:startDate>
        <xbrli:endDate>2025-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-152025-08-15_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-15</xbrli:startDate>
        <xbrli:endDate>2025-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-08-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-08-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-082025-08-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-08</xbrli:startDate>
        <xbrli:endDate>2025-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_BorrowingsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-082025-08-08_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-08</xbrli:startDate>
        <xbrli:endDate>2025-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-152025-08-15_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-15</xbrli:startDate>
        <xbrli:endDate>2025-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-152025-08-15_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-15</xbrli:startDate>
        <xbrli:endDate>2025-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000062" toRefs="Footnote000064"/>
  <ix:relationship fromRefs="Fact000063" toRefs="Footnote000065"/>
  <ix:relationship fromRefs="Fact000069" toRefs="Footnote000073"/>
  <ix:relationship fromRefs="Fact000070" toRefs="Footnote000073 Footnote000074"/>
  <ix:relationship fromRefs="Fact000071" toRefs="Footnote000073 Footnote000075"/>
  <ix:relationship fromRefs="Fact000072" toRefs="Footnote000073"/>
  <ix:relationship fromRefs="Fact000117" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000118" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000119" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000120" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000121" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000122" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000123" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000124" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000125" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000126" toRefs="Footnote000138"/>
  <ix:relationship fromRefs="Fact000128" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000129" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000130" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000131" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000132" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000133" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000134" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000135" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000136" toRefs="Footnote000139"/>
  <ix:relationship fromRefs="Fact000137" toRefs="Footnote000139"/>
  </ix:resources>
 </ix:header>
</div>


<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the U.S. Securities and Exchange Commission on August 15, 2025</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Act Registration No.&#160;<span id="xdx_901_edei--EntityFileNumber_c20250815__20250815_zBdqxErhn1Mh"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000011" name="dei:EntityFileNumber">333-287584</ix:nonNumeric></span></b></span></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Company Registration No.&#160;<span id="xdx_909_edei--InvestmentCompanyActFileNumber_c20250815__20250815_zqEZ3xoFjFxg"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000012" name="dei:InvestmentCompanyActFileNumber">811-22988</ix:nonNumeric></span></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 4pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>&#160;UNITED
STATES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span style="white-space: nowrap"><span id="xdx_903_edei--EntityInvCompanyType_c20250815__20250815_zvJtWqoDacPh"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000013" name="dei:EntityInvCompanyType">N-2</ix:nonNumeric></span></span></b></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; border-collapse: collapse; margin-right: auto">


<tr>

<td/>

<td style="vertical-align: bottom; width: 4%"/>
<td style="width: 96%"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--DocumentRegistrationStatement_c20250815__20250815_z0VOjFCbPnf4"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentRegistrationStatement">&#9746;</ix:nonNumeric></span></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Statement under the Securities
Act of 1933:</span></td></tr>
<tr style="font-size: 1pt">
<td style="height: 5px"/>
<td colspan="2" style="height: 5px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: right"><span id="xdx_907_edei--PreEffectiveAmendment_c20250815__20250815_zp5O6FL7Soz1"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000015" name="dei:PreEffectiveAmendment">&#9746;</ix:nonNumeric></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Effective
Amendment No. <span id="xdx_906_edei--PreEffectiveAmendmentNumber_c20250815__20250815_ziweXH4TOQa9"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000016" name="dei:PreEffectiveAmendmentNumber">1</ix:nonNumeric></span></span></td></tr>
<tr style="font-size: 1pt">
<td style="height: 8px"/>
<td colspan="2" style="height: 8px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Effective Amendment No.</span></td></tr>
<tr style="font-size: 1pt">
<td style="height: 2px"/>
<td colspan="2" style="height: 2px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td colspan="3" style="vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</span></p>

</td></tr>
<tr style="font-size: 1pt">
<td style="height: 8px"/>
<td colspan="2" style="height: 8px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--InvestmentCompanyActRegistration_c20250815__20250815_z5G4u0MefBe3"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000017" name="dei:InvestmentCompanyActRegistration">&#9746;</ix:nonNumeric></span></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Statement under the Investment
Company Act of 1940:</span></td></tr>
<tr style="font-size: 1pt">
<td style="height: 5px"/>
<td colspan="2" style="height: 5px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--InvestmentCompanyRegistrationAmendment_c20250815__20250815_zHhVMVB9v8Jf"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000018" name="dei:InvestmentCompanyRegistrationAmendment">&#9746;</ix:nonNumeric></span></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--AmendmentDescription_c20250815__20250815_z1TlG7lQcDbc"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000019" name="dei:AmendmentDescription">Amendment No.
<span id="xdx_90B_edei--InvestmentCompanyRegistrationAmendmentNumber_c20250815__20250815_zqcZTRYyNek9"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000020" name="dei:InvestmentCompanyRegistrationAmendmentNumber">1</ix:nonNumeric></span></ix:nonNumeric></span>&#160;</span></td></tr></table>

<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>

<p style="border-bottom: #000000 0pt solid; line-height: 4pt; margin-top: 0pt; margin-bottom: 0pt; width: 21%">&#160;</p>
<p style="font: 16pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20250815__20250815_zozwS6GmczSd"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000021" name="dei:EntityRegistrantName">Nuveen Global High
Income Fund</ix:nonNumeric></span></b></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exact Name of Registrant as Specified in the Declaration of Trust</span></p>
<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>
<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="border-bottom: #000000 0pt solid; line-height: 4pt; margin-top: 0pt; margin-bottom: 2pt; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20250815__20250815_zjdBhMbuiIAk"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000022" name="dei:EntityAddressAddressLine1">333
West Wacker Drive</ix:nonNumeric> </span><br/>
<span id="xdx_90D_edei--EntityAddressCityOrTown_c20250815__20250815_zwPLdGEcjB88"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000023" name="dei:EntityAddressCityOrTown">Chicago</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20250815__20250815_z7MzxdKRPGnd"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt-sec:stateprovnameen" id="Fact000024" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20250815__20250815_znqWV7yxgUcd"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000025" name="dei:EntityAddressPostalZipCode">60606</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
of Principal Executive Offices (Number, Street, City, State, Zip Code)</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--CityAreaCode_c20250815__20250815_zarHZ8chEw4b"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000026" name="dei:CityAreaCode">(800)</ix:nonNumeric></span>
<span id="xdx_904_edei--LocalPhoneNumber_c20250815__20250815_zyZ9VYWNxch6"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000027" name="dei:LocalPhoneNumber">257-8787</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
Telephone Number, including Area Code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-align: center"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--ContactPersonnelName_c20250815__20250815__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zdLqhSA6X8Ah"><ix:nonNumeric contextRef="From2025-08-152025-08-15_dei_BusinessContactMember" id="Fact000028" name="dei:ContactPersonnelName">Mark
L. Winget</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vice
                                            President and Secretary</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20250815__20250815__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z5mD5bz2Rpcc"><ix:nonNumeric contextRef="From2025-08-152025-08-15_dei_BusinessContactMember" id="Fact000029" name="dei:EntityAddressAddressLine1">333
                                            West Wacker Drive</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20250815__20250815__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zpE1ehcLFGE6"><ix:nonNumeric contextRef="From2025-08-152025-08-15_dei_BusinessContactMember" id="Fact000030" name="dei:EntityAddressCityOrTown">Chicago</ix:nonNumeric></span>,
<span id="xdx_909_edei--EntityAddressStateOrProvince_c20250815__20250815__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zLuP7CmKKSTa"><ix:nonNumeric contextRef="From2025-08-152025-08-15_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000031" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20250815__20250815__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_ztpacsAFNpVd"><ix:nonNumeric contextRef="From2025-08-152025-08-15_dei_BusinessContactMember" id="Fact000032" name="dei:EntityAddressPostalZipCode">60606</ix:nonNumeric></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
                                            and Address (Number, Street, City, State, Zip Code) of Agent for Service</span></p>
<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>
<p style="border-bottom: #000000 0pt solid; line-height: 4pt; margin-top: 0pt; margin-bottom: 2pt; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
                                            of Communications to: </i></span></p>
<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 100%; border-collapse: collapse; margin-right: auto">
<tr>
<td style="width: 32%"/>
<td style="vertical-align: bottom; width: 2%"/>
<td style="width: 32%"/>
<td style="vertical-align: bottom; width: 2%"/>
<td style="width: 32%"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric S. Purple, Esquire</b></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joel D. Corriero, Esquire</b></span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric F. Fess</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stradley
                                Ronon Stevens &amp; Young, LLP</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2000
K Street, N.W., Suite 700</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20006</b></span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stradley
                                Ronon Stevens &amp; Young, LLP</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2005
Market Street, Suite 2600</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Philadelphia,
Pennsylvania 19103</b></span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chapman
                                and Cutler LLP</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>111
West Monroe</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chicago,
                                            Illinois 60603</b></span></p></td></tr>
</table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
         Date of Commencement of Proposed Public Offering:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20250815__20250815_zI3CgQJUn2z1"><ix:nonNumeric contextRef="AsOf2025-08-15" id="Fact000033" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">From
time to time after the effective date of this Registration Statement.</ix:nonNumeric></span></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--DividendOrInterestReinvestmentPlanOnly_c20250815__20250815_zKdV5J62Edmh"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000034" name="dei:DividendOrInterestReinvestmentPlanOnly">&#9744;</ix:nonNumeric></span>
Check box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--DelayedOrContinuousOffering_c20250815__20250815_zKyPKpT62Rt9"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000035" name="dei:DelayedOrContinuousOffering">&#9746;</ix:nonNumeric></span>
     Check box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415
     under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment
     plan.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecef--PrimaryShelfFlag_c20250815__20250815_zDwXWTVjsFIj"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000036" name="cef:PrimaryShelfFlag">&#9746;</ix:nonNumeric></span>
Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EffectiveUponFiling462e_c20250815__20250815_zwBNm5wLznv5"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000037" name="dei:EffectiveUponFiling462e">&#9744;</ix:nonNumeric></span>
Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will
become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--AdditionalSecuritiesEffective413b_c20250815__20250815_zISalBjiU0Gi"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000038" name="dei:AdditionalSecuritiesEffective413b">&#9744;</ix:nonNumeric></span>
                                            Check box if this Form is a post-effective amendment to a registration statement filed pursuant
                                            to General Instruction B to register additional securities or additional classes of securities
                                            pursuant to Rule 413(b) under the Securities Act.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>It
is proposed that this filing will become effective (check appropriate box) </b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EffectiveWhenDeclaredSection8c_c20250815__20250815_zlgap4ZmsN22"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000039" name="dei:EffectiveWhenDeclaredSection8c">&#9744;</ix:nonNumeric></span>
when declared effective pursuant to Section&#160;8(c) of the Securities Act.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
appropriate, check the following box: </b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--NewEffectiveDateForPreviousFiling_c20250815__20250815_z16lpIdjFXpe"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000040" name="dei:NewEffectiveDateForPreviousFiling">&#9744;</ix:nonNumeric></span>
This [post-effective] amendment designates a new effective date for a previously filed [post-effective] amendment [registration statement].</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--AdditionalSecurities462b_c20250815__20250815_zyHobIkolKMk"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000041" name="dei:AdditionalSecurities462b">&#9744;</ix:nonNumeric></span>
                 This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act,
                 and the Securities Act registration statement number of the earlier effective registration statement for the same offering
                 is: <span style="text-decoration: underline">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--NoSubstantiveChanges462c_c20250815__20250815_zRd7ZBKNIL94"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000042" name="dei:NoSubstantiveChanges462c">&#9744;</ix:nonNumeric></span>
This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is: <span style="text-decoration: underline">&#8195;&#8195;&#8195;&#8195;&#8195;</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--ExhibitsOnly462d_c20250815__20250815_zscg5lhr81gk"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000043" name="dei:ExhibitsOnly462d">&#9744;</ix:nonNumeric></span>
This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is: <span style="text-decoration: underline">&#8195;&#8195;&#8195;&#8195;</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Check
                                            each box that appropriately characterizes the Registrant: </b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecef--RegisteredClosedEndFundFlag_c20250815__20250815_zaQkuNncQXv3"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000044" name="cef:RegisteredClosedEndFundFlag">&#9746;</ix:nonNumeric></span>
                                            Registered Closed-End Fund (closed-end company that is registered under the Investment Company
                                            Act of 1940 (&#8220;Investment Company Act&#8221;)).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecef--BusinessDevelopmentCompanyFlag_c20250815__20250815_zhaVFKG306Vg"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000045" name="cef:BusinessDevelopmentCompanyFlag">&#9744;</ix:nonNumeric></span>
Business Development Company (closed-end company that intends or has elected to be regulated as a business development company under
the Investment Company Act).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecef--IntervalFundFlag_c20250815__20250815_zw9QvNGK21Fg"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000046" name="cef:IntervalFundFlag">&#9744;</ix:nonNumeric></span>
                                            Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic
                                            repurchase offers under Rule 23c-3 under the Investment Company Act).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecef--PrimaryShelfQualifiedFlag_c20250815__20250815_zR5fG1Hszwk4"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleantrue" id="Fact000047" name="cef:PrimaryShelfQualifiedFlag">&#9746;</ix:nonNumeric></span>
A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityWellKnownSeasonedIssuer_c20250815__20250815_zNti8aYgznHb"><span style="-sec-ix-hidden: xdx2ixbrl0048">&#9744;</span></span>
Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20250815__20250815_zj32ePsLxFtj"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000049" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span>
Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 3pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
                                 If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended
                                 transition period for complying with any new or revised financial accounting standards provided pursuant
                                 to Section&#160;7(a)(2)(B) of Securities Act.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecef--NewCefOrBdcRegistrantFlag_c20250815__20250815_zigFv6yzv1v4"><ix:nonNumeric contextRef="AsOf2025-08-15" format="ixt:booleanfalse" id="Fact000050" name="cef:NewCefOrBdcRegistrantFlag">&#9744;</ix:nonNumeric></span>
New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing).</span></p>
<p style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 0pt; margin-bottom: 0pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment that specifically states that the Registration Statement shall thereafter become effective
in accordance with Section&#160;8(a) of the Securities Act or until the Registration Statement shall become effective on such date as
the Securities and Exchange Commission, acting pursuant to Section&#160;8(a), may determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>




<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><span style="text-decoration: underline">BASE PROSPECTUS</span></b></p> <p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right">


<img src="nuveenlogo.jpg" alt="LOGO"/>
 </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>$100,000,000</b></p>
<p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Common Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Preferred
Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Rights to Purchase Common Shares </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 17pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Nuveen Global High
Income Fund </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Offering</i></b><i>.</i>&#160;Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is offering, on an immediate,
continuous or delayed basis, in one or more offerings, with a maximum aggregate dollar offering price of up to $100,000,000, common shares (&#8220;Common Shares&#8221;), preferred
shares (&#8220;Preferred Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and collectively
with Common Shares and Preferred Shares, &#8220;Securities&#8221;), in any combination. The Fund may offer and sell such Securities
directly to one or more purchasers, to or through underwriters, through dealers or agents that the Fund designates from time to
time, or through a combination of these methods. The prospectus supplement relating to any offering of Securities will describe
such offering, including, as applicable, the names of any underwriters, dealers or agents and information regarding any applicable
purchase price, fee, commission or discount arrangements made with those underwriters, dealers or agents or the basis upon which
such amount may be calculated. The prospectus supplement relating to any Rights offering will set forth the number of Common Shares
issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights offering. For more information
about the manners in which the Fund may offer Securities, see &#8220;Plan of Distribution.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Fund</i>.</b>&#160;The Fund is a diversified, closed-end management investment company. The Fund&#8217;s investment objective is to provide a high level of current income. There can be no
assurance that the Fund will achieve its investment objective or that the Fund&#8217;s investment strategies will be successful.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
Prospectus, together with any related prospectus supplement, sets forth concisely information about the Fund that a prospective
investor should know before investing, and should be retained for future reference. Investing in Securities involves risks, including
the risks associated with the Fund&#8217;s use of leverage. You could lose some or all of your investment. You should consider
carefully these risks together with all of the other information in this Prospectus and any related prospectus supplement before
making a decision to purchase any of the Securities. See &#8220;<a href="#toc780884_9">Risk&#160;Factors</a>&#8221; beginning on
page 14.</b></span><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares are listed on the New York Stock Exchange (the &#8220;NYSE&#8221;). The trading or &#8220;ticker&#8221; symbol of the Common
Shares is &#8220;JGH.&#8221; The closing price of the Common Shares, as reported by the NYSE on August 8, 2025, was $<span id="xdx_901_eus-gaap--SharePrice_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGDcbE1JuF99"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.34</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Common Share. The net asset value of the Common Shares at the close of business on that same date was $<span id="xdx_905_eus-gaap--NetAssetValuePerShare_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z43qBH0e8Cwe"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.90</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Common Share. Preferred Shares and/or Rights issued by the Fund may also be listed on a securities exchange.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#8195;*&#8195;*</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this Prospectus, together with any related prospectus supplement, which contains important information about the Fund,
before deciding whether to invest and retain it for future reference. A Statement of Additional Information, dated August 19, 2025 (the &#8220;SAI&#8221;), containing additional information about the Fund has been filed with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) and is incorporated by reference in its entirety into this Prospectus. You may request a free
copy of the SAI, the table of contents of which is on the last page of this Prospectus, annual and semi-annual reports to shareholders
and other information about the Fund and make shareholder inquiries by calling (800)&#160;257-8787, by writing to the Fund at
333 West Wacker Drive, Chicago, Illinois 60606 or from the Fund&#8217;s website (http://www.nuveen.com). The information contained
in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus, except to the extent specifically
incorporated by reference herein. You also may obtain a copy of the SAI (and other information regarding the Fund) from the SEC&#8217;s
web site (http://www.sec.gov).</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this Prospectus is August 19, 2025.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution,
and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other governmental agency.
</b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the SEC nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus is truthful
or complete. Any representation to the contrary is a criminal offense. </b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc"></span>TABLE OF CONTENTS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 97%"/>

<td style="vertical-align: bottom; width: 1%"/>
<td/>
<td/>
<td/></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_1">Prospectus
                                 Summary</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">1</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_2">Summary
                                 of Fund Expenses</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">7</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_3">Financial
                                 Highlights</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">8</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_4">Trading
                                 and Net Asset Value Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_5">The
                                 Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_6">Use
                                 of Proceeds</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_7">The
                                 Fund&#8217;s Investments</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_8">Use
                                 of Leverage</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">11</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_9">Risk
                                 Factors</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_10">Management
                                 of the Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_11">Net
                                 Asset Value</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_12">Distributions</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_13">Dividend
                                 Reinvestment Plan</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_14">Plan
                                 of Distribution</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_15">Description
                                 of Shares</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">21</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_16">Rights
                                 Offerings</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">24</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_17">Certain
                                 Provisions in the Declaration of Trust and By-Laws</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">25</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_18">Repurchase
                                 of Fund Shares; Conversion to Open-End  Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">27</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_19">Tax
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">28</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_20">Custodian
                                 and Transfer Agent</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">29</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_21">Independent
                                 Registered Public Accounting Firm</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_22">Legal
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_23">Available
                                 Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_24">Incorporation
                                 By Reference</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>You should rely only on the information contained or incorporated by reference into this Prospectus and any related prospectus supplement. The Fund has not
authorized anyone to provide you with different information. The Fund is not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information contained in this Prospectus and any related
prospectus supplement is accurate as of any date other than the dates on their covers. The Fund will update this Prospectus to reflect any material changes to the disclosures herein. </b></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORWARD-LOOKING STATEMENTS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any projections, forecasts and estimates contained or incorporated by
reference herein are forward looking statements and are based upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any
projections, forecasts or estimates will not materialize or will vary significantly from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material. Some important factors that could
cause actual results to differ materially from those in any forward looking statements include changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency of defaults on underlying
investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually be achieved
by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections, forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after the
date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition. The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private
Securities Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_1"></span>PROSPECTUS SUMMARY </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>This is only a summary. You should review the more detailed
information contained elsewhere in this Prospectus and any related prospectus supplement and in the Statement of Additional Information (the &#8220;SAI&#8221;). </i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                       Fund </b></p></td>
<td>Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment
company. See &#8220;The Fund.&#8221; The Fund&#8217;s common shares, $0.01 par value per share (&#8220;Common Shares&#8221;), are traded
on the New&#160;York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;JGH.&#8221; Preferred Shares and/or Rights issued
by the Fund may also be listed on a securities exchange.</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%">&#160;</td>
<td style="text-align: left; vertical-align: top">The closing price of the Common Shares, as reported by the NYSE on August 8, 2025,
was <span id="xdx_907_eus-gaap--SharePrice_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zr7RPMJBWuO1">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.34</ix:nonFraction>
</span> per Common Share. The net asset value (&#8220;NAV&#8221;) of the Common Shares at the close of business on that same date was
$<span id="xdx_906_eus-gaap--NetAssetValuePerShare_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zUz84pmAN5Mj"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.90</ix:nonFraction></span>
per Common Share. As of August 8, 2025, the Fund had <span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zUR5fpWB3lp2"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" id="Fact000055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,177,393</ix:nonFraction></span>
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556. See &#8220;Description of Shares.&#8221;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                       Offering </b></p></td>
<td>The Fund may offer, from time to time, in one or more offerings, with a maximum aggregate dollar offering price of up to $100,000,000, Common Shares, preferred shares
(&#8220;Preferred Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and collectively with
Common Shares and Preferred Shares, &#8220;Securities&#8221;), in any combination, on terms to be determined at the time of the
offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through
dealers or agents that the Fund designates from time to time, or through a combination of these methods. The prospectus supplement
relating to any offering of Securities will describe such offering, including, as applicable, the names of any underwriters, dealers
or agents and information regarding any applicable purchase price, fee, commission or discount arrangements made with those underwriters,
dealers or agents or the basis upon which such amount may be calculated. For more information about the manners in which the Fund
may offer Securities, see &#8220;Plan of Distribution.&#8221; The prospectus supplement relating to any Rights offering will set
forth the number of Common Shares issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights
offering. The minimum price on any day at which the Common Shares may be sold will not be less than the NAV per Common Share at
the time of the offering plus the per share amount of any underwriting commission or discount; provided that Common Shares offered pursuant to Rights offerings
that meet certain conditions may be offered at a price below the then current NAV. See &#8220;Rights Offerings.&#8221;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                               Fund may not sell any Securities through agents, underwriters or dealers without delivery, or deemed delivery,
                               of a prospectus, including the appropriate prospectus supplement, describing the method and terms of the
                               particular offering of such Securities. You should
                               read this Prospectus and the applicable prospectus supplement carefully before you invest in our Securities.</span></p>
                              <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Objective
                 and Policies </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the Fund&#8217;s most recent
<a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks
of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221; as such investment objective and investment
policies may be supplemented from time to time, which are incorporated by reference herein, for a discussion of the Fund&#8217;s investment
objective and policies.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that
such strategies will be successful. For a more complete discussion of the Fund&#8217;s portfolio composition and its corresponding risks,
see &#8220;The Fund&#8217;s Investments&#8221; and &#8220;Risk Factors.&#8221;</span></td></tr><tr>
<td>&#160;</td>
<td style="text-align: left; vertical-align: top">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Adviser
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Fund Advisors, LLC (&#8220;Nuveen Fund
Advisors&#8221;), the Fund&#8217;s investment adviser, is responsible for overseeing the Fund&#8217;s overall investment strategy and
its implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad range of investment company
clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the management of the Fund&#8217;s
portfolio,&#160;manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and other administrative
services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect
subsidiary of Nuveen, LLC (&#8220;Nuveen&#8221;), the investment management arm of Teachers Insurance and Annuity Association of
America (&#8220;TIAA&#8221;). TIAA is a life insurance company founded in 1918 by the Carnegie Foundation for the Advancement of
Teaching and is the companion organization of College Retirement Equities Fund. As of June 30, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately $151.1 billion was managed by Nuveen Fund Advisors.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sub-Adviser</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Asset Management, LLC (&#8220;Nuveen Asset
Management&#8221;), located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s sub-adviser. Nuveen Asset Management,
a registered investment adviser, is a wholly-owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees the
day-to-day investment operations of the Fund.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                       of Leverage</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund uses leverage to pursue its investment
objective. The Fund may use leverage to the extent permitted by the Investment Company Act of 1940, as amended (the &#8220;1940
Act&#8221;). Accordingly, the Fund may source leverage through a number of methods including the issuance of &#8220;senior securities&#8221; as defined
under the 1940 Act. &#8220;Senior securities&#8221; include (1) certain borrowings, including certain loans from financial institutions;
(2) issuance of debt securities; and (3) issuance of preferred shares of beneficial interest (&#8220;Preferred Shares&#8221;). Additionally,
the Fund may use certain derivatives and other financing investments that have the economic effect of leverage by creating additional
investment exposures, such as investments in inverse floating rate securities and reverse repurchase agreements. The amount and sources
of leverage will vary depending on market conditions. See &#8220;Use of Leverage&#8221; for more information.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through borrowings and through the use of reverse repurchase agreements. The Fund has entered into a
364-day revolving line of credit. Interest is charged on these borrowings to the drawn amount at a rate per annum equal to one-month
Term SOFR (&#8220;Secured Overnight Financing Rate&#8221;) plus 0.90%. The Fund also accrued a 0.15% per annum commitment fee based
on the undrawn balance.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objective, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and  composition of the Fund&#8217;s holdings.
The Fund&#8217;s leverage ratio varies from time to time based upon such changes in the amount of leverage used and
variations in the value of the Fund&#8217;s holdings. So long as the net income received on the Fund&#8217;s investments
purchased with leverage proceeds exceeds the then current expense on any leverage, the investment of leverage proceeds will
generate more net income than if the Fund had not used leverage. Under these circumstances, the excess net income will be
available to pay higher distributions to Common Shareholders. However, if the net income received from the Fund&#8217;s
portfolio investments purchased with leverage is less than the then current expense on outstanding leverage, the Fund may be
required to utilize other Fund assets to make expense payments on outstanding leverage, which may result in a decline in
Common Share NAV and reduced net investment income available for distribution to Common Shareholders.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund may borrow for temporary or emergency purposes as permitted by the 1940 Act. There is no assurance that the Fund will continue to use leverage.
                                            The Fund&#8217;s use of leverage may not work as planned or achieve its goals.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, the Fund&#8217;s Managed
Assets are greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible for using leverage to pursue
the Fund&#8217;s investment objective. Nuveen Fund Advisors and Nuveen Asset Management base their decision regarding whether and how
much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether such use of leverage is in the best
interests of the Fund. However, a decision to employ or increase leverage has the effect, all other
things being equal, of increasing Managed Assets, and in turn Nuveen Fund Advisors&#8217; and Nuveen Asset Management&#8217;s management
fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest in determining whether to use or increase leverage. Nuveen Fund Advisors and Nuveen Asset Management seek to manage that conflict by recommending to the
Board of Trustees to leverage the Fund (or increase such leverage) only when they determine that such action would be in the best interests
of the Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the
impact of the use of leverage on that performance.</span></p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distributions
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund pays regular monthly cash distributions
to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution rate which may be set from time
to time). The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly
distributions and to distribute realized capital gains at least annually. In addition, in any monthly period, to maintain its
declared per common share distribution amount, the Fund may distribute more or less than its net investment income during the
period. In the event the Fund distributes more than its net investment income during any yearly period, such distributions may
also include realized gains and/or a return of capital. To the extent that a distribution includes a return of capital the NAV
per share may erode. If a distribution includes anything other than net investment income, the Fund provides a notice of the best
estimate of its distribution sources at the time. See &#8220;Distributions.&#8221;</span></td></tr>                                                                                                                                                                                                                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Fund reserves the right to change its distribution policy and the basis for establishing the rate of its monthly distributions
    at any time and may do so without prior notice to Common Shareholders.</span></p> </td></tr>
</table>
<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian
                 and Transfer Agent </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State Street Bank and Trust Company serves as the Fund&#8217;s
custodian, and Computershare Inc. and Computershare Trust Company, N.A. serves as the Fund&#8217;s transfer agent for the Common Shares.
The corresponding agent for any Preferred Shares to be offered pursuant to this Prospectus  will be identified in the related prospectus supplement. See &#8220;Custodian and Transfer
Agent.&#8221;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
                 Factors </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in the Fund involves risk. The Fund is designed
as a long-term investment and not as a trading vehicle. The Fund is not intended to be a complete investment program. Please refer to
the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective,
Investment Policies and Principal Risks of the Fund&#151;Principal Risks of the Funds,&#8221; as such principal risks may be supplemented
from time to time, which is incorporated by reference herein, for a discussion of the principal risks you should consider before making
an investment in the Fund. Any additional risks applicable to a particular offering of Securities will be set forth in the related prospectus
supplement.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                 of Proceeds </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise specified in a prospectus supplement,
the Fund will use the net proceeds from any offering of Securities, pursuant to this Prospectus, to make investments in accordance with
the Fund&#8217;s investment objective. See &#8220;Use of Proceeds.&#8221;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
                       Income Tax </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has elected to be treated, and intends to qualify each year,
as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).
To qualify for the favorable U.S. federal income tax treatment generally accorded to a RIC under Subchapter M of the Code the Fund must,
among other requirements, derive in each taxable year at least 90% of its gross income from certain prescribed sources and satisfy a diversification
test on a quarterly basis. If the Fund fails to satisfy the qualifying income or diversification requirements in any taxable year, the
Fund may be eligible for relief provisions if the failures are due to reasonable cause and not willful neglect and if a penalty tax is
paid with respect to each failure to satisfy the applicable requirements. Additionally, relief is provided for certain&#160;<i>de minimis</i>&#160;failures
of the diversification requirements where the Fund corrects the failure within a specified period. In order to be eligible for the relief
provisions with respect to a failure to meet the diversification requirements, the Fund may be required to dispose of certain assets.
If these relief provisions were not available to the Fund and it were to fail to qualify for treatment as a RIC for a taxable year, all
of its taxable income (including its net capital gain) would be subject to tax at the 21% regular corporate rate without any deduction
for distributions to shareholders, and such distributions would be taxable as ordinary dividends to the extent of the Fund&#8217;s current
and accumulated earnings and profits. To qualify to pay exempt-interest dividends, which are treated as items of interest excludable from
gross income for federal income tax purposes, at least 50% of the value of the total assets of the Fund must consist of obligations exempt
from regular income tax as of the close of each quarter of the Fund&#8217;s taxable year. If the proportion of taxable investments held
by the Fund exceeds 50% of the Fund&#8217;s total assets as of the close of any quarter of any Fund taxable year, the Fund will not for
that taxable year satisfy the general eligibility test that otherwise permits it to pay exempt-interest dividends.</span></td></tr>                                                                                                                                                                                                                                                                                                                                                                                                                                                <tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
                                         &#8220;Fund Tax Risk&#8221; as contained in the section of the Fund&#8217;s most recent
                                         <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective,
                                         Investment Policies and Principal Risks of the Fund&#151;Principal Risks of the Funds&#151;Fund
                                         Level and Other Risks.&#8221;</span></p></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
</table>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governing
                       Law </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Declaration of Trust (the &#8220;Declaration
of Trust&#8221;) is, and each Statement and Statement Supplement for Preferred Shares will be, governed by the laws of the Commonwealth
of Massachusetts.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_2"></span>SUMMARY
OF FUND EXPENSES</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000057" name="cef:PurposeOfFeeTableNoteTextBlock"><p id="xdx_80A_ecef--PurposeOfFeeTableNoteTextBlock_zrbQarXoWuf8" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the table below and the Examples below are to help you understand all fees and expenses that you, as a Common Shareholder,
would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable
to Common Shares, and not as a percentage of total assets or Managed Assets.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="AsOf2025-08-15" continuedAt="ConU000060-01" escape="true" id="Fact000060" name="cef:ShareholderTransactionExpensesTableTextBlock"><p id="xdx_806_ecef--ShareholderTransactionExpensesTableTextBlock_gL1STETTB-KEUBN_zfr3YikU5WP9" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr>
    <td style="vertical-align: top; font-size: 8pt; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Sales Charge (<span id="xdx_908_ecef--BasisOfTransactionFeesNoteTextBlock_c20250815__20250815_zUmr8miBFnN4"><ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000061" name="cef:BasisOfTransactionFeesNoteTextBlock">as a percentage of offering price</ix:nonNumeric></span>)</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecef--SalesLoadPercent_dp_c20250815__20250815_fKg_____zHFbg2t210La" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2025-08-15" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.00</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%<sup>*</sup></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan Fees <sup>(1)</sup></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecef--DividendReinvestmentAndCashPurchaseFees_pid_c20250815__20250815_fKDEp_zoBMXZWwQQv5" style="vertical-align: bottom; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2025-08-15" id="Fact000063" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">2.50</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 8pt"><span id="xdx_F01_zEew5cxfgfga" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 8pt"><span id="xdx_F14_ztv84zaBcaUg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000064" xml:lang="en-US">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</ix:footnote></span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; visibility: hidden; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F07_zv5AhwnVBhBk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span id="xdx_F1E_zBU8j1Hux776" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000065" xml:lang="en-US">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</ix:footnote></span></td>
</tr></table>


</ix:nonNumeric><p id="xdx_818_zv75mFKwXeb5" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>
<ix:nonNumeric contextRef="AsOf2025-08-15" continuedAt="ConU000068-01" escape="true" id="Fact000068" name="cef:AnnualExpensesTableTextBlock"><p id="xdx_808_ecef--AnnualExpensesTableTextBlock_gL1AETTB-TRF_zd9gQnXIjXKl" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; font-weight: bold; text-align: right; padding-bottom: 1pt; padding-left: 10pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Shares<sup>(2)</sup></b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Annual Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 75%; text-align: left">Management Fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_ecef--ManagementFeesPercent_dp_c20250815__20250815_fKDIp_z4WY5nEwWFV7" style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2025-08-15" id="Fact000069" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.18</ix:nonFraction>%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest and Other Related Expenses <sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250815__20250815_fKDIpKDMp_z0GP7Ja2P4lb" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2025-08-15" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.41</ix:nonFraction>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Expenses <sup>(4)</sup></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecef--OtherAnnualExpensesPercent_dp_c20250815__20250815_fKDIpKDQp_z8xgw44rdMv7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2025-08-15" id="Fact000071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.14</ix:nonFraction>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Annual Expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 2.5pt">&#160;</td><td id="xdx_986_ecef--TotalAnnualExpensesPercent_dp_c20250815__20250815_fKDIp_znclkbIxkkTi" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2025-08-15" id="Fact000072" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.73</ix:nonFraction>%</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_819_zkpprFS1eSOg" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<div id="xdx_C0D_gL1STETTB-KEUBN_zvJL6m3sHIh7"><ix:continuation id="ConU000060-01"><div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</span></td>
</tr></table></div></ix:continuation></div>
<div id="xdx_C0A_gL1AETTB-TRF_zAg6CGPjGFYj"><ix:continuation id="ConU000068-01"><div><p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F0C_zBCKezzeMNL" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span id="xdx_F1D_z2ROwh85iCug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000073" xml:lang="en-US">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.</ix:footnote></span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F01_z9TJ0NzsGamk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span id="xdx_F1E_zenYffoi5l82" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000074" xml:lang="en-US">Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#8217;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#8217;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</ix:footnote></span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F0C_zgvO4dJ2lWT" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span id="xdx_F11_z9V72rAVYfOh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000075" xml:lang="en-US"><span id="xdx_90A_ecef--OtherExpensesNoteTextBlock_c20250815__20250815_zdvSowkrm1ab"><ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000076" name="cef:OtherExpensesNoteTextBlock">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.</ix:nonNumeric></span></ix:footnote></span></td>
</tr></table></div></ix:continuation></div>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000078" name="cef:ExpenseExampleTableTextBlock"><p id="xdx_804_ecef--ExpenseExampleTableTextBlock_zMNIvguq0kzh" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example
</b></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following example illustrates the expenses, including the transaction fee (referred to as the &#8220;Maximum Sales Charge&#8221; in
the Shareholder Transaction Expenses table above), if any, that a common shareholder would pay on a $1,000 investment that is held
for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the
Fund and that the Fund&#8217;s Annual Expenses, as provided above, remain the same. The example also assumes a 5% annual return.
Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less
than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 1%">$</td><td id="xdx_989_ecef--ExpenseExampleYear01_c20250815__20250815_z22VtpbOXPA7" style="text-align: right; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2025-08-15" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47</ix:nonFraction></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250815__20250815_zNE7pnry5Iyb" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2025-08-15" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">123</ix:nonFraction></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98D_ecef--ExpenseExampleYears1to5_c20250815__20250815_zkAIFZhvLVw7" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2025-08-15" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201</ix:nonFraction></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_988_ecef--ExpenseExampleYears1to10_c20250815__20250815_zguNRQS9wNkk" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2025-08-15" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404</ix:nonFraction></span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
</table>



<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not
be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></span></p>

</ix:nonNumeric><p id="xdx_81C_zyXOdJXhS5z5" style="margin: 0pt 0"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_3"></span>FINANCIAL HIGHLIGHTS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights table is intended to help you understand the Fund&#8217;s financial performance for the periods presented.
Certain information reflects financial results for a single Common Share of the Fund. The information for the fiscal years or
periods, as applicable, ended December 31, 2024, December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020 has
been audited by PricewaterhouseCoopers LLP (&#8220;PwC&#8221;), an independent registered public accounting firm. The report of PwC,
is included in the Fund&#8217;s December 31, 2024 <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">Annual
Report</a>, which is incorporated by reference herein. The information in the table below for the fiscal years ended December 31,
2019 December 31, 2018, December 31, 2017, December 31, 2016 and December 31, 2015 is derived from the Fund's financial statements
for the fiscal year ended December 31, 2019. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: top">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_499_20240101__20241231_zqgKiPDtqYJ5" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_497_20230101__20231231_zs7f3kExH9u" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_497_20220101__20221231_zcyw1hYREzPh" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_499_20210101__20211231_zHRSa9FtSyl7" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_499_20200101__20201231_ze5oyAhgNZ52" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_495_20190101__20191231_zA0MFWD4FS42" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_49A_20180101__20181231_zOdKJEBKWxPh" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_490_20170101__20171231_zI0DAddeRhB3" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_491_20160101__20161231_zEj7MMSw3RC3" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td id="xdx_496_20150101__20151231_zY6Jd4facPq5" style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td colspan="29" style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended December 31</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1pt solid; vertical-align: middle; white-space: nowrap; width: 37%; text-align: left">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2024</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2019</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2018</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2017</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2016</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2015</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetAssetValuePerShare_iS_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTZaugjwIMV9" style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Beginning Common Share Net Asset Value (&#8220;NAV&#8221;)</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.37</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.79</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.63</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.97</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.14</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.01</ix:nonFraction> </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.51</ix:nonFraction> </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.82</ix:nonFraction> </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.05</ix:nonFraction> </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2014-12-31_us-gaap_CommonStockMember" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.46</ix:nonFraction> </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment Operations: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Investment Income (Loss)(a)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.99</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.82</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.95</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.04</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.10</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.19 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.26 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.42 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.47 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.58 </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Realized/Unrealized Gain (Loss) </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.72</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.00</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.08</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.17 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.42</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.71 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.83 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.64</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.71</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.82</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.48</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.96</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.06</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.36 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.13 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.30 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.06</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Less Distributions to Common Shareholders: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">From Net Investment Income </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.13</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.95</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.99</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.98</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.07</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.20</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.27</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.34</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.51</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.23</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">From Accumulated Net Realized Gains</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Return of Capital</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.11</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.29</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.37</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.32</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.04</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.03</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.08</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.10</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.03</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.34</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.24</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.24</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.36</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.30</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.11</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.23</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.44</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.54</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.57</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Common Share:</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
    <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount Per Share Repurchased and Retired</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.01</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.01</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.09</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount Per Share Repurchased and Retired through Tender Offer</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetAssetValuePerShare_iE_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zc0vLffQfE09">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending NAV</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.84</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.37</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.79</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.63</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.97</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.14</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.01</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.51</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" id="Fact000103" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.82</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.05</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--SharePrice_iE_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5R8dXyvfsYa" style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending Share Price</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.84</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.20</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.25</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.88</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.55</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.38</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.65</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" id="Fact000113" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.91</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" id="Fact000114" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.99</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.74</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Common Share Total Returns: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Based on NAV(b)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.39</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.15</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.10</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.39</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.54</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.67</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.25</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.85</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(10.36</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Based on Share Price(b)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20.80</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(21.07</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.84</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.88</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.93</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.97</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.14</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.26</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(12.07</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Common Share Supplemental Data/Ratios Applicable to Common Shares</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending Net Assets (000) </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">320,863</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">309,940</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">296,494</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">385,474</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">393,299</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">420,480 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">371,082 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">430,058 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">414,084 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">374,403 </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ratios to Average Net Assets(c)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Expenses</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.73</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.68</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.64 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.51 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.08 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.97 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.86 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Investment Income (Loss) </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.29</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.94</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.84 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.10 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.70 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8.91 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8.36 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Portfolio Turnover Rate</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">93</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">43 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">77 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Borrowings at the End of Period:</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_402_ecef--SeniorSecuritiesAmt_iE_pn3n3_hus-gaap--DebtInstrumentAxis__custom--BorrowingsOutstandingMember_zgmbDK3hyClf">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Aggregate Amount Outstanding (000)<sup id="xdx_F41_zL1ylW6EjHN1">(d)</sup></span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2024-12-31_custom_BorrowingsOutstandingMember" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,000</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-12-31_custom_BorrowingsOutstandingMember" id="Fact000118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,000</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_BorrowingsOutstandingMember" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">127,000</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_BorrowingsOutstandingMember" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">159,000</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_BorrowingsOutstandingMember" id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,200</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_BorrowingsOutstandingMember" id="Fact000122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175,200</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_BorrowingsOutstandingMember" id="Fact000123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175,200</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_BorrowingsOutstandingMember" id="Fact000124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175,200</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_BorrowingsOutstandingMember" id="Fact000125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164,800</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_BorrowingsOutstandingMember" id="Fact000126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">170,500</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iE_pid_hus-gaap--DebtInstrumentAxis__custom--BorrowingsOutstandingMember_zQfVAxvaTKi2" style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Asset Coverage Per $1,000 Share<sup id="xdx_F45_znGKiJ0RZ7Q4">(e)</sup></span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2024-12-31_custom_BorrowingsOutstandingMember" id="Fact000128" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,085</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-12-31_custom_BorrowingsOutstandingMember" id="Fact000129" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,605</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_BorrowingsOutstandingMember" id="Fact000130" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,335</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_BorrowingsOutstandingMember" id="Fact000131" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,424</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_BorrowingsOutstandingMember" id="Fact000132" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,636</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_BorrowingsOutstandingMember" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,400</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_BorrowingsOutstandingMember" id="Fact000134" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,118</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_BorrowingsOutstandingMember" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,455</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_BorrowingsOutstandingMember" id="Fact000136" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,513</ix:nonFraction></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_BorrowingsOutstandingMember" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,196</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="width: 97%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on average shares outstanding.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based on Common Share NAV is the combination of changes in common share NAV, reinvested dividend income at NAV and reinvested capital gains distributions at NAV, if any. The last dividend declared in the period, which is typically paid on the first business day of the following month, is assumed to be reinvested at the ending NAV. The actual reinvest price for the last dividend declared in the period may often be based on the Fund&#8217;s market price (and not its NAV), and therefore may be different from the price used in the calculation. Total returns are not annualized. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based on Common Share Price is the combination of changes in the market price per share and the effect of reinvested dividend income and reinvested capital gains distributions, if any, at the average price paid per share at the time of reinvestment. The last dividend declared in the period, which is typically paid on the first business day of the following month, is assumed to be reinvested at the ending market price. The actual reinvestment for the last dividend declared in the period may take place over several days, and in some instances may not be based on the market price, so the actual reinvestment price may be different from the price used in the calculation. Total returns are not annualized. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Net Investment Income (Loss) ratios reflect income earned and expenses incurred on assets attributable to preferred shares and/or borrowings and/or reverse repurchase agreements, where applicable.<br/>
&#9679; Each ratio includes the effect of all interest expenses paid and other costs related to preferred shares and/or borrowings and/or reverse repurchase agreements, where applicable, as follows:</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">Ratios of Interest<br/> Expense to Average<br/> Net Assets<br/> Applicable to<br/> Common Shares</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration: underline">Year Ended 12/31:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2.41</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.46</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.59</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.19</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2017</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.78</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2016</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.66</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2015</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 3%; font-size: 10pt"><span id="xdx_F0B_zNOv5XQWxfwg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="vertical-align: top; width: 97%; font-size: 10pt"><span id="xdx_F1B_zzcg1yVLX4Z7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000138" xml:lang="en-US">Aggregate Amount Outstanding: Aggregate amount outstanding represents the principal amount outstanding or liquidation preference as of the end of the relevant fiscal year.</ix:footnote></span></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt"><span id="xdx_F0C_zeThzNlYJBtd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span id="xdx_F1F_z7E38LSOyCXj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000139" xml:lang="en-US">Asset Coverage Per $1,000: Asset coverage per $1,000 is calculated by subtracting the Fund&#8217;s liabilities and indebtedness not represented by senior securities from the Fund&#8217;s total assets, dividing the result by the aggregate amount of the Fund&#8217;s senior securities representing indebtedness then outstanding (if applicable), plus the aggregate of the involuntary liquidation preference of the outstanding preferred shares, if applicable, and multiplying the result by 1,000.</ix:footnote></span></td>
    </tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000141" name="cef:SharePriceTableTextBlock"><p id="xdx_801_ecef--SharePriceTableTextBlock_zdWh8ptpiHr3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_4"></span>TRADING AND NET ASSET VALUE INFORMATION </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 9pt; text-indent: 0.5in"><span style="font-size: 10pt">The
following table shows for the periods indicated: (i) the high and low sales prices for Common Shares reported as of the end of
the day on the NYSE, (ii) the corresponding NAV per share, and (iii) the premium/(discount) to NAV per share at which the Common
Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in
relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount
to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might
be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of
such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion
of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of
these actions, or that share repurchases or tender offers will actually reduce market discount.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_484_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuCHvqTmVXa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_487_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBB8e1Uf9PXd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_48D_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBc5J9RZspIb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_48B_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8NmHmx9pI1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDutwyfxEyp" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_481_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z21wOlRowup7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Closing Market Price per</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">NAV per Common Share on</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Premium/(Discount) on</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Share</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left">Fiscal Quarter Ended</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td></tr>
  <tr id="xdx_419_20250401__20250630_zM9lTEaGmH3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left">June 2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000142" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000143" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.48</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000144" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.53</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000145" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.89</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000146" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.92</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000147" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">10.94</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_419_20250101__20250331_zHWKXhKyUCs" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000148" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000149" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.97</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000151" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.57</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.94</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000153" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.67</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_410_20241001__20241231_zUmRX5EZHbK1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000155" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.94</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000157" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000158" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.02</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000159" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.96</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
    <tr id="xdx_418_20240701__20240930_z0lIAUAyXFvl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000160" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000161" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000162" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000163" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000164" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.09</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000165" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.83</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41F_20240401__20240630_zJHsfptO6WNi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000166" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000167" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000168" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000169" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000170" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.40</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.16</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_411_20240101__20240331_zdvtip8DnOt8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000172" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.92</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000173" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.96</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000174" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000175" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000176" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.37</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000177" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">9.19</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_411_20231001__20231231_zDvjGFQx3mF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000178" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000179" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000180" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000181" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.09</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000182" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">8.52</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000183" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.98</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_414_20230701__20230930_zGHPN2PYxPv9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000184" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.99</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000185" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000186" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000187" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000188" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.13</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000189" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">12.19</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_417_20230401__20230630_zSdPY0UAoHp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000190" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000191" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.65</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000192" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000193" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000194" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">10.53</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000195" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.25</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41F_20230101__20230331_zfU4zFoXq7j7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000196" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.62</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000197" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.67</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000198" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.55</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000199" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000200" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.86</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000201" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.23</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">The
net asset value per Common Share, the market price, and percentage of premium/(discount) to net asset value per Common Share on
August 8, 2025, $<span id="xdx_90D_eus-gaap--NetAssetValuePerShare_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU4lu6AhTKg8"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000202" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.90</ix:nonFraction></span>,
$<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeyPXPR4uDRg"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-08-08_us-gaap_CommonStockMember" id="Fact000203" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.34</ix:nonFraction></span>
and <span id="xdx_90D_ecef--LatestPremiumDiscountToNavPercent_dp_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zl1icWeTPzj1">(<ix:nonFraction name="cef:LatestPremiumDiscountToNavPercent" contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" id="Fact000204" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.03</ix:nonFraction>)</span>%,
respectively. As of August 8, 2025, the Fund had <span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zjXU7y2alWX5"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" id="Fact000205" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,177,393</ix:nonFraction></span>
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556.</span></p>

</ix:nonNumeric><p id="xdx_813_zrj8SjUS4mPc" style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_5"></span>THE FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund is a diversified, closed-end management investment company registered under the
                                         1940 Act. The Fund was organized as a Massachusetts business trust on August 5, 2014
                                         and commenced investment operations on November 24, 2014. The Fund&#8217;s Common Shares
                                         are listed on the NYSE under the symbol &#8220;JGH.&#8221; Preferred Shares and/or Rights
                                         issued by the Fund may also be listed on a securities exchange.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000207" name="cef:OutstandingSecuritiesTableTextBlock"><p id="xdx_802_ecef--OutstandingSecuritiesTableTextBlock_zei1WqnakaNe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The following
provides information about the Fund&#8217;s outstanding Common Shares and Preferred Shares as of August 8, 2025:</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Title of Class</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Authorized</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount&#160;Held<br/>by&#160;the&#160;Fund&#160;or<br/>for
    its Account</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%"><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zNOrXQo0Js73"><ix:nonNumeric contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" escape="true" id="Fact000208" name="cef:OutstandingSecurityTitleTextBlock">Common Shares</ix:nonNumeric></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_908_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSUQBH3uM0Fc"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" id="Fact000209" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zOOS0BO3oyAi"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember" id="Fact000210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,177,393</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zPfdigaMtJOi"><ix:nonNumeric contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember" escape="true" id="Fact000211" name="cef:OutstandingSecurityTitleTextBlock">Preferred Shares</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zFEKBtmf8Lx7"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember" id="Fact000212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zw1nn6RIxOKg"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember" id="Fact000213" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_81A_zcrYYkVjI5G2" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_6"></span>USE
 OF PROCEEDS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified in a prospectus supplement, the net proceeds from any offering will be invested in accordance with the Fund&#8217;s
investment objective and policies as stated below. The Fund currently anticipates that it will be able to invest substantially
all of the net proceeds in investments that meet the Fund&#8217;s investment objective and policies within approximately three
months of the receipt of such proceeds. Pending investment, it is anticipated that the proceeds will be invested in short-term
or long-term securities issued by the U.S. Government and its agencies or instrumentalities or in high-quality, short-term money
market instruments.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_7"></span>THE
FUND&#8217;S INVESTMENTS </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000215" name="cef:InvestmentObjectivesAndPracticesTextBlock"><p id="xdx_800_ecef--InvestmentObjectivesAndPracticesTextBlock_zHvGdh4Snm44" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objective and Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221;
as such investment objective and investment policies may be supplemented from time to time, which is incorporated by reference herein,
for a discussion of the Fund&#8217;s investment objective and policies.</span></p> </ix:nonNumeric><p id="xdx_81C_z3KJ9O7pcrO8" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
Composition and Other Information </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Policies&#151;Portfolio Contents,&#8221; as such portfolio
contents may be supplemented from time to time, which is incorporated by reference herein, for a discussion of the investments principally
included in the Fund&#8217;s portfolio. More detailed information about the Fund&#8217;s portfolio investments are contained in the SAI
under &#8220;The Fund&#8217;s Investments.&#8221;</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
                                            Turnover </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Fund may engage in portfolio trading when considered appropriate, but short-term trading
                                         will not be used as the primary means of achieving the Fund&#8217;s investment objective.
                                         For the fiscal year ended December 31, 2024, the Fund&#8217;s portfolio turnover rate was
                                         93%. However, there are no limits on the Fund&#8217;s
                                         rate of portfolio turnover, and investments may be sold without regard to length of time
                                         held when, in Nuveen Asset Management&#8217;s opinion, investment considerations warrant
                                         such action. A higher portfolio turnover rate would result in correspondingly greater
                                         brokerage commissions and other transactional expenses that are borne by the Fund. Although
                                         these commissions and expenses are not reflected in the Fund&#8217;s &#8220;Annual Expenses,&#8221;
                                         they will be reflected in the Fund&#8217;s total return. In addition, high portfolio turnover
                                         may result in the realization of net short-term capital gains by the Fund which, when
                                         distributed to shareholders, will be taxable as ordinary income. See &#8220;Tax Matters.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            investment policies specifically identified in the SAI as such are considered fundamental
                                            and may not be changed without shareholder approval. See &#8220;Investment Restrictions&#8221;
                                            in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="toc780884_8"></span><b>USE
OF LEVERAGE</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                                                           Fund uses leverage to pursue its investment objective. The Fund may use leverage to the extent permitted by the 1940 Act. Accordingly, the Fund
                                                                           may source leverage through a number of methods including the issuance of &#8220;senior securities&#8221; as defined under the 1940 Act. Additionally, the Fund may use certain derivatives and other financing investments that have the economic effect of leverage by creating additional investment exposures, such as investments in inverse floating rate securities and reverse repurchase agreements. See &#8220;Investment Restrictions&#8221; in the SAI. For a discussion of risks, see &#8220;Fund Level and Other Risks&#151;Reverse Repurchase Agreement Risk,&#8221; as such risk
                                                                           is contained in the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal
                                                                           Risks of the Fund&#151;Principal Risks of the Funds.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through borrowings and through the use of reverse repurchase agreements. The Fund has entered into a
364-day revolving line of credit. Interest is charged on these borrowings to the drawn amount at a rate per annum equal to one-month
Term SOFR (&#8220;Secured Overnight Financing Rate&#8221;) plus 0.90%. The Fund also accrued a 0.15% per annum commitment fee based
on the undrawn balance.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may use derivatives, such as interest rate swaps with varying terms, in order to hedge duration risk or manage the interest rate
expense associated with all or a portion of its leverage. Interest rate swaps are bi-lateral agreements whereby parties agree to exchange
future payments, typically based upon the differential of a fixed rate and a variable rate, on a specified notional amount. Interest
rate swaps can enable the Fund to effectively convert its variable leverage expense to fixed, or vice-versa. For example, if the Fund
issues leverage having a short-term floating rate of interest, the Fund could use interest rate swaps to hedge against a rise in the
short-term benchmark interest rates associated with its outstanding leverage. In doing so, the Fund would seek to achieve lower leverage
costs, and thereby enhance Common Share distributions, over an extended period, which would be the result if short-term market interest
rates on average exceed the fixed interest rate over the term of the swap. To the extent the fixed swap rate is greater than short-term
market interest rates on average over the period, overall costs associated with leverage will be greater (and thereby reduce distributions
to Common Shareholders) than if the Fund had not entered into the interest rate swap(s).</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund also may borrow for temporary or emergency purposes as permitted by the 1940 Act. There is not assurance
that the Fund will use leverage. The Fund&#8217;s use of leverage may not work as planned or achieve its goals.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objective, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and composition of the Fund&#8217;s holdings. The Fund&#8217;s leverage ratio will vary from time to time
based upon such changes in the amount of leverage used and variations in the value of the Fund&#8217;s holdings. So long as
the net income received from the Fund&#8217;s investments purchased with leverage proceeds exceeds the then current expense
of any leverage, the investment of the proceeds of leverage will generate more net income than if the Fund had not leveraged
itself. Under these circumstances, the excess net income will be available to pay higher distributions to Common
Shareholders. However, if the net income received from the Fund&#8217;s portfolio investments purchased with the proceeds
of leverage is less than the current expense of any leverage, the Fund may be required to utilize other Fund assets to make
interest or dividend payments on its leveraging instruments which may result in a decline in Common Share NAV and reduced net
investment income available for distribution to Common Shareholders.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, it is anticipated
that the Fund&#8217;s Managed Assets will be greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible
for using leverage to pursue the Fund&#8217;s investment objective. Nuveen Fund Advisors and Nuveen Asset Management will base their
decision regarding whether and how much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether
such use of leverage is in the best interests of the Fund. However, a decision to employ or increase leverage will have the effect, all other things being equal, of increasing Managed Assets and in turn Nuveen Fund Advisors&#8217; and
Nuveen Asset Management&#8217;s management fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest
in determining whether to use or increase leverage, including the use of the Facility. Nuveen Fund Advisors and Nuveen Asset Management
will seek to manage that conflict by using leverage only when they determine that it would be in the best interests of the
Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the Fund&#8217;s
degree of overall use of leverage and the impact of the use of leverage on that performance.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
 1940 Act generally defines a &#8220;senior security&#8221; as any bond, debenture, note, or similar obligation or instrument constituting
 a security and evidencing indebtedness, and any stock of a class having priority over any other class as to distribution of assets or
 payment of dividends; however, the term does not include any promissory note or other evidence of indebtedness issued in consideration
 of any loan, extension, or renewal thereof, made for temporary purposes and in an amount not exceeding five percent of the value of
 the Fund&#8217;s total assets. A loan shall be presumed to be for temporary purposes if it is repaid within 60 days and is not extended
 or renewed. Accordingly, &#8220;senior securities&#8221; include (i) the issuance of Preferred Shares; (ii) certain borrowings (including certain loans from financial
institutions); and (iii) the issuance of debt securities.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred Shares if, immediately after the
issuance of Preferred Shares, the asset coverage ratio with respect to such Preferred Shares would be less than 200%. With respect to
any such Preferred Shares, asset coverage means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness
not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the
aggregate liquidation preference of such Preferred Shares.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities representing indebtedness&#8221; if, immediately after the
issuance of such senior securities representing indebtedness, the asset coverage ratio with respect to such senior securities would
be less than 300%. &#8220;Senior securities representing indebtedness&#8221; include certain borrowings (including certain loans
from financial institutions) and debt securities. &#8220;Senior securities representing indebtedness&#8221; may also include other
investments or transactions in accordance with the 1940 Act, such as reverse repurchase agreements or similar financing transactions depending upon their treatment under Rule 18f-4 of the 1940
Act. In accordance with Rule 18f-4 under the 1940 Act, when the Fund engages in reverse repurchase agreements or similar financing transactions,
such as transactions in inverse floating rate securities, the Fund may either (i) maintain asset coverage in accordance with Section 18
of the 1940 Act with respect to such transactions and any other senior securities, including Preferred Shares and borrowings, or (ii)
treat such transactions as &#8220;derivatives transactions&#8221; and comply with Rule 18f-4 with respect to such transactions. With respect to any such senior securities representing debt, asset
coverage means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by
senior securities (as defined in the 1940 Act), bears to the aggregate amount of such borrowing represented by senior securities
issued by the Fund.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund issues senior securities and the asset coverage with respect to such senior securities declines below the required ratios discussed
above (as a result of market fluctuations or otherwise), the Fund may sell portfolio securities when it may be disadvantageous to do
so.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of leverage used by the Fund may result in the Fund being subject to certain covenants, asset coverage or other portfolio composition
limits by its lenders, debt or preferred securities purchasers, rating agencies that may rate the debt or preferred securities, or reverse
repurchase counterparties. Such limitations may be more stringent than those imposed by the 1940 Act and may impact whether the Fund
is able to maintain its desired amount of leverage. At this time Nuveen Fund Advisors does not believe that any such potential investment
limitations will impede it from managing the Fund&#8217;s portfolio in accordance with its investment objective and policies.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilization
of leverage is a speculative investment technique and involves certain risks to the Common Shareholders, including increased variability
of the Fund&#8217;s net income, distributions and NAV in relation to market changes. See &#8220;Leverage Risk,&#8221; as such risk is
contained in the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#8212;Current
Investment Objective, Investment Policies and Principal Risks of the Fund&#8212;Principal Risks of the Funds&#8212;Fund Level and Other
Risks.&#8221; There is no assurance that the Fund will use leverage or that the Fund&#8217;s use of leverage will work as planned or
achieve its goals.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000217" name="cef:EffectsOfLeverageTextBlock"><p id="xdx_805_ecef--EffectsOfLeverageTextBlock_zyCmkKFzT6E3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Effects of Leverage </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a>
on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks of the Fund&#151;Effects of Leverage,&#8221; as such may be supplemented from time to time, which is incorporated by
reference herein, for a discussion of the effects of leverage.</p>

</ix:nonNumeric><p id="xdx_815_zM54WhcvbaG7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000219" name="cef:RiskFactorsTableTextBlock"><p id="xdx_80A_ecef--RiskFactorsTableTextBlock_zgI7h8CAncd8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_9"></span>RISK
 FACTORS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                            is inherent in all investing. Investing in any investment company security involves risk,
                                            including the risk that you may receive little or no return on your investment or even that
                                            you may lose part or all of your investment. Please refer to the section of the Fund&#8217;s
                                            most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
                                            Objective, Investment Policies and Principal Risks of the Fund&#151;Principal Risks of
                                            the Funds,&#8221; as such principal risks may be supplemented from time to time, which is
                                            incorporated by reference herein, for a discussion of the principal risks you should consider
                                            before making an investment in the Fund. Any additional risks applicable to a particular offering
                                            of Securities will be set forth in the related prospectus supplement.</span></p> </ix:nonNumeric><p id="xdx_816_zrxgozvp3nRi" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_10"></span>MANAGEMENT
                                            OF THE FUND </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trustees
                                            and Officers </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board of Trustees is responsible for the management of the Fund, including supervision of
                                            the duties performed by Nuveen Fund Advisors and Nuveen Asset Management. The names and business
                                            addresses of the trustees and officers of the Fund and their principal occupations and other
                                            affiliations during the past five years are set forth under &#8220;Management of the Fund&#8221;
                                            in the SAI.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
                                            Adviser, Sub-Adviser and Portfolio Managers </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Adviser.</i>&#160;Nuveen Fund Advisors, LLC, the Fund&#8217;s investment adviser, is responsible for overseeing the Fund&#8217;s
overall investment strategy and implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad
range of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the
management of the Fund&#8217;s portfolio, manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and
other administrative services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund
Advisors is an indirect subsidiary of Nuveen, the investment management arm of TIAA. TIAA is a life insurance company founded
in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College Retirement Equities
Fund. As of June 30, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately
$151.1 billion was managed by Nuveen Fund Advisors.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sub-Adviser.</i>&#160;Nuveen
Asset Management, LLC, located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s sub-adviser pursuant to a
sub-advisory agreement between Nuveen Fund Advisors and Nuveen Asset Management (the &#8220;Sub-Advisory Agreement&#8221;). Nuveen Asset
Management, a registered investment adviser, is a wholly owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees day-to-day
investment operations of the Fund. Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management is compensated for the services it
provides to the Fund with a portion of the management fee Nuveen Fund Advisors receives from the Fund. Nuveen Fund Advisors and Nuveen
Asset Management retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Portfolio
                                         Managers.</i> Nuveen Asset Management is responsible for the execution of specific investment
                                         strategies and day-to-day investment operations of the Fund. Nuveen Asset Management
                                         manages the Nuveen funds using a team of analysts and portfolio managers that focuses
                                         on a specific group of funds. The day-to-day operation of the Fund and the execution
                                         of its specific investment strategies is the primary responsibility of Katherine Renfrew, John Espinosa, Brenda A. Langenfeld, CFA, James Kim, and Mark Zheng, CFA, the designated portfolio managers of the Fund. Mses. Langenfeld and Renfrew and Mr. Espinosa have served as
portfolio managers of the Fund since March 2023, and Messrs. Kim and Zheng have served as portfolio managers of the Fund since February
2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Katherine Renfrew&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and the sector lead for emerging markets corporates and quasi-sovereigns and all developed market quasi-sovereigns.
She is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team and serves as a lead and&#160;co-portfolio&#160;manager
across Nuveen&#8217;s suite of emerging markets debt strategies. Katherine joined the firm in 1997 and has held several roles relating
to emerging markets debt including South American regional analyst, trader, manager for the firm&#8217;s investments in Eastern Europe,
Middle East and Africa (EMEA) regions, and Asian and EMEA regional analyst. Prior to joining the firm, she was a fixed income securities
analyst at MONY Capital Management and a financial analyst at Mattel Toys.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">John Espinosa&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and is the sector lead for sovereigns. He also oversees all investment research across Nuveen&#8217;s global
fixed income and is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team. John serves as a lead
and&#160;co-portfolio&#160;manager across Nuveen&#8217;s suite of emerging markets debt and&#160;non-U.S.&#160;developed fixed income
strategies. John is a member of the Investment Committee, which establishes investment policy for all global fixed income products. John
has nearly two decades of fixed income investment industry experience and previously managed the organization&#8217;s global sovereign
and emerging markets debt research teams. John joined the firm in 2004 as a quantitative analyst and associate portfolio manager for the
CREF Bond Total Return strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Brenda A. Langenfeld, CFA, is a portfolio manager for Nuveen&#8217;s
global fixed income team and a member of the preferred securities sector team. She is the lead manager for Nuveen&#8217;s preferred and
income-focused&#160;closed-end&#160;funds and portfolio manager of the Preferred Securities and Income strategy. She joined the preferred
securities sector team in 2011. Brenda has been a&#160;co-manager&#160;for the Real Asset Income strategy since 2015, which invests in
income generating debt and equity securities from both the real estate and infrastructure segments. In 2020 she became&#160;co-manager&#160;of
the Credit Income strategy. Prior to her portfolio management roles, Brenda was a member of the high-grade credit sector team, responsible
for trading corporate bonds. Previously, she was a member of the securitized debt sector team, trading mortgage-backed securities, asset-backed
securities and commercial mortgage-backed securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">James Kim&#160;is a portfolio manager for Nuveen&#8217;s leveraged
finance team with a focus on the management of high yield mandates. James is the lead manager of the High Yield Income strategy and a&#160;co-manager&#160;on
the High Yield, Real Asset Income and Credit Income strategies. He is also head of special situations, leading workouts and opportunistic
investing for the leveraged finance platform. Previously, James was&#160;co-head&#160;of global fixed income research and head of the
leveraged finance research team, overseeing its daily investment process. He also served as the&#160;co-head&#160;of research at Nuveen
affiliate Symphony Asset Management, leading the firm&#8217;s research team, daily investment process and opportunistic investments across
its various mandates. Prior to this, he was a distressed generalist and an industry analyst responsible for a number of different industries,
including energy, power, metals&#160;&amp; mining and chemicals, providing long and short ideas across the capital structure. Prior to
joining the firm, James was an associate at Greywolf Capital in its special situations group and an analyst at Watershed Asset Management.
He began his career at Goldman Sachs, as an investment banking analyst both in the Strategy Group and Energy&#160;&amp; Power Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Mark Zheng, CFA, is a portfolio manager for Nuveen, focused on Multi-Sector
portfolio management. He is currently lead manager of a diversified, total return component portfolio for the CREF Real Estate Account.
He is also a&#160;co-manager&#160;for the Stable Value Account. Mark is a member of the Core and Core-Plus Strategy teams. Mark provides
strategic and quantitative analysis across a broad set of Multi-Sector Fixed Income strategies incorporating emerging markets, mortgage-backed
securities, high yield bond and loans and&#160;non-agency&#160;structured products. Since joining the firm in 2010, he has held several
positions, including&#160;co-manager&#160;of fixed income ETFs. He also served as a research analyst for investments in mortgage-backed
securities and as a business analyst for fixed income business applications. Prior to working in the financial services industry, Mark
worked in the engineering industry, providing consulting services for global pharmaceutical, chemical, and manufacturing firms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Portfolio Managers&#8217; compensation, other accounts managed by the Portfolio Managers and the Portfolio
Managers&#8217; ownership of securities in the Fund is provided in the SAI. The SAI is available free of charge by calling (800) <span style="white-space: nowrap">257-8787</span> or by visiting the Fund&#8217;s website at www.nuveen.com. The
information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus or the SAI, except to the extent specifically incorporated by reference herein or in the SAI. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Investment Management and <span style="white-space: nowrap">Sub-Advisory</span>
Agreements </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Investment Management
Agreement.</i>&#8195;Pursuant to an investment management agreement between Nuveen Fund Advisors and the Fund (the &#8220;Investment Management Agreement&#8221;), the Fund has agreed to pay an annual management fee for the services and facilities
provided by Nuveen Fund Advisors, payable on a monthly basis, based on the sum of a fund-level fee and a complex-level fee, as described below. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Fund-Level Fee.</i>&#8195;The annual fund-level fee for the Fund, payable monthly, is calculated according to the following schedule: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">


<tr>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                         Daily Managed Assets*</b></span></p></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fund Level</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fee Rate</b></span></span></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>


<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 86%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the first $500 million</span></p></td>
<td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 10%">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.7000%</span></td>
<td style="white-space: nowrap; vertical-align: bottom; width: 1%"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.6750%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.6500%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-size: 10pt">.6250%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                managed assets over $2 billion</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-size: 10pt">.6000%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Complex-Level
Fee.</i>&#8195;The overall complex-level fee, payable monthly, begins at a maximum rate of 0.1600% of the Fund&#8217;s
average daily managed assets, with breakpoints for eligible complex-level assets above $124.3 billion. Therefore, the maximum management
fee rate for the Fund is the Fund-level fee plus 0.1600%. The current overall complex-level fee schedule is as follows:</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Asset Breakpoint Level*</b></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Fee</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the first $124.3 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1600%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $75.7 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1350%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $200 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1325%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For eligible assets over $400 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1300%</td></tr>
  </table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">*</td>
<td style="text-align: left; vertical-align: top">See &#8220;Investment Adviser, Sub-Adviser and Portfolio Managers&#8221; in the
SAI for more detailed information about the complex-level fee and eligible complex-level assets.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As
                                         of June 30, 2025, the complex-level fee rate for the Fund was 0.1569%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In addition to the fee of Nuveen Fund Advisors, the Fund pays all other
costs and expenses of its operations, including compensation of its trustees (other than those affiliated with Nuveen Fund Advisors and Nuveen Asset Management), custodian, transfer agency and dividend disbursing expenses, legal fees, expenses of
independent auditors, expenses of repurchasing shares, expenses associated with any borrowings, expenses of issuing any Preferred Shares, expenses of preparing, printing and distributing shareholder reports, notices, proxy statements and reports to
governmental agencies, and taxes, if any. All fees and expenses are accrued daily and deducted before payment of dividends to investors. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board of Trustees&#8217; most recent approval of the Investment Management Agreement for the Fund may be found in
the Fund&#8217;s semi-annual report to shareholders dated June 30, 2024.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Sub-Advisory
Agreement. </i>Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management will receive from Nuveen Fund Advisors a management
fee equal to 44.4444% of Nuveen Fund Advisors&#8217; net management fee from the Fund. Nuveen Fund Advisors and Nuveen Asset Management
retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board&#8217;s most recent decision to approve the Sub-Advisory Agreement for the Fund may be found in the
Fund&#8217;s semi-annual report to shareholders dated June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control Persons and Principal Holders of Common Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as noted below in the table, to the Fund&#8217;s knowledge,
no persons own of record or beneficially, five percent or more of any class of shares of the Fund as of July 31, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8192;Class</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Name and Address</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of<br/>
    Shares Owned</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
    Owned</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Shares</span></td>
    <td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 43%"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">McGowan
    Group Asset Management,&#160;Inc.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200
    Crescent Court</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
    657</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
    TX 75201</span></p></td>
    <td style="vertical-align: bottom; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,706,721</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.99%</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Trust Portfolios L.P.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Trust Advisors L.P.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Charger Corporation</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120
    East Liberty Drive, Suite 400</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wheaton,
    IL 60187</span></p></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,180,236</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.41%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_11"></span>NET ASSET VALUE </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund&#8217;s NAV per Common Share is determined
as of the close of trading (normally 4:00 p.m. Eastern time) on each day the NYSE is open for business. NAV is calculated by taking the
market value of the Fund&#8217;s total assets, less all liabilities, and dividing by the total number of Common Shares outstanding. The
result, rounded to the nearest cent, is the NAV per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund utilizes independent pricing services approved
by its valuation designee to value portfolio instruments at their market value. Independent pricing services typically value non-equity
portfolio instruments utilizing a range of market-based inputs and assumptions, including readily available market quotations obtained
from broker-dealers making markets in such instruments, cash flows and transactions for comparable instruments. In pricing certain securities,
particularly less liquid and lower quality securities, the pricing services may consider information about a security, its issuer or market
activity provided by Nuveen Fund Advisors or Nuveen Asset Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The valuations for fixed-income securities and certain
derivative instruments are typically the prices supplied by independent third party pricing services, which may use market prices or broker/dealer
quotations or a variety of fair valuation techniques and methodologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Specific types of investments are valued as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="padding-bottom: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collateralized Loan Obligations (&#8220;CLOs&#8221;). The
Fund generally uses non-binding indicative prices provided by independent pricing service(s) and/or broker(s) as the primary basis for
determining the value of the CLOs, which may be adjusted for pending distributions, as applicable, as of the applicable valuation date.
These prices are non-binding and may not be determinative of an actual transaction price. In valuing the Fund&#8217;s CLO holdings, Nuveen
Fund Advisors may also consider a variety of other factors it deems relevant, including recent trading prices for specific investments,
recent purchases and sales known to the Fund in similar securities, other information known to the Fund relating to the securities, and
discounted cash flows based on output from a third-party financial model, using projected future cash flows.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Investments. For non-U.S. traded investments whose
principal local markets close before the close of the NYSE, the Fund may adjust the local closing price based upon such factors as developments
in non-U.S. markets, the performance of U.S. securities markets and the performance of instruments trading in U.S. markets that represent
non-U.S. investments. The Fund may rely on an independent fair valuation service in making any such fair value determinations. If the
Fund holds portfolio instruments that are primarily listed on non-U.S. exchanges, the value of such instruments may change on days when
the Fund&#8217;s NAV is calculated.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If a price cannot be obtained from a pricing service
or other pre-approved source, or if the Fund&#8217;s valuation designee deems such price to be unreliable, or if a significant event occurs
after the close of the local market but prior to the time at which the Fund&#8217;s NAV is calculated, a portfolio instrument will be
valued at its fair value as determined in good faith by the Fund&#8217;s valuation designee. The Fund&#8217;s valuation designee may determine
that a price is unreliable in various circumstances. For example, a price may be deemed unreliable if it has not changed for an identified
period of time, or has changed from the previous day&#8217;s price by more than a threshold amount, and recent transactions and/or broker
dealer price quotations differ materially from the price in question.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Board of Trustees has designated Nuveen Fund Advisors
as the Fund&#8217;s valuation designee pursuant to Rule 2a-5 under the 1940 Act and delegated to Nuveen Fund Advisors the day-to-day responsibility
of making fair value determinations. All fair value determinations made by Nuveen Fund Advisors are subject to review by the Board of
Trustees. As a general principle, the fair value of a portfolio instrument is the amount that an owner might reasonably expect to receive
upon the instrument&#8217;s current sale. A range of factors and analysis may be considered when determining fair value, including relevant
market data, interest rates, credit considerations and/or issuer specific news. However, fair valuation involves subjective judgments,
and it is possible that the fair value determined for a portfolio instrument may be materially different from the value that could be
realized upon the sale of that instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_12"></span>DISTRIBUTIONS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund pays
regular monthly cash distributions to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution
rate which may be set from time to time). The Fund intends to distribute all or substantially all of its net investment income
each year through its regular monthly distributions and to distribute realized capital gains at least annually. In addition, in
any monthly period, to maintain its declared per common share distribution amount, the Fund may distribute more or less than its
net investment income during the period. In the event the Fund distributes more than its net investment income during any yearly
period, such distributions may also include realized gains and/or a return of capital.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent that a distribution includes a return of capital the NAV per share may erode. A return of capital may occur, for example, when
some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund&#8217;s investment performance and should not be confused with &#8220;yield&#8221; or &#8220;income.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund&#8217;s distribution includes anything other than net investment income, the Fund will
provide a notice to Common Shareholders of its best estimate of the distribution sources at the time of the distribution. These estimates may not match the final tax characterization (for the full year&#8217;s distributions) contained in the Common
Shareholders&#8217; <span style="white-space: nowrap">1099-DIV</span> forms after the end of the year. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">While the Fund intends to distribute all realized capital gains at least annually, the Fund may elect to retain all or a portion of any net
capital gain (which is the excess of net long-term capital gain over net short-term capital loss) otherwise allocable to Common Shareholders and pay U.S. federal income tax on the retained gain. As provided under U.S. federal income tax law, Common
Shareholders of record as of the end of the Fund&#8217;s taxable year will include their share of the retained net capital gain in their income for the year as a long-term capital gain (regardless of their holding period in the common shares), and
will be entitled to an income tax credit or refund for the federal income tax deemed paid on their behalf by the Fund. If the Fund&#8217;s total distributions during a given year is an amount that exceeds the Fund&#8217;s current and accumulated
earnings and profits, the excess would be treated by Common Shareholders as return of capital for federal income tax purposes to the extent of the Common Shareholder&#8217;s basis in their shares and thereafter as capital gain. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Distributions
                                         will be reinvested in additional shares under the Fund&#8217;s Dividend Reinvestment Plan
                                         unless a shareholder elects to receive cash. The Fund reserves the right to change its
                                         distribution policy and the basis for establishing the rate of its monthly distributions
                                         at any time and may do so without prior notice to Common Shareholders.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_13"></span>DIVIDEND REINVESTMENT PLAN </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Dividend
Reinvestment Plan,&#8221; which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment plan. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_14"></span>PLAN OF DISTRIBUTION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to time on an immediate, continuous or delayed basis, in one or more offerings under this
Prospectus and a related prospectus supplement, on terms to be determined at the time of the offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through dealers or agents that the
Fund designates from time to time, or through a combination of these methods. Sales of Securities may be made in transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended (the
&#8220;1933 Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any offering of Securities will describe the terms of such offering, including, as applicable: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the names of any agents, underwriters or dealers; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any sales loads, underwriting discounts and commissions or agency fees and
other items constituting underwriters&#8217; or agents&#8217; compensation;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any discounts, commissions, fees or concessions allowed or reallowed or paid to dealers or agents; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the public offering or purchase price of the offered Securities, the estimated net proceeds the Fund will receive from the sale and the use of proceeds; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any securities exchange on which the offered Securities may be listed. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any Rights offering will set forth the number of Common Shares issuable upon the exercise of each Right
(or number of Rights) and the other terms of such Rights offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Direct Sales </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities directly to, and solicit offers from, institutional investors or others who may be deemed to be
underwriters as defined in the 1933 Act for any resales of Securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the Internet, to sell offered Securities directly. The Fund will describe
the terms of any of those sales in a prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Agents </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities through an agent or agents
designated by the Fund from time to time. An agent may sell Securities it has purchased from the Fund as principal to other dealers for resale to investors and other purchasers, and may reallow all or any portion of the discount received in
connection with the purchase from the Fund to the dealers. After the initial offering of Securities, the offering price (in the case of Securities to be resold at a fixed offering price), the concession and the discount may be changed. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Underwriters </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If any underwriters are involved in the offer and sale of Securities,
such Securities will be acquired by the underwriters and may be resold by them, either at a fixed public offering price established at the time of offering or from time to time in one or more negotiated transactions or otherwise, at prices related
to prevailing market prices determined at the time of sale. Unless otherwise set forth in the applicable prospectus supplement, the obligations of the underwriters to purchase Securities will be subject to conditions precedent and the underwriters
will be obligated to purchase all Securities described in the prospectus supplement if any are purchased. Any initial public offering price and any discounts or concessions allowed or <span style="white-space: nowrap">re-allowed</span> or paid to
underwriters may be changed from time to time. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with
an offering of Common Shares, if a prospectus supplement so indicates, the Fund may grant the underwriters an option to purchase additional Common Shares at the public offering price, less the underwriting discounts and commissions, within 45 days
from the date of the prospectus supplement, to cover any overallotments. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By
Dealers </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to
time through one or more dealers who would purchase the securities as principal. The dealers then may resell the offered Securities to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set
forth the names of the dealers and the terms of the transaction in the prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>General </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any underwriters, dealer or agent participating in an offering of Securities may be deemed to be an &#8220;underwriter,&#8221; as that term is
defined in the 1933 Act, of Securities so offered and sold, and any discounts and commission received by them, and any profit realized by them on resale of the offered Securities for whom they act as agent, may be deemed to be underwriting discounts
and commissions under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, dealers and
agents may be entitled, under agreements entered into with the Fund, to indemnification by the Fund against some liabilities, including liabilities under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer to sell Securities either at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated prices. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To facilitate an offering of Common Shares in an underwritten transaction and in accordance with industry practice, the underwriters may engage
in transactions that stabilize, maintain, or otherwise affect the market price
of the Common Shares or any other Security. Those transactions may include overallotment, entering stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions
allowed to an underwriter or a dealer. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An overallotment in connection with an offering creates a short position in the Common Shares for the underwriter&#8217;s own account. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing, or maintaining the price of the Common Shares. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the price of the Common Shares by bidding for, and purchasing, the Common Shares or any other Securities in the open
market in order to reduce a short position created in connection with the offering. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering when the Common Shares originally sold by the syndicate member are purchased in
syndicate covering transactions or otherwise. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any of
these activities may stabilize or maintain the market price of the Securities above independent market levels. Underwriters are not required to engage in these activities and may end any of these activities at any&#160;time. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any Rights offering, the Fund may also enter into a
standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s) will purchase Common Shares remaining unsubscribed for after the Rights offering. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unless otherwise indicated in the prospectus supplement, each series of
offered Preferred Shares will be a new issue of securities for which there currently is no market. Any underwriters to whom Preferred Shares are sold for public offering and sale may make a market in such Preferred Shares as permitted by applicable
laws and regulations, but such underwriters will not be obligated to do so, and any such market making may be discontinued at any time without notice. Accordingly, there can be no assurance as to the development or liquidity of any market for the
Preferred Shares. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, agents and dealers may engage in
transactions with or perform services, including various investment banking and other services, for the Fund and/or any of the Fund&#8217;s affiliates in the ordinary course of business. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The maximum amount of compensation to be received by any Financial
Industry Regulatory Authority (&#8220;FINRA&#8221;) member or independent broker-dealer will not exceed the applicable FINRA limit for the sale of any securities being offered pursuant to Rule 415 under the Securities Act. We will not pay any
compensation to any underwriter or agent in the form of warrants, options, consulting or structuring fees or similar arrangements. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent permitted under the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time act as
a broker or dealer and receive fees in connection with the execution of the Fund&#8217;s portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an
underwriter. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A prospectus and accompanying prospectus supplement
in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of Securities for sale to their online brokerage account holders. Such allocations of Securities for Internet
distributions will be made on the same basis as other allocations. In addition, Securities may be sold by the underwriters to securities dealers who resell Securities to online brokerage account holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <ix:nonNumeric contextRef="AsOf2025-08-15" escape="true" id="Fact000221" name="cef:CapitalStockTableTextBlock"><p id="xdx_801_ecef--CapitalStockTableTextBlock_zBFtFcuzIDH9" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="toc780884_15"></span>DESCRIPTION OF SHARES </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Common Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
Declaration of Trust authorizes the issuance of an unlimited number of Common Shares. The Common Shares have a par value of $0.01 per
share and, subject to the rights of holders of any Preferred Shares, have equal rights to the payment of dividends and the distribution
of assets upon liquidation. The Common Shares when issued, are fully paid and, subject to matters discussed in &#8220;Certain Provisions
in the Declaration of Trust and By-Laws,&#8221; non-assessable, and have no preemptive or conversion rights or rights to cumulative voting.
A copy of the Declaration of Trust is filed with the SEC as an exhibit to the Fund&#8217;s registration statement of which this Prospectus
is a part.&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span id="xdx_90D_ecef--SecurityVotingRightsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zChXo54FbiDf"><ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_CommonStockMember" escape="true" id="Fact000222" name="cef:SecurityVotingRightsTextBlock">Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#8217;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.</ix:nonNumeric></span> <span id="xdx_907_ecef--SecurityDividendsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsp5KmGlzEGe"><ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_CommonStockMember" escape="true" id="Fact000223" name="cef:SecurityDividendsTextBlock">Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#8220;&#151;Preferred Shares&#8221; below.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Common Shares
are listed on the NYSE and trade under the ticker symbol &#8220;JGH.&#8221; The Fund intends to hold annual meetings of shareholders
so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such
listing. The Fund does not issue share certificates.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unlike open-end funds, closed-end funds like the Fund do not provide
daily redemptions. Rather, if a shareholder determines to buy additional Common Shares or sell shares already held, the shareholder may conveniently do so by trading on the exchange through a broker or otherwise. Common shares of closed-end
investment companies may frequently trade on an exchange at prices lower than NAV. Common shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and have during other periods traded at
prices lower than NAV. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), call protection, dividend stability, portfolio credit quality, NAV, relative demand for and supply of such shares in the market, general market
and economic conditions, and other factors beyond the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than NAV in the future. The Common Shares are designed primarily for long-term
investors, and investors in the Common Shares should not view the Fund as a vehicle for trading purposes. See &#8220;Repurchase of Fund Shares; Conversion to Open-End Fund.&#8221; </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Preferred Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund&#8217;s Declaration of Trust authorizes the issuance of an unlimited number of Preferred
                                         Shares in one or more classes or series, with rights as determined by the Board of Trustees,
                                         by action of the Board of Trustees without the approval of the Common Shareholders. The Fund currently has no Preferred Shares outstanding. The discussion below generally describes the rights of the
                                         holders of Preferred Shares, although the terms of any Preferred Shares that
                                         may be issued by the Fund may be the same as, or different from, the terms described
                                         below, subject to the applicable Statement, applicable law and the Declaration of Trust.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>


<ix:exclude><!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><h5 id="xdx_23E_z3g9mUffo05e" style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5></ix:exclude>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Under
                                            the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred
                                            Shares if, immediately after the issuance of Preferred Shares, the asset coverage ratio would
                                            be less than 200%. See &#8220;Use of Leverage.&#8221; Additionally, the Fund will generally
                                            not be permitted to purchase any of its Common Shares or declare dividends (except a dividend
                                            payable in Common Shares) or other distributions on its Common Shares unless, at the time
                                            of such purchase or declaration, the asset coverage ratio with respect to such Preferred
                                            Shares, after taking into account such purchase or distribution, is at least 200%. Preferred
                                            Shares issued by the Fund have priority over the Common Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">For so long as any Preferred Shares are outstanding, the Fund will not:
(1) declare or pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares) in respect of the Common Shares, (2) call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares,
or (3) pay any proceeds of the liquidation of the Fund in respect of the Common Shares, unless, in each case, (A) immediately thereafter, the Fund shall be in compliance with the 200% asset coverage limitations set forth under the 1940 Act after
deducting the amount of such dividend or other distribution or redemption or purchase price or liquidation proceeds and (B) all cumulative dividends and other distributions of shares of all series of Preferred Shares of the Fund due on or prior to
the date of the applicable dividend, distribution, redemption, purchase or acquisition shall have been declared and paid. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember" escape="true" id="Fact000226" name="cef:SecurityDividendsTextBlock"><p id="xdx_843_ecef--SecurityDividendsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zm6RpaeqHXCk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Dividends and Distributions and Priority of Payment</i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund issues Preferred Shares, the Fund&#8217;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember" escape="true" id="Fact000228" name="cef:SecurityLiquidationRightsTextBlock"><p id="xdx_84C_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWlL7ZRXLuTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Liquidation Preference </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember" escape="true" id="Fact000230" name="cef:SecurityVotingRightsTextBlock"><p id="xdx_84D_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zoIdSC74EcR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Voting Rights </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the election of the Fund&#8217;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#8217;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#8217; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#8217;s trustees until all dividends in arrears have been paid or declared and set apart for payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<ix:exclude><!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><h5 id="xdx_23A_z8CKlmJuDlak" style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5></ix:exclude>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#8217;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#8217;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#8217;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#8217;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#8220;Investment Restrictions&#8221; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> </ix:nonNumeric><ix:nonNumeric contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember" escape="true" id="Fact000233" name="cef:PreferredStockRestrictionsOtherTextBlock"><p id="xdx_84C_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zTYhDHWW3yQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Redemption, Purchase and Sale of Preferred Shares </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.</p>

</ix:nonNumeric><p id="xdx_855_zRG6NWYQWhU" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><p id="xdx_814_z1O38xUY37D2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_16"></span>RIGHTS OFFERINGS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund may in the future, and at its discretion, choose to make offerings of Rights to
                                         its shareholders to purchase Common Shares. Rights may be issued independently or together
                                         with any other offered security and may or may not be transferable by the person purchasing
                                         or receiving the rights. In connection with a Rights offering to shareholders, the Fund
                                         would distribute certificates or other documentation evidencing the Rights and a prospectus
                                         supplement to the Fund&#8217;s shareholders as of the record date that the Fund sets for
                                         determining the shareholders eligible to receive Rights in such Rights offering. Any
                                         such future Rights offering will be made in accordance with the 1940 Act and, to the
                                         extent such Rights are transferable, will comply with applicable interpretations of the
                                         SEC or its staff, as such interpretations may be modified in the future, which currently
                                         require that: (i) the Fund&#8217;s Board of Trustees make a good faith determination that
                                         such offering would result in a net benefit to existing shareholders; (ii) the offering
                                         fully protects shareholders&#8217; preemptive rights and does not discriminate among shareholders
                                         (except for the possible effect of not offering fractional rights); (iii) management
                                         uses its best efforts to ensure an adequate trading market in the Rights for use by shareholders
                                         who do not exercise such Rights; and (iv) the ratio of such transferable Rights offering
                                         does not exceed one new share for each three rights held.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The applicable prospectus supplement would describe the following terms
of the Rights (to the extent each is applicable) in respect of which this Prospectus is being delivered: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the period of time the offering would remain open; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the underwriter or distributor, if any, of the Rights and any associated underwriting fees or discounts applicable to purchases of the Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the title of such Rights; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the exercise price for such Rights (or method of calculation thereof); </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of such Rights issued in respect of each share; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of Rights required to purchase a single share;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights are transferable and the market on which they may be traded if they are transferable; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if such Rights are transferable, a discussion regarding
the Board of Trustees&#8217; basis for determining that such offering would result in a net benefit to existing shareholders;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the date on which the right to exercise such Rights will commence, and the date on which such right will expire (subject to any extension); </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">termination rights the Fund may have in connection with such Rights offering;
and</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any other terms of such Rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such Rights. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A certain number of Rights would entitle the holder of the Right(s) to
purchase for cash such number of shares at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the Rights offered thereby. Rights would be exercisable at any time up to the
close of
business on the expiration date for such Rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised Rights would become void. Upon
expiration of the Rights offering and the receipt of payment and the Rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the Rights agent, or any other office
indicated in the prospectus supplement, the Common Shares purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered
securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_17"></span>CERTAIN PROVISIONS IN THE DECLARATION OF
TRUST AND <span style="white-space: nowrap">BY-LAWS</span> </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General</i>. The By-laws of the Fund provide that by becoming a shareholder of the Fund, each shareholder shall be deemed to have agreed to
be bound by the terms of the Declaration of Trust and By-laws. However, neither the Declaration of Trust nor the By-laws purport to require the waiver of a shareholder&#8217;s rights under the federal securities laws. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Shareholder and Trustee Liability</i>. Under Massachusetts law,
shareholders could, under certain circumstances, be held personally liable for the Fund&#8217;s obligations. However, the Declaration of Trust contains an express disclaimer of shareholder liability for the Fund&#8217;s debts or obligations and
requires that notice of such limited liability be given in each agreement, obligation or instrument entered into or executed by the Fund or the trustees. The Declaration of Trust further provides for indemnification out of the Fund&#8217;s assets and
property for all loss and expense of any shareholder held personally liable for the Fund&#8217;s obligations. Thus, the risk of a shareholder incurring financial loss on account of shareholder liability is limited to circumstances in which the Fund
would be unable to meet its obligations. The Fund believes that the likelihood of such circumstances is remote. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Declaration of
Trust provides that the Fund&#8217;s obligations are not binding upon the Fund&#8217;s trustees individually, but only upon the
Fund&#8217;s assets and property, and that the trustees shall not be liable for errors of judgment or mistakes of fact or law.
Nothing in the Declaration of Trust, however, protects a trustee against any liability to which the trustee would otherwise be
subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct
of the trustee&#8217;s office. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Anti-Takeover
Provisions</i>. The Declaration of Trust and By-laws include provisions that could limit the ability of other entities or persons to
acquire control of the Fund or to convert the Fund to open-end status. The By-laws require the Board of Trustees be divided into
three classes with staggered terms. See &#8220;Management of the Fund&#8221; in the SAI. This provision of the By-laws could delay
for up to two years the replacement of a majority of the Board of Trustees. When Preferred Shares are issued, holders of Preferred
Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees. In addition, the Declaration of Trust
requires a vote by holders of at least two-thirds of the Common Shares and, if issued, Preferred Shares, voting together as a single
class, except as described below, to authorize (1) a conversion of the Fund from a closed-end to an open-end investment company, (2)
a merger or consolidation of the Fund, or a series or class of the Fund, with any corporation, association, trust or other
organization or a reorganization of the Fund, or a series or class of the Fund, (3) a sale, lease or transfer of all or
substantially all of the Fund&#8217;s assets (other than in the regular course of the Fund&#8217;s investment activities), (4) in
certain circumstances, a termination of the Fund, or a series or class of the Fund or (5) a removal of trustees by shareholders, and
then only for cause, unless, with respect to (1) through (5), such transaction has already been authorized by the affirmative vote
of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the
affirmative vote of the holders of at least a majority of the Fund&#8217;s Common Shares and, if issued, Preferred Shares
outstanding at the time, voting together as a single class, would be required; provided, however, that where only a particular class
or series is affected (or, in the case of removing a trustee, when the trustee has been elected by only one class), only the
required vote by the applicable class or series will be required. However, approval of shareholders would not be required for any
transaction, whether deemed a merger, consolidation, reorganization or otherwise whereby the Fund issues shares in connection with
the acquisition of assets (including those subject to liabilities) from any other investment company or similar entity. In the case
of the conversion of the Fund from a closed-end investment company to an open-end investment company, or in the case of any of the
foregoing transactions constituting a plan of reorganization that adversely affects the holders of any outstanding Preferred Shares,
the action in question also would require the affirmative vote of the holders of at least two-thirds of the Preferred Shares
outstanding at the time, voting as a separate class, unless such transaction has already been authorized by the affirmative vote of
two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the
affirmative vote of the holders of at least a majority of the Fund&#8217;s Preferred Shares outstanding at the time would be
required. None of the foregoing provisions may be amended except by the vote of at least two-thirds of the Common Shares and any
Preferred Shares voting together as a single class. The votes required to approve the conversion of the Fund from a closed-end to an
open-end investment company or to approve transactions constituting a plan of reorganization which adversely affects the holders of
preferred shares are higher than those required by the 1940 Act. The Board of Trustees believes that the provisions of the
Declaration of Trust relating to such higher votes are in the best interest of the Fund and its shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Procedural Requirements on Derivative Actions, Exclusive
Jurisdiction and Jury Trial Waiver</i>. The By-laws of the Fund contain certain provisions affecting potential shareholder claims against the Fund, including procedural requirements for derivative actions, an exclusive forum provision, and the
waiver of shareholder rights to a jury trial. Massachusetts is considered a &#8220;universal demand&#8221; state, meaning that under Massachusetts corporate law a shareholder must make a demand on the company before bringing a derivative action (i.e.,
a lawsuit brought by a shareholder on behalf of the company). The By-laws of the Fund provide detailed procedures for the bringing of derivative actions by shareholders which are modeled on the substantive provisions of the Massachusetts corporate
law derivative demand statute. The procedures are intended to permit legitimate inquiries and claims while avoiding the time, expense, distraction, and other harm that can be caused to the Fund or its shareholders as a result of spurious shareholder
demands and derivative actions. Among other things, these procedures: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that before bringing a derivative action, a shareholder must make a written demand to the Fund; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a 90-day review period, subject to extension in certain circumstances, for the Board of Trustees to evaluate the shareholder&#8217;s demand; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a mechanism for the Board of Trustees to submit the question of whether to maintain a derivative action to a vote of shareholders; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the Fund does not notify the requesting shareholder of the rejection of the demand within the applicable review period, the shareholder may commence a derivative action; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish bases upon which a trustee will not be considered to be not independent for purposes of evaluating a derivative demand; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the trustees who are independent for purposes of considering a shareholder demand determine in good faith within the applicable review period that the maintenance of a derivative action is not in the
best interest of the Fund, the shareholder shall not be permitted to maintain a derivative action unless the shareholder first sustains the burden of proof to the court that the decision of the trustees not to pursue the requested action was not a
good faith exercise of their business judgment on behalf of the Fund. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">These procedures may be more restrictive than procedures for bringing derivative suits applicable to other investment companies. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The By-laws also
                                                                           require that actions by shareholders against the Fund, except for actions under the U.S. federal securities laws, be brought only in
                                                                           a certain federal court in Massachusetts, or if not permitted to be brought in federal court, then in the Business Litigation
                                                                           Session of the Massachusetts Superior Court in Suffolk County (the &#8220;Exclusive Jurisdictions&#8221;), and that the right to jury
                                                                           trial be waived to the fullest extent permitted by law. Other investment companies may not be subject to similar restrictions. The
                                                                           designation of Exclusive Jurisdictions may make it more expensive for a shareholder to bring a suit than if the shareholder were
                                                                           permitted to select another jurisdiction. In the event a shareholder selects another jurisdiction to bring its suit and the venue
                                                                           for such suit is subsequently changed back to an Exclusive Jurisdiction through the legal process, then such shareholder shall be
                                                                           required to reimburse all expenses incurred by the Fund or any other person in effecting such change of venue back to the Exclusive
                                                                           Jurisdiction. Also, the designation of Exclusive Jurisdictions and the waiver of jury trials limit a shareholder&#8217;s ability to
                                                                           litigate a claim in the jurisdiction and in a manner that may be more favorable to the shareholder. It is possible that a court may
                                                                           choose not to enforce these provisions of the Fund&#8217;s By-laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Preemptive
Rights</i>. The Declaration of Trust provides that Common Shareholders shall have no right to acquire, purchase or subscribe for any
shares or investments of the Fund, other than such right, if any, as the Fund&#8217;s Board of Trustees in its discretion may determine. As of the
date of this Prospectus, no preemptive rights have been granted by the Board of Trustees.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Reference should be made to the Declaration of Trust and By-laws on
file with the SEC for the full text of these provisions. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_18"></span>REPURCHASE OF FUND SHARES; CONVERSION TO <span style="white-space: nowrap">OPEN-END</span> FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            Fund is a closed-end investment company and as such its shareholders will not have the right
                                            to cause the Fund to redeem their shares. Instead, the Common Shares will trade in the open
                                            market at a price that will be a function of several factors, including dividend levels (which
                                            are in turn affected by expenses), NAV, call protection, dividend stability, portfolio credit
                                            quality, relative demand for and supply of such shares in the market, general market and
                                            economic conditions and other factors. Because shares of closed-end investment companies
                                            may frequently trade at prices lower than NAV, the Fund&#8217;s Board of Trustees has currently
                                            determined that, at least annually, it will consider action that might be taken to reduce
                                            or eliminate any material discount from NAV in respect of Common Shares, which may include
                                            the repurchase of such shares in the open market or in private transactions, the making of
                                            a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment
                                            company. The Fund cannot assure you that its Board of Trustees will decide to take any of
                                            these actions, or that share repurchases or tender offers will actually reduce market discount.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If
                                         the Fund converted to an open-end investment company, it would be required to redeem
                                         all Preferred Shares, if any, then outstanding (requiring in turn that
                                         it liquidate a portion of its investment portfolio), and the Common Shares would no longer
                                         be listed on the NYSE or elsewhere and it would likely have to significantly reduce any
                                         leverage it is then employing, which may require a repositioning of its investment portfolio,
                                         which may in turn generate substantial transaction costs, which would be borne by Common
                                         Shareholders, and may adversely affect Fund performance and Fund distributions. In contrast
                                         to a closed-end investment company, shareholders of an open-end investment company may
                                         require the company to redeem their shares at any time (except in certain circumstances
                                         as authorized by the 1940 Act or the rules thereunder) at their NAV, less any redemption
                                         charge that is in effect at the time of redemption. The Fund currently expects that any
                                         such redemptions would be made in cash. The Fund may charge sales or redemption fees
                                         upon conversion to an open-end fund. In order to avoid maintaining large cash positions
                                         or liquidating favorable investments to meet redemptions, open-end investment companies
                                         typically engage in a continuous offering of their shares. Open-end investment companies
                                         are thus subject to periodic asset in-flows and out-flows that can complicate portfolio
                                         management. The Board of Trustees may at any time propose conversion of the Fund to an
                                         open-end investment company depending upon its judgment as to the advisability of such
                                         action in light of circumstances then prevailing.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Before
                                            deciding whether to take any action if the Common Shares trade below NAV, the Fund&#8217;s
                                            Board of Trustees would consider all relevant factors, including the extent and duration
                                            of the discount, the liquidity of the Fund&#8217;s portfolio, the impact of any action that
                                            might be taken on the Fund or its shareholders, and market considerations. Based on these
                                            considerations, even if the Fund&#8217;s shares should trade at a discount, the Board of Trustees
                                            may determine that, in the interest of the Fund and its shareholders, no action should be
                                            taken.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_19"></span>TAX MATTERS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following information is meant as a general summary
for U.S. Common Shareholders. Please see the SAI for additional information. Investors should rely on their own tax adviser for advice
about the particular federal, state and local tax consequences to them of investing in the Fund. This summary does not discuss the tax
consequences of an investment in Rights or Preferred Shares. The tax consequences of such an investment will be discussed in the relevant
prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has elected and intends to qualify each year
to be treated as a RIC under Subchapter M of the Internal Revenue Code. In order to qualify for treatment as a RIC, the Fund must satisfy
certain requirements regarding the sources of its income, the diversification of its assets and the distribution of its income. Provided
that the Fund timely distributes its income it is not expected to be subject to federal income tax. Dividends paid out of the Fund&#8217;s
investment company taxable income (which includes dividends the Fund receives, interest income and net short-term capital gain) will generally
be taxable to shareholders as ordinary income, except as described below with respect to qualified dividend income. Net capital gain distributions
(the excess of net long-term capital gain over net short-term capital loss) are generally taxable at rates applicable to long-term capital
gains regardless of how long a shareholder has held its shares. Long-term capital gains for non-corporate shareholders are currently taxable
at a maximum federal income tax rate of 20%. In addition, certain individuals, estates and trusts are subject to a 3.8% Medicare tax on
net investment income, including net capital gains and other taxable dividends. Corporate shareholders are taxed on capital gain at the
same rates as apply to ordinary income. Distributions derived from qualified dividend income and received by a non- corporate shareholder
will be taxed at the rates applicable to long-term capital gain. In order for some portion of the dividends received by a shareholder
to be qualified dividend income, the Fund must meet certain holding period and other requirements with respect to the dividend-paying
stocks in its portfolio and the non-corporate shareholder must meet certain holding period and other requirements with respect to its
shares of the Fund. Taxable distributions are taxable whether or not such distributions are reinvested in the Fund. Dividend distributions
may be subject to state and local taxation, depending on a shareholder&#8217;s situation. The Fund&#8217;s investment strategies may significantly
limit its ability to make distributions eligible to be reported as qualified dividend income or for the dividends-received deduction for
corporate shareholders. While the Fund may invest in municipal securities the interest income from which is exempt from regular federal
income tax, the Fund does not expect to satisfy the requirements to pay exempt-interest dividends to shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Fund&#8217;s total distributions exceed both
the current taxable year&#8217;s earnings and profits and accumulated earnings and profits from prior years, the excess generally will
be treated as a tax-free return of capital up to and including the amount of a shareholder&#8217;s tax basis in its shares of the Fund,
and thereafter as capital gain. Upon a sale of shares of the Fund, the amount, if any, by which the sales price exceeds the basis in the
shares of the Fund is gain subject to federal income tax. Because a return of capital reduces basis in the shares of the Fund, it will
increase the amount of gain or decrease the amount of loss on a shareholder&#8217;s subsequent disposition of the shares of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As a regulated investment company, the Fund will not
be subject to federal income tax in any taxable year provided that it meets certain distribution requirements. The Fund may retain for
investment some (or all) of its net capital gain. If the Fund retains any net capital gain or investment company taxable income, it will
be subject to tax at the regular corporate rate on the amount retained. If the Fund retains any net capital gain, it may designate the
retained amount as undistributed capital gains in a notice to its shareholders who if subject to federal income tax on long-term capital
gains, (i) will be required to include in income for federal income tax purposes, as long-term capital gain, their share of such undistributed
amount; (ii) will be entitled to credit their proportionate shares of the federal income tax paid by the Fund on such undistributed amount
against their federal income tax liabilities, if any; and (iii) may claim refunds to the extent the credit exceeds such liabilities. For
federal income tax purposes, the basis of shares owned by a shareholder of the Fund will be increased by an amount equal to the difference
between the amount of undistributed capital gains included in the shareholder&#8217;s gross income and the tax deemed paid by the shareholder
under clause (ii) of the preceding sentence. Unless a shareholder&#8217;s investment in the Fund is through a tax-exempt entity or tax
deferred retirement account, such as a 401(k) plan, the shareholder will normally have to pay federal income taxes, and any applicable
state or local taxes, on the dividends and other distributions the shareholder receives from the Fund, whether it takes the distributions
in cash or reinvest them in additional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Fund utilizes leverage through borrowings, or
otherwise, asset coverage limitations imposed by the 1940 Act as well as additional restrictions that may be imposed by certain lenders
on the payment of dividends or distributions potentially could limit or eliminate the Fund&#8217;s ability to make distributions on its
common shares and/or preferred shares, if any, until the asset coverage is restored. These limitations could prevent the Fund from distributing
at least 90% of its investment company taxable income as is required under the Code and therefore might jeopardize the Fund&#8217;s qualification
as a regulated investment company and/or might subject the Fund to a nondeductible 4% federal excise tax. The Fund endeavors to avoid
restrictions on its ability to distribute dividends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Dividends declared by the Fund in October, November
or December, payable to shareholders of record in such a month, and paid during the following January will be treated as having been received
by shareholders in the year the distributions were declared.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Investments by the Fund in zero coupon or other discount
securities will result in income to the Fund equal to a portion of the excess of the face value of the securities over their issue price
(the &#8220;original issue discount&#8221; or &#8220;OID&#8221;) each year that the securities are held, even though the Fund may receive
no cash interest payments or may receive cash interest payments that are less than the income recognized for tax purposes. In addition,
any market discount recognized on a market discount bond is taxable as ordinary income. A market discount bond is a bond acquired in the
secondary market at a price below redemption value, or below adjusted issue price if issued with original issue discount. Absent an election
by the Fund to include the market discount in income as it accrues, gain on the Fund&#8217;s disposition of such an obligation will be
treated as ordinary income rather than capital gain to the extent of the accrued market discount. Because the income required to be recognized
by the Fund as a result of the OID and/or market discount rules may not be matched by a corresponding cash payment to the Fund, the Fund
may be required to borrow money or dispose of securities to be able to make distributions to its shareholders in order to qualify for
treatment as a RIC and eliminate taxes at the Fund level.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Each shareholder will receive an annual statement summarizing
the U.S. federal income tax status of all distributions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Unless your investment in the Fund is through a tax-exempt
entity or tax deferred retirement account, the repurchase, sale or exchange of Common Shares normally will result in capital gain or loss
to Common Shareholders who hold their shares as capital assets. Generally, a shareholder&#8217;s gain or loss will be long-term capital
gain or loss if the shares have been held for more than one year even though the increase in value in such Common Shares may be at least
partly attributable to tax-exempt interest income. For non-corporate taxpayers, long-term capital gains are currently taxed at rates of
up to 20%. Short-term capital gains and other ordinary income are taxed to non-corporate taxpayers at ordinary income rates. If a shareholder
sells or otherwise disposes of Common Shares before holding them for six months, any loss on the sale or disposition will be treated as
a long-term capital loss to the extent of any amounts treated as distributions to the common shareholder of long-term capital gain (including
any amount credited to the common shareholder as undistributed capital gain). Any loss realized by a shareholder on the disposition of
shares held 6 months or less is disallowed to the extent of the amount of exempt-interest dividends received by the shareholder with respect
to Common Shares. Any loss realized on a sale or exchange of shares of the Fund will be disallowed to the extent those shares of the Fund
are replaced by substantially identical shares of the Fund (including shares acquired by reason of participation in the Plan) within a
period of 61 days beginning 30 days before and ending 30 days after the date of disposition of the original shares, or to the extent the
shareholder enters into a contract or option to repurchase shares within such period. In that event, the basis of the replacement shares
of the Fund will be adjusted to reflect the disallowed loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund may be required to withhold (as &#8220;backup
withholding&#8221;) U.S. federal income tax for distributions (including exempt-interest dividends) and repurchase proceeds payable to
a shareholder if the shareholder fails to provide the Fund with the shareholder&#8217;s correct taxpayer identification number or to make
required certifications, or if the shareholder has been notified by the IRS that the shareholder is subject to backup withholding. The
backup withholding rate is 24%. Backup withholding is not an additional tax; rather, it is a way in which the IRS ensures it will collect
taxes otherwise due. Any amounts withheld may be credited against a shareholder&#8217;s U.S. federal income tax liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund may invest in other instruments the U.S. federal
income tax treatment of which is uncertain or subject to re-characterization by the IRS. To the extent the tax treatment of such instruments
or their income differs from the tax treatment expected by the Fund, it could affect the timing or character of income recognized by the
Fund, requiring the Fund to purchase or sell instruments, or otherwise change its portfolio, in order to comply with the tax rules applicable
to RICs under the Code. Common Shareholders may be subject to state, local and foreign taxes on their Fund distributions. Shareholders
are advised to consult their own tax advisers with respect to the particular consequences to them of an investment in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_20"></span>CUSTODIAN AND TRANSFER AGENT </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            custodian of the assets of the Fund is State Street Bank and Trust Company, located at One
                                            Congress Street, Suite&#160;1, Boston, Massachusetts 02114-2016 (the &#8220;Custodian&#8221;).
                                            The Custodian performs custodial, fund accounting and portfolio accounting services. The
                                            Fund&#8217;s transfer, shareholder services and dividend paying agent with respect to the
                                            Fund&#8217;s Common Shares is Computershare Inc. and Computershare Trust Company, N.A., located
                                            at 150 Royall Street, Canton, Massachusetts 02021. The transfer agent, tender and dividend
                                            paying agent and calculation agent for any Preferred Shares, will be identified in the applicable
                                            prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_21"></span>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">PricewaterhouseCoopers LLP (&#8220;PwC&#8221;),
                                         an independent registered public accounting firm, provides auditing services to the Fund. The principal business address of PwC is One North Wacker Dr, Chicago, IL 60606.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_22"></span>LEGAL MATTERS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Certain legal
matters in connection with the offering will be passed upon for the Fund by Stradley Ronon Stevens &amp; Young, LLP, located at
2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp; Young, LLP may rely as to certain matters
of Massachusetts law on the opinion of Morgan, Lewis &amp; Bockius LLP. Any additional legal opinions will be described in a prospectus supplement.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_23"></span>AVAILABLE
INFORMATION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund is subject to the informational
requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the 1940 Act and is required to file reports, proxy statements and other information with the SEC. Reports, proxy statements, and other information
about the Fund can be inspected at the offices of the NYSE. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">This
Prospectus does not contain all of the information in the Fund&#8217;s Registration Statement, including amendments, exhibits, and schedules. Statements in this Prospectus about the contents of any contract or other document are not necessarily
complete and, in each instance, reference is made to the copy of the contract or other document filed as an exhibit to the Registration Statement, each such statement being qualified in all respects by this reference. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Fund and the Securities can be found
in the Fund&#8217;s Registration Statement (including amendments, exhibits, and schedules) on Form <span style="white-space: nowrap">N-2</span> filed with the SEC. The SEC maintains a website (http://www.sec.gov) that contains the Fund&#8217;s
Registration Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, including proxy statements and reports filed under the Exchange Act. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_24"></span>INCORPORATION BY REFERENCE </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The documents listed below, and any reports and other documents
subsequently filed with the SEC pursuant to Section&#160;30(b)(2) of the 1940 Act and Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the offering will be incorporated by reference into this Prospectus and deemed
to be part of this Prospectus from the date of the filing of such reports and documents: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The Fund&#8217;s <a href="#toc780884_25">SAI</a>, dated August 19,
2025; and</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm"><span style="text-decoration: underline">annual report</span></a> on Form N-CSR for the fiscal year ended December 31, 2024.</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>






<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The description of the Common Shares contained in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312514416828/d772175d8a12b.htm">Registration
Statement</a> on Form 8-A (File&#160;No.&#160;001-36753) filed with the SEC on November 18, 2014, including any amendment or report
filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The information incorporated by reference is considered to be part of
this Prospectus, and later information that the Fund files with the SEC will automatically update and supersede this information. Incorporated materials not delivered with the Prospectus may be obtained, without charge, by calling (800) <span style="white-space: nowrap">257-8787,</span> by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#8217;s website (<span style="text-decoration: underline">http://www.nuveen.com</span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"></h5>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 120pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 120pt">&#160;</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 24pt">&#160;</p> <p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center">


<img src="nuveenlogo.jpg" alt="LOGO"/>
 </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 120pt">&#160;</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 24pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 72pt">&#160;</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">All
                                            dealers that effect transactions in Common Shares, whether or not participating in this offering,
                                            may be required to deliver a Prospectus.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: right"><b>EPR-JGH-0825P</b></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b>NUVEEN GLOBAL HIGH INCOME FUND</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center">333 West Wacker Drive </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Chicago,
Illinois 60606 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_25"></span>STATEMENT
OF ADDITIONAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b></b>August 19, 2025</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company registered under
the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund was organized as a Massachusetts business
trust on August 5, 2014 and commenced investment operations on November 24, 2014.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This Statement of
Additional Information (the &#8220;SAI&#8221;) relating to the common shares (&#8220;Common Shares&#8221;) of the Fund does not
constitute a prospectus, but should be read in conjunction with the Fund&#8217;s prospectus relating thereto dated August 19, 2025
(the &#8220;Prospectus&#8221;) and any related prospectus supplement. This SAI does not include all information that a prospective
investor should consider before purchasing such shares. Investors should obtain and read the Prospectus and any related prospectus
supplement prior to purchasing. In addition, the Fund&#8217;s financial statements and the independent registered public accounting
firm&#8217;s report therein included in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual
report</a> dated December 31, 2024, are incorporated herein by reference. A copy of the Prospectus may be obtained without charge by
calling (800)&#160;257-8787. You may also obtain a copy of the Prospectus on the U.S. Securities and Exchange Commission&#8217;s
(the &#8220;SEC&#8221;) web site (http://www.sec.gov). Capitalized terms used but not defined in this SAI have the meanings ascribed
to them in the Prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b>TABLE OF CONTENTS </b></p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 100%; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 90%"/>

<td style="width: 10%"/>
</tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_1">Use of Proceeds</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_2">Investment Objectives and Policies</a></p></td>
<td style="vertical-align: bottom; text-align: right">2</td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_3">Investment Restrictions</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_4">The Fund&#8217;s Investments </a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_5">Management of the Fund</a></p></td>
<td style="vertical-align: bottom; text-align: right">30</td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_6">Investment Adviser, <span style="white-space: nowrap">Sub-Adviser</span> and Portfolio
Managers </a></p></td>
<td style="vertical-align: bottom; text-align: right">56</td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_7">Code of Ethics</a></p></td>
<td style="vertical-align: bottom; text-align: right">62</td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_8">Proxy Voting Policies</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_9">Portfolio Transactions and Brokerage</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_10">Tax Matters</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">64</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_11">Financial Statements</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">74</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_12">Custodian and Transfer Agent</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_13">Independent Registered Public Accounting Firm</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_14">Legal Matters</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_15">Additional Information</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_16">Appendix A</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">A-1</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"><a href="#sai780884_17">Appendix B</a></p></td>
<td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">B-1</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
</table>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_1"></span>USE OF PROCEEDS </b></p>
 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_2"></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specified in a prospectus
supplement, the net proceeds from any offering will be invested in accordance with the Fund&#8217;s investment objective and
policies as stated below. The Fund currently anticipates that it will be able to invest substantially all of the net proceeds
in investments that meet the Fund&#8217;s investment objective and policies within approximately three months of the receipt
of such proceeds. Pending investment, it is anticipated that the proceeds will be invested in short-term or long-term securities
issued by the U.S. Government and its agencies or instrumentalities or in high-quality, short-term money market instruments.</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b>INVESTMENT OBJECTIVE AND POLICIES </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form <span style="white-space: nowrap">N-CSR</span> entitled
&#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221; as such investment objective and investment policies may
be supplemented from time to time, which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objective and policies. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_3"></span>INVESTMENT
RESTRICTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">The following investment restrictions are fundamental policies
for the Fund and may not be changed without the approval of the holders of a majority of the outstanding common shares of such Fund. For
this purpose, &#8220;a majority of the outstanding shares&#8221; means the vote of (1) 67% or more of the voting securities present at
a meeting, if the holders of more than 50% of the outstanding voting securities are present or represented by proxy; or (2) more than
50% of the outstanding voting securities, whichever is less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td>Issue senior securities, as defined in the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;), except as permitted
by the 1940 Act;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(2)</td><td>Borrow money, except as permitted by the 1940 Act and exemptive orders granted under the 1940 Act;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(3)</td><td>Act as underwriter of another issuer&#8217;s securities, except to the extent that the Fund may be deemed to be an underwriter within
the meaning of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in connection with the purchase and sale of
portfolio securities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(4)</td><td>Invest more than 25% of its total assets in securities of issuers in any one industry, provided, however, that such limitation shall
not apply to obligations issued or guaranteed by the U.S. Government or by its agencies or instrumentalities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(5)</td><td>Purchase or sell real estate, except pursuant to the exercise by the Fund of its rights under loan agreements and except to the extent
that interests in senior loans in which the Fund may invest are considered to be interests in real estate; and this shall not prevent
the Fund from investing in securities of companies that deal in real estate or are engaged in the real estate business, including real
estate investment trusts, and securities secured by real estate or interests therein and the Fund may hold and sell real estate or mortgages
on real estate acquired through default, liquidation, or other distributions of an interest in real estate as a result of the Fund&#8217;s
ownership of such securities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(6)</td><td>Purchase or sell physical commodities unless acquired as a result of ownership of securities or other instruments, or except pursuant
to the exercise by the Fund of its rights under loan agreements and except to the extent that interests in senior loans in which the Fund
may invest are considered to be interests in commodities, and this shall not prevent the Fund from purchasing or selling options, futures
contracts or derivative instruments or from investing in securities or other instruments backed by physical commodities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(7)</td><td>Make loans, except as permitted by the 1940 Act, and exemptive orders granted under the 1940 Act; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(8)</td><td>With respect to 75% of the value of the Fund&#8217;s total assets, purchase any securities (other than obligations issued or guaranteed
by the United States government or by its agencies or instrumentalities, and securities issued by other investment companies), if as a
result more than 5% of the Fund&#8217;s total assets would then be invested in securities of a single issuer or if as a result the Fund
would hold more than 10% of the outstanding voting securities of any single issuer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">With respect to restrictions 1 and 2, Section
18(c) of the 1940 Act generally limits a registered closed-end investment company to issuing one class of senior securities representing
indebtedness and one class of senior securities representing stock, except that the class of indebtedness or stock may be issued in one
or more series, and promissory notes or other evidences of indebtedness issued in consideration of any loan, extension, or renewal thereof,
made by a bank or other person and privately arranged, and not intended to be publicly distributed, are not deemed a separate class of
senior securities. With respect to restriction 2, Section 18(a) of the 1940 Act generally prohibits a registered closed-end fund from
incurring borrowings if, immediately thereafter, the aggregate amount of its borrowings exceeds 33 1/3% of its total assets. With respect
to restriction 7, Section 21 of the 1940 Act makes it unlawful for a registered investment company, like the Fund, to lend money or other
property if (i) the investment company&#8217;s policies set forth in its registration statement do not permit such a loan or (ii) the
borrower controls or is under common control with the investment company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">For the purpose of applying the limitation
set forth in investment restriction number 8 above, a governmental issuer shall be deemed the single issuer of a security when its assets
and revenues are separate from other governmental entities and its securities are backed only by its assets and revenues. Similarly, in
the case of a non-governmental issuer, if the security is backed only by the assets and revenues of the non-governmental issuer, then
such non-governmental issuer would be deemed to be the single issuer. Where a security is also backed by the enforceable obligation of
a superior or unrelated governmental or other entity (other than a bond insurer), it shall also be included in the computation of securities
owned that are issued by such governmental or other entity. Where a security is guaranteed by a governmental entity or some other facility,
such as a bank guarantee or letter of credit, such a guarantee or letter of credit would be considered a separate security and would be
treated as an issue of such government, other entity or bank. When a municipal bond is insured by bond insurance, it shall not be considered
a security that is issued or guaranteed by the insurer; instead, the issuer of such municipal bond will be determined in accordance with
the principles set forth above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">Subject to certain exemptions under the
1940 Act, the Fund may invest only up to 10% of its total assets in the aggregate in shares of other investment companies and only up
to 5% of its total assets in any one investment company, provided the investment does not represent more than 3% of the voting stock of
the acquired investment company at the time such shares are purchased. As a shareholder in any investment company, the Fund will bear
its ratable share of that investment company&#8217;s expenses, and will remain subject to payment of the Fund&#8217;s management, advisory
and administrative fees with respect to assets so invested. Holders of common shares would therefore be subject to duplicative expenses
to the extent the Fund invests in other investment companies. In addition, the securities of other investment companies may be leveraged
and therefore will be subject to leverage risks described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">In addition to the foregoing fundamental
investment policies, the Fund is also subject to the following non-fundamental restrictions and policies, which may be changed by the
Board. The Fund may not:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td>Sell securities short, except that the Fund may make short sales of securities if, at all times when a short position is open, the
Fund owns at least an equal amount of such securities or securities convertible into or exchangeable for, without payment of any further
consideration, securities of the same issuer as, and equal in amount to, the securities sold short, and provided that transactions in
options, futures contracts, options on futures contracts, or other derivative instruments are not deemed to constitute selling securities
short.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(2)</td><td>Purchase securities of open-end or closed-end investment companies except in compliance with the 1940 Act or any exemptive relief
obtained thereunder. The Fund will rely on representations of borrowers in loan agreements in determining whether such borrowers are investment
companies.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(3)</td><td>Purchase securities of companies for the purpose of exercising control, except to the extent that exercise by the Fund of its rights
under loan agreements would be deemed to constitute exercising control.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">The restrictions and other limitations
set forth above will apply only at the time of purchase of securities and will not be considered violated unless an excess or deficiency
occurs or exists immediately after and as a result of an acquisition of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.25in">The Fund may be subject to certain restrictions
imposed by either guidelines of one or more credit rating agencies that may issue ratings for preferred shares, commercial paper or notes,
or, if the Fund borrows from a lender, by the lender. These guidelines may impose asset coverage or portfolio composition requirements that
are more stringent than those imposed on the Fund by the 1940 Act. If these restrictions were to apply, it is not anticipated that these
covenants or guidelines would impede the Adviser and/or the Sub-Adviser from managing the Fund&#8217;s portfolio in accordance with the
Fund&#8217;s investment objective(s) and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_4"></span>THE FUND&#8217;S INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><span style="background-color: white"><b>Non-U.S.
Government and Supranational Debt Securities, Including Emerging Markets Investments</b>&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Fund may invest in debt securities of governmental issuers in all countries, including emerging market countries. These debt securities
may include: fixed-income securities issued or guaranteed by governments and governmental agencies or instrumentalities; fixed-income
securities issued by government owned, controlled or sponsored entities; interests in entities organized and operated for the purpose
of restructuring the investment characteristics of instruments issued by any of the above issuers; Brady Bonds, which are debt securities
issued under the framework of the Brady Plan as a means for debtor nations to restructure their outstanding external indebtedness; participations
in loans between governments and financial institutions; or fixed income securities </span>issued by supranational entities such as the
World Bank or the European Economic Community. A supranational entity is a bank, commission or company established or financially supported
by the national governments of one or more countries to promote reconstruction or development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">An investment in debt
obligations of non-U.S. governments and their political subdivisions (sovereign debt) involves special risks that are not present in corporate
debt obligations. The non-U.S. issuer of the sovereign debt or the non-U.S. governmental authorities that control the repayment of the
debt may be unable or unwilling to repay principal or interest when due, and the Fund may have limited recourse in the event of a default.
During periods of economic uncertainty, the market prices of sovereign debt may be more volatile than prices of debt obligations of U.S.
issuers. In the past, certain non-U.S. countries have encountered difficulties in servicing their debt obligations, withheld payments
of principal and interest and declared moratoria on the payment of principal and interest on their sovereign debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The ability of a non-U.S.
sovereign issuer, especially in an emerging market country, to make timely and ultimate payments on its debt obligations will be strongly
influenced by the sovereign issuer&#8217;s balance of payments, including export performance, its access to international credits and
investments, fluctuations of interest rate and the extent of its non-U.S. reserves. A country whose exports are concentrated in a few
commodities or whose economy depends on certain strategic imports could be vulnerable to fluctuations in international prices of these
commodities or imports. To the extent that a country receives payment for its export in currencies other than dollars, its ability to
make debt payments denominated in dollars could be adversely affected. If a sovereign issuer cannot generate sufficient earnings from
non-U.S. trade to service its external debt, it may need to depend on continuing loans and aid from non-U.S. governments, commercial banks
and multinational organizations. There may be no bankruptcy proceedings similar to those in the United States by which defaulted interest
may be collected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">A sovereign debtor&#8217;s
willingness or ability to repay principal and pay interest in a timely manner may be affected by, among other factors, its cash flow situation,
the extent of its non-U.S. currency reserves, the availability of sufficient non-U.S. currency, the relative size of the debt service
burden, the sovereign debtor&#8217;s policy toward its principal international lenders and local political constraints. Sovereign debtors
may also be dependent on expected disbursements from non-U.S. governments, multilateral agencies and other entities to reduce principal
and interest arrearages on their debt. The failure of a sovereign debtor to implement economic reforms, achieve specified levels of economic
performance or repay principal or interest when due may result in the cancellation of third-party commitments to lend funds to the sovereign
debtor, which may further impair such debtor&#8217;s ability or willingness to service its debts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Sovereign Debt
Securities.<b>&#160;</b></i>The Fund may invest in debt securities and other instruments that are issued by, or that are related to, government,
government-related and supranational issuers, including those located, or conducting their business, in emerging markets countries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The ability of a&#160;non-U.S.&#160;sovereign
issuer, especially in an emerging market country, to make timely and ultimate payments on its debt obligations will be strongly influenced
by the sovereign issuer&#8217;s balance of payments, including export performance, its access to international credits and investments,
fluctuations of interest rate and the extent of its foreign reserves. A country whose exports are concentrated in a few commodities or
whose economy depends on certain strategic imports could be vulnerable to fluctuations in international prices of these commodities or
imports. To the extent that a country receives payment for its export in currencies other than dollars, its ability to make debt payments
denominated in dollars could be adversely affected. If a sovereign issuer cannot generate sufficient earnings from foreign trade to service
its external debt, it may need to depend on continuing loans and aid from foreign governments, commercial banks and multinational organizations.
There may be no bankruptcy proceedings similar to those in the U.S. by which defaulted interest may be collected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 40; Options: NewSection; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Additional factors
that may influence the ability or willingness to service debt include, but are not limited to, a country&#8217;s cash flow situation,
the availability or sufficient foreign exchange on the date a payment is due, the relative size of its debt service burden to the economy
as a whole, and its government&#8217;s policy towards the International Monetary Fund, the International Bank for Reconstruction and
Development and other international agencies to which a government debtor may be subject. The Fund may invest in debt securities issued
by issuers located, or conducting their business in, emerging market countries, and investments in such debt securities are particularly
speculative. Heightened risks of investing in emerging markets sovereign debt include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk of default by a governmental issuer or guarantor. In the event of a default, the Fund may have limited legal recourse against the issuer and/or guarantor.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk of restructuring certain debt obligations. This may include reducing and rescheduling interest and principal payments or requiring lenders to extend additional credit, which may adversely affect the value of these investments.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">In addition, risks
of investing in emerging markets securities include: smaller market capitalization of securities markets, which may suffer periods of
relative illiquidity, significant price volatility, restrictions on foreign investment, and possible repatriation of investment income
and capital. In addition, foreign investors may be required to register the proceeds of sales, future economic or political crises could
lead to price controls, forced mergers, expropriation or confiscatory taxation, seizure, nationalization, or creation of government monopolies.
The currencies of emerging market countries may experience significant declines against the U.S. dollar, and devaluation may occur subsequent
to investments in these currencies by the Fund. Inflation and rapid fluctuations in inflation rates have had, and may continue to have,
negative effects on the economies and securities markets of certain emerging markets countries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Senior Loans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Senior loans hold
the most senior position in the capital structure of a borrower, are typically secured with specific collateral and have a claim on the
assets and/or stock of the borrower that is senior to that held by subordinated debt holders and stockholders of the borrower. The capital
structure of a borrower may include senior loans, senior and junior subordinated debt, preferred stock and common stock issued by the
borrower, typically in descending order of seniority with respect to claims on the borrower&#8217;s assets. The proceeds of senior loans
primarily are used by borrowers to finance leveraged buyouts, recapitalizations, mergers, acquisitions, stock repurchases,&#160;re-financings,&#160;internal
growth and for other corporate purposes. A senior loan is typically originated, negotiated and structured by a U.S. or&#160;non-U.S.&#160;commercial
bank, insurance company, finance company or other financial institution (&#8220;Agent&#8221;) for a lending syndicate of financial institutions
which typically includes the Agent (&#8220;Lenders&#8221;). The Agent typically administers and enforces the senior loan on behalf of
the other Lenders in the syndicate. In addition, an institution, typically but not always the Agent, holds any collateral on behalf of
the Lenders. In executing the Fund&#8217;s investment strategies, the portfolio management team may consider in its discretion certain
environmental, social, governance, climate, sustainability and other related factors to the extent any of these factors are deemed financially
relevant from an investment perspective. Whether and the degree to which any of these factors are considered largely depends on the particular
portfolio management team, strategy, asset classes, securities, and other factors, which could vary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Senior loans, like
most other debt obligations, are subject to the risk of default. Default in the payment of interest or principal on a senior loan results
in a reduction in income to the Fund, a reduction in the value of the senior loan and a decrease in the Fund&#8217;s net asset value (&#8220;NAV&#8221;).
This decrease in the Fund&#8217;s NAV would be magnified by the Fund&#8217;s use of leverage. The risk of default increases
in the event of an economic downturn or a substantial increase in interest rates. An increased risk of default could result in a decline
in the value of senior loans and in the Fund&#8217;s NAV.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 41; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Many senior loans
in which the Fund may invest may not be rated by a nationally recognized statistical rating organization (&#8220;NRSRO&#8221;), generally will not be registered with the SEC and generally will not be listed
on a securities exchange. In addition, the amount of public information available with respect to senior loans generally may be less
extensive than that available for registered and exchange-listed securities. Economic and other events (whether real or perceived) can
reduce the demand for certain senior loans or senior loans generally, which may reduce market prices and cause the Fund&#8217;s NAV per share to fall. The frequency and magnitude of such changes cannot be predicted. Senior loans may not be rated at the time that
the Fund purchases them. If a senior loan is rated at the time of purchase, Nuveen Asset Management may consider the rating when evaluating
the senior loan but may not view ratings as a determinative factor in investment decisions. As a result, the Fund is more dependent on
the credit analysis abilities of Nuveen Asset Management. Because of the protective terms of most senior loans, it is possible that the
Fund is more likely to recover more of its investment in a defaulted senior loan than would be the case for most other types of defaulted
debt securities.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">In the case of collateralized
senior loans, there is no assurance that sale of the collateral would raise enough cash to satisfy the borrower&#8217;s payment obligation
or that the collateral can or will be liquidated. In the event of bankruptcy, liquidation may not occur and the court may not give lenders
the full benefit of their senior positions. If the terms of a senior loan do not require the borrower to pledge additional collateral
in the event of a decline in the value of the original collateral, the Fund will be exposed to the risk that the value of the collateral
will not at all times equal or exceed the amount of the borrower&#8217;s obligations under the senior loan. To the extent that a senior
loan is collateralized by stock in the borrower or its subsidiaries, such stock may lose all of its value in the event of bankruptcy of
the borrower. Uncollateralized senior loans involve a greater risk of loss. Some senior loans in which the Fund may invest are subject
to the risk that a court, pursuant to fraudulent conveyance or other similar laws, could subordinate such senior loans to presently existing
or future indebtedness of the borrower or take other action detrimental to the holders of senior loans, such as the Fund, including, under
certain circumstances, invalidating such senior loans. Lenders commonly have certain obligations pursuant to the loan agreement, which
may include the obligation to make additional loans or release collateral in certain circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">No active trading market
currently exists for some of the senior loans in which the Fund may invest and, thus, those loans may be illiquid. Liquidity relates to
the ability of the Fund to sell an investment in a timely manner at a price approximately equal to its value on the Fund&#8217;s books.
The illiquidity of some senior loans may impair the Fund&#8217;s ability to realize the full value of its assets in the event of a voluntary
or involuntary liquidation of such assets. Because of the lack of an active trading market, illiquid securities are also difficult to
value and prices provided by external pricing services may not reflect the true fair value of the securities. The risks of illiquidity
are particularly important when the Fund&#8217;s operations require cash, and may in certain circumstances require that the Fund sell
other investments or borrow to meet short-term cash requirements. To the extent that a secondary market does exist for certain senior
loans, the market may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods. The market
for senior loans could be disrupted in the event of an economic downturn or a substantial increase or decrease in interest rates. This
could result in increased volatility in the market and in the Fund&#8217;s NAV and market price per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">If legislation or
state or federal regulators impose additional requirements or restrictions on the ability of financial institutions to make loans that
are considered highly leveraged transactions, the availability of senior loans for investment by the Fund may be adversely affected. In
addition, such requirements or restrictions could reduce or eliminate sources of financing for certain borrowers. This would increase
the risk of default. If legislation or federal or state regulators require financial institutions to dispose of senior loans that are
considered highly leveraged transactions or subject such senior loans to increased regulatory scrutiny, financial institutions may determine
to sell such senior loans. Such sales could result in prices that, in the opinion of Nuveen Asset Management, do not represent fair value.
If the Fund attempts to sell a senior loan at a time when a financial institution is engaging in such a sale, the price the Fund could
get for the senior loan may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Any lender, which
could include the Fund, is subject to the risk that a court could find the lender liable for damages in a claim by a borrower arising
under the common laws of tort or contracts or anti-fraud provisions of certain securities laws for actions taken or omitted to be taken
by the lenders under the relevant terms of a loan agreement or in connection with actions with respect to the collateral underlying the
senior loan. The Fund may purchase participations in senior loans. By purchasing a participation interest in a loan, the Fund acquires
some or all of the interest of a bank or other financial institution in a loan to a corporate borrower. Under a participation, the Fund
generally will have rights that are more limited than the rights of lenders or of persons who acquire a senior loan by assignment. In
a participation, the Fund typically has a contractual relationship with the lender selling the participation, but not with the borrower.
As a result, the Fund assumes the credit risk of the lender selling the participation in addition to the credit risk of the borrower.
In the event of insolvency of the lender selling the participation, the Fund may be treated as a general creditor of the lender and may
not have a senior claim to the lenders&#8217; interest in the senior loan. A lender selling a participation and other persons interpositioned
between the lender and the Fund with respect to participations will likely conduct their principal business activities in the banking,
finance and financial services industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 42; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund may purchase
and retain in its portfolio senior loans where the borrowers have experienced, or may be perceived to be likely to experience, credit
problems, including involvement in or recent emergence from bankruptcy reorganization proceedings or other forms of debt restructuring.
Such investments may provide opportunities for enhanced income as well as capital appreciation. At times, in connection with the restructuring
of a senior loan either outside of bankruptcy court or in the context of bankruptcy court proceedings, the Fund may determine or be required
to accept equity securities or junior debt securities in exchange for all or a portion of a senior loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Corporate Debt Securities</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: justify; text-indent: 0.5in">Corporate debt securities
are fully taxable debt obligations issued by corporations. These securities fund capital improvements, expansions, debt refinancing or
acquisitions that require more capital than would ordinarily be available from a single lender. Investors in corporate debt securities
lend money to the issuing corporation in exchange for interest payments and repayment of the principal at a set maturity date. Rates on
corporate debt securities are set according to prevailing interest rates at the time of the issue, the credit rating of the issuer, the
length of the maturity and other terms of the security, such as a call feature. Corporate debt securities are subject to the risk of an
issuer&#8217;s inability to meet principal and interest payments on the obligations and may also be subject to price volatility due to
such factors as market interest rates, market perception of the creditworthiness of the issuer and general market liquidity. In addition,
corporate restructurings, such as mergers, leveraged buyouts, takeovers or similar corporate transactions are often financed by an increase
in a corporate issuer&#8217;s debt securities. As a result of the added debt burden, the credit quality and market value of an issuer&#8217;s
existing debt securities may decline significantly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>High Yield Debt Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">&#160;High yield
and comparable unrated debt securities (also known as &#8220;junk&#8221; bonds) are typically issued by companies without long track records
of sales and earnings, or by companies that have questionable credit strength. These securities: (a)&#160;will likely have some quality
and protective characteristics that, in the judgment of the NRSRO, are outweighed by large uncertainties or major risk exposures to adverse
conditions; and (b)&#160;are predominantly speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal
in accordance with the terms of the obligation. The yields on high yield and comparable unrated debt securities generally are higher than
the yields available on investment-grade debt securities. However, investments in these securities generally involve greater volatility
of price and risk of loss of income and principal, including the possibility of default by or insolvency of the issuers of such securities.
Since the risk of default is higher for high yield and comparable unrated debt securities, the Fund will try to minimize the risks inherent
in investing in these securities by engaging in credit analysis, diversification, and attention to current developments and trends affecting
interest rates and economic conditions. The Fund will attempt to identify those issuers of high yield and comparable unrated debt securities
with a financial condition that is adequate to meet future obligations, has improved, or is expected to improve in the future. Accordingly,
with respect to these types of securities, the Fund may be more dependent on credit analysis than is the case for higher quality bonds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The market values
of certain high yield and comparable unrated debt securities tend to be more sensitive to individual corporate developments and changes
in economic conditions than higher-rated securities. In addition, issuers of these securities often are highly leveraged and may not have
more traditional methods of financing available to them so that their ability to service their debt obligations during an economic downturn
or during sustained periods of rising interest rates may be impaired. The risk of loss due to default by such issuers is significantly
greater because high yield and comparable unrated debt securities generally are unsecured and frequently are subordinated to senior indebtedness.
The Fund may incur additional expenses to the extent that it is required to seek recovery upon a default in the payment of principal or
interest on such securities. The existence of limited markets for these securities may diminish the Fund&#8217;s ability to: (a)&#160;obtain
accurate market quotations for purposes of valuing such securities and calculating its NAV; and (b)&#160;sell the securities
at fair value either to meet redemption requests or to respond to changes in the economy or in financial markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 43; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">An economic recession
could severely disrupt the market for such securities and adversely affect the value of such securities. Any such economic downturn also
could severely and adversely affect the ability of the issuers of such securities to repay principal and pay interest thereon. Because
certain high yield and comparable unrated debt securities may be issued by non-U.S. companies, some of which may be located in emerging
markets countries, there are certain additional risks associated with such investments. See &#8220;&#8212;Securities Issued by Non-U.S. Issuers.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><b>Convertible Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Convertible
securities are bonds, debentures, notes, preferred securities or other securities that may be converted or exchanged (by the holder or
the issuer) into shares of the underlying common stock (or cash or securities of equivalent value) at a stated exchange ratio or predetermined
price (the &#8220;conversion price&#8221;). Convertible securities have general characteristics similar to both debt securities and common
stock. The interest paid on convertible securities may be fixed or floating rate. Floating rate convertible securities may specify an
interest rate or rates that are conditioned upon changes to the market price of the underlying common stock. Convertible securities also
may be issued in zero coupon form with an original issue discount. See &#8220;&#8212;Zero Coupon and&#160;Payment-In-Kind&#160;Securities.&#8221;
Although to a lesser extent than with debt securities, the market value of convertible securities tends to decline as interest rates increase
and, conversely, tends to increase as interest rates decline. In addition, because of the conversion feature, the market value of convertible
securities tends to vary with fluctuations in the market value of the underlying common stock and, therefore, will also react to variations
in the general market for common stock. Depending upon the relationship of the conversion price to the market value of the underlying
common stock, a convertible security may trade more like a common stock than a debt instrument. A convertible security generally entitles
the holder to receive interest paid or accrued until the convertible security matures or is redeemed, converted or exchanged. Convertible
securities rank senior to common stock in a corporation&#8217;s capital structure and, therefore, generally entail less risk than the
corporation&#8217;s common stock, although the extent to which such risk is reduced depends in large measure upon the degree to which
the convertible security sells above its value as a debt obligation. Before conversion, convertible securities have characteristics similar
to&#160;non-convertible&#160;debt obligations and can provide for a stable stream of income with generally higher yields than common stock.
However, convertible securities fall below debt obligations of the same issuer in order of preference or priority in the event of a liquidation,
and are typically unrated or rated lower than such debt obligations. In addition, contingent payment convertible securities allow the
issuer to claim deductions based on its nonconvertible cost of debt which generally will result in deductions in excess of the actual
cash payments made on the securities (and accordingly, holders will recognize income in amounts in excess of the cash payments received).
There can be no assurance of current income because the issuers of the convertible securities may default on their obligations. The convertible
securities in which the Fund may invest may be below investment grade quality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Convertible securities
generally offer lower interest or dividend yields than&#160;non-convertible&#160;securities of similar credit quality because of the potential
for capital appreciation. A convertible security, in addition to providing current income, offers the potential for capital appreciation
through the conversion feature, which enables the holder to benefit from any increases in the market price of the underlying common stock.
The common stock underlying convertible securities may be issued by a different entity than the issuer of the convertible securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The value of convertible
securities is influenced by both the yield of&#160;non-convertible&#160;securities of comparable issuers and by the value of the underlying
common stock. The value of a convertible security viewed without regard to its conversion feature (i.e., strictly on the basis of its
yield) is sometimes referred to as its &#8220;investment value.&#8221; The investment value of the convertible security typically will
fluctuate based on the credit quality of the issuer and will fluctuate inversely with changes in prevailing interest rates. However, at
the same time, the convertible security will be influenced by its &#8220;conversion value,&#8221; which is the market value of the underlying
common stock that would be obtained if the convertible security were converted. Conversion value fluctuates directly with the price of
the underlying common stock, and will therefore be subject to risks relating to the activities of the issuer and/or general market and
economic conditions. Depending upon the relationship of the conversion price to the market value of the underlying security, a convertible
security may trade more like an equity security than a debt instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 44; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">If, because of a
low price of the common stock, the conversion value is substantially below the investment value of the convertible security, the price
of the convertible security is governed principally by its investment value. If the conversion value of a convertible security increases
to a point that approximates or exceeds its investment value, the value of the security will be principally influenced by its conversion
value. A convertible security will sell at a premium over its conversion value to the extent investors place value on the right to acquire
the underlying common stock while holding a fixed-income security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Mandatory convertible
securities are distinguished as a subset of convertible securities because the conversion is not optional and the conversion price at
maturity (or redemption) is based solely upon the market price of the underlying common stock, which may be significantly less than par
or the price (above or below par) paid. Mandatory convertible securities may be called for conversion by the issuer after a particular
date and under certain circumstances (including at a specified price) established upon its issuance. For these reasons, the risks associated
with the investing in mandatory convertible securities most closely resemble the risks inherent in common stock. Mandatory convertible
securities customarily pay a higher coupon yield to compensate for the potential risk of additional price volatility and loss upon redemption.
Since the correlation of common stock risk increases as the security approaches its redemption date, there can be no assurance that the
higher coupon will compensate for the potential loss. If a mandatory convertible security is called for conversion, the Fund will be
required to either convert it into the underlying common stock or sell it to a third party, which may have an adverse effect on the Fund&#8217;s
ability to achieve its investment objective. Convertible securities generally offer lower interest or dividend yields than&#160;non-convertible&#160;fixed-income
securities of similar credit quality because of the potential for capital appreciation. The market values of convertible securities tend
to decline as interest rates increase and, conversely, to increase as interest rates decline. However, a convertible security&#8217;s
market value also tends to reflect the market price of the common stock of the issuing company, particularly when the stock price is
greater than the convertible security&#8217;s conversion price. The conversion price is defined as the predetermined price or exchange
ratio at which the convertible security can be converted or exchanged for the underlying common stock. As the market price of the underlying
common stock declines below the conversion price, the price of the convertible security tends to be increasingly influenced more by the
yield of the convertible security than by the market price of the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Mortgage-Related and Other Asset-Backed
Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Mortgage-related
securities are debt instruments that provide periodic payments consisting of interest and/or principal that are derived from or related
to payments of interest and/or principal on underlying mortgages. Additional payments on mortgage-related securities may be made out of
unscheduled prepayments of principal resulting from the sale of the underlying property, or from refinancing or foreclosure, net of fees
or costs that may be incurred. The mortgage-related securities in which the Fund invests will typically pay variable rates of interest,
although the Fund may invest in fixed-rate obligations as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund may invest
in certain asset-backed securities as discussed below. Asset-backed securities are payment claims that are securitized in the form of
negotiable paper that is issued by a financing company (generally called a special purpose vehicle or &#8220;SPV&#8221;). These securitized
payment claims are, as a rule, corporate financial assets brought into a pool according to specific diversification rules. The SPV is
a company founded solely for the purpose of securitizing these claims and its only asset is the risk arising out of this diversified asset
pool. On this basis, marketable securities are issued which, due to the diversification of the underlying risk, generally represent a
lower level of risk than the original assets. The redemption of the securities issued by the SPV takes place at maturity out of the cash
flow generated by the collected claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">A collateralized
loan obligation (&#8220;CLO&#8221;) is a structured credit security issued by an SPV that was created to reapportion the risk and return
characteristics of a pool of assets. The assets, typically senior loans, are used as collateral supporting the various debt tranches issued
by the SPV. The key feature of the CLO structure is the prioritization of the cash flows from a pool of debt securities among the several
classes of CLO holders, thereby creating a series of obligations with varying rates and maturities appealing to a wide range of investors.
CLOs generally are secured by an assignment to a trustee under an indenture pursuant to which the bonds are issued of collateral consisting
of a pool of debt instruments, usually,&#160;non-investment&#160;grade bank loans. Payments with respect to the underlying debt securities
generally are made to the trustee under the indenture. CLOs are designed to be retired as the underlying debt instruments are repaid.
In the event of sufficient early prepayments on such debt instruments, the class or series of CLO first to mature generally will be retired
prior to maturity. Therefore, although in most cases the issuer of CLOs will not supply additional collateral in the event of such prepayments,
there will be sufficient collateral to secure their priority with respect to other CLO tranches that remain outstanding. The credit quality
of these securities depends primarily upon the quality of the underlying assets, their priority with respect to other CLO tranches and
the level of credit support and/or enhancement provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 45; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The underlying assets
(e.g., loans) are subject to prepayments which shorten the securities&#8217; maturity and may lower their return. If the credit support
or enhancement is exhausted, losses or delays in payment may result if the required payments of principal and interest are not made. The
value of these securities also may change because of changes in the market&#8217;s perception of the creditworthiness of the servicing
agent for the pool, the originator of the pool, or the financial institution or fund providing the credit support or enhancement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund also may
invest in collateralized debt obligations (&#8220;CDOs&#8221;). A CDO is a structured credit security issued by an SPV that was created
to reapportion the risk and return characteristics of a pool of assets. The assets, typically&#160;non-investment&#160;grade bonds, leveraged
loans, and other asset-backed obligations, are used as collateral supporting the various debt and equity tranches issued by the SPV. CDOs
operate similarly to CLOs and are subject to the same inherent risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Generally,
rising interest rates tend to extend the duration of fixed-rate mortgage-related securities, making them more sensitive to changes in
interest rates. As a result, in a period of rising interest rates, mortgage-related securities held by the Fund may exhibit additional
volatility. This is known as extension risk. Nuveen Asset Management&#160;expects that the Fund will focus its mortgage-related investments
principally in adjustable rate mortgage-related and other asset- backed securities, which should minimize the Fund&#8217;s overall sensitivity
to interest rate volatility and extension risk. However, because interest rates on most adjustable rate mortgage-related and other asset-backed
securities typically only reset periodically (e.g., monthly or quarterly), changes in prevailing interest rates (and particularly sudden
and significant changes) can be expected to cause some fluctuation in the market value of these securities, including declines in market
value as interest rates rise. In addition, adjustable and fixed rate mortgage-related securities are subject to prepayment risk. This
can reduce the Fund&#8217;s returns because the Fund may have to reinvest that money at lower prevailing interest rates. Below investment
grade securities frequently have call features that allow an issuer to redeem a security at dates prior to its stated maturity at a specified
price (typically greater than par) only if certain prescribed conditions are met (commonly referred to as call protection). An issuer
may redeem a lower grade security if, for example, the issuer can refinance the debt at a lower cost due to declining interest rates
or an improvement in the credit standing of the issuer. senior loans typically have no such call protection. For premium bonds (bonds
acquired at prices that exceed their par or principal value) purchased by the Fund, prepayment risk may be increased. The Fund&#8217;s
investments in other asset-backed securities are subject to risks similar to those associated with mortgage-related securities, as well
as additional risks associated with the nature of the assets and the servicing of those assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><i>Mortgage-Backed
Securities.</i> The Fund may invest in mortgage-backed securities (&#8220;MBS&#8221;) guaranteed by, or secured by collateral that is
guaranteed by, the United States government, its agencies, instrumentalities or sponsored corporations. MBS are structured debt obligations
collateralized by pools of commercial or residential mortgages. Pools of mortgage loans and mortgage-related loans, such as mezzanine
loans, are assembled into pools of assets that secure or back securities sold to investors by various governmental, government-related
and private organizations. MBS in which the Fund may invest include those with fixed, floating or variable interest rates, those with
interest rates that change based on a specified index of interest rates and those with interest rates that change inversely to changes
in interest rates, as well as those that do not bear interest.</p>

<!-- Field: Page; Sequence: 46; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><i>Commercial Mortgage-Backed
Securities.</i> The Fund may invest in commercial mortgage-backed securities (&#8220;CMBS&#8221;). CMBS generally are multi-class debt
or pass-through certificates secured or backed by mortgage loans on commercial properties. CMBS generally are structured to provide protection
to the senior class investors against potential losses on the underlying mortgage loans. This protection generally is provided by having
the holders of subordinated classes of securities take the first loss if there are defaults on the underlying commercial mortgage loans.
Other protection, which may benefit all of the classes or particular classes, may include issuer guarantees, reserve funds, cross-collateralization
and over-collateralization. The Fund may invest in CMBS issued or sponsored by commercial banks, savings and loan institutions, mortgage
bankers, private mortgage insurance companies and other&#160;non-governmental&#160;issuers. CMBS have no governmental guarantee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.5in; background-color: white"><i>Asset-Backed Securities.</i>
The Fund may also invest in asset-backed securities (&#8220;ABS&#8221;). ABS are securities that are primarily serviced by the cash flows
of a discrete pool of receivables or other financial assets, either fixed or revolving, that by their terms convert into cash within
a finite time period. Asset-backed securitization is a financing technique in which financial assets, in many cases themselves less liquid,
are pooled and converted into instruments that may be offered and sold in the capital markets. While residential mortgages were the first
financial assets to be securitized in the form of MBS,&#160;non-mortgage&#160;related securitizations have grown to include many other
types of financial assets, such as credit card receivables, auto loans and student loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Other Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Common Stocks.</i>&#160;The
Fund may acquire common stocks and other equity securities. Common stocks generally represent an ownership interest in an issuer, without
preference over any other class of securities, including such issuer&#8217;s fixed income securities and senior equity securities. Dividend
payments generally are not guaranteed and so may be discontinued by the issuer at its discretion or because of the issuer&#8217;s inability
to satisfy its liabilities. Further, an issuer&#8217;s history of paying dividends does not guarantee that it will continue to pay dividends
in the future. In addition to dividends, under certain circumstances the Fund may benefit from capital appreciation of an issuer&#8217;s
common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Preferred Securities.&#160;</i>The
Fund may invest in preferred securities. Preferred securities, which generally pay fixed or adjustable rate dividends or interest to
investors, have preference over common stock in the payment of dividends or interest and the liquidation of a company&#8217;s assets,
which means that a company typically must pay dividends or interest on its preferred securities before paying any dividends on its common
stock. On the other hand, preferred securities are junior to all forms of the company&#8217;s debt, including both senior and subordinated
debt. Because of their subordinated position in the capital structure of an issuer, the ability to defer dividend or interest payments
for extended periods of time without triggering a default from legal action and certain other features, preferred securities are often
treated as equity-like instruments by both issuers and investors, as their quality and value are heavily dependent on the profitability
and cash flows of the issuer rather than on any legal claims to specific assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Contingent Capital
Securities.&#160;</i>The Fund may invest in Contingent Capital Securities (&#8220;CoCos&#8221;). CoCos are hybrid preferred or debt securities,
issued primarily by non-U.S. financial institutions, which have loss absorption mechanisms benefitting the issuer built into their terms.
CoCos generally provide for mandatory conversion into the common stock of the issuer or a write-down of the principal amount or value
of the CoCo upon the occurrence of certain &#8220;triggers.&#8221; These triggers are generally linked to regulatory capital thresholds
or regulatory actions calling into question the issuing banking institution&#8217;s continued viability as a going-concern. Equity conversion
or principal write-down features are tailored to the issuer and its regulatory requirements and, unlike traditional convertible securities,
conversions are not voluntary. In the event of a conversion, the market price of the issuer&#8217;s common stock received by the fund
likely would have declined, perhaps substantially, and might continue to decline. Further, the issuer&#8217;s common stock would be subordinate
to the issuer&#8217;s other classes of securities. A principal write down could result in the fund losing all or a portion of its investment.
For some CoCos, coupon payments are entirely discretionary and may be cancelled by the issuer at any time, for any reason, and for any
length of time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 47; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Other Corporate
Debt Securities</i>. The Fund may invest in corporate debt securities, including corporate bonds. Corporate bonds generally are used by
corporations to borrow money from investors. The issuer pays the investor a fixed or variable rate of interest and normally must repay
the amount borrowed on or before maturity. Certain bonds are &#8220;perpetual&#8221; in that they have no maturity date. The Fund may
invest in bonds and other debt securities of any quality. Corporate debt securities are fully taxable debt obligations issued by corporations.
These securities fund capital improvements, expansions, debt refinancing or acquisitions that require more capital than would ordinarily
be available from a single lender. Investors in corporate debt securities lend money to the issuing corporation in exchange for interest
payments and repayment of the principal at a set maturity date. Rates on corporate debt securities are set according to prevailing interest
rates at the time of the issue, the credit rating of the issuer, the length of the maturity and other terms of the security, such as a
call feature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in"><i>Loans</i>. The Fund may invest in loans,
including senior loans, as described above. These loans are typically made by or issued to corporations primarily to finance acquisitions,
refinance existing debt, support organic growth, or pay out dividends. The loans that the Fund invests typically bear interest at a floating
rate, although some loans may pay a fixed rate. Floating rate loans have interest rates that reset periodically, typically monthly or
quarterly. The interest rates on floating rate loans are generally based on a percentage above the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), a U.S. bank&#8217;s prime or
base rate, the overnight federal funds rate or another rate, but may still be based on a percentage above the legacy LIBOR. A loan participation
is an arrangement where the lender of a loan sells an interest, or participation, in the loan to an investor. Like an assignment, the
terms of the participation are privately negotiated, but unlike an assignment the holder of the participation does not have a contractual
relationship with the borrower and must rely on the lender to pass on to the investor the payments made by the borrower and to enforce
the rights to collateral. Unfunded commitments are contractual obligations by lenders (such as the Fund) to loan an amount in the future
or that is due to be contractually funded in the future. Loan assignments may be arranged through private negotiations between potential
assignees and potential assignors, and the rights and obligations acquired by the purchaser of an assignment may differ from, and be more
limited than, those held by the assigning lender.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in">Loans may have restrictive covenants limiting
the ability of a borrower to incur additional debt or to further borrow or encumber its assets. The types of covenants included in loan
agreements generally vary depending on market conditions, the creditworthiness of the borrower, the nature of the collateral securing
the loan and other factors. Such restrictive covenants normally allow for early intervention and proactive mitigation of credit risk by
providing lenders with the ability to (1) intervene and either prevent or restrict actions that may potentially compromise the borrower&#8217;s
ability to repay the loan and/or (2) obtain concessions from the borrower in exchange for waiving or amending a particular covenant. Loans
with fewer or weaker restrictive covenants may limit the Fund&#8217;s ability to intervene or obtain additional concessions from borrowers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Real Estate Investment
Trusts</i>. Real Estate Investment Trusts (&#8220;REITs&#8221;) are typically publicly traded corporations or trusts that invest in residential
or commercial real estate. REITs generally can be divided into the following three types: (i) equity REITs which invest the majority of
their assets directly in real property and derive their income primarily from rents and capital gains or real estate appreciation; (ii)
mortgage REITs which invest the majority of their assets in real estate mortgage loans and derive their income primarily from interest
payments; and (iii) hybrid REITs which combine the characteristics of equity REITs and mortgage REITs. The Fund can invest in common stock,
preferred securities, debt securities and convertible securities issued by REITs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Structured Notes</i>.
The Fund may utilize structured notes, which are privately negotiated debt obligations or economically equivalent instruments where the
principal and/or interest to be received by the investor is determined by reference to the performance of a benchmark asset, market or
interest rate (an &#8220;embedded index&#8221;), such as selected securities or loans, an index of securities or loans, or specified interest
rates, or the differential performance of two assets or markets. The Fund may utilize structured notes and similar instruments for investment
purposes and also for hedging purposes. Structured notes may be issued by corporations, including banks, as well as by governmental agencies.
Structured notes frequently are assembled in the form of medium-term notes, but a variety of forms are available and may be used in particular
circumstances. The terms of such structured notes normally provide that their principal and/or interest payments are to be adjusted upwards
or index while the structured notes are outstanding. As a result, the interest and/or principal payments that may be made on a structured
product may vary widely, depending on a variety of factors, including the volatility of the embedded index and the effect of changes in
the embedded index on principal and/or interest payments. The rate of return on structured notes may be determined by applying a multiplier
to the performance or differential performance of the referenced index(es) or other asset(s). Application of the multiplier involves leverage
that will serve to magnify the potential for gain and the risk of loss. Nuveen Asset Management&#160;may utilize structured notes for
investment purposes and also for risk management purposes, such as to reduce the duration and interest rate sensitivity of the Fund&#8217;s
portfolio. While structured notes may offer the potential for a favorable rate of return from time to time, they also entail certain risks.
Structured notes may be less liquid than other debt securities, and the price of structured notes may be more volatile. In some cases,
depending on the terms of the embedded index, a structured note may provide that the principal and/or interest payments may be adjusted
below zero. Structured notes also may involve significant credit risk and risk of default by the counterparty. Although structured notes
are not necessarily illiquid, Nuveen Fund Advisors believes that currently most structured notes are illiquid. Like other sophisticated
strategies, the Fund&#8217;s use of structured notes may not work as intended. If the value of the embedded index changes in a manner
other than that expected by Nuveen Asset Management,&#160;principal and/or interest payments received on the structured notes may be substantially
less than expected. Also, if Nuveen Asset Management&#160;uses structured notes to reduce the duration of the Fund&#8217;s portfolio,
this may limit the Fund&#8217;s return when having a longer duration of the Fund&#8217;s portfolio, this may limit the Fund&#8217;s return
when having a longer duration would be beneficial (for instance, when interest rates decline).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 48; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>U.S. Government
Securities</i>. The Fund may invest in U.S. Government securities. U.S. Government securities include (1)&#160;U.S. Treasury obligations,
which differ in their interest rates, maturities and times of issuance: U.S. Treasury bills (maturities of one year or less), U.S. Treasury
notes (maturities of one year to ten years) and U.S. Treasury bonds (generally maturities of greater than ten years) and (2)&#160;obligations
issued or guaranteed by U.S. Government agencies and instrumentalities that are supported by any of the following: (i)&#160;the full faith
and credit of the U.S. Treasury, (ii)&#160;the right of the issuer to borrow an amount limited to a specific line of credit from the U.S.
Treasury, (iii)&#160;discretionary authority of the U.S. Government to purchase certain obligations of the U.S. Government agency or instrumentality
or (iv)&#160;the credit of the agency or instrumentality While the U.S. Government provides financial support to such U.S. Government-sponsored
agencies or instrumentalities, no assurance can be given that it always will do so since it is not so obligated by law. The U.S. Government,
its agencies and instrumentalities do not guarantee the market value of their securities. Consequently, the value of such securities may
fluctuate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Below Investment
Grade Securities.</i>&#160;Investments in below investment grade securities, commonly referred to as junk bonds or high yield debt, generally
provide greater income and increased opportunity for capital appreciation than investments in higher quality securities, but they also
typically entail greater price volatility and principal and income risk, including the possibility of issuer default and bankruptcy. Issuers
of below investment grade securities may be highly leveraged and may not have available to them more traditional methods of financing.
Securities in the lowest investment grade category also may be considered to possess some speculative characteristics by certain rating
agencies. In addition, analysis of the creditworthiness of issuers of below investment grade securities may be more complex than for issuers
of higher quality securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Below investment
grade securities may be more susceptible to real or perceived adverse economic and competitive industry conditions than investment grade
securities. A projection of an economic downturn or of a period of rising interest rates, for example, could cause a decline in lower-grade
security prices because the advent of a recession could lessen the ability of an issuer to make principal and interest payments on its
debt obligations. If an issuer of below investment grade securities defaults, in addition to risking payment of all or a portion of interest
and principal, the Fund may incur additional expenses to seek recovery. In the case of below investment grade securities structured as
zero coupon or&#160;payment-in-kind&#160;securities, their market prices will normally be affected to a greater extent by interest rate
changes, and therefore tend to be more volatile than securities which pay interest currently and in cash. Nuveen Asset Management&#160;seeks
to reduce these risks through diversification, credit analysis and attention to current developments and trends in both the economy and
financial markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The secondary market
for below investment grade securities may not be as liquid as the secondary market for more highly rated securities, a factor which may
have an adverse effect on the Fund&#8217;s ability to dispose of a particular security. There are fewer dealers in the market for below
investment grade securities than for investment grade obligations. The prices quoted by different dealers may vary significantly and the
spread between the bid and ask price is generally much larger than for higher quality instruments. Under adverse market or economic conditions,
the secondary market for below investment grade securities could contract further, independent of any specific adverse changes in the
condition of a particular issuer, and these instruments may become illiquid. As a result, the Fund could find it more difficult to sell
these securities or may be able to sell the securities only at prices lower than if such securities were widely traded. Prices realized
upon the sale of such lower rated or unrated securities, under these circumstances, may be less than the prices used in calculating the
Fund&#8217;s NAV.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 49; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Adverse publicity
and investor perceptions, whether or not based on fundamental analysis, may decrease the values and liquidity of below investment grade
securities, especially in a thinly traded market. When secondary markets for below investment grade securities are less liquid than the
market for investment grade securities, it may be more difficult to value the securities because such valuation may require more research,
and elements of judgment may play a greater role in the valuation because there is less reliable, objective data available. During periods
of thin trading in these markets, the spread between bid and asked prices is likely to increase significantly and the Fund may have greater
difficulty selling its portfolio securities. The Fund will be more dependent on Nuveen Asset Management&#8217;s research and analysis
when investing in below investment grade securities. Nuveen Asset Management&#160;seeks to minimize the risks of investing in all securities
through&#160;in-depth&#160;credit analysis and attention to current developments in interest rates and market conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The ratings of Moody&#8217;s,
S&amp;P and Fitch represent their opinions as to the quality of the securities they rate. It should be emphasized, however, that ratings
are general and are not absolute standards of quality. Consequently, in the case of debt obligations, certain debt obligations with the
same maturity, coupon and rating may have different yields while debt obligations with the same maturity and coupon with different ratings
may have the same yield. For these reasons, the use of credit ratings as the sole method of evaluating lower-grade securities can involve
certain risks. For example, credit ratings evaluate the safety of principal and interest payments, not the market value risk of lower-grade
securities. Also, credit rating agencies may fail to change credit ratings in a timely fashion to reflect events since the security was
last rated. Nuveen Asset Management&#160;does not rely solely on credit ratings when selecting securities for the Fund, and develops its
own independent analysis of issuer credit quality.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Fund&#8217;s credit quality policies apply only at the time a security is purchased, and the Fund is not required to dispose of a security
in the event that a rating agency or Nuveen Asset Management&#160;downgrades its assessment of the credit characteristics of a particular
issue. In determining whether to retain or sell such a security, Nuveen Asset Management&#160;may consider such factors as its assessment
of the credit quality of the issuer of such security, the price at which such security could be sold and the rating, if any, assigned
to such security by other rating agencies. However, analysis of the creditworthiness of issuers of below investment grade securities may
be more complex than for issuers of higher quality debt securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-right: 0; margin-bottom: 0; background-color: white"><b>Securities
Issued by&#160;Non-U.S.&#160;Issuers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>General</i>. The
Fund may invest in securities of&#160;non-U.S.&#160;issuers that are U.S. dollar or&#160;non-U.S.&#160;dollar denominated. The Fund may
invest in any region of the world and invest in companies operating in developed countries such as Canada, Japan, Australia, New Zealand
and most Western European countries. An &#8220;emerging market&#8221; country is any country determined to have an emerging markets economy,
considering, among other things, factors such as whether the country has a&#160;low-to-middle&#160;income economy according to the World
Bank or its related organizations, the country&#8217;s credit rating, its political and economic stability and the development of its
financial and capital markets. These countries generally include countries located in Latin America, the Caribbean, Asia, Africa, the
Middle East and Eastern and Central Europe. Securities of&#160;non-U.S.&#160;issuers include American Depository Receipts (&#8220;ADRs&#8221;), Global Depositary Receipts (&#8220;GDRs&#8221;) or
other securities representing underlying shares of&#160;non-U.S.&#160;issuers. Positions in those securities are not necessarily denominated
in the same currency as the common stock into which they may be converted. ADRs are receipts typically issued by an American bank or trust
company evidencing ownership of the underlying securities. GDRs are U.S. dollar-denominated receipts evidencing ownership of&#160;non-U.S.&#160;securities.
Generally, ADRs, in registered form, are designed for the U.S. securities markets and GDRs, in bearer form, are designed for use in&#160;non-U.S.&#160;securities
markets. The Fund may invest in sponsored or unsponsored ADRs. In the case of an unsponsored ADR, the Fund is likely to bear its proportionate
share of the expenses of the depository and it may have greater difficulty in receiving shareholder communications than it would have
with a sponsored ADR.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 50; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Investors should
understand and consider carefully the risks involved in investing in securities of&#160;non-U.S.&#160;issuers. Investing in securities
of&#160;non-U.S.&#160;issuers involves certain considerations comprising both risks and opportunities not typically associated with investing
in securities of U.S. issuers. These considerations include: (i)&#160;less publicly available information about&#160;non-U.S.&#160;issuers
or markets due to less rigorous disclosure or accounting standards or regulatory practices; (ii)&#160;many&#160;non-U.S.&#160;markets
are smaller, less liquid and more volatile, meaning that, in a changing market, Nuveen Asset Management&#160;may not be able to sell the
Fund&#8217;s portfolio securities at times, in amounts or at prices it considers reasonable; (iii)&#160;potential adverse effects of fluctuations
in currency exchange rates or controls on the value of the Fund&#8217;s investments; (iv)&#160;the economies of&#160;non-U.S.&#160;countries
may grow at slower rates than expected or may experience a downturn or recession; (v)&#160;the impact of economic, political, social or
diplomatic developments may adversely affect the securities markets; (vi)&#160;withholding and other&#160;non-U.S.&#160;taxes may decrease
the Fund&#8217;s return; (vii)&#160;certain&#160;non-U.S.&#160;countries may impose restrictions on the ability of&#160;non-U.S.&#160;issuers
to make payments of principal and/or interest to investors located outside the U.S. due to blockage of foreign currency exchanges or otherwise;
and (viii)&#160;possible seizure, expropriation or nationalization of the company or its assets. These risks are more pronounced to the
extent that the Fund invests a significant amount of its investments in issuers located in one region and to the extent that the Fund
invests in securities of issuers in emerging markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Although the Fund
may hedge its exposure to certain of these risks, including the foreign currency exchange rate risk, there can be no assurance that the
Fund will enter into hedging transactions at any time or at times or under circumstances in which it might be advisable to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Debt Obligations
of&#160;Non-US&#160;Governments</i>. An investment in debt obligations of&#160;non-U.S.&#160;governments and their political subdivisions
(sovereign debt) involves special risks that are not present in corporate debt obligations. The&#160;non-U.S.&#160;issuer of the sovereign
debt or the&#160;non-U.S.&#160;governmental authorities that control the repayment of the debt may be unable or unwilling to repay principal
or interest when due, and the Fund may have limited recourse in the event of a default. During periods of economic uncertainty, the market
prices of sovereign debt may be more volatile than prices of debt obligations of U.S. issuers. In the past, certain&#160;non-U.S.&#160;countries
have encountered difficulties in servicing their debt obligations, withheld payments of principal and interest and declared moratoria
on the payment of principal and interest on their sovereign debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">A sovereign debtor&#8217;s
willingness or ability to repay principal and pay interest in a timely manner may be affected by, among other factors, its cash flow situation,
the extent of its&#160;non-U.S.&#160;currency reserves, the availability of sufficient&#160;non-U.S.&#160;currency, the relative size
of the debt service burden, the sovereign debtor&#8217;s policy toward its principal international lenders and local political constraints.
Sovereign debtors may also be dependent on expected disbursements from&#160;non-U.S.&#160;governments, multilateral agencies and other
entities to reduce principal and interest arrearages on their debt. The failure of a sovereign debtor to implement economic reforms, achieve
specified levels of economic performance or repay principal or interest when due may result in the cancellation of third-party commitments
to lend funds to the sovereign debtor, which may further impair such debtor&#8217;s ability or willingness to service its debts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><i>Eurodollar Instruments
and Yankee Bonds</i>. The Fund may invest in Eurodollar instruments and Yankee bonds. Yankee bonds are U.S. dollar denominated bonds typically
issued in the U.S. by&#160;non-U.S.&#160;governments and their agencies and&#160;non-U.S.&#160;banks and corporations. These investments
involve risks that are different from investments in securities issued by U.S. issuers, including potential unfavorable political and
economic developments,&#160;non-U.S.&#160;withholding or other taxes, seizure of&#160;non-U.S.&#160;deposits, currency controls, interest
limitations or other governmental restrictions which might affect payment of principal or interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><i>Catastrophe Bonds.</i>
Catastrophe bonds are typically backed by a secured collateral account. Exposure to catastrophe bonds results in gains or losses that
typically are contingent upon, or formulaically related to, defined trigger events. Examples of trigger events include hurricanes, earthquakes,
weather-related phenomena or statistics relating to such events. If a trigger event, as defined within the terms of the bond, involves
losses or other metrics exceeding a specific magnitude in the geographic region and/or time period specified therein, the Fund may lose
a portion or all of its investments in such security, including accrued interest and/or principal invested in such security. If no trigger
event occurs, the Fund would typically recover its principal plus interest.</p>

<!-- Field: Page; Sequence: 51; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Zero Coupon and&#160;Payment-In-Kind&#160;Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund&#8217;s
investments in debt securities may be in the form of a zero coupon bond or&#160;payment-in-kind&#160;securities. Zero coupon bonds are
debt obligations that do not entitle the holder to any periodic payments of interest for the entire life of the obligation. When held
to its maturity, its return comes from the difference between the purchase price and its maturity value.&#160;Payment-in-kind&#160;securities
(&#8220;PIKs&#8221;) pay dividends or interest in the form of additional securities of the issuer, rather than in cash. Each of these
instruments is typically issued and traded at a deep discount from its face amount. The amount of the discount varies depending on such
factors as the time remaining until maturity of the securities, prevailing interest rates, the liquidity of the security and the perceived
credit quality of the issuer. The market prices of zero coupon bonds and PIKs generally are more volatile than the market prices of debt
instruments that pay interest currently and in cash and are likely to respond to changes in interest rates to a greater degree than do
other types of securities having similar maturities and credit quality. In order to qualify for treatment as a regulated investment company
under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the Fund must generally distribute for each year at least
90% of its net investment income, including the original issue discount accrued on zero coupon bonds and PIKs. Because the Fund will not
on a current basis receive cash payments from the issuer of these securities in respect of any accrued original issue discount, in some
years the Fund may have to distribute cash obtained from selling portfolio holdings of the Fund in order to avoid unfavorable tax consequences.
In some circumstances, such sales might be necessary in order to satisfy cash distribution requirements even though investment considerations
might otherwise make it undesirable for the Fund to sell securities at such time. Under many market conditions, investments in zero coupon
bonds and PIKs may be illiquid, making it difficult for the Fund to dispose of them or determine their current value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>When-Issued and Delayed-Delivery Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund may buy
and sell municipal securities on a when-issued or delayed delivery basis, making payment or taking delivery at a later date, normally
within 15 to 45 days of the trade date. On such transactions, the payment obligation and the interest rate are fixed at the time the buyer
enters into the commitment. Income generated by any such assets which provide taxable income for federal income tax purposes is includable
in the taxable income of the Fund and, to the extent distributed, will be taxable to shareholders. The Fund may enter into contracts to
purchase municipal securities on a forward basis (i.e., where settlement will occur more than 60 days from the date of the transaction)
only to the extent that the Fund specifically collateralizes such obligations with a security that is expected to be called or mature
within 60 days before or after the settlement date of the forward transaction. The commitment to purchase securities on a when-issued,
delayed delivery or forward basis may involve an element of risk because no interest accrues on the bonds prior to settlement and, at
the time of delivery, the market value may be less than cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #000000"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #000000"><b>Derivatives and Hedging Strategies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">The Fund may
enter into certain derivative instruments in pursuit of its investment objective, including to seek to enhance return, to hedge certain
risks of its investments in fixed-income securities or as a substitute for a position in the underlying asset. Such instruments include
options, financial futures contracts, swap contracts (including interest rate, credit default swaps and currency swaps), options on financial
futures, options on swap contracts, forward foreign currency contracts and options on foreign currencies or other derivative instruments.
The Fund&#8217;s use of currency-related derivative instruments will be limited to hedging purposes only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">&#8220;Hedging&#8221;
is a term used for various methods of seeking to preserve portfolio capital value by offsetting price changes in one investment through
making another investment whose price should tend to move in the opposite direction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">A &#8220;derivative&#8221;
is a financial contract whose value is based on (or &#8220;derived&#8221; from) a traditional security (such as a stock or a bond), an
asset (such as a commodity like gold), or a market index (such as the S&amp;P National Bond Fund Index). Some forms of derivatives may
trade on exchanges, while non-standardized derivatives, which tend to be more specialized and complex, trade in &#8220;over-the-counter&#8221; (&#8220;OTC&#8221;) or a one-on-one basis. It may be desirable and possible in various market environments to partially hedge the portfolio
against fluctuations in market value due to market interest rate or credit quality fluctuations, or instead to gain a desired investment
exposure, by entering into various types of derivative transactions, including financial futures and index futures as well as related
put and call options on such instruments, structured notes, or interest rate swaps on taxable or tax-exempt securities or indexes (which
may be &#8220;forward-starting&#8221;), credit default swaps, and options on interest rate swaps, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<!-- Field: Page; Sequence: 52; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #000000"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">These
transactions present certain risks. In particular, the imperfect correlation between price movements in the futures contract and price
movements in the securities being hedged creates the possibility that losses on the hedge by the Fund may be greater than gains in the
value of the securities in the Fund&#8217;s portfolio. In addition, futures and options markets may not be liquid in all circumstances.
As a result, in volatile markets, the Fund may not be able to close out the transaction without incurring losses substantially greater
than the initial deposit. Finally, the potential deposit requirements in futures contracts create an ongoing greater potential financial
risk than do options transactions, where the exposure is limited to the cost of the initial premium. Losses due to hedging transactions
will reduce yield. The Fund will invest in these instruments only in markets believed by the Adviser and/or the Sub-Adviser to be active
and sufficiently liquid. Net gains, if any, from hedging and other portfolio transactions will be distributed as taxable distributions
to shareholders. Successful implementation of most hedging strategies will generate taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Both
parties entering into an index or financial futures contract are required to post an initial deposit, typically equal to from 1% to 5%
of the total contract price. Typically, option holders enter into offsetting closing transactions to enable settlement in cash rather
than take delivery of the position in the future of the underlying security. Interest rate swap and credit default swap transactions are
typically entered on a net basis, meaning that the two payment streams are netted out with the Fund receiving or paying, as the case may
be, only the net amount of the two payments. The Fund will sell only covered futures contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">There
is no assurance that these derivative strategies will be available at any time or that Nuveen Fund Advisors and/or Nuveen Asset Management
will determine to use them for the Fund or, if used, that the strategies will be successful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Short
Sales</i>. The Fund may make short sales of securities if, at all times when a short position is open, the Fund owns at least an equal
amount of such securities or securities convertible into or exchangeable for, without payment of any further consideration, securities
of the same issuer as, and equal in amount to, the securities sold short. This technique is called selling short &#8220;against the box.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">In a short sale, the
Fund will not deliver from its portfolio the securities sold and will not receive immediately the proceeds from the sale. Instead, the
Fund will borrow the securities sold short from a broker-dealer through which the short sale is executed and the broker-dealer will deliver
such securities, on behalf of the Fund, to the purchaser of such securities. Such broker-dealer will be entitled to retain the proceeds
from the short sale until the Fund delivers to such broker-dealer the securities sold short. In addition, the Fund will be required to
pay the broker-dealer the amount of any dividends paid on shares sold short. Finally, to secure its obligation to deliver to such broker-dealer
the securities sold short, the Fund must deposit and continuously maintain in a separate account with its custodian an equivalent amount
of the securities sold short or securities convertible into or exchangeable for such securities without the payment of additional consideration.
The Fund is said to have a short position in the securities sold until it delivers to the broker-dealer the securities sold, at which
time the Fund will receive the proceeds of the sale. Because the Fund ordinarily will want to continue to hold securities in its portfolio
that are sold short, the Fund will normally close out a short position by purchasing on the open market and delivering to the broker-dealer
an equal amount of the securities sold short, rather than delivering portfolio securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">Short sales may protect
the Fund against the risk of losses in the value of its portfolio securities because any unrealized losses with respect to such portfolio
securities should be wholly or partially offset by a corresponding gain in the short position. However, any potential gain in such portfolio
securities should be wholly or partially offset by a corresponding loss in the short position. The extent to which such gains or losses
are offset will depend upon the amount of securities sold short relative to the amount the Fund owns, either directly or indirectly, and,
in the case where the Fund owns convertible securities, changes in the conversion premium. The Fund will incur transaction costs in connection
with short sales.</p>

<!-- Field: Page; Sequence: 53; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">In addition to enabling
the Fund to hedge against market risk, short sales may afford the Fund an opportunity to earn additional current income to the extent
the Fund is able to enter into arrangements with broker- dealers through which the short sales are executed to receive income with respect
to the proceeds of the short sales during the period the Fund&#8217;s short positions remain open.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; background-color: white">The Code imposes constructive
sale treatment for federal income tax purposes on certain hedging strategies with respect to appreciated financial positions. Under these
rules, the Fund will recognize gain, but not loss, with respect to securities if it enters into short sales or &#8220;offsetting notional
principal contracts&#8221; (as defined by the Code) with respect to, or futures or forward contracts to deliver, the same or substantially
identical property, or if it enters into such transactions and then acquires the same or substantially identical property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white; color: #000000"><i>Options
on Securities</i>.&#160;&#160;&#160;&#160;In order to hedge against adverse market shifts, the Fund may purchase put and call options
on stock, bonds or other securities. In addition, the Fund may seek to hedge a portion of its portfolio investments through writing (i.e.,
selling) covered put and call options. A put option embodies the right of its purchaser to compel the writer of the option to purchase
from the option holder an underlying security or its equivalent at a specified price at any time during the option period. In contrast,
a call option gives the purchaser the right to buy the underlying security covered by the option or its equivalent from the writer of
the option at the stated exercise price at any time during the option period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white; color: #000000">As
a holder of a put option, the Fund will have the right to sell the securities underlying the option and as the holder of a call option,
the Fund will have the right to purchase the securities underlying the option, in each case at their exercise price at any time during
the option period prior to the option&#8217;s expiration date. The Fund may choose to exercise the options it holds, permit them to expire
or terminate them prior to their expiration by entering into closing sale or purchase transactions. In entering into a closing sale or
purchase transaction, the Fund would sell an option of the same series as the one it has purchased. The ability of the Fund to enter into
a closing sale transaction with respect to options purchased and to enter into a closing purchase transaction with respect to options
sold depends on the existence of a liquid secondary market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white; color: #000000">In
purchasing a put option, the Fund will seek to benefit from a decline in the market price of the underlying security, while in purchasing
a call option, the Fund will seek to benefit from an increase in the market price of the underlying security. If an option purchased is
not sold or exercised when it has remaining value, or if the market price of the underlying security remains equal to or greater than
the exercise price, in the case of a put, or remains equal to or below the exercise price, in the case of a call, during the life of the
option, the option will expire worthless. For the purchase of an option to be profitable, the market price of the underlying security
must decline sufficiently below the exercise price, in the case of a put, and must increase sufficiently above the exercise price, in
the case of a call, to cover the premium and transaction costs. Because option premiums paid by the Fund are small in relation to the
market value of the instruments underlying the options, purchasing options can result in amounts of leverage to the Fund. The leverage
caused by trading in options could cause the Fund&#8217;s NAV to be subject to more frequent and wider fluctuation than would be the case
if the Fund did not invest in options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white; color: #000000">The
Fund will receive a premium when it writes put and call options, which increases the Fund&#8217;s return on the underlying security in
the event the option expires unexercised or is closed out at a profit. By writing a call, the Fund will limit its opportunity to profit
from an increase in the market value of the underlying security above the exercise price of the option for as long as the Fund&#8217;s
obligation as the seller of the option continues. Upon the exercise of a put option written by the Fund, the Fund may suffer an economic
loss equal to the difference between the price at which the Fund is required to purchase the underlying security and its market value
at the time of the option exercise, less the premium received for writing the option. Upon the exercise of a call option written by the
Fund, the Fund may suffer an economic loss equal to an amount not less than the excess of the security&#8217;s market value at the time
of the option exercise over the Fund&#8217;s acquisition cost of the security, less the sum of the premium received for writing the option
and the difference, if any, between the call price paid to the Fund and the Fund&#8217;s acquisition cost of the security. Thus, in some
periods the Fund might receive less total return and in other periods greater total return from its hedged positions than it would have
received from its underlying securities unhedged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white; color: #000000"><i>Options
on Stock and Bond Indexes</i>.&#160;&#160;&#160;&#160;The Fund may purchase put and call options on stock indexes and bond indexes to
hedge against risks of market-wide price movements affecting its assets. In addition, the Fund may write covered put and call options
on stock and bond indexes. The advisability of using stock or bond index options to hedge against the risk of market-wide movements will
depend on the extent of diversification of the Fund&#8217;s investments and the sensitivity of its investments to factors influencing
the underlying index. The effectiveness of purchasing or writing stock or bond index options as a hedging technique will depend upon the
extent to which price movements in the Fund&#8217;s investments correlate with price movements in the stock or bond index selected. In
addition, successful use by the Fund of options on stock or bond indexes will be subject to the ability of the adviser to predict correctly
changes in the relationship of the underlying index to the Fund&#8217;s portfolio holdings. No assurance can be given that Nuveen Asset
Management&#8217;s judgment in this respect will be correct.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 54; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Stock
and Bond Index Futures Contracts</i>.&#160;&#160;&#160;&#160;The Fund may purchase and sell stock or bond index futures as a hedge against
movements in the equity or bond markets. Stock and bond index futures contracts are agreements in which one party agrees to deliver to
the other an amount of cash equal to a specific dollar amount times the difference between the value of a specific stock or bond index
at the close of the last trading day of the contract and the price at which the agreement is made. No physical delivery of securities
is made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">For
example, if Nuveen Asset Management expects general stock or bond market prices to decline, they might sell a futures contract on a particular
stock or bond index. If that index does in fact decline, the value of some or all of the securities in the Fund&#8217;s portfolio may
also be expected to decline, but that decrease would be offset in part by the increase in the value of the Fund&#8217;s position in such
futures contract. If, on the other hand, Nuveen Asset Management expects general stock or bond market prices to rise, they might purchase
a stock or bond index futures contract as a hedge against an increase in prices of particular securities they want ultimately to purchase.
If in fact the stock or bond index does rise, the price of the particular securities intended to be purchased may also increase, but that
increase would be offset in part by the increase in the value of the Fund&#8217;s futures contract resulting from the increase in the
index. The Fund may purchase futures contracts on a stock or bond index to enable Nuveen Asset Management to gain immediate exposure to
the underlying securities market pending the investment in individual securities of the Fund&#8217;s portfolio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Parties
to a futures contract must make &#8220;initial margin&#8221; deposits to secure performance of the contract. There are also requirements
to make &#8220;variation margin&#8221; deposits from time to time as the value of the futures contract fluctuates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">The
potential loss related to the purchase of an option on a futures contract is limited to the premium paid for the option (plus transaction
costs).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">With
respect to options purchased by the Fund, there are no daily cash payments made by the Fund to reflect changes in the value of the underlying
contract; however, the value of the option does change daily and that change would be reflected in the NAV of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Other
Futures Contracts and Options on Futures Contracts</i>.&#160;&#160;&#160;&#160;The Fund&#8217;s use of derivative instruments also may
include (i)&#160;U.S. Treasury security or U.S. Government Agency security futures contracts; and (ii)&#160;options on U.S. Treasury
security or U.S. Government Agency security futures contracts. All such instruments must be traded and listed on an exchange. U.S. Treasury
and U.S. Government Agency futures contracts are standardized contracts for the future delivery of a U.S. Treasury Bond or U.S. Treasury
Note or a U.S. Government Agency security or their equivalent at a future date at a price set at the time of the contract. An option
on a U.S. Treasury or U.S. Government Agency futures contract, as contrasted with the direct investment in such a contract, gives the
purchaser of the option the right, in return for the premium paid, to assume a position in a U.S. Treasury or U.S. Government Agency
futures contract at a specified exercise price at any time on or before the expiration date of the option. Upon exercise of an option,
the delivery of the futures position by the seller of the option to the holder of the option will be accompanied by delivery of the accumulated
balance in the seller&#8217;s future margin account, which represents the amount by which the market price of the futures contract exceeds
the exercise price of the option on the futures contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Risks
Associated with Futures Contracts and Options on Futures Contracts</i>.&#160;&#160;&#160;&#160;Futures prices are affected by many factors,
such as current and anticipated short-term interest rates, changes in volatility of the underlying instrument and the time remaining until
expiration of the contract. A purchase or sale of a futures contract may result in losses in excess of the amount invested in the futures
contract. While the Fund may enter into futures contracts and options on futures contracts for hedging purposes, the use of futures contracts
and options on futures contracts might result in a poorer overall performance for the Fund than if it had not engaged in any such transactions.
If, for example, the Fund had insufficient cash, it might have to sell a portion of its underlying portfolio of securities in order to
meet daily variation margin requirements on its futures contracts or options on futures contracts at a time when it might be disadvantageous
to do so. There may be an imperfect correlation between the Fund&#8217;s portfolio holdings and futures contracts or options on futures
contracts entered into by the Fund, which may prevent the Fund from achieving the intended hedge or expose the Fund to risk of loss. The
degree of imperfection of correlation depends on circumstances such as: variations in speculative market demand for futures, futures options
and the related securities, including technical influences in futures and futures options trading and differences between the securities
markets and the securities underlying the standard contracts available for trading. Futures prices are affected by many factors, such
as current and anticipated short-term interest rates, changes in volatility of the underlying instrument and the time remaining until
the expiration of the contract. Further, the Fund&#8217;s use of futures contracts and options on futures contracts to reduce risk involves
costs and will be subject to Nuveen Asset Management&#8217;s ability to predict correctly changes in interest rate relationships or other
factors. A decision as to whether, when and how to use futures contracts involves the exercise of skill and judgment, and even a well-conceived
transaction may be unsuccessful to some degree because of market behavior or unexpected stock price or interest rate trends. No assurance
can be given that Nuveen Asset Management&#8217;s judgment in this respect will be correct.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 55; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Futures
exchanges may limit the amount of fluctuation permitted in certain futures contract prices during a single trading day. The daily limit
establishes the maximum amount that the price of a futures contract may vary either up or down from the previous day&#8217;s settlement
price at the end of the current trading session. Once the daily limit has been reached in a futures contract subject to the limit, no
more trades may be made on that day at a price beyond that limit. The daily limit governs only price movements during a particular trading
day and therefore does not limit potential losses because the limit may work to prevent the liquidation of unfavorable positions. For
example, futures prices have occasionally moved to the daily limit for several consecutive trading days with little or no trading, thereby
preventing prompt liquidation of positions and subjecting some holders of futures contracts to substantial losses. Stock index futures
contracts are not normally subject to such daily price change limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>The
Fund may invest in other options</i>.&#160;&#160;&#160;&#160;An option is an instrument that gives the holder of the instrument the right,
but not the obligation, to purchase or sell a predetermined number of specific securities (i.e., preferred stocks, common stocks or bonds)
at a stated price within the expiration period of the instrument, which is generally less than 12 months from its issuance. If the right
is not exercised after a specified period but prior to the expiration, the option expires. Both put and call options may be used by the
Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">The
Fund may purchase and sell various other kinds of financial futures contracts and options thereon. Futures contracts may be based on
various debt securities and securities indexes. Such transactions involve a risk of loss or depreciation due to unanticipated adverse
changes in securities prices, which may exceed the Fund&#8217;s initial investment in these contracts. The Fund only purchases or sells
futures contracts or related options in compliance with the rules of the Commodity Futures Trading Commission (&#8220;CFTC&#8221;). These transactions involve transaction costs. There can
be no assurance that the Fund&#8217;s use of futures will be advantageous to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Interest
Rate Swaps, Caps, Collars and Floors.</i>&#160;The Fund expects that the Fund&#8217;s portfolio investments in adjustable rate debt instruments
in which the Fund may invest will serve as a hedge against the risk that common share net income and/or returns may decrease due to rising
market dividend or interest rates on any preferred shares or borrowings. If market conditions are deemed favorable, the Fund also may
enter into interest rate swap or cap transactions to attempt to protect itself from such interest rate risk on the remaining amount of
any outstanding preferred shares and/or borrowings. Interest rate swaps involve the Fund&#8217;s agreement with the swap counterparty
to pay a fixed rate payment in exchange for the counterparty agreeing to pay the Fund a payment at a variable rate that is expected to
approximate the rate on the Fund&#8217;s variable rate payment obligation on borrowings or any variable rate preferred shares. The payment
obligations would be based on the notional amount of the swap. The Fund may use an interest rate cap, which would require it to pay a
premium to the cap counterparty and would entitle it, to the extent that a specified variable rate index exceeds a predetermined fixed
rate, to receive from the counterparty payment of the difference based on the notional amount. The Fund would use interest rate swaps
or caps only with the intent to reduce or eliminate the risk that an increase in short-term interest rates could have on common share
net earnings as a result of leverage. The purchase of an interest rate floor entitles the purchaser, to the extent that a specified index
falls below a predetermined interest rate, to receive payments of interest on a notional principal amount from the party selling such
interest rate floor. Interest rate collars involve selling a cap and purchasing a floor or vice versa to protect the Fund against interest
rate movements exceeding given minimum or maximum levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 56; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000">Because adjustable
rate debt instruments in which the Fund may invest and the Fund&#8217;s preferred shares and borrowings generally pay interest or dividends
based on short-term market interest rates, the Fund&#8217;s investments in adjustable rate debt instruments may potentially offset the
leverage risks borne by the Fund relating to the fluctuations on common share income due to variations in the preferred share dividend
rate and/or the interest rate on borrowings. The Fund will usually enter into swaps or caps on a net basis; that is, the two payment streams
will be netted out in a cash settlement on the payment date or dates specified in the instrument, with the Fund receiving or paying, as
the case may be, only the net amount of the two payments. The Fund will not enter into any interest rate swap unless the claims-paying
ability of the other party thereto is considered to be investment grade by Nuveen Fund Advisors. If there is a default by the other party
to such a transaction, the Fund will have contractual remedies pursuant to the agreements related to the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">The
Fund may use interest rate swaps for risk management purposes only and not as a speculative investment and would typically use interest
rate swaps to shorten the average interest rate reset time of the Fund&#8217;s holdings. The use of interest rate transactions, such as
interest rate swaps and caps, is a highly specialized activity that involves investment techniques and risks different from those associated
with ordinary portfolio security transactions. Depending on the state of interest rates in general, the Fund&#8217;s use of interest rate
swaps or caps could enhance or harm the overall performance of the Common Shares. To the extent there is a decline in interest rates,
the value of the interest rate swap or cap could decline, and could result in a decline in the NAV of
Common Shares. In addition, if short-term interest rates are lower than the Fund&#8217;s fixed rate of payment on the interest rate swap,
the swap will reduce common share net earnings. If, on the other hand, short-term interest rates are higher than the fixed rate of payment
on the interest rate swap, the swap will enhance common share net earnings. Buying interest rate caps could enhance the performance of
the common shares by providing a maximum leverage expense. Buying interest rate caps could also decrease the net earnings of the common
shares in the event that the premium paid by the Fund to the counterparty exceeds the additional amount the Fund would have been required
to pay had it not entered into the cap agreement. The Fund will not enter into interest rate swap or cap transactions in an aggregate
notional amount that exceeds the remainder of the outstanding amount of the Fund&#8217;s leverage, less the amount of adjustable rate
debt instruments in the Fund&#8217;s portfolio. The Fund has no current intention of selling an interest rate swap or cap. The Fund will
monitor its interest rate swap and cap transactions with a view to insuring that it remains in compliance with all applicable tax requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Interest
rate swaps and caps do not involve the delivery of securities or other underlying assets or principal. Accordingly, the risk of loss with
respect to interest rate swaps is limited to the net amount of interest payments that the Fund is contractually obligated to make. If
the counterparty defaults, the Fund would not be able to use the anticipated net receipts under the swap or cap to offset the interest
payments on borrowings or dividend payments on the preferred shares. Depending on whether the Fund would be entitled to receive net payments
from the counterparty on the swap or cap, which in turn would depend on the general state of short-term interest rates at that point in
time, such a default could negatively impact the performance of the common shares. Although this will not guarantee that the counterparty
does not default, the Fund will not enter into an interest rate swap or cap transaction with any counter-party that Nuveen Fund Advisors
believes does not have the financial resources to honor its obligation under the interest rate swap or cap transaction. Further, Nuveen
Fund Advisors will continually monitor the financial stability of a counterparty to an interest rate swap or cap transaction in an effort
to proactively protect the Fund&#8217;s investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">In
addition, at the time the interest rate swap or cap transaction reaches its scheduled termination date, there is a risk that the Fund
would not be able to obtain a replacement transaction or that the terms of the replacement would not be as favorable as on the expiring
transaction. If this occurs, it could have a negative impact on the performance of the Fund&#8217;s common shares. The Fund may choose
or be required to prepay any borrowings or redeem some or all of the preferred shares. This redemption would likely result in the Fund
seeking to terminate early all or a portion of any swap or cap transaction. Such early termination of a swap could result in termination
payment by or to the Fund. An early termination of a cap could result in a termination payment to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i></i></p>

<!-- Field: Page; Sequence: 57; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Total
Return Swaps.&#160;</i>The Fund will enter into total return swaps only on a net basis. In a total return swap, one party agrees to pay
the other the &#8220;total return&#8221; of a defined underlying asset during a specified period, in return for periodic payments based
on a fixed or variable interest rate or the total return from other underlying assets. A total return swap may be applied to any underlying
asset but is most commonly used with equity indices, single stocks, bonds and defined baskets of loans and mortgages. The Fund might enter
into a total return swap involving an underlying index or basket of securities to create exposure to a potentially widely-diversified
range of securities in a single trade. An index total return swap can be used by Nuveen Fund Advisors and/or Nuveen Asset Management to
assume risk, without the complications of buying the component securities from what may not always be the most liquid of markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 66pt; background-color: white; color: #000000">Such
instruments may include total return swaps whose prices, in Nuveen Asset Management&#8217;s opinion, correlate with the prices of the
instruments in which the Fund may primarily invest. Total return swaps are contracts in which one party agrees to
make payments of the total return from the underlying asset(s), which may include indices, securities or baskets of securities during
the specified period, in return for payments equal to a fixed or floating rate of interest or the total return from other underlying asset(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">The
Fund may utilize total return swaps as a component of &#8220;synthetic&#8221; investments. A &#8220;synthetic&#8221; investment is comprised
of two components that, when combined, replicate or emulate the economic exposure of a third investment. The Fund may use the combination
of a total return swap and cash equivalents to replicate or emulate exposure to adjustable rate debt instruments. The cash equivalent
market value effectively represents the &#8220;principal&#8221; portion of such &#8220;synthetic&#8221; instrument exposure,
and the total return swap market value (not notional value) represents the &#8220;interest&#8221; and/or &#8220;return&#8221; portion
of such adjustable rate debt instruments exposure. When combined, these two components provide the investment profile of a direct investment
in portfolio instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Currency
Swaps. </i>A currency swap is an agreement between two parties to exchange equivalent fixed amounts in two different currencies for a
fixed period of time. The exchange of currencies at the inception date of the contract takes place at the current spot rate. Such an agreement
may provide that, for the duration of the swap, each party pays interest to the other on the received amount at an agreed upon fixed or
floating interest rate. When the contract ends, the parties re-exchange the currencies at the initial exchange rate, a specified rate,
or the then current spot rate. Some currency swaps may not provide for exchanging currencies, but only for exchanging interest cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Credit
Default Swaps.&#160;&#160;&#160;&#160;</i>The Fund may enter into credit default swap contracts for risk management purposes, including
diversification. A credit default swap is a bilateral contract that enables an investor to buy or sell protection against a defined-issuer
credit event. Credit default swaps may require initial premium (discount) payments as well as periodic payments (receipts) related to
the interest leg of the swap or to the default of a reference obligation. If the Fund is a seller of a contract, the Fund would be required
to pay the par (or other agreed upon) value of a referenced debt obligation to the counterparty in the event of a default or other credit
event by the reference issuer, such as a U.S. or foreign corporate issuer, with respect to such debt obligations. In return, the Fund
would receive from the counterparty a periodic stream of payments over the term of the contract provided that no event of default has
occurred. If no default occurs, the Fund would keep the stream of payments and would have no payment obligations. As the seller, the Fund
would be subject to investment exposure on the notional amount of the swap. If the Fund is a buyer of a contract, the Fund would have
the right to deliver a referenced debt obligation and receive the par (or other agreed-upon) value of such debt obligation from the counterparty
in the event of a default or other credit event (such as a credit downgrade) by the reference issuer, such as a U.S. or foreign corporation,
with respect to its debt obligations. In return, the Fund would pay the counterparty a periodic stream of payments over the term of the
contract provided that no event of default has occurred. If no default occurs, the counterparty would keep the stream of payments and
would have no further obligations to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">The
Fund may enter into credit default swap agreements either as a buyer or a seller. The Fund may buy protection to attempt to mitigate the
risk of default or credit quality deterioration in an individual security or a segment of the fixed income securities market to which
it has exposure, or to take a &#8220;short&#8221; position in individual bonds or market segments which it does not own. The Fund may
sell protection in an attempt to gain exposure to the credit quality characteristics of particular bonds or market segments without investing
directly in those bonds or market segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 58; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">As
the buyer of protection in a credit default swap, the Fund would pay a premium (by means of an upfront payment or a periodic stream of
payments over the term of the agreement) in return for the right to deliver a referenced bond or group of bonds to the protection seller
and receive the full notional or par value (or other agreed upon value) upon a default (or similar event) by the issuer(s) of the underlying
referenced obligation(s). If no default occurs, the protection seller would keep the stream of payments and would have no further obligation
to the Fund. Thus, the cost to the Fund would be the premium paid with respect to the agreement. However, if a credit event occurs the
Fund may elect to receive the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the reference
entity that may have little or no value. The Fund bears the risk that the protection seller may fail to satisfy its payment obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">If
the Fund is a seller of protection in a credit default swap and no credit event occurs, the Fund would generally receive an up-front
payment or a periodic stream of payments over the term of the swap. However, if a credit event occurs, generally the Fund would have
to pay the buyer the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the
reference entity that may have little or no value. As the protection seller, the Fund effectively adds economic leverage to its
portfolio because, in addition to being subject to investment exposure on its total net assets, the Fund is subject to investment
exposure on the notional amount of the swap. Thus, the Fund bears the same risk as it would by buying the reference
obligations directly, plus the additional risks related to obtaining investment exposure through a derivative instrument discussed
below under &#8220;&#8212;Risks Associated with Swap Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"><span style="background-color: white"><i>Swap
Options.</i> A swap option is a contract that gives a counterparty the right (but not the obligation), in return for payment of a premium,
to enter into a new swap agreement or to shorten, extend, cancel, or otherwise modify an existing swap agreement at some designated future
time on specified terms. A cash-settled option on a swap gives the purchaser the right, in return for the premium paid, to receive an
amount of cash equal to the value of the underlying swap as of the exercise date. The Fund may write (sell) and purchase put and call
swap options. Depending on the terms of the particular option agreement, the Fund generally would incur a greater degree of risk when
it writes a swap option than when it purchases a swap option. When the Fund purchases a swap option, it risks losing only the amount
of the premium it has paid should it decide to let the option expire unexercised. However, when the Fund writes a swap option, upon exercise
of the option the Fund would become obligated according to the terms of the underlying agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Risks
Associated with Swap Transactions.</i>&#160;&#160;&#160;&#160;The use of swap transactions is a highly specialized activity which involves
strategies and risks different from those associated with ordinary portfolio security transactions. If the Nuveen Fund Advisors and/or
Nuveen Asset Management is incorrect in its forecasts of default risks, market spreads or other applicable factors or events, the investment
performance of the Fund would diminish compared with what it would have been if these techniques were not used. As the protection seller
in a credit default swap, the Fund effectively adds economic leverage to its portfolio because, in addition to being subject to investment
exposure on its total net assets, the Fund is subject to investment exposure on the notional amount of the swap. The Fund generally may
close out a swap, cap, floor, collar or other two-party contract only with its particular counterparty, and generally may transfer a position
only with the consent of that counterparty. In addition, the price at which the Fund may close out such a two party contract may not correlate
with the price change in the underlying reference asset. If the counterparty defaults, the Fund will have contractual remedies, but there
can be no assurance that the counterparty will be able to meet its contractual obligations or that the Fund will succeed in enforcing
its rights. It also is possible that developments in the derivatives market, including changes in government regulation, could adversely
affect the Fund&#8217;s ability to terminate existing swap or other agreements or to realize amounts to be received under such agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Futures
and Options on Futures Generally.</i>&#160;&#160;&#160;&#160;A futures contract is an agreement between two parties to buy and sell a
security, index or interest rate (each a &#8220;financial instrument&#8221;) for a set price on a future date. Certain futures contracts,
such as futures contracts relating to individual securities, call for making or taking delivery of the underlying financial instrument.
However, these contracts generally are closed out before delivery by entering into an offsetting purchase or sale of a matching futures
contract (same exchange, underlying financial instrument, and delivery month). Other futures contracts, such as futures contracts on interest
rates and indices, do not call for making or taking delivery of the underlying financial instrument, but rather are agreements pursuant
to which two parties agree to take or make delivery of an amount of cash equal to the difference between the value of the financial instrument
at the close of the last trading day of the contract and the price at which the contract was originally written. These contracts also
may be settled by entering into an offsetting futures contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 59; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Unlike
when the Fund purchases or sells a security, no price is paid or received by the Fund upon the purchase or sale of a futures contract.
Initially, the Fund will be required to deposit with the futures broker, known as a futures commission merchant (&#8220;FCM&#8221;),
an amount of cash or securities equal to a varying specified percentage of the contract amount. This amount is known as initial margin.
The margin deposit is intended to ensure completion of the contract. Minimum initial margin requirements are established by the futures
exchanges and may be revised. In addition, FCMs may establish margin deposit requirements that are higher than the exchange minimums.
Cash held in the margin account generally is not income producing. However, coupon-bearing securities, such as Treasury securities, held
in margin accounts generally will earn income. Subsequent payments to and from the FCM, called variation margin, will be made on a daily
basis as the price of the underlying financial instrument fluctuates, making the futures contract more or less valuable, a process known
as marking the contract to market. Changes in variation margin are recorded by the Fund as unrealized gains or losses. At any time prior
to expiration of the futures contract, the Fund may elect to close the position by taking an opposite position that will operate to terminate
its position in the futures contract. A final determination of variation margin is then made, additional cash is required to be paid
by or released to the Fund, and the Fund realizes a gain or loss. In the event of the bankruptcy or insolvency of an FCM that holds margin
on behalf of the Fund, the Fund may be entitled to the return of margin owed to it only in proportion to the amount received by the FCM&#8217;s
other customers, potentially resulting in losses to the Fund. Futures transactions also involve brokerage costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">A futures
option gives the purchaser of such option the right, in return for the premium paid, to assume a long position (call) or short position
(put) in a futures contract at a specified exercise price at any time during the period of the option. Upon exercise of a call option,
the purchaser acquires a long position in the futures contract and the writer is assigned the opposite short position. Upon the exercise
of a put option, the opposite is true.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Limitations
on the Use of Futures, Futures Options and Swaps.&#160;&#160;&#160;&#160;</i>Nuveen Fund Advisors has claimed, with respect to the Fund,
the exclusion from the definition of &#8220;commodity pool operator&#8221; under the Commodity Exchange Act, as amended (&#8220;CEA&#8221;),
provided by CFTC Regulation 4.5 and is therefore not currently subject to registration
or regulation as such under the CEA with respect to the Fund. In addition, Nuveen Asset Management has claimed the exemption from registration
as a commodity trading advisor provided by CFTC Regulation 4.14(a)(8) and is therefore not currently subject to registration or regulation
as such under the CEA with respect to the Fund. In February 2012, the CFTC announced substantial amendments to certain exemptions, and
to the conditions for reliance on those exemptions, from registration as a commodity pool operator. Under amendments to the exemption
provided under CFTC Regulation 4.5, if the Fund uses futures, options on futures, or swaps other than for bona fide hedging purposes (as
defined by the CFTC), the aggregate initial margin and premiums on these positions (after taking into account unrealized profits and unrealized
losses on any such positions and excluding the amount by which options that are &#8220;in-the-money&#8221; at the time of purchase are
&#8220;in-the-money&#8221;) may not exceed 5% of the Fund&#8217;s NAV, or alternatively, the aggregate net notional value of those positions
may not exceed 100% of the Fund&#8217;s NAV (after taking into account unrealized profits and unrealized losses on any such positions).
The CFTC amendments to Regulation 4.5 took effect on December&#160;31, 2012, and the Fund intends to comply with amended Regulation 4.5&#8217;s
requirements such that Nuveen Fund Advisors will not be required to register as a commodity pool operator with the CFTC with respect to
the Fund. The Fund reserves the right to employ futures, options on futures and swaps to the extent allowed by CFTC regulations in effect
from time to time and in accordance with the Fund&#8217;s policies. However, the requirements for qualification as a &#8220;regulated
investment company&#8221; under the Code, may limit the extent to which the Fund may employ futures, options on futures or swaps.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Credit-Linked
Notes</i>.&#160;&#160;&#160;&#160;The Fund may invest in credit-linked notes (&#8220;CLN&#8221;) for risk management purposes, including
diversification. A CLN is a derivative instrument that is a synthetic obligation between two or more parties where the payment of principal
and/or interest is based on the performance of some obligation (a reference obligation). In addition to credit risk of the reference obligation
and interest rate risk, the purchaser/seller of the CLN is subject to counterparty risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 60; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Currency
Exchange Transactions.&#160;</i>The Fund may enter into currency exchange transactions to hedge the Fund&#8217;s exposure to foreign currency
exchange rate risk in the event the Fund invests in&#160;non-U.S.&#160;dollar denominated securities of&#160;non-U.S.&#160;issuers. The
Fund&#8217;s currency transactions will be limited to portfolio hedging involving portfolio positions. Portfolio hedging is the use of
a forward contract with respect to a portfolio security position denominated or quoted in a particular currency. A forward contract is
an agreement to purchase or sell a specified currency at a specified future date (or within a specified time period) and price set at
the time of the contract. Forward contracts are usually entered into with banks, foreign exchange dealers or broker-dealers, are not exchange-
traded, and are usually for less than one year, but may be renewed. At the maturity of a forward contract to deliver a particular currency,
the Fund may either sell the portfolio security related to such contract and make delivery of the currency, or it may retain the security
and either acquire the currency on the spot market or terminate its contractual obligation to deliver the currency by purchasing an offsetting
contract with the same currency trader obligating it to purchase on the same maturity date the same amount of the currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">It
is impossible to forecast with absolute precision the market value of portfolio securities at the expiration of a forward contract. Accordingly,
it may be necessary for the Fund to purchase additional currency on the spot market (and bear the expense of such purchase) if the market
value of the security is less than the amount of currency that the Fund is obligated to deliver and if a decision is made to sell the
security and make delivery of the currency. Conversely, it may be necessary to sell on the spot market some of the currency received upon
the sale of the portfolio security if its market value exceeds the amount of currency the Fund is obligated to deliver.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">If
the Fund retains the portfolio security and engages in an offsetting transaction, the Fund will incur a gain or a loss to the extent that
there has been movement in forward contract prices. If the Fund engages in an offsetting transaction, it may subsequently enter into a
new forward contract to sell the currency. Should forward prices decline during the period between the Fund&#8217;s entering into a forward
contract for the sale of a currency and the date it enters into an offsetting contract for the purchase of the currency, the Fund will
realize a gain to the extent the price of the currency it has agreed to sell exceeds the price of the currency it has agreed to purchase.
Should forward prices increase, the Fund will suffer a loss to the extent the price of the currency it has agreed to purchase exceeds
the price of the currency it has agreed to sell. A default on the contract would deprive the Fund of unrealized profits or force the Fund
to cover its commitments for purchase or sale of currency, if any, at the current market price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">Hedging
against a decline in the value of a currency does not eliminate fluctuations in the prices of portfolio securities or prevent losses if
the prices of such securities decline. Such transactions also preclude the opportunity for gain if the value of the hedged currency should
rise. Moreover, it may not be possible for the Fund to hedge against a devaluation that is so generally anticipated that the Fund is not
able to contract to sell the currency at a price above the devaluation level it anticipates. The cost to the Fund of engaging in currency
exchange transactions varies with such factors as the currency involved, the length of the contract period, and prevailing market conditions.
Since currency exchange transactions are usually conducted on a principal basis, no fees or commissions are involved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Other Hedging
Transactions</i>.&#160;&#160;&#160;&#160;The Fund may invest in relatively new instruments without a significant trading history for purposes
of hedging the Fund&#8217;s portfolio risks. As a result, there can be no assurance that an active secondary market will develop or continue
to exist.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"><i>Risks
associated with hedging transactions</i>.&#160;&#160;&#160;&#160;The Fund may use derivatives or other instruments for purposes of hedging
its portfolio against declining markets. There may be an imperfect correlation between the Fund&#8217;s portfolio holdings and such derivatives,
which may prevent the Fund from achieving the intended consequences of the applicable hedging transaction or expose the Fund to risk of
loss. Further, the Fund&#8217;s use of derivatives and other instruments to reduce risk involves costs and will be subject to Nuveen Asset
Management&#8217;s ability to predict correctly changes in the relationships of such hedging instruments to the Fund&#8217;s portfolio
or other factors. No assurance can be given that Nuveen Asset Management&#8217;s judgment in this respect will be correct. Consequently,
the use of hedging transactions might result in a poorer overall performance for the Fund, whether or not adjusted for risk, than if the
Fund had not hedged its portfolio. In addition, no assurance can be given that the Fund will enter into hedging transactions at times
or under circumstances in which it would be advisable to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white; color: #000000"></p>

<!-- Field: Page; Sequence: 61; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.5in; background-color: white; color: #000000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Illiquid Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund may invest
in illiquid securities (i.e., securities that are not readily marketable), including, but not limited to, restricted securities (securities
the disposition of which is restricted under the federal securities laws), securities that may be resold only pursuant to Rule 144A under
the 1933 Act, and repurchase agreements with maturities in excess of seven days. Illiquid securities may also include securities legally restricted as to resale, such as securities issued pursuant to Section 4(a)(2)
of the 1933 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">Restricted securities
may be sold only in privately negotiated transactions or in a public offering with respect to which a registration statement is in effect
under the 1933 Act. Where registration is required, the Fund may be obligated to pay all or part of the registration expenses and a considerable
period may elapse between the time of the decision to sell and the time the Fund may be permitted to sell a security under an effective
registration statement. If, during such a period, adverse market conditions were to develop, the Fund might obtain a less favorable price
than that which prevailed when it decided to sell. Illiquid securities will be priced at fair value as determined in good faith by the
Board or its designee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Short-Term/Long-Term Debt Securities;
Temporary Defensive Positions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">During temporary
defensive periods (e.g., during periods of adverse market, economic or political conditions), the Fund may invest up to 100% of its Managed
Assets in cash equivalents and investment grade debt securities, including obligations issued or guaranteed by the U.S. government, its
agencies and instrumentalities. In such a case, the Fund may not pursue or achieve its investment objective. These investments are defined
to include, without limitation, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr>
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. government securities, including bills, notes and bonds differing as to maturity and rates of interest that are either issued or guaranteed by the U.S. Treasury or by U.S. government agencies or instrumentalities. U.S. government agency securities include securities issued by (a)&#160;the Federal Housing Administration, Farmers Home Administration, Export-Import Bank of the United States, Small Business Administration, and the Government National Mortgage Association, whose securities are supported by the full faith and credit of the United States; (b)&#160;the Federal Home Loan Banks, Federal Intermediate Credit Banks, and the Tennessee Valley Authority, whose securities are supported by the right of the agency to borrow from the U.S. Treasury; (c)&#160;the Federal National Mortgage Association, whose securities are supported by the discretionary authority of the U.S. government to purchase certain obligations of the agency or instrumentality; and (d)&#160;the Student Loan Marketing Association, whose securities are supported only by its credit. While the U.S. government provides financial support to such U.S. government-sponsored agencies or instrumentalities, no assurance can be given that it always will do so since it is not so obligated by law. The U.S. government, its agencies, and instrumentalities do not guarantee the market value of their securities. Consequently, the value of such securities may fluctuate.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr>
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates of Deposit issued against funds deposited in a bank or a savings and loan association. Such certificates are for a definite period of time, earn a specified rate of return, and are normally negotiable. The issuer of a certificate of deposit agrees to pay the amount deposited plus interest to the bearer of the certificate on the date specified thereon. Under current Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) regulations, the maximum insurance payable as to any one certificate of deposit is $250,000; therefore, certificates of deposit purchased by the Fund may not be fully insured.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr>
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase agreements, which involve purchases of debt securities. At the time the Fund purchases securities pursuant to a repurchase agreement, it simultaneously agrees to resell and redeliver such securities to the seller, who also simultaneously agrees to buy back the securities at a fixed price and time. This assures a predetermined yield for the Fund during its holding period, since the resale price is always greater than the purchase price and reflects an agreed-upon market rate. Such actions afford an opportunity for the Fund to invest temporarily available cash. The Fund may enter into repurchase agreements only with respect to obligations of the U.S. government, its agencies or instrumentalities; certificates of deposit; or bankers&#8217; acceptances in which the Fund may invest. Repurchase agreements may be considered loans to the seller, collateralized by the underlying securities. The risk to the Fund is limited to the ability of the seller to pay the agreed-upon sum on the repurchase date; in the event of default, the repurchase agreement provides that the Fund is entitled to sell the underlying collateral. If the seller defaults under a repurchase agreement when the value of the underlying collateral is less than the repurchase price, the Fund could incur a loss of both principal and interest. Nuveen Fund Advisors monitors the value of the collateral at the time the action is entered into and at all times during the term of the repurchase agreement. Nuveen Fund Advisors does so in an effort to determine that the value of the collateral always equals or exceeds the agreed-upon repurchase price to be paid to the Fund. If the seller were to be subject to a federal bankruptcy proceeding, the ability of the Fund to liquidate the collateral could be delayed or impaired because of certain provisions of the bankruptcy laws.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 62; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">(4)</span></td>
    <td style="font: 12pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Commercial paper, which consists of short-term unsecured promissory notes, including variable rate master demand notes issued by corporations to finance their current operations. Master demand notes are direct lending arrangements between the Fund and a corporation. There is no secondary market for such notes. However, they are redeemable by the Fund at any time. Nuveen Asset Management&#160;will consider the financial condition of the corporation (e.g., earning power, cash flow, and other liquidity measures) and will continuously monitor the corporation&#8217;s ability to meet all of its financial obligations, because the Fund&#8217;s liquidity might be impaired if the corporation were unable to pay principal and interest on demand. Investments in commercial paper will be limited to commercial paper rated in the highest categories by an NRSRO and which mature within one year of the date of purchase or carry a variable or floating rate of interest.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; background-color: white"><b>Other Investment Companies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund may invest
in securities of other open- or&#160;closed-end&#160;investment companies that invest primarily in securities of the types in which the
Fund may invest directly. In addition, the Fund may invest a portion of its Managed Assets in pooled investment vehicles (other than investment
companies) that invest primarily in securities of the types in which the Fund may invest directly. The Fund generally expects that it
may invest in other investment companies and/or other pooled investment vehicles either during periods when it has large amounts of uninvested
cash, such as the period shortly after the Fund receives the proceeds of a large purchase of common shares, preferred shares and/or borrowings,
or during periods when there is a shortage of attractive securities of the types in which the Fund may invest in directly available in
the market. The Fund may invest in investment companies that are advised by Nuveen Fund Advisors or its affiliates to the extent permitted
by applicable law and/or pursuant to exemptive relief from the SEC. As an investor in an investment company, the Fund will bear its ratable
share of that investment company&#8217;s expenses, and would remain subject to payment of the Fund&#8217;s advisory and administrative
fees with respect to assets so invested. Nuveen Asset Management&#160;will take expenses into account when evaluating the investment merits
of an investment in the investment company relative to available securities of the types in which the Fund may invest directly. In addition,
the securities of other investment companies also may be leveraged and therefore will be subject to the same leverage risks described
herein. As described in the section entitled &#8220;Risk Factors,&#8221; the NAV and market value of leveraged shares will
be more volatile and the yield to shareholders will tend to fluctuate more than the yield generated by unleveraged shares. The Fund will
consider the investments of underlying investment companies when determining compliance with Rule&#160;35d-1&#160;under the 1940 Act.
Moreover, the Fund will consider the investments of underlying investment companies when determining compliance with its own concentration
policy, to the extent the Fund has sufficient information about such investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>Lending of Portfolio Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">To increase its income,
the Fund may lend its portfolio securities to broker-dealers and banks. Any such loan must be continuously secured by collateral in cash
or cash equivalents maintained on a current basis in an amount at least equal to the market value of the securities loaned by the Fund.
The Fund would continue to receive the equivalent of the interest or dividends paid by the issuer on the securities loaned through payments
from the borrower. The Fund would also receive an additional return that may be in the form of a fixed fee or a percentage of the collateral.
The Fund may pay reasonable fees to persons unaffiliated with the Fund for services in arranging these loans. The Fund would have the
right to call the loan and obtain the securities loaned at any time on notice of not more than five business days. As with other extensions
of credit, risks of delay in recovery or even loss of rights in the collateral exist should the borrower of the financial instruments
fail financially. However, the loans would be made only to firms deemed by Nuveen Asset Management&#160;to be creditworthy and when, in
the judgment of Nuveen Asset Management,&#160;the consideration which can be earned currently from loans of this type justifies the attendant
risk. The creditworthiness of firms to which the Fund lends its portfolio holdings will be monitored on an ongoing basis by Nuveen Asset
Management.&#160;Although no specific policy limits the percentage of the Fund&#8217;s assets which the Fund may lend, under current SEC
guidance the Fund may not have on loan at any given time securities representing more than&#160;one-third&#160;of its total asset value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 63; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-indent: 0.5in; background-color: white">The Fund would not
have the right to vote the securities during the existence of the loan but would call the loan to permit voting of the securities, if,
in Nuveen Asset Management&#8217;s&#160;judgment, a material event requiring a shareholder vote would otherwise occur before the loan
was repaid. In the event of bankruptcy or other default of the borrower, the Fund could experience both delays in liquidating the loan
collateral or recovering the loaned securities and losses, including (a)&#160;possible decline in the value of the collateral or in the
value of the securities loaned during the period while the Fund seeks to enforce its rights thereto, (b)&#160;possible subnormal levels
of income and lack of access to income during this period, and (c)&#160;expenses of enforcing its rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Repurchase Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund may enter into repurchase agreements (the
purchase of a security coupled with an agreement to resell that security at a higher price) with respect to its permitted investments.
The Fund&#8217;s repurchase agreements will provide that the value of the collateral underlying the repurchase agreement will always be
at least equal to the repurchase price, including any accrued interest earned on the agreement, and will be marked-to-market daily. The
agreed-upon repurchase price determines the yield during the Fund&#8217;s holding period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Repurchase agreements are considered to be loans collateralized
by the underlying security that is the subject of the repurchase contract. The Fund only enters into repurchase agreements with registered
securities dealers or domestic banks that, in Nuveen Asset Management&#8217;s opinion, present minimal credit risk. The risk to the Fund
is limited to the ability of the issuer to pay the agreed-upon repurchase price on the delivery date; however, although the value of
the underlying collateral at the time the transaction is entered into always equals or exceeds the agreed-upon repurchase price, if the
value of the collateral declines there is a risk of loss of both principal and interest. In the event of default, the collateral may
be sold but the Fund might incur a loss if the value of the collateral declines, and might incur disposition costs or experience delays
in connection with liquidating the collateral. In addition, if bankruptcy proceedings are commenced with respect to the seller of the
security, realization upon the collateral by the Fund may be delayed or limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Nuveen Asset Management will monitor the value of
the collateral at the time the transaction is entered into and at all times subsequent during the term of the repurchase agreement in
an effort to determine that such value always equals or exceeds the agreed-upon repurchase price. In the event the value of the collateral
declines below the repurchase price, Nuveen Asset Management will demand additional collateral from the issuer to increase the value
of the collateral to at least that of the repurchase price, including interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 64; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_5"></span>MANAGEMENT
 OF THE FUND</b><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trustees and Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The management of the Fund, including
general supervision of the duties performed for the Fund under the Investment Management Agreement (as defined under &#8220;Investment
Adviser, Sub-Adviser and Portfolio Managers&#8212;Investment Management Agreement and Related Fees&#8221;), is the responsibility
of the Board. The number of Trustees of the Fund is twelve, all of whom are not interested persons (referred to herein as &#8220;Independent
Trustees&#8221;). None of the Independent Trustees has ever been a director, trustee or employee of, or consultant to, Nuveen
LLC (&#8220;Nuveen&#8221;), Nuveen Fund Advisors, Nuveen Asset Management, or their affiliates. The Board is divided into three
classes, Class I, Class II and Class III, the Class I Trustees serving until the 2025 annual meeting, the Class II Trustees serving
until the 2026 annual meeting and the Class III Trustees serving until the 2027 annual meeting, in each case until their respective
successors are elected and qualified, as described below. Currently, Michael A. Forrester, Thomas J. Kenny, Margaret L. Wolff
and Robert L. Young are slated in Class I, Joseph A. Boateng, Amy B. R. Lancellotta, John K. Nelson and Terence J. Toth are slated
in Class II, and Joanne T. Medero, Albin F. Moschner, Loren M. Starr and Matthew Thornton III are slated in Class III. As each
Trustee&#8217;s term expires, shareholders will be asked to elect Trustees and such Trustees shall be elected for a term expiring
at the time of the third succeeding annual meeting subsequent to their election or thereafter in each case when their respective
successors are duly elected and qualified. These provisions could delay for up to two years the replacement of a majority of the
Board. See &#8220;Certain Provisions in the Declaration of Trust and By-Laws&#8221; in the prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.2pt 0pt 15.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The officers of the Fund serve annual
terms through August of each year and are elected on an annual basis. The names, business addresses and years of birth of the
Trustees and officers of the Fund, their principal occupations and other affiliations during the past five years, the number of
portfolios each oversees and other trusteeships they hold are set forth below. Except as noted in the table below, the Trustees
of the Fund are directors or trustees, as the case may be, of 216 Nuveen-sponsored registered investment companies (the &#8220;Nuveen
Funds&#8221;), which includes 145 open-end mutual funds, 47 closed-end funds and 24 Nuveen-sponsored exchange-traded funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.2pt 0pt 15.25pt; text-indent: 0.4in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 65; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table
                                            of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Independent Trustees:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0">Thomas J. Kenny<br/>
                                         333 West Wacker Drive</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">Chicago, IL 60606</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">1963</p></td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class I Length of Service&#8212;Since 2011.</td><td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Advisory Director (2010&#8211;2011), Partner (2004&#8211;2010),
    Managing Director (1999&#8211;2004) and Co- Head of Global Cash and Fixed Income Portfolio Management Team (2002&#8211;2010),
    Goldman Sachs Asset Management (asset management).</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Director (since 2015) and Chair of the Finance and Investment
    Committee (since 2018), Aflac Incorporated; formerly, Director (2021-2022), ParentSquare; formerly, Director (2021-2022) and
    Finance Committee Chair (2016- 2022), Sansum Clinic; formerly, Advisory Board Member (2017-2019), B&#8217;Box; formerly, Member
    (2011-2020), the University of California at Santa Barbara Arts and Lectures Advisory Council; formerly, Investment Committee
    Member (2012-2020), Cottage Health System; formerly, Board Member (2009-2019) and President of the Board (2014- 2018), Crane
    Country Day School; Trustee (2011-2023) and Chairman (2017-2023), the College Retirement Equities Fund; Manager (2011-2023)
    and Chairman (2017-2023), TIAA Separate Account VA-1</td></tr>
</table>


<!-- Field: Page; Sequence: 66; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top">Robert L. Young<br/> 333 West Wacker Drive<br/> Chicago, IL
    60606<br/>
    1963</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Chair of the <br/> Board and Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class I Length of Service&#8212; Since 2017, Chair
    since January 1, 2025.</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Chief Operating Officer and Director, J.P. Morgan
    Investment Management Inc. (financial services) (2010-2016); formerly, President and Principal Executive Officer (2013-2016),
    and Senior Vice President and Chief Operating Officer (2005-2010), of J.P. Morgan Funds; formerly, Director and various officer
    positions for J.P. Morgan Investment Management Inc. (formerly, JPMorgan Funds Management, Inc. and formerly, One Group Administrative
    Services) and JPMorgan Distribution Services, Inc. (financial services) (formerly, One Group Dealer Services, Inc.) (1999-2017).</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">None</td></tr>
</table>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 67; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
                                         A. Boateng<sup>*</sup></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333
                                         West Wacker Drive</span></p>
                                                                  <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago,
                                         IL 60606</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1963</span></p></td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class II. Length of Service &#8212;Since 2019.</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Chief Investment Officer, Casey Family Programs (since 2007);
    formerly, Director of U.S. Pension Plans, Johnson &amp; Johnson (2002-2006).</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">215</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Board Member, Lumina Foundation (since 2018) and Waterside
    School (since 2021); Board Member (2012- 2019) and Emeritus Board Member (since 2020), Year-Up Puget Sound; Investment Advisory
    Committee Member and Former Chair (since 2007), Seattle City Employees&#8217; Retirement System; Investment Committee Member
    (since 2012), The Seattle Foundation; Trustee (2018- 2023), the College Retirement Equities Fund; Manager (2019- 2023), TIAA
    Separate Account VA- 1.</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
                                         A. Forrester<sup>*</sup></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333
                                         West Wacker Drive</span></p>
                                                      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago,
                                         IL 60606</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1967</span></p></td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Trustee</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Class I. Length of Service &#8212;Since 2007.</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Formerly, Chief Executive Officer (2014&#8211;2021) and Chief Operating
    Officer (2007&#8211;2014), Copper Rock Capital Partners, LLC.</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">215</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Director, Aflac Incorporated (since 2025); Trustee, Dexter Southfield School
    (since 2019); Member (since 2020), Governing Council of the Independent Directors Council (IDC); Trustee, the College Retirement
    Equities Fund and Manager, TIAA Separate Account VA-1 (2007-2023).</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Amy B.R. Lancellotta<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/>
    1959</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Trustee</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Class II Length of Service&#8212;Since 2021</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Formerly, Managing Director, IDC (supports the fund independent director
    community and is part of the Investment Company Institute (ICI), which represents regulated investment companies) (2006-2019);
    formerly, various positions with ICI (1989-2006).</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">216</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">President (since 2023) and Member (since 2020) of the Board of Directors,
    Jewish Coalition Against Domestic Abuse (JCADA).</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 68; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top">Joanne T. Medero<br/> 333 West Wacker Drive<br/> Chicago, IL
    60606<br/>
    1954</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class III Length of Service&#8212;Since 2021</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Managing Director, Government Relations and Public
    Policy (2009-2020) and Senior Advisor to the Vice Chairman (2018-2020), BlackRock, Inc. (global investment management firm);
    formerly, Managing Director, Global Head of Government Relations and Public Policy, Barclays Group (IBIM) (investment banking,
    investment management businesses) (2006-2009); formerly, Managing Director, Global General Counsel and Corporate Secretary,
    Barclays Global Investors (global investment management firm) (1996-2006); formerly, Partner, Orrick, Herrington &amp; Sutcliffe
    LLP (law firm) (1993-1995); formerly, General Counsel, Commodity Futures Trading Commission (government agency overseeing
    U.S. derivatives markets) (1989- 1993); formerly, Deputy Associate Director/Associate Director for Legal and Financial Affairs,
    Office of Presidential Personnel, The White House (1986-1989).</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Member (since 2019) of the Board of Directors, Baltic- American
    Freedom Foundation (seeks to provide opportunities for citizens of the Baltic states to gain education and professional development
    through exchanges in the U.S.).</td></tr>
</table>


<!-- Field: Page; Sequence: 69; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/>
    the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s) <br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top">Albin F. Moschner<br/> 333 West Wacker Drive<br/> Chicago,
    IL 60606<br/>
    1952</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class III Length of Service&#8212;Since 2016</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Founder and Chief Executive Officer, Northcroft Partners,
    LLC, (management consulting), (since 2012); previously, held positions at Leap Wireless International, Inc., (consumer wireless
    service) including Consultant (2011-2012), Chief Operating Officer (2008-2011) and Chief Marketing Officer (2004-2008); formerly,
    President, Verizon Card Services division of Verizon Communications, Inc. (telecommunications services) (2000-2003); formerly,
    President, One Point Services at One Point Communications (telecommunications services) (1999-2000); formerly, Vice Chairman
    of the Board, Diba, Incorporated (internet technology provider) (1996- 1997); formerly, various executive positions (1991-1996)
    and Chief Executive Officer (1995-1996) of Zenith Electronics Corporation (consumer electronics).</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Chairman (2019), and Director (2012-2019), USA
    Technologies, Inc. (a provider of solutions and services to facilitate electronic payment transactions); formerly, Director,
    Wintrust Financial Corporation (1996-2016).</td></tr>
</table>


<!-- Field: Page; Sequence: 70; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top">John K. Nelson<br/> 333 West Wacker Drive<br/> Chicago, IL
    60606<br/>
    1962</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class II Length of Service&#8212;Since 2016</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Senior External Advisor to the Financial Services
    practice of Deloitte Consulting LLP (consulting and accounting) (2012-2014); Chief Executive Officer of ABN AMRO Bank N.V.,
    North America (insurance), and Global Head of the Financial Markets Division (2007-2008), with various executive leadership
    roles in ABN AMRO Bank N.V. between 1996 and 2007.</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Member of Board of Directors (2008-2023) of Core12
    LLC (private firm which develops branding, marketing and communications strategies for clients); formerly, Member of the President&#8217;s
    Council (2010-2019) of Fordham University; formerly, Director (2009-2018) of the Curran Center for Catholic American Studies;
    formerly, Trustee and Chairman of The Board of Trustees of Marian University (2011-2013).</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loren
M. Starr*</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333 West Wacker Drive</span></p>
                                                      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago,
                                         IL 60606</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1961</span></p></td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Trustee</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Class III Length of Service&#8212;Since 2022</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Independent Consultant/Advisor (since 2021), Vice Chair, Senior Managing
    Director (2020&#8211; 2021), Chief Financial Officer, Senior Managing Director (2005&#8211;2020), Invesco Ltd (asset management).</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">215</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Director (since 2023) and Chair of the Board (since 2025), formerly, Chair of the Audit Committee (2024-2025),
    AMG; formerly, Chair and Member of the Board of Directors (2014- 2021), Georgia Leadership Institute for School Improvement
    (GLISI); formerly, Chair and Member of the Board of Trustees (2014- 2018), Georgia Council on Economic Education (GCEE); Trustee,
    the College Retirement Equities Fund and Manager, TIAA Separate Account VA-1 (2022-2023).</td></tr>
</table>


<!-- Field: Page; Sequence: 71; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address <br/>
and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s) <br/>
Held with the<br/>
 Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><br/> Principal Occupation(s)<br/>
    During Past Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios in<br/> Fund
    Complex<br/>
    Overseen by<br/>
    Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/>
    Directorships <br/>
    Held by<br/>
    Trustee <br/>
    During Past <br/>
    Five Years</td></tr>
<tr style="text-align: left; vertical-align: top">
    <td style="width: 20%">Matthew Thornton III<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1958</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%">Trustee</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%">Term&#8212;Class III Length of Service &#8212;Since 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formerly, Executive Vice
    President and Chief Operating Officer (2018- 2019), FedEx Freight Corporation, a subsidiary of FedEx Corporation (&#8220;FedEx&#8221;)
    (provider of transportation, ecommerce and business services through its portfolio of companies); formerly, Senior Vice President,
    U.S. Operations (2006-2018), Federal Express Corporation, a subsidiary of FedEx.</span></td><td style="width: 1%">&#160;</td>
    <td style="width: 11%">216</td><td style="width: 1%">&#160;</td>
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member of the Board of
    Directors (since 2014), The Sherwin-Williams Company (develops, manufactures, distributes and sells paints, coatings and related
    products); Member of the Board of Directors (since 2020), Crown Castle International (provider of communications infrastructure);
    formerly, Member of the Board of Directors (2012-2018), Safe Kids Worldwide<sup>&#174;</sup> (a non-profit organization dedicated
    to preventing childhood injuries).</span></td></tr>
</table>


<!-- Field: Page; Sequence: 72; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 20%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s)<br/> Held with
    the<br/>
    Trust</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; font-weight: bold; text-align: center">Number of <br/>
    Portfolios in <br/>
    Fund Complex <br/>
    Overseen by <br/>
    Trustee</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; font-weight: bold; text-align: center">Other<br/> Directorships<br/>
    Held by<br/> Trustee<br/> During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Terence J. Toth<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1959</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Trustee</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Class II Length of Service&#8212; Since 2008</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Formerly, Co-Founding Partner, Promus Capital (investment advisory firm)
    (2008-2017); formerly, Director of Quality Control Corporation (manufacturing) (2012- 2021); formerly, Director, Fulcrum IT
    Service LLC (information technology services firm to government entities) (2010- 2019); formerly, Director, LogicMark LLC
    (health services) (2012-2016); formerly, Director, Legal &amp; General Investment Management America, Inc. (asset management)
    (2008- 2013); formerly, CEO and President, Northern Trust Global Investments (financial services) (2004-2007); Executive Vice
    President, Quantitative Management &amp; Securities Lending (2000- 2004); prior thereto, various positions with Northern Trust
    Company (financial services) (since 1994).</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">216</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Formerly, Chair and Member of the Board of Directors (2021- 2024), Kehrein
    Center for the Arts (philanthropy); Member of the Board of Directors (since 2008), Catalyst Schools of Chicago (philanthropy);
    Member of the Board of Directors (since 2012), formerly, Investment Committee Chair (2017-2022), Mather Foundation (philanthropy);
    formerly, Member (2005-2016), Chicago Fellowship Board (philanthropy); formerly, Member, Northern Trust Mutual Funds Board
    (2005-2007), Northern Trust Global Investments Board (2004- 2007), Northern Trust Japan Board (2004-2007), Northern Trust
    Securities Inc. Board (2003-2007) and Northern Trust Hong Kong Board (1997-2004).</td></tr>
</table>


<!-- Field: Page; Sequence: 73; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name, Business Address<br/> and Year of Birth</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position(s)<br/> Held with the<br/> Trust</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term of Office<br/> and Length of<br/>
    Time Served in<br/> the Fund<br/> Complex</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal Occupation(s)<br/> During Past
    Five Years</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Portfolios<br/> in Fund<br/>
    Complex<br/>
    Overseen by<br/> Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other<br/> Directorships<br/> Held by<br/>
    Trustee<br/>
    During Past<br/> Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: left; vertical-align: top">Margaret L. Wolff<br/> 333 West Wacker Drive<br/> Chicago,
    IL 60606<br/>
    1955</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Trustee</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 12%; text-align: left; vertical-align: top">Term&#8212;Class I Length of Service&#8212;Since 2016</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Formerly, Of Counsel (2005- 2014), Skadden, Arps, Slate,
    Meagher &amp; Flom LLP (Mergers &amp; Acquisitions Group) (legal services).</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 11%; text-align: left; vertical-align: top">216</td><td style="width: 1%; text-align: left; vertical-align: top">&#160;</td>
    <td style="width: 20%; text-align: left; vertical-align: top">Member of the Board of Trustees (since 2005), New York-Presbyterian
    Hospital; Member of the Board of Trustees (since 2004) formerly, Chair (2015-2022), The John A. Hartford Foundation (philanthropy
    dedicated to improving the care of older adults); formerly, Member (2005-2015) and Vice Chair (2011-2015) of the Board of
    Trustees of Mt. Holyoke College; formerly, Member of the Board of Directors (2013- 2017) of Travelers Insurance Company of
    Canada and The Dominion of Canada General Insurance Company (each, a part of Travelers Canada, the Canadian operation of The
    Travelers Companies, Inc.).</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Boateng, Mr. Forrester and Mr. Starr were each elected or appointed as a board member of each of the Nuveen Funds except Nuveen Multi-Market
Income Fund for which each serves as a consultant.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 21%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s) Held<br/> with
    the Fund</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served with<br/> Funds in the<br/> Fund Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 50%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><b>Officers of the Fund:</b></td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">David J. Lamb<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1963</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Chief Administrative Officer (Principal Executive Officer)</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2015</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director of Nuveen Fund Advisors, LLC, Nuveen Securities,
    LLC and Nuveen; has previously held various positions with Nuveen.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Brett E. Black<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1972</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Chief Compliance Officer</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2022</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Managing Director, Chief Compliance Officer of Nuveen; formerly, Vice
    President (2014-2022), Chief Compliance Officer and Anti- Money Laundering Compliance Officer (2017-2022) of BMO Funds, Inc.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Mark J. Czarniecki<br/> 901 Marquette Avenue<br/> Minneapolis, MN 55402<br/>
    1979</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2013</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Managing Director and Assistant Secretary of Nuveen Securities, LLC and
    Nuveen Fund Advisors, LLC; Managing Director and Associate General Counsel of Nuveen; Managing Director Assistant Secretary
    and Associate General Counsel of Nuveen Asset Management, LLC; has previously held various positions with Nuveen; Managing
    Director, Associate General Counsel and Assistant Secretary of Teachers Advisors, LLC and TIAA-CREF Investment Management,
    LLC.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Marc Cardella <br/>
    8500 Andrew Carnegie Blvd <br/>
    Charlotte, NC 28262 <br/>
    1984</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Controller (Principal Financial Officer)</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2024</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director, Head of Public Investment Finance of Nuveen; Senior
    Managing Director of Nuveen Fund Advisors, LLC, Nuveen Asset Management, LLC, Teachers Advisors, LLC and TIAA-CREF Investment
    Management, LLC, Managing Director of Teachers Insurance and Annuity Association of America and TIAA SMA Strategies LLC; Principal
    Financial Officer, Principal Accounting Officer and Treasurer of TIAA Separate Account VA-1 and the College Retirement Equities
    Fund.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Joseph T. Castro <br/>
    333 West Wacker Drive <br/>
    Chicago, IL 60606 <br/>
    1964</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2025</td><td>&#160;</td>
    <td style="text-align: left; vertical-align: top">Executive Vice President, Chief Risk and Compliance Officer, formerly,
    Senior Managing Director and Head of Compliance, Nuveen; Executive Vice President, formerly, Senior Managing Director, Nuveen
    Securities, LLC; Senior Managing Director, Nuveen Fund Advisors, LLC and Nuveen, LLC.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Jeremy D. Franklin<br/> 8500 Andrew Carnegie Blvd.<br/> Charlotte, NC 28262<br/>
    1983</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2024</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Managing Director and Assistant Secretary, Nuveen Fund Advisors, LLC;
    Vice President Associate General Counsel and Assistant Secretary, Nuveen Asset Management, LLC, Teachers Advisors, LLC and
    TIAA-CREF Investment Management, LLC; Vice President and Associate General Counsel, Teachers Insurance and Annuity Association
    of America; Vice President and Assistant Secretary, TIAA-CREF Funds and TIAA-CREF Life Funds; Vice President, Associate General
    Counsel, and Assistant Secretary, TIAA Separate Account VA-1 and College Retirement Equities Fund; has previously held various
    positions with TIAA.</td></tr>
</table>


<!-- Field: Page; Sequence: 75; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 21%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s) Held <br/> with
    the Fund</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served with<br/> Funds in the<br/> Fund Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 50%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Diana R. Gonzalez<br/> 8500 Andrew Carnegie Blvd.<br/> Charlotte, NC 28262<br/>
    1978</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2017</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary of Nuveen Fund Advisors, LLC;
    Vice President, Associate General Counsel and Assistant Secretary of Nuveen Asset Management, LLC, Teachers Advisors, LLC
    and TIAA-CREF Investment Management, LLC; Vice President and Associate General Counsel of Nuveen.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Nathaniel T. Jones<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/>
    1979</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2016</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director, Head of Public Product of Nuveen; President, formerly, Senior Managing
Director of Nuveen Fund Advisors, LLC; has previously held various positions
with Nuveen, Chartered Financial Analyst.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Brian H. Lawrence<br/> 8500 Andrew Carnegie Blvd.<br/> Charlotte, NC 28262<br/>
    1982</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2023</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Associate General Counsel of Nuveen; Vice President,
    Associate General Counsel and Assistant Secretary of Teachers Advisors, LLC and TIAA-CREF Investment Management, LLC; formerly
    Corporate Counsel of Franklin Templeton (2018-2022).</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Tina M. Lazar<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1961</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2002</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Managing Director of Nuveen Securities, LLC.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Brian J. Lockhart<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/>
    1974</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2019</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director and Head of Investment Oversight of Nuveen;
    Senior Managing Director of Nuveen Fund Advisors, LLC; has previously held various positions with Nuveen; Chartered Financial
    Analyst and Certified Financial Risk Manager.</td></tr>
</table>


<!-- Field: Page; Sequence: 76; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 21%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s) Held<br/> with
    the Fund</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served with<br/> Funds in the<br/> Fund Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 50%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">John M. McCann<br/> 8500 Andrew Carnegie Blvd.<br/> Charlotte, NC 28262<br/>
    1975</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2022</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director, Division General Counsel of Nuveen; Senior Managing
Director, General Counsel and Secretary of Nuveen Fund Advisors, LLC;
Managing Director, Associate General Counsel and Assistant Secretary of
Nuveen Asset Management, LLC; Managing Director and Assistant Secretary of
TIAA SMA Strategies LLC; Managing Director, Associate General Counsel and
Assistant Secretary of College Retirement Equities Fund, TIAA Separate Account
VA-1, TIAA-CREF Funds, TIAA-CREF Life Funds, Teachers Insurance and
Annuity Association of America, Teacher Advisors LLC, TIAA-CREF
Investment Management, LLC, and Nuveen Alternative Advisors LLC; has
previously held various positions with Nuveen/TIAA.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Kevin J. McCarthy<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/>
    1966</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite Length of Service&#8212;Since 2007</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Executive Vice President, Secretary and General Counsel of Nuveen Investments,
    Inc.; Executive Vice President and Assistant Secretary of Nuveen Securities, LLC and Nuveen Fund Advisors, LLC; Executive
    Vice President and Secretary of Nuveen Asset Management, LLC, Teachers Advisors, LLC, TIAA-CREF Investment Management, LLC
    and Nuveen Alternative Investments, LLC; Executive Vice President, Associate General Counsel and Assistant Secretary of TIAA-CREF
    Funds and TIAA-CREF Life Funds; has previously held various positions with Nuveen/TIAA; Vice President and Secretary of Winslow
    Capital Management, LLC; formerly, Vice President (2007-2021) and Secretary (2016-2021) of NWQ Investment Management Company,
    LLC and Santa Barbara Asset Management, LLC.</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 21%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">R. Tanner Page<br/>
333 West Wacker Drive<br/>
Chicago, IL 60606</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1985</p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; font-size: 10pt; text-align: left">Vice President and Treasurer</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 14%; font-size: 10pt; text-align: left">Term&#8212;Indefinite Length of<br/>
Service&#8212;Since
    2025</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 50%; font-size: 10pt">Managing Director, formerly, Vice President of Nuveen; has previously held various positions with Nuveen.</td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 77; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 21%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s) Held<br/> with
    the Fund</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served with<br/> Funds in the<br/> Fund Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 50%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">William A. Siffermann<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/>
    1975</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite<br/> Length of<br/> Service&#8212;<br/> Since 2017</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Senior Managing Director of Nuveen.</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 78; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 21%; font-weight: bold; text-align: left">Name, Business Address<br/>
    and Year of Birth</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 12%; font-weight: bold; text-align: center">Position(s) Held<br/> with
    the Fund</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Term of Office<br/> and Length
    of<br/>
    Time Served with<br/> Funds in the<br/> Fund Complex</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 50%; font-weight: bold; text-align: center">Principal Occupation(s)<br/>
    During Past Five Years</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Mark L. Winget<br/> 333 West Wacker Drive<br/> Chicago, IL 60606<br/> 1968</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President<br/> and Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite<br/> Length of<br/> Service&#8212;<br/> Since 2008</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President and Assistant Secretary of Nuveen Securities, LLC and
    Nuveen Fund Advisors, LLC; Vice President, Associate General Counsel and Assistant Secretary of Teachers Advisors, LLC and
    TIAA-CREF Investment Management, LLC and Nuveen Asset Management, LLC; Vice President and Associate General Counsel of Nuveen.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top">Rachael Zufall<br/> 8500 Andrew Carnegie Blvd.<br/> Charlotte, NC 28262<br/>
    1973</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Vice President<br/> and Assistant<br/> Secretary</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Term&#8212;Indefinite<br/> Length of<br/> Service&#8212;<br/> Since 2022</td><td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Managing Director and Assistant Secretary of Nuveen Fund Advisors, LLC;
    Managing Director, Associate General Counsel and Assistant Secretary of the College Retirement Equities Fund, TIAA Separate
    Account VA-1, TIAA-CREF Funds and TIAA-CREF Life Funds; Managing Director, Associate General Counsel and Assistant Secretary
    of Teacher Advisors, LLC and TIAA-CREF Investment Management, LLC; Managing Director of Nuveen, LLC and of TIAA.</td></tr>
</table>


<!-- Field: Page; Sequence: 79; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt"><a href="#toc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents</span></a></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure and Risk Oversight </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board oversees the operations and management of the Fund, including the duties performed for the Fund by Nuveen Fund Advisors.
The Board has adopted a unitary board structure. A unitary board consists of one group of trustees who serves on the board of
every fund in the complex. In adopting a unitary board structure, the Trustees seek to provide effective governance through establishing
a board the overall composition of which will, as a body, possess the appropriate skills, diversity (including, among other things,
gender, race and ethnicity), independence and experience to oversee the Fund&#8217;s business. With this overall framework in
mind, when the Board, through its Nominating and Governance Committee discussed below, seeks nominees for the Board, the Trustees
consider not only the candidate&#8217;s particular background, skills and experience, among other things, but also whether such
background, skills and experience enhance the Board&#8217;s diversity and at the same time complement the Board given its current
composition and the mix of skills and experiences of the incumbent Trustees. The Nominating and Governance Committee believes
that the Board generally benefits from diversity of background (including, among other things, gender, race and ethnicity), skills,
experience and views among Trustees, and considers this a factor in evaluating the composition of the Board, but has not adopted
any specific policy on diversity or any particular definition of diversity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes the unitary board structure enhances good and effective governance, particularly given the nature of the structure
of the investment company complex. Funds in the same complex generally are served by the same service providers and personnel
and are governed by the same regulatory scheme which raises common issues that must be addressed by the Trustees across the fund
complex (such as compliance, valuation, liquidity, brokerage, trade allocation or risk management). The Board believes it is more
efficient to have a single board review and oversee common policies and procedures which increases the Board&#8217;s knowledge
and expertise with respect to the many aspects of fund operations that are complex-wide in nature. The unitary structure also
enhances the Board&#8217;s influence and oversight over Nuveen Fund Advisors and other service providers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In an effort to enhance the independence
of the Board, the Board also has a Chair that is an Independent Trustee. The Board recognizes that a chair can perform an important
role in setting the agenda for the Board, establishing the boardroom culture, establishing a point person on behalf of the Board
for Fund management and reinforcing the Board&#8217;s focus on the long-term interests of shareholders. The Board recognizes that
a chair may be able to better perform these functions without any conflicts of interests arising from a position with Fund management.
Accordingly, the Trustees have elected Mr. Young to serve as an independent Chair of the Board. Pursuant to the Fund&#8217;s By-Laws,
the Chairs shall perform all duties incident to the office of Chair of the Board and such other duties as from time to time may
be assigned to him or her by the Trustees or the By-Laws. Specific responsibilities of the Chairs include (i) coordinating with
fund management in the preparation of the agenda for each meeting of the Board; (ii) presiding at all meetings of the Board and
of the shareholders; and (iii) serving as a liaison with other trustees, the Trust&#8217;s officers and other fund management
personnel, and counsel to the independent trustees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Although the Board has direct responsibility
over various matters (such as advisory contracts and underwriting contracts), the Board also exercises certain of its oversight
responsibilities through several committees that it has established and which report back to the full Board. The Board believes
that a committee structure is an effective means to permit Trustees to focus on particular operations or issues affecting the
Nuveen Funds, including risk oversight. More specifically, with respect to risk oversight, the Board has delegated matters relating
to valuation, compliance and investment risk to certain committees (as summarized below). In addition, the Board believes that
the periodic rotation of Trustees among the different committees allows the Trustees to gain additional and different perspectives
of the Fund&#8217;s operations. The Board has established seven standing committees: the Executive Committee, the Dividend Committee,
the Audit Committee, the Compliance, Risk Management and Regulatory Oversight Committee, the Investment Committee, the Nominating
and Governance Committee and the Closed-End Funds Committee. The Board may also from time to time create ad hoc committees to
focus on particular issues as the need arises. The membership and functions of the standing committees are summarized below. For
more information on the Board, please visit www.nuveen.com/fundgovernance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Executive Committee, which meets between
regular meetings of the Board, is authorized to exercise all of the powers of the Board. The members of the Executive Committee are
Mr. Young, Chair, Mr. Kenny, Mr. Nelson and Mr. Toth. During the fiscal year ended December 31, 2024 the Executive Committee met
five times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Dividend Committee is authorized
to declare distributions (with subsequent ratification by the Board) on each Nuveen Fund&#8217;s shares, including, but not limited
to, regular and special dividends, capital gains and ordinary income distributions. The Dividend Committee operates under a written
charter adopted and approved by the Board. The members of the Dividend Committee are Mr. Thornton, Chair, Mr. Kenny, Ms. Lancellotta,
Mr. Nelson and Mr. Starr. During the fiscal year ended December 31, 2024 the Dividend Committee met ten times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board has an Audit Committee, in
accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (the &#8220;1934 Act&#8221;) that is composed of Independent
Trustees who are also &#8220;independent&#8221; as that term is defined in the listing standards pertaining to closed-end funds
of the NYSE. The Audit Committee assists the Board in: the oversight and monitoring of the accounting and financial reporting
policies, processes and practices of the Nuveen Funds, and the audits of the financial statements of the Nuveen Funds; the quality
and integrity of the financial statements of the Nuveen Funds; the Nuveen Funds&#8217; compliance with legal and regulatory requirements
relating to the Nuveen Funds&#8217; financial statements; the independent auditors&#8217; qualifications, performance and independence;
and the Valuation Policy of the Nuveen Funds and the internal valuation group of the Adviser, as valuation designee for the Nuveen
Funds. It is the responsibility of the Audit Committee to select, evaluate and replace any independent auditors (subject only
to Board approval and, if applicable, shareholder ratification) and to determine their compensation. The Audit Committee is also
responsible for, among other things, overseeing the valuation of securities comprising the Nuveen Funds&#8217; portfolios. The
Audit Committee is also primarily responsible for the oversight of the Valuation Policy and actions taken by the Adviser, as valuation
designee of the Funds, though its internal valuation group which provides regular reports to the Audit Committee, reviews any
issues relating to the valuation of the Nuveen Funds&#8217; securities brought to its attention, and considers the risks to the
Nuveen Funds in assessing the possible resolutions to these matters. The Audit Committee may also consider any financial risk
exposures for the Nuveen Funds in conjunction with performing its functions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 81; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To fulfill its oversight duties, the
Audit Committee regularly meets with Fund management to discuss the Nuveen Funds&#8217; annual and semi-annual reports and has
regular meetings with the external auditors for the Nuveen Funds and the Adviser&#8217;s internal audit group. In assessing financial
risk disclosure, the Audit Committee also may review, in a general manner, the processes the Board or other Board committees have
in place with respect to risk assessment and risk management as well as compliance with legal and regulatory matters relating
to the Nuveen Funds&#8217; financial statements. The Audit Committee operates under a written Audit Committee Charter (the &#8220;Charter&#8221;)
adopted and approved by the Board, which Charter conforms to the listing standards of the NYSE. Members of the Audit Committee
are independent (as set forth in the Charter) and free of any relationship that, in the opinion of the Trustees, would interfere
with their exercise of independent judgment as an Audit Committee member. The members of the Audit Committee are Mr. Nelson, Chair,
Mr. Boateng, Ms. Lancellotta, Mr. Starr, Ms. Wolff, Mr. Thornton, and Mr. Young, each of whom is an Independent Trustee of the
Nuveen Funds. Mr. Boateng, Mr. Moschner, Mr. Nelson, Mr. Starr and Mr. Young have each been designated as an &#8220;audit committee
financial expert&#8221; as defined by the rules of the SEC. A copy of the Charter is available at https://www.nuveen.com/fund-governance.
During the fiscal year ended December 31, 2024, the Audit Committee met 14 times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compliance, Risk Management and
Regulatory Oversight Committee (the &#8220;Compliance Committee&#8221;) is responsible for the oversight of compliance issues,
risk management and other regulatory matters affecting the Nuveen Funds that are not otherwise under or within the jurisdiction
of the other committees. The Board has adopted and periodically reviews policies and procedures designed to address the Nuveen
Funds&#8217; compliance and risk matters. As part of its duties, the Compliance Committee: reviews the policies and procedures
relating to compliance matters and recommends modifications thereto as necessary or appropriate to the full Board; develops new
policies and procedures as new regulatory matters affecting the Nuveen Funds arise from time to time; evaluates or considers any
comments or reports from examinations from regulatory authorities and responses thereto; and performs any special reviews, investigations
or other oversight responsibilities relating to risk management, compliance and/or regulatory matters as requested by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the Compliance Committee
is responsible for risk oversight, including, but not limited to, the oversight of general risks related to investments which
are not reviewed by other committees, such as liquidity and derivatives usage; risks related to product structure elements, such
as leverage; techniques that may be used to address the foregoing risks, such as hedging and swaps and Fund operational risk and
risks related to the overall operation of the TIAA/Nuveen enterprise and, in each case, the controls designed to address or mitigate
such risks. In assessing issues brought to the Compliance Committee&#8217;s attention or in reviewing a particular policy, procedure,
investment technique or strategy, the Compliance Committee evaluates the risks to the Nuveen Funds in adopting a particular approach
compared to the anticipated benefits to the Nuveen Funds and their shareholders. In fulfilling its obligations, the Compliance
Committee meets on a quarterly basis. The Compliance Committee receives written and oral reports from the Fund&#8217;s Chief Compliance
Officer (&#8220;CCO&#8221;) and meets privately with the CCO at each of its quarterly meetings. The CCO also provides an annual
report to the full Board regarding the operations of the Nuveen Funds&#8217; and other service providers&#8217; compliance programs
as well as any recommendations for modifications thereto. Certain matters not addressed at the committee level are addressed by
another committee or directly by the full Board. The Compliance Committee operates under a written charter adopted and approved
by the Board. The members of the Compliance Committee are Ms. Wolff, Chair, Mr. Forrester, Mr. Kenny, Ms. Medero, Mr. Moschner
and Mr. Toth. During the fiscal year ended December 31, 2024, the Compliance Committee met five times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 82; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Nominating and Governance Committee
is responsible for seeking, identifying and recommending to the Board qualified candidates for election or appointment to the
Board. In addition, the Nominating and Governance Committee oversees matters of corporate governance, including the evaluation
of Board performance and processes, the assignment and rotation of committee members, and the establishment of corporate governance
guidelines and procedures, to the extent necessary or desirable, and matters related thereto. The Nominating and Governance Committee
recognizes that as demands on the Board evolve over time (such as through an increase in the number of funds overseen or an increase
in the complexity of the issues raised), the Nominating and Governance Committee must continue to evaluate the Board and committee
structures and their processes and modify the foregoing as may be necessary or appropriate to continue to provide effective governance.
Accordingly, the Nominating and Governance Committee has a separate meeting each year to, among other things, review the Board
and committee structures, their performance and functions, and recommend any modifications thereto or alternative structures or
processes that would enhance the Board&#8217;s governance of the Nuveen Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the Nominating and Governance
Committee, among other things: makes recommendations concerning the continuing education of Trustees; monitors performance of
legal counsel; establishes and monitors a process by which security holders are able to communicate in writing with Trustees;
and periodically reviews and makes recommendations about any appropriate changes to Trustee compensation. In the event of a vacancy
on the Board, the Nominating and Governance Committee receives suggestions from various sources, including shareholders, as to
suitable candidates. Suggestions should be sent in writing to William Siffermann, Manager of Fund Board Relations, Nuveen, 333
West Wacker Drive, Chicago, Illinois 60606. The Nominating and Governance Committee sets appropriate standards and requirements
for nominations for new Trustees and each nominee is evaluated using the same standards. However, the Nominating and Governance
Committee reserves the right to interview any and all candidates and to make the final selection of any new Trustees. In considering
a candidate&#8217;s qualifications, each candidate must meet certain basic requirements, including relevant skills and experience,
time availability (including the time requirements for due diligence meetings with sub-advisers and service providers) and, if
qualifying as an Independent Trustee candidate, independence from the Adviser, sub-advisers, Nuveen Asset Management, underwriters
and other service providers, including any affiliates of these entities. These skill and experience requirements may vary depending
on the current composition of the Board, since the goal is to ensure an appropriate range of skills, diversity and experience,
in the aggregate. Accordingly, the particular factors considered and weight given to these factors will depend on the composition
of the Board and the skills and backgrounds of the incumbent Trustees at the time of consideration of the nominees. All candidates,
however, must meet high expectations of personal integrity, independence, governance experience and professional competence. All
candidates must be willing to be critical within the Board and with Fund management and yet maintain a collegial and collaborative
manner toward other Trustees. The Nominating and Governance Committee operates under a written charter adopted and approved by
the Board, a copy of which is available on the Funds&#8217; website at https://www.nuveen.com/fund-governance, and is composed
entirely of Independent Trustees, who are also &#8220;independent&#8221; as defined by NYSE listing standards. Accordingly, the
members of the Nominating and Governance Committee are Mr. Young, Chair, Mr. Boateng, Mr. Forrester, Mr. Kenny, Ms. Lancellotta,
Ms. Medero, Mr. Moschner, Mr. Nelson, Mr. Starr, Mr. Thornton, Mr. Toth and Ms. Wolff. During the fiscal year ended
December 31, 2024, the Nominating and Governance Committee met five times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Investment Committee is responsible
for the oversight of Nuveen Fund performance, investment risk management and other portfolio-related matters affecting the Nuveen
Funds which are not otherwise the jurisdiction of the other Board committees. As part of such oversight, the Investment Committee
reviews each Nuveen Fund&#8217;s investment performance and investment risks, which may include, but is not limited to, an evaluation
of Nuveen Fund performance relative to investment objectives, benchmarks and peer group; a review of risks related to portfolio
investments, such as exposures to particular issuers, market sectors, or types of securities, as well as consideration of other
factors that could impact or are related to Nuveen Fund performance; and an assessment of Nuveen Fund objectives, policies and
practices as such may relate to Nuveen Fund performance. In assessing issues brought to the committee&#8217;s attention or in
reviewing an investment policy, technique or strategy, the Investment Committee evaluates the risks to the Nuveen Funds in adopting
or recommending a particular approach or resolution compared to the anticipated benefits to the Nuveen Funds and their shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 83; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In fulfilling its obligations, the Investment
Committee receives quarterly reports from the investment oversight and the investment risk groups at Nuveen. Such groups also
report to the full Board on a quarterly basis and the full Board participates in further discussions with fund management at its
quarterly meetings regarding matters relating to Nuveen Fund performance and investment risks, including with respect to the various
drivers of performance and Nuveen Fund use of leverage and hedging. Accordingly, the Board directly and/or in conjunction with
the Investment Committee oversees the investment performance and investment risk management of the Nuveen Funds. The Investment
Committee operates under a written charter adopted and approved by the Board. This committee is composed of the independent Trustees
of the Nuveen Funds. Accordingly, the members of the Investment Committee are Mr. Boateng and Ms. Lancellotta, Co-Chairs, Mr.
Forrester, Mr. Kenny, Ms. Medero, Mr. Moschner, Mr. Nelson, Mr. Starr, Mr. Thornton, Mr. Toth, Ms. Wolff and Mr. Young. During
the fiscal year ended December 31, 2024, the Investment Committee met four times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Closed-End Funds Committee is responsible
for assisting the Board in the oversight and monitoring of the Nuveen funds that are registered as closed-end management investment
companies (&#8220;Closed-End Funds&#8221;). The Closed-End Funds Committee may review and evaluate matters related to the formation
and the initial presentation to the Board of any new Closed-End Fund and may review and evaluate any matters relating to any existing
Closed-End Fund. The Closed-End Funds Committee receives updates on the secondary closed-end fund market and evaluates the premiums
and discounts of the Nuveen closed-end funds, including the Fund, at each quarterly meeting. The Closed-End Funds Committee reviews,
among other things, the premium and discount trends in the broader closed-end fund market, by asset category and by closed-end
fund; the historical total return performance data for the Nuveen closed-end funds, including the Fund, based on net asset value
and price over various periods; the volatility trends in the market; the use of leverage by the Nuveen closed-end funds, including
the Fund; the distribution data of the Nuveen closed-end funds, including the Fund, and as compared to peer averages; and a summary
of common share issuances, if any, and share repurchases, if any, during the applicable quarter by the Nuveen closed-end funds,
including the Fund. The Closed-End Funds Committee regularly engages in more in-depth discussions of premiums and discounts of
the Nuveen closed-end funds. Additionally, the Closed-End Funds Committee members participate in in-depth workshops to explore,
among other things, actions to address discounts of the Nuveen closed-end funds, potential share repurchases and available leverage
strategies and their use. The Closed-End Funds Committee operates under a written charter adopted and approved by the Board. The
members of the Closed-End Funds Committee are Mr. Moschner, Chair, Mr. Kenny, Mr. Nelson, Mr. Starr, Mr. Thornton, Ms. Wolff and
Mr. Young. During the fiscal year ended December 31, 2024, the Closed-End Funds Committee met four times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Board Diversification and Trustee Qualifications </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Listed below for each current Trustee
are the experiences, qualifications, attributes and skills that led to the conclusion, as of the date of this document, that each
current Trustee should serve as a trustee of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Joseph A. Boateng.&#8195;</i></b>
Since 2007, Mr. Boateng has served as the Chief Investment Officer for Casey Family Programs. He was previously Director of U.S.
Pension Plans for Johnson &amp; Johnson from 2002-2006. Mr. Boateng is a board member of the Lumina Foundation and Waterside School,
an emeritus board member of Year Up Puget Sound, member of the Investment Advisory Committee and former Chair for the Seattle
City Employees&#8217; Retirement System, and an Investment Committee Member for The Seattle Foundation. Mr. Boateng previously
served on the Board of Trustees for the College Retirement Equities Fund (2018-2023) and on the Management Committee for TIAA
Separate Account VA-1 (2019-2023). Mr. Boateng received a B.S. from the University of Ghana and an M.B.A. from the University
of California, Los Angeles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 84; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Michael A.
Forrester.</i></b>&#8195;From 2007 to 2021, Mr. Forrester held various positions with Copper Rock Capital Partners, LLC
(&#8220;Copper Rock&#8221;), including Chief Executive Officer (2014-2021), Chief Operating Officer (&#8220;COO&#8221;) (2007-2014)
and Board Member (2007-2021). Mr. Forrester is currently a member of the Independent Directors Council Governing Council of the
Investment Company Institute. He also serves as a Director of Aflac Incorporated and is on the Board of Trustees of the Dexter
Southfield School. Mr. Forrester previously served on the Board of Trustees for the College Retirement Equities Fund and on the
Management Committee for TIAA Separate Account VA-1 (2007-2023). Mr. Forrester has a B.A. from Washington and Lee University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Thomas J. Kenny.</i></b>&#8195;Mr.
Kenny served as an Advisory Director (2010-2011), Partner (2004-2010), Managing Director (1999-2004) and Co-Head (2002-2010) of
Goldman Sachs Asset Management&#8217;s Global Cash and Fixed Income Portfolio Management team, having worked at Goldman Sachs
since 1999. Mr. Kenny is a Director and the Chair of the Finance and Investment Committee of Aflac Incorporated and a Director
of ParentSquare. He is a Former Director and Finance Committee Chair for the Sansum Clinic; former Advisory Board Member, B&#8217;Box;
former Member of the University of California at Santa Barbara Arts and Lectures Advisory Council; former Investment Committee
Member at Cottage Health System; and former President of the Board of Crane Country Day School. Mr. Kenny previously served on
the Board of Trustees (2011-2023) and as Chairman (2017-2023) for the College Retirement Equities Fund and on the Management Committee
(2011-2023) and as Chairman (2017- 2023) for TIAA Separate Account VA-1. He received a B.A. from the University of California,
Santa Barbara, and an M.S. from Golden Gate University. He is also a Chartered Financial Analyst.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Amy B. R. Lancellotta.</i></b>&#8195;After
30 years of service, Ms. Lancellotta retired at the end of 2019 from the Investment Company Institute (&#8220;ICI&#8221;), which
represents regulated investment companies on regulatory, legislative and securities industry initiatives that affect funds and
their shareholders. From November 2006 until her retirement, Ms. Lancellotta served as Managing Director of ICI&#8217;s Independent
Directors Council (&#8220;IDC&#8221;), which supports fund independent directors in fulfilling their responsibilities to promote
and protect the interests of fund shareholders. At IDC, Ms. Lancellotta was responsible for all ICI and IDC activities relating
to the fund independent director community. In conjunction with her responsibilities, Ms. Lancellotta advised and represented
IDC, ICI, independent directors and the investment company industry on issues relating to fund governance and the role of fund
directors. She also directed and coordinated IDC&#8217;s education, communication, governance and policy initiatives. Prior to
serving as Managing Director of IDC, Ms. Lancellotta held various other positions with ICI beginning in 1989. Before joining ICI,
Ms. Lancellotta was an associate at two Washington, D.C. law firms. In addition, since 2020, she has been a member of the Board
of Directors of the Jewish Coalition Against Domestic Abuse (JCADA), an organization that seeks to end power-based violence, empower
survivors and ensure safe communities. Ms. Lancellotta received a B.A. degree from Pennsylvania State University in 1981 and a
J.D. degree from the National Law Center, George Washington University (currently known as &#8220;George Washington University
Law School&#8221;) in 1984. Ms. Lancellotta joined the Board in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Joanne T. Medero.</i></b>&#8195;Ms.
Medero has over 30 years of financial services experience and, most recently, from December 2009 until her retirement in July
2020, she was a Managing Director in the Government Relations and Public Policy Group at BlackRock, Inc. (&#8220;BlackRock&#8221;).
From July 2018 to July 2020, she was also Senior Advisor to BlackRock&#8217;s Vice Chairman, focusing on public policy and corporate
governance issues. In 1996, Ms. Medero joined Barclays Global Investors (&#8220;BGI&#8221;), which merged with BlackRock in 2009.
At BGI, she was a Managing Director and served as Global General Counsel and Corporate Secretary until 2006. Then, from 2006 to
2009, Ms. Medero was a Managing Director and Global Head of Government Relations and Public Policy at Barclays Group (IBIM), where
she provided policy guidance and directed legislative and regulatory advocacy programs for the investment banking, investment
management and wealth management businesses. Before joining BGI, Ms. Medero was a Partner at Orrick, Herrington &amp; Sutcliffe
LLP from 1993 to 1995, where she specialized in derivatives and financial markets regulation issues. Additionally, she served
as General Counsel of the Commodity Futures Trading Commission (the &#8220;CFTC&#8221;) from 1989 to 1993 and, from 1986 to 1989,
she was Deputy Associate Director/Associate Director for Legal and Financial Affairs at The White House Office of Presidential
Personnel. Further, from 2006 to 2010, Ms. Medero was a member of the CFTC Global Markets Advisory Committee and she has been
actively involved in financial industry associations, serving as Chair of the Steering Committee of the SIFMA (Securities Industry
and Financial Markets Association) Asset Management Group (2016-2018) and Chair of the CTA (Commodity Trading Advisor), CPO (Commodity
Pool Operator) and Futures Committee of the Managed Funds Association (2010-2012). Ms. Medero also chaired the Corporations, Antitrust
and Securities Practice Group of The Federalist Society for Law and Public Policy (from 2010 to 2022 and 2000 to 2002). In addition,
since 2019, she has been a member of the Board of Directors of the Baltic-American Freedom Foundation, which seeks to provide
opportunities for citizens of the Baltic states to gain education and professional development through exchanges in the United
States. Ms. Medero received a B.A. degree from St. Lawrence University in 1975 and a J.D. degree from George Washington University
Law School in 1978. Ms. Medero joined the Board in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 85; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Albin F. Moschner</i>.</b>&#8195;Mr.
Moschner is a consultant in the wireless industry and, in July 2012, founded Northcroft Partners, LLC, a management consulting
firm that provides operational, management and governance solutions. Prior to founding Northcroft Partners, LLC, Mr. Moschner
held various positions at Leap Wireless International, Inc., a provider of wireless services, where he was a consultant from February
2011 to July 2012, Chief Operating Officer from July 2008 to February 2011, and Chief Marketing Officer from August 2004 to June
2008. Before he joined Leap Wireless International, Inc., Mr. Moschner was President of the Verizon Card Services division of
Verizon Communications, Inc. from 2000 to 2003, and President of One Point Services at One Point Communications from 1999 to 2000.
Mr. Moschner also served at Zenith Electronics Corporation as Director, President and Chief Executive Officer from 1995 to 1996,
and as Director, President and Chief Operating Officer from 1994 to 1995. Mr. Moschner was formerly Chairman (2019) and a member
of the Board of Directors (2012-2019) of USA Technologies, Inc. and, from 1996 until 2016, he was a member of the Board of Directors
of Wintrust Financial Corporation. In addition, he is emeritus (since 2018) of the Advisory Boards of the Kellogg School of Management
(1995-2018) and the Archdiocese of Chicago Financial Council (2012-2018). Mr. Moschner received a Bachelor of Engineering degree
in Electrical Engineering from The City College of New York in 1974 and a Master of Science degree in Electrical Engineering from
Syracuse University in 1979. Mr. Moschner joined the Board in 2016.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>John K. Nelson.</i></b>&#8195;Mr.
Nelson formerly served on the Board of Directors of Core12, LLC from 2008 to 2023, a private firm which develops branding, marketing,
and communications strategies for clients. Mr. Nelson has extensive experience in global banking and markets, having served in
several senior executive positions with ABN AMRO Holdings N.V. and its affiliated entities and predecessors, including LaSalle
Bank Corporation from 1996 to 2008, ultimately serving as Chief Executive Officer of ABN AMRO N.V. North America. During his tenure
at the bank, he also served as Global Head of its Financial Markets Division, which encompassed the bank&#8217;s Currency, Commodity,
Fixed Income, Emerging Markets, and Derivatives businesses. He was a member of the Foreign Exchange Committee of the Federal Reserve
Bank of the United States and during his tenure with ABN AMRO served as the bank&#8217;s representative on various committees
of The Bank of Canada, European Central Bank, and The Bank of England. Mr. Nelson previously served as a senior, external advisor
to the financial services practice of Deloitte Consulting LLP (2012-2014). At Fordham University, he served as a director of The
President&#8217;s Council (2010-2019) and previously served as a director of The Curran Center for Catholic American Studies (2009-2018).
He served as a trustee and Chairman of The Board of Trustees of Marian University (2011-2013). Mr. Nelson is a graduate of Fordham
University, holding a BA in Economics and an MBA in Finance. Mr. Nelson joined the Board in 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Loren M. Starr.</i></b>&#8195;Mr.
Starr was Vice Chair, Senior Managing Director from 2020 to 2021, and Chief Financial Officer, Senior Managing Director from 2005
to 2020, for Invesco Ltd. Mr. Starr is also a Director and Chair of the Board for AMG. He is former Chair and member
of the Board of Directors, Georgia Leadership Institute for School Improvement (GLISI); former Chair and member of the Board of
Trustees, Georgia Council on Economic Education (GCEE). Mr. Starr previously served on the Board of Trustees for the College Retirement
Equities Fund and on the Management Committee for TIAA Separate Account VA-1 (2022-2023). Mr. Starr received a B.A. and a B.S.
from Columbia College, an M.B.A. from Columbia Business School, and an M.S. from Carnegie Mellon University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 86; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Matthew Thornton III.</i></b>&#8195;Mr.
Thornton has over 40 years of broad leadership and operating experience from his career with FedEx Corporation (&#8220;FedEx&#8221;),
which, through its portfolio of companies, provides transportation, e-commerce and business services. In November 2019, Mr. Thornton
retired as Executive Vice President and Chief Operating Officer of FedEx Freight Corporation (FedEx Freight), a subsidiary of
FedEx, where, from May 2018 until his retirement, he had been responsible for day-to-day operations, strategic guidance, modernization
of freight operations and delivering innovative customer solutions. From September 2006 to May 2018, Mr. Thornton served as Senior
Vice President, U.S. Operations at Federal Express Corporation (FedEx Express), a subsidiary of FedEx. Prior to September 2006,
Mr. Thornton held a range of positions of increasing responsibility with FedEx, including various management positions. In addition,
Mr. Thornton currently (since 2014) serves on the Board of Directors of The Sherwin-Williams Company, where he is a member of
the Audit Committee and the Nominating and Corporate Governance Committee, and the Board of Directors of Crown Castle International
(since 2020), where he is a member of the Strategy Committee and the Compensation Committee. Formerly (2012-2018), he was a member
of the Board of Directors of Safe Kids Worldwide<sup>&#174;</sup>, a non-profit organization dedicated to the prevention of childhood
injuries. Mr. Thornton is a member (since 2014) of the Executive Leadership Council (ELC), the nation&#8217;s premier organization
of global black senior executives. He is also a member of the National Association of Corporate Directors (NACD). Mr. Thornton
has been recognized by Black Enterprise on its 2017 list of the Most Powerful Executives in Corporate America and by Ebony on
its 2016 Power 100 list of the world&#8217;s most influential and inspiring African Americans. Mr. Thornton received a B.B.A.
degree from the University of Memphis in 1980 and an M.B.A. from the University of Tennessee in 2001. Mr. Thornton joined the
Board in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Terence J. Toth.</i></b>&#8195;Mr.
Toth was a Co-Founding Partner of Promus Capital (2008-2017). From 2012 to 2021, he was a Director of Quality Control Corporation,
from 2008 to 2013, he was a Director of Legal &amp; General Investment Management America, Inc. From 2004 to 2007, he was Chief
Executive Officer and President of Northern Trust Global Investments, and Executive Vice President of Quantitative Management
&amp; Securities Lending from 2000 to 2004. He also formerly served on the Board of the Northern Trust Mutual Funds. He joined
Northern Trust in 1994 after serving as Managing Director and Head of Global Securities Lending at Bankers Trust (1986 to 1994)
and Head of Government Trading and Cash Collateral Investment at Northern Trust from 1982 to 1986. He formerly served as Chair
of the Board of the Kehrein Center for the Arts (2021-2024) and is on the Board of Catalyst Schools of Chicago since 2008. He
is on the Mather Foundation Board since 2012 and was Chair of its Investment Committee from 2017 to 2022 and previously served
as a Director of LogicMark LLC (2012-2016) and of Fulcrum IT Service LLC (2010-2019). Mr. Toth graduated with a Bachelor of Science
degree from the University of Illinois, and received his MBA from New York University. In 2005, he graduated from the CEO Perspectives
Program at Northwestern University. Mr. Toth joined the Board in 2008.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Margaret L. Wolff.</i></b>&#8195;Ms.
Wolff retired from Skadden, Arps, Slate, Meagher &amp; Flom LLP in 2014 after more than 30 years of providing client service in
the Mergers &amp; Acquisitions Group. During her legal career, Ms. Wolff devoted significant time to advising boards and senior
management on U.S. and international corporate, securities, regulatory and strategic matters, including governance, shareholder,
fiduciary, operational and management issues. Ms. Wolff has been a trustee of New York-Presbyterian Hospital since 2005 and, since
2004, she has served as a trustee of The John A. Hartford Foundation (a philanthropy dedicated to improving the care of older
adults) where she formerly served as Chair from 2015 to 2022. From 2013 to 2017, she was a Board member of Travelers Insurance
Company of Canada and The Dominion of Canada General Insurance Company (each of which is a part of Travelers Canada, the Canadian
operation of The Travelers Companies, Inc.). From 2005 to 2015, she was a trustee of Mt. Holyoke College and served as Vice Chair
of the Board from 2011 to 2015. Ms. Wolff received her Bachelor of Arts from Mt. Holyoke College and her Juris Doctor from Case
Western Reserve University School of Law. Ms. Wolff joined the Board in 2016.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Robert L. Young.</i></b>&#8195;Mr.
Young, the Nuveen Funds&#8217; Independent Chair, has more than 30 years of experience in the investment management industry.
From 1997 to 2017, he held various positions with J.P. Morgan Investment Management Inc. (&#8220;J.P. Morgan Investment&#8221;)
and its affiliates (collectively, &#8220;J.P. Morgan&#8221;). Most recently, he served as Chief Operating Officer and Director
of J.P. Morgan Investment (from 2010 to 2016) and as President and Principal Executive Officer of the J.P. Morgan Funds (from
2013 to 2016). As Chief Operating Officer of J.P. Morgan Investment, Mr. Young led service, administration and business platform
support activities for J.P. Morgan&#8217;s domestic retail mutual fund and institutional commingled and separate account businesses,
and co-led these activities for J.P. Morgan&#8217;s global retail and institutional investment management businesses. As President
of the J.P. Morgan Funds, Mr. Young interacted with various service providers to these funds, facilitated the relationship between
such funds and their boards, and was directly involved in establishing board agendas, addressing regulatory matters, and establishing
policies and procedures. Before joining J.P. Morgan, Mr. Young, a former Certified Public Accountant (CPA), was a Senior Manager
(Audit) with Deloitte &amp; Touche LLP (formerly, Touche Ross LLP), where he was employed from 1985 to 1996. During his tenure
there, he actively participated in creating, and ultimately led, the firm&#8217;s midwestern mutual fund practice. Mr. Young holds
a Bachelor of Business Administration degree in Accounting from the University of Dayton and, from 2008 to 2011, he served on
the investment committee of its board of trustees. Mr. Young joined the Board in 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 87; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 0"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share Ownership </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth the dollar
range of equity securities beneficially owned by each Trustee as of December 31, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr>
    <td style="width: 537px">&#160;</td>
    <td style="vertical-align: bottom; width: 58px">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; width: 58px">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Independent
                                    Trustees</b>&#160;</p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar&#160;Range</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of&#160;Equity</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in&#160;the Fund</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate&#160;Dollar&#160;Range</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Equity&#160;Securities&#160;in</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Registered</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Companies</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overseen&#160;by&#160;Trustees&#160;in</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family&#160;of&#160;Investment</b></span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Joseph A. Boateng</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Michael A. Forrester</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Thomas J. Kenny</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Amy B. R. Lancellotta</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Joanne T. Medero</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Albin F. Moschner</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">John K. Nelson</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Loren M. Starr</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Matthew Thornton III</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Terence J. Toth</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Margaret L. Wolff</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">None</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">Over $100,000</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt">Robert L. Young</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">Over&#160;$100,000</td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">Over $100,000</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 88; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 9%">The table below
 presents information on Trustees who own securities in companies (other than registered investment companies) that are advised
 by entities that are under common control with the Fund&#8217;s investment adviser as of December 31, 2024:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name of Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name&#160;of<br/> Owners/Relationships<br/> to&#160;Trustee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Title&#160;of<br/> Class</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of<br/> Securities<sup>(2)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percent&#160;of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Class<sup>(3)</sup></b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%; text-align: left">Thomas J. Kenny</td><td style="width: 1%">&#160;</td>
    <td style="width: 24%; text-align: left">Thomas Joseph Kenny 2021 Trust (Mr.&#160;Kenny is Initial Trustee and Settlor.)</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: left">Global Timber Resources LLC</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">0.01</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KSHFO, LLC<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">Global Timber Resources Investor Fund, LP</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">567,738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.01</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KSHFO, LLC<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">TIAA-CREF Global Agriculture II LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">717,269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.05</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KSHFO, LLC<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">Global Agriculture II AIV (US) LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">681,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.17</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 9%">&#160;</p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(1)</sup></td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Nuveen Fund Advisors, as well as the investment advisers to these Companies, are indirectly commonly controlled
by Nuveen, LLC. </p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(2)</sup></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">These
                                         amounts reflect the current value of holdings as of December 31, 2024. As of the date
                                         of this SAI, that is the most recent information available regarding the Companies.</p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(3)</sup></td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">These percentages reflect the overall amount committed to invest in the Companies, not current ownership
percentages. </p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(4)</sup></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Mr.&#160;Kenny
                                         owns 6.60% of KSFHO, LLC.</p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.75in">As of July 31, 2025, the officers and Trustees as a group beneficially owned less than 1% of any class of the Fund&#8217;s outstanding securities.
Other than as noted in the table above, as of July 31, 2025, none of the independent Trustees
or their immediate family members owned, beneficially, or of record, any security of Nuveen Fund Advisors, Nuveen Asset Management
or Nuveen Investments (or any entity controlled by or under common control with Nuveen Fund Advisors, Nuveen Asset Management
or Nuveen Investments).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Compensation </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The following
table shows, for each Independent Trustee, (1) the aggregate compensation paid by the Fund for its fiscal year ended December 31, 2024,
(2) the amount of total compensation paid by the Fund that has been deferred and (3) the total compensation paid to each Trustee
by the Nuveen Funds during the calendar year ended December 31, 2024. The Fund does not have a retirement or pension plan. The
officers and Trustees affiliated with Nuveen Investments serve without any compensation from the Fund. Certain of the Nuveen Funds
have a deferred compensation plan (the &#8220;Compensation Plan&#8221;) that permits any Trustee who is not an &#8220;interested
person&#8221; of certain Nuveen Funds to elect to defer receipt of all or a portion of his or her compensation as a Trustee. The
deferred compensation of a participating Trustee is credited to the book reserve account of a Nuveen Fund when the compensation
would otherwise have been paid to the Trustee. The value of the Trustee&#8217;s deferral account at any time is equal to the value
that the account would have had if contributions to the account had been invested and reinvested in shares of one or more of the
eligible Nuveen Funds. At the time for commencing distributions from a Trustee&#8217;s deferral account, the Trustee may elect
to receive distributions in a lump sum or over a period of five years. The Fund is not liable for any other Nuveen Fund&#8217;s
obligations to make distributions under the Compensation Plan.</p>
 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>


<!-- Field: Page; Sequence: 89; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>





<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Aggregate<br/>
 Compensation <br/>
    from Fund<sup>(1)</sup></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount of Total<br/>
 Compensation <br/>
From the
    Fund <br/>
That Has <br/>
Been Deferred<sup>(2)</sup></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Compensation <br/>
from Fund and <br/>
Fund
    Complex<sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Joseph A. Boateng<sup>(4)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">815</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">203</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">464,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael A. Forrester<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">480,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Thomas J. Kenny<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">610,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amy B.R. Lancellotta</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">469,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joanne T. Medero</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">404</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">461,987</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Albin F. Moschner</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">481,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">John K. Nelson</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">483,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loren M. Starr<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">299</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">479,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Matthew Thornton III</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Terence J. Toth</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">575,750</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Margaret L. Wolff</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">479</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">535,644</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Robert L. Young</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">828</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">502,381</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(1)</sup>&#160;</td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The
                                         compensation paid, including deferred amounts, to the independent Directors for the fiscal
                                         year ended December 31, 2024 for services to the Fund.</p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(2)</sup>&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Pursuant to a deferred compensation agreement with certain of the Nuveen Funds, deferred amounts are treated as
though an equivalent dollar amount has been invested in shares of one or more eligible Nuveen Funds. Total deferred fees for the Fund (including the return from the assumed investment in the eligible Nuveen Funds) payable are stated above.
</p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(3)</sup>&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Based
                                            on the compensation paid (including any amounts deferred) for the calendar year ended December&#160;31,
                                            2024 for services to the Nuveen open-end and closed-end funds. Because the funds in the Fund
                                            Complex have different fiscal year ends, the amounts shown in this column are presented on
                                            a calendar year basis.</p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left"><sup>(4)</sup>&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Messrs. Boateng, Forrester, Kenny, and Starr were appointed to the Board, effective January&#160;1, 2024. </p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>



<!-- Field: Page; Sequence: 90; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Prior to January&#160;1,
 2025, Independent Trustees received a $350,000 annual retainer, plus they received (a) an annual retainer of $30,000 for membership
 on the Audit Committee and Compliance, Risk Management and Regulatory Oversight Committee, respectively; and (b) an annual retainer
 of $20,000 for membership on the Dividend Committee, Investment Committee, Nominating and Governance Committee and Open-End Fund
 Committee, respectively. In addition to the payments described above, the Chair and/or Co-Chair of the Board received $140,000
 annually; the Chair and/or Co-Chair of the Audit Committee and the Compliance, Risk Management and Regulatory Oversight Committee
 received $30,000 annually; and the Chair and/or Co-Chair of the Dividend Committee, Investment Committee, Nominating and Governance
 Committee and the Open-End Fund Committee received $20,000 annually. Trustees were paid either $1,000 or $2,500 for any ad hoc
 meetings of the Board or its standing committees depending upon the meeting&#8217;s length and immediacy. For any special assignment
 committees, the Chair and/or Co-Chair were paid a quarterly fee of $1,250 and Trustees were paid a quarterly fee of $5,000. The
 annual retainers, fees and expenses of the Board were allocated among the funds in the Nuveen Fund Complex on the basis of relative
 net assets, although a minimum amount may have been established to be allocated to each fund. In certain instances fees and expenses
 were allocated only to those funds that were discussed at a given meeting.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Effective January
1, 2025, Independent Trustees receive a $350,000 annual retainer, plus they receive (a) an annual retainer of $35,000 for membership
on the Audit Committee and Compliance, Risk Management and Regulatory Oversight Committee, respectively; (b) an annual retainer
of $30,000 for membership on the Investment Committee; and (c) an annual retainer of $25,000 for membership on the Dividend Committee,
Nominating and Governance Committee and Closed-End Funds Committee, respectively. In addition to the payments described above,
the Chair of the Board receives $150,000, annually; the Chair of the Audit Committee and Compliance, Risk Management and Regulatory
Oversight Committee receive $35,000, annually; the Chair and/or Co-Chair of the Investment Committee receives $30,000, annually;
and the Chair of the Dividend Committee, Nominating and Governance Committee and Closed-End Funds Committee receive $25,000, annually.
Trustees will be paid either $1,000 or $2,500 for any ad hoc meetings of the Board or its Committees depending upon the meeting&#8217;s
length and immediacy. For any special assignment committees, the Chair and/or Co-Chair will be paid a quarterly fee starting at
$1,250 and members will be paid a quarterly fee starting at $5,000. The annual retainers, fees and expenses of the Board are allocated
among the funds in the Nuveen Fund complex in an equitable manner, although a minimum amount may be established to be allocated
to each fund. In certain instances, fees and expenses will be allocated only to those funds that are discussed at a given meeting.</p>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_6"></span>INVESTMENT ADVISER, <span style="white-space: nowrap">SUB-ADVISER</span> AND PORTFOLIO MANAGERS </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Investment
Adviser. </b>Nuveen Fund Advisors, LLC, the Fund&#8217;s investment adviser, is responsible for overseeing the Fund&#8217;s overall
investment strategy and implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad range
of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the management
of the Fund&#8217;s portfolio, manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and other administrative
services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect
subsidiary of Nuveen, LLC (&#8220;Nuveen&#8221;), the investment management arm of Teachers Insurance and Annuity Association of
America (&#8220;TIAA&#8221;). TIAA is a life insurance company founded in 1918 by the Carnegie Foundation for the Advancement of
Teaching and is the companion organization of College Retirement Equities Fund. As of June 30, 2025, Nuveen managed approximately
$1.3 trillion in assets, of which approximately $151.1 billion was managed by Nuveen Fund Advisors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Investment Management Agreement and Related Fees.</b> Pursuant to an investment management
agreement between Nuveen Fund Advisors and the Fund (the &#8220;Investment Management Agreement&#8221;), the Fund has agreed to pay an annual management fee for the overall advisory and administrative services and general office facilities provided by
Nuveen Fund Advisors. The Fund&#8217;s management fee is separated into two components&#151;a complex-level component, based on the aggregate amount of all fund assets managed by Nuveen Fund Advisors, and a specific fund-level component, based only
on the amount of assets within the Fund. This pricing structure enables Nuveen fund shareholders to benefit from growth in the assets within each individual fund as well as from growth in the amount of complex-wide assets managed by Nuveen Fund
Advisors. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Fund-Level
Fee.</b> The annual fund-level fee for the Fund, payable monthly, is calculated according to the following schedule:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr>
    <td style="width: 90%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 6%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap">
        <p style="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Average Daily
Managed Assets*&#160;</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund-Level&#160;</b></span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fee&#160;Rate</b></span></p></td>
    <td>&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the first $500&#160;million</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.7000%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500&#160;million</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.6750%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500&#160;million</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.6500%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500&#160;million</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.6250%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For managed assets over $2&#160;billion</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.6000%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"/></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>




<!-- Field: Page; Sequence: 91; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Complex-Level
 Fee. &#160;</b>The overall complex-level fee, payable monthly, begins at a maximum rate of 0.1600% of the Fund&#8217;s
 average daily managed assets, with breakpoints for eligible complex-level assets above $124.3 billion. Therefore, the maximum management
 fee rate for the Fund is the Fund-level fee plus 0.1600%. The current overall complex-level fee schedule is as follows:</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level Asset Breakpoint Level*</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level Fee</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0; padding-left: 0">For the first $124.3 billion</td>
    <td style="text-align: right; padding-right: 0; padding-left: 0">0.1600%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0; padding-left: 0">For the next $75.7 billion</td>
    <td style="text-align: right; padding-right: 0; padding-left: 0">0.1350%</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0; padding-left: 0">For the next $200 billion</td>
    <td style="text-align: right; padding-right: 0; padding-left: 0">0.1325%</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 0; padding-left: 0">For eligible assets over $400 billion</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 0; padding-left: 0">0.1300%</td></tr>
  </table>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 22pt; text-align: left">*</td><td style="text-align: left">The complex-level fee is calculated based upon the aggregate daily
&#8220;eligible assets&#8221; of all Nuveen-branded closed-end funds and Nuveen Mutual Funds. Except as described below, eligible assets
include the net assets of all Nuveen-branded closed-end funds and Nuveen Mutual Funds organized in the United States. Eligible assets
do not include the net assets of: Nuveen fund-of-funds, Nuveen money market funds, Nuveen index funds, Nuveen Large Cap Responsible Equity
Fund or Nuveen Life Large Cap Responsible Equity Fund. In addition, eligible assets include a fixed percentage of the aggregate net assets
of the active equity and fixed income Nuveen Mutual Funds advised by Teachers Advisors, LLC (&#8220;TAL&#8221;) (except those identified
above). Eligible assets will include all of the aggregate net assets of TAL-advised active equity and fixed income Nuveen Mutual Funds
(except those identified above) on May 1, 2033. Eligible assets include closed-end fund assets managed by Nuveen Fund Advisors that are
attributable to financial leverage. For these purposes, financial leverage includes the closed-end funds&#8217; use of preferred stock
and borrowings and certain investments in the residual interest certificates (also called inverse floating rate securities) in tender
option bond (TOB) trusts, including the portion of assets held by a TOB trust that has been effectively financed by the trust&#8217;s
issuance of floating rate securities, subject to an agreement by Nuveen Fund Advisors as to certain funds to limit the amount of such
assets for determining eligible assets in certain circumstances.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-indent: 0.5in">As of June 30, 2025,
the complex-level fee rate for the Fund was 0.1569%.</p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The following
table sets forth the management fee paid by the Fund for the last three fiscal years: &#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Management&#160;Fee<br/>
    Net&#160;of&#160;Expense<br/>Reimbursement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expense<br/>Reimbursement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 69%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                         year&#160;ended&#160;December 31, 2022</p></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,963,845</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&#151;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                 year&#160;ended&#160;December 31, 2023</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,570,237  </td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#151;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                 year&#160;ended&#160;December 31, 2024</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,721,431</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#151;</td><td style="text-align: left"/></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">In addition to the fee
of Nuveen Fund Advisors, the Fund pays all other costs and expenses of its operations, including compensation of its Directors (other
than those affiliated with Nuveen Fund Advisors and Nuveen Asset Management), custodian, transfer agency and dividend disbursing expenses,
legal fees, expenses of independent auditors, expenses of repurchasing shares, expenses of preparing, printing and distributing shareholder
reports, notices, proxy statements and reports to governmental agencies and taxes, if any. All fees and expenses are accrued daily and
deducted before payment of dividends to investors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&#160;</p>




<!-- Field: Page; Sequence: 92; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Investment Sub-Adviser.
 </b>Pursuant to a sub-advisory agreement between Nuveen Fund Advisors and Nuveen Asset Management (the &#8220;Sub-Advisory Agreement&#8221;),&#160;Nuveen
 Asset Management, LLC, located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s sub-adviser. Nuveen Asset
 Management, a registered investment adviser, is a wholly-owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees
 day-to-day operations and provides portfolio management services to the Fund. Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management
 is compensated for the services it provides to the Fund with a portion of the management fee Nuveen Fund Advisors receives from the
 Fund. Nuveen Fund Advisors and Nuveen Asset Management retain the right to reallocate investment advisory responsibilities and fees
 between themselves in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b><span style="white-space: nowrap">Sub-Advisory</span>
                                                                                     Agreement and Related Fees.</b> Pursuant to the <span style="white-space: nowrap">Sub-Advisory</span> Agreement, Nuveen Asset
                                                                                     Management receives from Nuveen Fund Advisors a management fee equal to 44.4444% of Nuveen Fund Advisor&#8217;s net management fee
                                                                                     from the Fund.  Nuveen Fund Advisors and Nuveen Asset
                                                                                     Management retain the right to reallocate investment advisory responsibilities and fees between themselves in the future. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The following
table sets forth the management fee paid by Nuveen Fund Advisors to Nuveen Asset Management for the last three fiscal years:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Sub-Advisory&#160;Fee&#160;Paid&#160;by<br/>Nuveen&#160;Fund&#160;Advisors<br/>to&#160;Nuveen
    Asset<br/>Management</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                         year ended December 31, 2022</p></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,761,707</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                 year ended December 31, 2023</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,586,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; text-align: left">Fiscal
                                 year ended December 31, 2024</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,653,968</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Portfolio Managers.</b>&#8195;Unless
otherwise indicated, the information below is provided as of the date of this SAI.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Portfolio Management</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Katherine Renfrew&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and the sector lead for emerging markets corporates and quasi-sovereigns and all developed market quasi-sovereigns.
She is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team and serves as a lead and&#160;co-portfolio&#160;manager
across Nuveen&#8217;s suite of emerging markets debt strategies. Katherine joined the firm in 1997 and has held several roles relating
to emerging markets debt including South American regional analyst, trader, manager for the firm&#8217;s investments in Eastern Europe,
Middle East and Africa (EMEA) regions, and Asian and EMEA regional analyst. Prior to joining the firm, she was a fixed income securities
analyst at MONY Capital Management and a financial analyst at Mattel Toys.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">John Espinosa&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and is the sector lead for sovereigns. He also oversees all investment research across Nuveen&#8217;s global
fixed income and is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team. John serves as a lead
and&#160;co-portfolio&#160;manager across Nuveen&#8217;s suite of emerging markets debt and&#160;non-U.S.&#160;developed fixed income
strategies. John is a member of the Investment Committee, which establishes investment policy for all global fixed income products. John
has nearly two decades of fixed income investment industry experience and previously managed the organization&#8217;s global sovereign
and emerging markets debt research teams. John joined the firm in 2004 as a quantitative analyst and associate portfolio manager for the
CREF Bond Total Return strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Brenda A. Langenfeld, CFA, is a portfolio manager for Nuveen&#8217;s
global fixed income team and a member of the preferred securities sector team. She is the lead manager for Nuveen&#8217;s preferred and
income-focused&#160;closed-end&#160;funds and portfolio manager of the Preferred Securities and Income strategy. She joined the preferred
securities sector team in 2011. Brenda has been a&#160;co-manager&#160;for the Real Asset Income strategy since 2015, which invests in
income generating debt and equity securities from both the real estate and infrastructure segments. In 2020 she became&#160;co-manager&#160;of
the Credit Income strategy. Prior to her portfolio management roles, Brenda was a member of the high-grade credit sector team, responsible
for trading corporate bonds. Previously, she was a member of the securitized debt sector team, trading mortgage-backed securities, asset-backed
securities and commercial mortgage-backed securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">James Kim&#160;is a portfolio manager for Nuveen&#8217;s leveraged
finance team with a focus on the management of high yield mandates. James is the lead manager of the High Yield Income strategy and a&#160;co-manager&#160;on
the High Yield, Real Asset Income and Credit Income strategies. He is also head of special situations, leading workouts and opportunistic
investing for the leveraged finance platform. Previously, James was&#160;co-head&#160;of global fixed income research and head of the
leveraged finance research team, overseeing its daily investment process. He also served as the&#160;co-head&#160;of research at Nuveen
affiliate Symphony Asset Management, leading the firm&#8217;s research team, daily investment process and opportunistic investments across
its various mandates. Prior to this, he was a distressed generalist and an industry analyst responsible for a number of different industries,
including energy, power, metals&#160;&amp; mining and chemicals, providing long and short ideas across the capital structure. Prior to
joining the firm, James was an associate at Greywolf Capital in its special situations group and an analyst at Watershed Asset Management.
He began his career at Goldman Sachs, as an investment banking analyst both in the Strategy Group and Energy&#160;&amp; Power Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Mark Zheng, CFA, is a portfolio manager for Nuveen, focused
on Multi-Sector portfolio management. He is currently lead manager of a diversified, total return component portfolio for the CREF Real
Estate Account. He is also a&#160;co-manager&#160;for the Stable Value Account. Mark is a member of the Core and Core-Plus Strategy teams.
Mark provides strategic and quantitative analysis across a broad set of Multi-Sector Fixed Income strategies incorporating emerging markets,
mortgage-backed securities, high yield bond and loans and&#160;non-agency&#160;structured products. Since joining the firm in 2010, he
has held several positions, including&#160;co-manager&#160;of fixed income ETFs. He also served as a research analyst for investments
in mortgage-backed securities and as a business analyst for fixed income business applications. Prior to working in the financial services
industry, Mark worked in the engineering industry, providing consulting services for global pharmaceutical, chemical, and manufacturing
firms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 93; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Other Accounts Managed.</i>
The Portfolio Managers also have responsibility for the day-to-day management of accounts other than the Fund. Information regarding
these other accounts is set forth below.&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="padding: 0pt; width: 28%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; width: 1%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; width: 36%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; width: 1%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; width: 15%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; width: 1%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; width: 15%; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; line-height: 100%; text-indent: 0pt"><b>Portfolio Manager</b></td>
    <td style="padding: 0pt; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; line-height: 100%"><b>Type of <br/>
Account Managed</b></td>
    <td style="padding: 0pt; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; white-space: nowrap; line-height: 100%"><b>&#8194;&#8195;Number&#160;of&#8195;&#8194;<br/>
&#8195;&#8195;Accounts&#8195;&#8195;</b></td>
    <td style="padding: 0pt; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; line-height: 100%"><b>Assets*</b></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="7" style="padding: 0pt; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">Katherine Renfrew</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Registered Investment Company</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">5</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$6.21&#160;billion</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Pooled Investment Vehicles</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">3</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$852.75&#160;million</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Accounts</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">1</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$252.89&#160;million</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">John Espinosa</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Registered Investment Company</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">2</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$949.25&#160;million</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Pooled Investment Vehicles</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">2</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$229.59&#160;million</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Accounts</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">1</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$224.98&#160;million</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">Brenda A. Langenfeld</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Registered Investment Company</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">9</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$11.87&#160;billion</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Pooled Investment Vehicles</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">2</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$62.41&#160;million</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Accounts</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">4,097</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$2.84&#160;billion</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">James Kim</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Registered Investment Company</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">0</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$0</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Pooled Investment Vehicles</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">0</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$0</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Accounts</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">1</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$204.80&#160;million</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">Mark Zheng</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Registered Investment Company</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">1</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$88.75&#160;million</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Pooled Investment Vehicles</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">0</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$0</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">Other Accounts</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">0</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">$0</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 6pt">__________________</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 22pt; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Assets are as of December 31, 2024.
None of the assets in these accounts are subject to an advisory fee based on performance.</span></td>
</tr></table>



 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">As shown in the above
 table, the Portfolio Managers may manage other accounts in addition to the Fund. The potential for conflicts of interest exists when
 a portfolio manager manages other accounts with a similar investment objective and strategies to the Fund (&#8220;Similar
 Accounts&#8221;). Potential conflicts may include, for example, conflicts between investment strategies and conflicts in the
 allocation of investment opportunities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Responsibility for managing Nuveen Fund Advisors&#8217;
clients&#8217; portfolios is organized according to investment strategies. Generally, client portfolios with similar strategies are managed using the same objective, approach and philosophy. Therefore, portfolio holdings, relative position sizes and
sector exposures tend to be similar across similar portfolios which minimizes the potential for conflicts of interest. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Fund
Advisors may receive more compensation with respect to certain Similar Accounts than that received with respect to the Fund or may receive compensation based in part on the performance of certain Similar Accounts. This may create a potential
conflict of interest for the Portfolio Managers by providing an incentive to favor these Similar Accounts when, for example, placing securities transactions. Potential conflicts of interest may arise with both the aggregation and allocation of
securities transactions and allocation of limited investment opportunities. Allocations of aggregated trades, particularly trade orders that were only partially completed due to limited availability, and allocation of investment opportunities
generally, could raise a potential conflict of interest. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset Management has policies and procedures designed to manage these
conflicts described above such as allocation of investment opportunities to achieve fair and equitable allocation of investment opportunities among its clients over time. For example, orders for the same equity security are aggregated on a continual
basis throughout each trading day consistent with Nuveen Asset Management&#8217;s duty of best execution for its clients. If aggregated trades are fully executed, accounts participating in the trade will be allocated their pro rata share on an
average price basis. Partially completed orders will be allocated among the participating accounts on a <span style="white-space: nowrap">pro-rata</span> average price basis as well. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Compensation.</i> Portfolio managers are compensated through a combination of base salary and variable components consisting of (i)&#160;a
cash bonus; (ii)&#160;a long-term performance award; and (iii)&#160;participation in a profits interest plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 94; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Base salary.</i> A portfolio manager&#8217;s base salary is determined based upon an analysis
of the portfolio manager&#8217;s general performance, experience and market levels of base pay for such position. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Cash bonus</i>. A
portfolio manager is eligible to receive an annual cash bonus that is based on three variables: risk-adjusted investment performance relative to benchmark generally measured over the most recent one, three and five year periods (unless the portfolio
manager&#8217;s tenure is shorter), ranking versus Morningstar peer funds generally measured over the most recent one, three and five year periods (unless the portfolio manager&#8217;s tenure is shorter), and management and peer reviews. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Long-term performance award.</i> A portfolio manager is eligible to receive a long-term performance award that vests after three years. The
amount of the award when granted is based on the same factors used in determining the cash bonus. The value of the award at the completion of the three-year vesting period is adjusted based on the risk-adjusted investment performance of Fund(s)
managed by the portfolio manager during the vesting period and the performance of the TIAA organization as a whole. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Profits interest
plan.</i> Portfolio managers are eligible to receive profits interests in Nuveen Asset Management and its affiliate, Teachers Advisors, LLC, which vest over time and entitle their holders to a percentage of the firms&#8217; annual profits. Profits
interests are allocated to each portfolio manager based on such person&#8217;s overall contribution to the firms. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">There are generally no
differences between the methods used to determine compensation with respect to the Fund and the Other Accounts shown in the table above. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Material conflicts of interest</i>. Actual or apparent conflicts of interest may arise when a portfolio manager has <span style="white-space: nowrap"><span style="white-space: nowrap">day-to-day</span></span> management responsibilities with respect to more than one account. More specifically, portfolio managers who manage multiple accounts are presented a number of
potential conflicts, including, among others, those discussed below. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The management of multiple accounts may result in a portfolio
manager devoting unequal time and attention to the management of each account. Nuveen Asset Management seeks to manage such competing interests for the time and attention of portfolio managers by having portfolio managers focus on a particular
investment discipline. Most accounts managed by a portfolio manager in a particular investment strategy are managed using the same investment models. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">If a portfolio manager identifies a limited investment opportunity which may be suitable for more than one account, an account may not be able
to take full advantage of that opportunity due to an allocation of filled purchase or sale orders across all eligible accounts. To deal with these situations, Nuveen Asset Management has adopted procedures for allocating limited opportunities across
multiple accounts. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">With respect to many of its clients&#8217; accounts, Nuveen Asset Management determines which broker to use to execute
transaction orders, consistent with its duty to seek best execution of the transaction. However, with respect to certain other accounts, Nuveen Asset Management may be limited by the client with respect to the selection of brokers or may be
instructed to direct trades through a particular broker. In these cases, Nuveen Asset Management may place separate, <span style="white-space: nowrap">non-simultaneous,</span> transactions for the Fund and other accounts which may temporarily affect
the market price of the security or the execution of the transaction, or both, to the detriment of the Fund or the other accounts. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Some
                                            clients are subject to different regulations. As a consequence of this difference in regulatory
                                            requirements, some clients may not be permitted to engage in all the investment techniques
                                            or transactions or to engage in these transactions to the same extent as the other accounts
                                            managed by the portfolio manager. Finally, a conflict of interest arises where Nuveen Asset
                                            Management has an incentive, such as a performance-based management fee, which relates to
                                            the management of some accounts, with respect to which a portfolio manager has day-to-day
                                            management responsibilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 95; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Conflicts of interest may also arise when the <span style="white-space: nowrap">sub-adviser</span>
invests one or more of its client accounts in different or multiple parts of the same issuer&#8217;s capital structure, including investments in public versus private securities, debt versus equity, or senior versus junior/subordinated debt, or
otherwise where there are different or inconsistent rights or benefits. Decisions or actions such as investing, trading, proxy voting, exercising, waiving or amending rights or covenants, workout activity, or serving on a board, committee or other
involvement in governance may result in conflicts of interest between clients holding different securities or investments. Generally, individual portfolio managers will seek to act in a manner that they believe serves the best interest of the
accounts they manage. In cases where a portfolio manager or team faces a conflict among its client accounts, it will seek to act in a manner that it believes best reflects its overall fiduciary duty, which may result in relative advantages or
disadvantages for particular accounts. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset Management has adopted certain compliance procedures which are designed to address
these types of conflicts common among investment managers. However, there is no guarantee that such procedures will detect each and every situation in which a conflict arises. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset Management or its affiliates, including TIAA, sponsor an array of financial products for retirement and other investment goals,
and provide services worldwide to a diverse customer base. Accordingly, from time to time, the Fund may be restricted from purchasing or selling securities, or from engaging in other investment activities because of regulatory, legal or contractual
restrictions that arise due to another client account&#8217;s investments and/or the internal policies of Nuveen Asset Management, TIAA or its affiliates designed to comply with such restrictions. As a result, there may be periods, for example, when
Nuveen Asset Management will not initiate or recommend certain types of transactions in certain securities or instruments with respect to which investment limits have been reached. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The investment activities of Nuveen Asset Management or its affiliates may also limit the investment strategies and rights of the Fund. For
example, in certain circumstances where the Fund invests in securities issued by companies that operate in certain regulated industries, in certain emerging or international markets, or are subject to corporate or regulatory ownership definitions,
or invest in certain futures and derivative transactions, there may be limits on the aggregate amount invested by Nuveen Asset Management or its affiliates for the Fund and other client accounts that may not be exceeded without the grant of a
license or other regulatory or corporate consent. If certain aggregate ownership thresholds are reached or certain transactions undertaken, the ability of Nuveen Asset Management, on behalf of the Fund or other client accounts, to purchase or
dispose of investments or exercise rights or undertake business transactions may be restricted by regulation or otherwise impaired. As a result, Nuveen Asset Management, on behalf of the Fund or other client accounts, may limit purchases, sell
existing investments, or otherwise restrict or limit the exercise of rights (including voting rights) when Nuveen Asset Management, in its sole discretion, deems it appropriate in light of potential regulatory or other restrictions on ownership or
other consequences resulting from reaching investment thresholds. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Fund
shares owned by the Portfolio Managers.</i> As of December 31, 2024, the Portfolio Managers beneficially owned (as determined pursuant
to Rule 16a-1(a)(2) under the 1934 Act) shares of the Fund having values within the indicated dollar range.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0pt; white-space: nowrap; line-height: 115%; text-indent: 0pt"><b>Portfolio Manager</b></td>
    <td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding: 0pt; text-align: center; line-height: 115%"><b>Dollar Range of Equity Securities Beneficially<br/>
 Owned in the Fund</b></td>
    <td style="padding: 0pt; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt; width: 77%">Katherine Renfrew&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; text-align: right; vertical-align: bottom; line-height: 100%; text-indent: 0pt; width: 20%">None</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt; width: 1%">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">John Espinosa&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: right; vertical-align: bottom; line-height: 100%; text-indent: 0pt">None</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">Brenda A. Langenfeld</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: right; vertical-align: bottom; line-height: 100%; text-indent: 0pt">None</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">James Kim&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: right; vertical-align: bottom; line-height: 100%; text-indent: 0pt">None</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; line-height: 100%; text-indent: 0pt">Mark Zheng</td>
    <td style="padding: 0pt; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: right; vertical-align: bottom; line-height: 100%; text-indent: 0pt">None</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 100%; text-indent: 0pt">&#160;</td></tr>
  </table>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>

<!-- Field: Page; Sequence: 96; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_7"></span>CODE OF ETHICS </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund, Nuveen Fund Advisors, Nuveen Asset Management, Nuveen Securities and other related entities have adopted a combined code of ethics
(the &#8220;Code of Ethics&#8221;) that essentially prohibits certain of their personnel, including the Portfolio Managers, from engaging in personal investments that compete or interfere with, or attempt to take advantage of a client&#8217;s,
including the Fund&#8217;s, anticipated or actual portfolio transactions, and are designed to assure that the interests of clients, including Fund shareholders, are placed before the interests of personnel in connection with personal investment
transactions. Personnel subject to the Code of Ethics may purchase shares of the Fund subject to the restriction set forth in the Code of Ethics. While personnel subject to the Code of Ethics may generally invest in securities in which the Fund may
also invest, portfolio managers of municipal bond funds, such as the Fund, may not do so. Text-only versions of the Code of Ethics can be viewed online or downloaded from the EDGAR Database on the SEC&#8217;s internet website at www.sec.gov. In
addition, a copy of the Code of Ethics may be obtained, after paying the appropriate duplicating fee, by <span style="white-space: nowrap">e-mail</span> request at <span style="text-decoration: underline">publicinfo@sec.gov.</span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_8"></span>PROXY VOTING POLICIES </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund has delegated authority to Nuveen Fund Advisors to vote
proxies for securities held by the Fund, and Nuveen Fund Advisors has in turn delegated that responsibility to Nuveen Asset Management.
Nuveen Fund Advisors&#8217; proxy voting policy establishes minimum standards for the exercise of proxy voting authority by Nuveen Asset
Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">In the rare event that an issuer were to issue a proxy or that
the Fund were to receive a proxy issued by a cash management security, Nuveen Asset Management will vote proxies in accordance with the
Nuveen Proxy Voting Guidelines, which are attached, along with the Nuveen Proxy Voting Policy and Nuveen Proxy Voting Conflicts of Interest
Policy and Procedures, as Appendix B to this SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset Management relies on a dedicated team of professionals
responsible for reviewing and voting proxies. In analyzing a proposal, in addition to exercising their professional judgment, these professionals
utilize various sources of information to enhance their ability to evaluate the proposal. These sources may include research from third
party proxy advisory firms and other consultants, various corporate governance-focused organizations, related publications and Nuveen
investment professionals. Based on their analysis of proposals and guided by the Nuveen Proxy Voting Guidelines, these professionals then
vote in a manner intended solely to advance the best interests of Fund shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset Management believes that they have implemented policies,
procedures and processes designed to prevent conflicts of interest from influencing proxy voting decisions. These include (i)&#160;oversight
by the Nuveen Fund Board or a designated committee thereof; (ii)&#160;a clear separation of proxy voting functions from external client
relationship and sales functions; and (iii)&#160;the active monitoring of required annual disclosures of potential conflicts of interest
by individuals who have direct roles in executing or influencing the Fund&#8217;s proxy voting by Nuveen&#8217;s legal and compliance
professionals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">There could be rare instances in which an individual who has
a direct role in executing or influencing the Fund&#8217;s proxy voting (e.g., Nuveen&#8217;s proxy voting professionals, a Board member,
or a senior executive of the &#160;Fund, Nuveen Fund Advisors, Nuveen Asset Management or their affiliates) is either a director or executive
of a portfolio company or may have some other association with a portfolio company. In such cases, this individual is required to recuse
himself or herself from all decisions related to proxy voting for that portfolio company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Voted Proxies.</i>&#160;Information regarding how your Fund
voted proxies relating to portfolio securities during the most recent&#160;12-month&#160;period ended June&#160;30 is available without
charge by accessing the Fund&#8217;s Proxy Voting Report on Form N-PX, which is available through both Nuveen&#8217;s website at&#160;http://www.nuveen.com/en-us/closed-end-funds&#160;or
the SEC&#8217;s website at http://www.sec.gov.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_9"></span>PORTFOLIO TRANSACTIONS AND BROKERAGE </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Subject to the
supervision of the Board, Nuveen Asset Management is responsible for decisions to purchase and sell securities for the Fund, the
negotiation of the prices to be paid and the allocation of transactions among various dealer firms. Transactions on stock exchanges
involve the payment by the Fund of brokerage commissions. There generally is no stated commission in the case of securities traded
OTC but the price paid by the Fund usually includes an undisclosed dealer commission or mark-up. Transactions in the OTC market can
also be placed with broker-dealers who act as agents and charge brokerage commissions for effecting OTC transactions. The Fund may
place its OTC transactions either directly with principal market makers, or with broker-dealers if that is consistent with Nuveen
Asset Management&#8217;s obligation to obtain best qualitative execution. In certain instances, the Fund may make purchases of
underwritten issues at prices that include underwriting fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 97; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Portfolio securities may be purchased directly from an
underwriter or in the OTC market from the principal dealers in such securities, unless it appears that a better price or execution may be obtained through other means. Portfolio securities will not be purchased from Nuveen Investments or its
affiliates or affiliates of Nuveen Fund Advisors except in compliance with the 1940 Act. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">It is Nuveen Asset Management&#8217;s policy to
seek the best execution under the circumstances of each trade. Nuveen Asset Management will evaluate price as the primary consideration, with the financial condition, reputation and responsiveness of the dealer considered secondary in determining
best execution. Given the best execution obtainable, it will be Nuveen Asset Management&#8217;s practice to select dealers that, in addition, furnish research information (primarily credit analyses of issuers and general economic reports) and
statistical and other services to Nuveen Asset Management. It is not possible to place a dollar value on information and statistical and other services received from dealers. Since it is only supplementary to Nuveen Asset Management&#8217;s own
research efforts, the receipt of research information is not expected to reduce significantly Nuveen Asset Management&#8217;s expenses. While Nuveen Asset Management will be primarily responsible for the placement of the business of the Fund, Nuveen
Asset Management&#8217;s policies and practices in this regard must be consistent with the foregoing and will, at all times, be subject to review by the Board of the Fund. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Asset
Management may manage other investment accounts and investment companies for other clients that may invest in the same types of
securities as the Fund and that may have an investment objective similar to that of the Fund. Nuveen Asset Management seeks to
allocate portfolio transactions equitably whenever concurrent decisions are made to purchase or sell assets or securities by the
Fund and another advisory account. If an aggregated order cannot be filled completely, allocations will generally be made on a pro
rata basis. An order may not be allocated on a pro rata basis where, for example (i)&#160;consideration is given to portfolio
managers who have been instrumental in developing or negotiating a particular investment; (ii)&#160;consideration is given to an
account with specialized investment policies that coincide with the particulars of a specific investment; (iii)&#160;pro rata
allocation would result in <span style="white-space: nowrap">odd-lot</span> or de minimis amounts being allocated to a portfolio or
other client; or (iv)&#160;where Nuveen Asset Management reasonably determines that departure from a pro rata allocation is
advisable. There may also be instances where the Fund will not participate at all in a transaction that is allocated among other
accounts. While these allocation procedures could have a detrimental effect on the price or amount of the securities available to
the Fund from time to time, it is the opinion of the Board that the benefits available from Nuveen Asset Management&#8217;s
management outweigh any disadvantage that may arise from Nuveen Asset Management&#8217;s larger management activities and its need
to allocate securities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Substantially all of the Fund&#8217;s trades are
effected on a principal basis. The following table sets forth the aggregate amount of brokerage commissions paid by the Fund for the last three fiscal years: </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 100%; border-collapse: collapse; margin-right: auto">


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom: #000000 1px solid; vertical-align: bottom; text-align: center"><b>Brokerage&#160;Commissions
Paid</b></td>
<td style="vertical-align: bottom">&#160;</td></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255); page-break-inside: avoid">
<td style="vertical-align: top; width: 78%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em">Fiscal
                                         year ended December 31, 2022</p></td>
<td style="vertical-align: bottom; width: 1%">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; width: 8%">$</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 12%">2,096</td>
<td style="white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em">Fiscal
                                year ended December 31, 2023</p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom">$</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">875</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255); page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em">Fiscal
                                year ended December 31, 2024</p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom">$</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">753</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">During the fiscal
year ended December 31, 2024, the Fund did not pay commissions to brokers in return for research services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt; text-indent: 0.5in">During the fiscal
year ended December 31, 2024, the Fund acquired certain securities of its regular brokers or dealers, as defined in Rule 10b-1 under
the 1940 Act, or of the parents of the brokers or dealers. The following table sets forth those brokers or dealers and states the
value of the Fund&#8217;s aggregate holdings of the securities of each issuer as of close of the fiscal year ended December 31,
2024:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Broker/Dealer</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Issuer</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Aggregate Fund</b></p>
                                                                             <p style="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Holdings of
                                                                             Broker</b></p>
                                                                             <p style="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>/Dealer
                                            or Parent (as of December 31, 2024)</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Barclays Capital</td><td style="width: 4%">&#160;</td>
    <td style="width: 37%; text-align: left">Barclays PLC</td><td style="width: 3%">&#160;</td>
    <td style="width: 9%; text-align: left">$</td>
    <td style="width: 12%; text-align: right">1,525,997</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">BNP Paribas</td><td>&#160;</td>
    <td style="text-align: left">BNP Paribas SA</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">3,542,477</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Citigroup Global Markets Inc.</td><td>&#160;</td>
    <td style="text-align: left">Citigroup Inc</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Morgan Stanley &amp; Co.</td><td>&#160;</td>
    <td style="text-align: left">Morgan Stanley</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">1,226,397</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Aptos,sans-serif">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Morgan Stanley Capital Services LLC</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">UBS Securities LLC</td><td>&#160;</td>
    <td style="text-align: left">UBS Group AG</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">3,472,171</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Wells Fargo Securities, LLC</td><td>&#160;</td>
    <td style="text-align: left">Wells Fargo &amp; Co</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td>&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 98; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_10"></span>TAX MATTERS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Set forth below is a discussion of certain
U.S. federal income tax issues concerning the Fund and the purchase, ownership and disposition of the Common Shares. Because tax laws
are complex and often change, you should consult your tax advisor about the tax consequences of an investment in the Fund. This discussion
does not purport to be complete or to deal with all aspects of U.S. federal income taxation that may be relevant to Common Shareholders
in light of their particular circumstances. Unless otherwise noted, this discussion assumes you are a U.S. Common Shareholder (as defined
below) and that you hold your shares as a capital asset (generally, for investment). A U.S. Common Shareholder means a person (other than
a partnership) that is for U.S. federal income tax purposes (i) an individual citizen or resident of the United States, (ii) a corporation
(or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United
States, any state thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation
regardless of its source or (iv) a trust if it (1) is subject to the primary supervision of a court within the United States and one or
more United States persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect
under applicable United States Treasury regulations to be treated as a United States person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This discussion is based upon present provisions
of the Code, the regulations promulgated thereunder, and judicial and administrative ruling authorities, all of which are subject to change,
which change may be retroactive. We have not sought and will not seek any ruling from the Internal Revenue Service (&#8220;IRS&#8221;)
regarding any matters discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a
position contrary to those set forth below. Prospective investors should consult their own tax advisers with regard to the U.S. federal
tax consequences of the purchase, ownership, or disposition of Common Shares, as well as the tax consequences arising under the laws of
any state, local, foreign, or other taxing jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The discussion below does not represent a
detailed description of the U.S. federal income tax considerations relevant to special classes of taxpayers including, without limitation,
financial institutions, insurance companies, taxpayers subject to the alternative minimum tax, a partnership or other pass-through entity
for U.S. federal income tax purposes, U.S. Common Shareholders whose &#8220;functional currency&#8221; is not the U.S. dollar, tax-exempt
organizations, a controlled foreign corporation or a passive foreign investment company, dealers in securities or currencies, traders
in securities or commodities that elect mark-to-market treatment, persons with &#8220;applicable financial statements&#8221; within the
meaning of Section 451(b) of the Code, or persons that will hold Common Shares as a position in a &#8220;straddle,&#8221; &#8220;hedge&#8221;
or as part of a &#8220;constructive sale&#8221; for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">If a partnership (or any other entity treated
as a partnership for U.S. federal income tax purposes) holds Common Shares, the tax treatment of a partner in the partnership generally
will depend upon the status of the partner and the activities of the partnership. Partnerships that hold Common Shares and partners in
such a partnership should consult their tax advisors about the U.S. federal income tax considerations of the purchase, ownership and disposition
of Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund has elected to be treated and intends
to qualify each year as a RIC under the Code. To qualify as a RIC, the Fund must, among other things, derive in each taxable year at least
90% of its gross income from (i) dividends, interest, payments with respect to securities loans and gains from the sale or other disposition
of stock, securities or foreign currencies or other income derived with respect to its business of investing in such stock, securities
or currencies, and (ii) net income derived from an interest in a qualified publicly traded partnership. A &#8220;qualified publicly traded
partnership&#8221; is a publicly traded partnership that meets certain requirements with respect to the nature of its income. To qualify
as a RIC, the Fund must also satisfy certain requirements with respect to the diversification of its assets. The Fund must, at the close
of each quarter of the taxable year, diversify its holdings so that, at the end of each quarter of the taxable year, (i) at least 50%
of the market value of the Fund&#8217;s assets is represented by cash and cash items (including receivables), U.S. government securities,
the securities of other regulated investment companies and other securities, with such other securities of any one issuer limited for
the purposes of this calculation to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not greater than 10%
of the outstanding voting securities of such issuer, and (ii) not more than 25% of the value of its total assets is invested in the securities
(other than U.S. government securities or the securities of other regulated investment companies) of a single issuer, of two or more issuers
which the Fund controls and are engaged in the same, similar or related trades or businesses, or the securities of one or more qualified
publicly traded partnerships. Finally, to qualify for treatment as a RIC, the Fund must distribute at least 90% of its investment company
taxable income (which includes, among other items, dividends, interest, income from the interests in certain qualified publicly traded
partnerships, and net short-term capital gains in excess of net long-term capital losses) and 90% of its net tax-exempt income each taxable
year. If the Fund failed to meet the asset diversification test described above with respect to any quarter, the Fund would nevertheless
be considered to have satisfied the requirements for such quarter if the Fund cured such failure within six months and either (i) such
failure was de minimis or (ii) (a) such failure was due to reasonable cause and not due to willful neglect and (b) the Fund reported the
failure under Treasury regulations to be adopted and paid an excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 99; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As a RIC, the Fund generally will not be
subject to U.S. federal income tax on its investment company taxable income (as that term is defined in the Code, but without regard to
the deduction for dividends paid net tax-exempt income) and net capital gain (the excess of net long-term capital gain over net short-term
capital loss), if any, that it distributes to shareholders. If the Fund retains any net capital gain or investment company taxable income,
it will be subject to tax at the corporate income tax rate on the amount retained. If the Fund retains any net capital gain, it may report
the retained amount as undistributed capital gains as part of its annual reporting to its shareholders who, if subject to U.S. federal
income tax on long-term capital gains, (i) will be required to include in income for U.S. federal income tax purposes, as long-term capital
gain, their share of such undistributed amount; (ii) will be entitled to credit their proportionate shares of the tax paid by the Fund
on such undistributed amount against their U.S. federal income tax liabilities, if any; and (iii) will be entitled to claim refunds to
the extent the credit exceeds such liabilities. For U.S. federal income tax purposes, the tax basis of Common Shares owned by a Common
Shareholder of the Fund will be increased by an amount equal to the difference between the amount of undistributed capital gains included
in the shareholder&#8217;s gross income and the tax deemed paid by the Common Shareholder under clause (ii) of the preceding sentence.
The Fund intends to distribute to its Common Shareholders at least annually that portion of its investment company taxable income necessary
to maintain its qualification as a RIC, as well as net capital gains (except for net capital gains credited to them but retained by the
Fund).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Capital losses in excess of capital gains
(&#8220;net capital losses&#8221;) are not permitted to be deducted against a RIC&#8217;s net investment income. Instead, for U.S. federal
income tax purposes, potentially subject to certain limitations, the Fund may carry net capital losses from any taxable year forward to
offset capital gains in future years. If the Fund has a net capital loss, the excess of the Fund&#8217;s net short-term capital losses
over its net long-term capital gains is treated as a short-term capital loss arising on the first day of the Fund&#8217;s next taxable
year, and the excess (if any) of the Fund&#8217;s net long-term capital losses over its net short-term capital gains is treated as a long-term
capital loss arising on the first day of the Fund&#8217;s next taxable year. The carryover of capital losses may be limited under the
general loss limitation rules if the Fund experiences an ownership change as defined in the Internal Revenue Code. Generally, the Fund
may not carry forward any losses other than net capital losses. Under certain circumstances, the Fund may elect to treat certain losses
as though they were incurred on the first day of the taxable year immediately following the taxable year in which they were actually incurred.
As of December 31, 2024, the Fund&#8217;s tax year end, the Fund had unused capital loss carryforwards available for federal income tax purposes
to be applied against future capital gains, if any, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0pt"><b>Not subject to expiration:</b>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding: 0pt; width: 85%; text-indent: 0pt; line-height: 115%">Short-Term</td>
    <td style="padding: 0pt; width: 1%; text-indent: 0pt; line-height: 115%">&#160;</td>
    <td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt">$</td>
    <td style="padding: 0pt; text-align: right; width: 12%; line-height: 115%; text-indent: 0pt">28,220,391</td>
    <td style="padding: 0pt; width: 1%; text-indent: 0pt; line-height: 115%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%">Long-Term</td>
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%">&#160;</td>
    <td style="padding: 0pt; line-height: 115%; text-indent: 0pt">$</td>
    <td style="padding: 0pt; text-align: right; line-height: 115%; text-indent: 0pt">108,308,860</td>
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%"><b>Total</b></td>
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%">$</td>
    <td style="padding: 0pt; text-align: right; line-height: 115%; text-indent: 0pt">136,529,251</td>
    <td style="padding: 0pt; text-indent: 0pt; line-height: 115%"><b>&#160;&#160;</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; text-indent: 0.5in">Amounts not distributed on a timely basis in
accordance with a calendar year distribution requirement are subject to a nondeductible 4% excise tax. To prevent imposition of the excise
tax, the Fund must distribute during each calendar year an amount equal to the sum of (1) at least 98% of its ordinary income (not taking
into account any capital gains or losses) for the calendar year, (2) at least 98.2% of its capital gains in excess of its capital losses
(adjusted for certain ordinary losses) for the one-year period ending October 31 of the calendar year, and (3) any ordinary income and
capital gains for previous years that were not distributed during those years. A distribution will be treated as paid on December 31
of the current calendar year if it is declared by the Fund in October, November or December with a record date in such a month and paid
by the Fund during January of the following calendar year. Such distributions will be taxable to shareholders in the calendar year in
which the distributions are declared, rather than the calendar year in which the distributions are received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund failed to qualify
as a RIC or failed to satisfy the 90% distribution requirement in any taxable year, and was unable to cure such failure, the Fund would
be taxed as an ordinary corporation on its taxable income (even if such income were distributed to its shareholders) and all distributions
out of earnings and profits would be taxed to shareholders as ordinary dividends. Such distributions generally would be eligible (i)
to be treated as &#8220;qualified dividend income&#8221; in the case of individual and other noncorporate shareholders and (ii) for the
dividends received deduction (&#8220;DRD&#8221;) in the case of corporate shareholders. In addition, in order to requalify for taxation
as a RIC, the Fund could be required to recognize unrealized gains, pay substantial taxes and interest, and make certain distributions.
In addition, the Fund could be required to recognize unrealized gains, pay substantial taxes and interest and make substantial distributions
before requalifying as a RIC. The Board of Trustees reserves the right not to maintain the qualification of the Fund as a RIC if it determines
such course of action to be beneficial to Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 100; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Distributions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Distributions of the Fund&#8217;s net capital gain
(&#8220;capital gain distributions&#8221;), if any, are taxable to shareholders as long-term capital gain, regardless of their holding
period in the Common Shares. All other distributions out of the Fund&#8217;s earnings and profits (including distributions of the Fund&#8217;s
net realized short-term capital gains) will be taxable as ordinary income. The maximum long-term capital gain tax rate applicable to individuals
is 20%. No assurance can be given as to what percentage of the distributions paid on the Common Shares, if any, will consist of long-term
capital gains or what the tax rates on various types of income will be in future years. None of the Fund, Nuveen Fund Advisors or the
Subadvisers provides tax advice to investors in the Fund or has any knowledge of a particular investor&#8217;s tax situation. As a result,
investors should consult their own tax advisers when determining the tax characterization of any distributions from the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, for any calendar year, the Fund&#8217;s total
distributions exceed the Fund&#8217;s current and accumulated earnings and profits, the excess will be treated as a tax-free return of
capital to each shareholder (up to the amount of the shareholder&#8217;s basis in his or her Common Shares) and thereafter as gain from
the sale of Common Shares (assuming the Common Shares are held as a capital asset). The amount treated as a tax-free return of capital
will reduce the shareholder&#8217;s adjusted basis in his or her Common Shares (but not below zero), thereby increasing the potential
gain or reducing the potential loss on the subsequent sale or other disposition of the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An additional tax at a rate of 3.8% applies to
some or all of the net investment income of certain non-corporate taxpayers. For this purpose, &#8220;net investment income&#8221; includes
interest, dividends (including dividends paid with respect to Common Shares), annuities, royalties, rent, net gain attributable to the
disposition of property not held in a trade or business (including net gain from the sale, exchange or other taxable disposition of Common
Shares) and certain other income, but will be reduced by any deductions properly allocable to such income or net gain. Shareholders are
advised to consult their own tax advisors regarding the taxation of net investment income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Shareholders will be notified annually as to the
U.S. federal tax status of distributions, and shareholders receiving distributions in the form of additional shares will receive a report
as to the NAV of those shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The IRS currently requires that a RIC that has
two or more classes of stock allocate to each such class proportionate amounts of each type of its income (such as ordinary income, capital
gains, dividends qualifying for the dividends received deduction, qualified dividend income, interest-related dividends and short-term
capital gain dividends) based upon the percentage of total dividends paid out of current or accumulated earnings and profits to each class
for the tax year. Accordingly, the Fund intends to allocate capital gain dividends, if any, between its Common Shares and Preferred Shares
in proportion to the total dividends paid out of current or accumulated earnings and profits to each class with respect to such tax year.
Distributions in excess of the Fund&#8217;s current and accumulated earnings and profits, if any, however, will not be allocated proportionately
among the Common Shares and Preferred Shares. Since the Fund&#8217;s current and accumulated earnings and will first be used to pay dividends
on the Preferred Shares, distributions in excess of such earnings and profits, if any, will be made disproportionately to Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 101; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Sale, Exchange or Liquidation of Fund Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The sale, exchange or repurchase of Fund shares
may give rise to a gain or loss. In general, any gain or loss realized upon a taxable disposition of Fund shares treated as a sale or
exchange for U.S. federal income tax purposes will be treated as long-term capital gain or loss if the shares have been held for more
than twelve months. Otherwise, such gain or loss on the taxable disposition of Fund shares will be treated as short-term capital gain
or loss. However, any loss realized upon a taxable disposition of Fund shares held for six months or less will be treated as long-term,
rather than short-term, to the extent of any long-term capital gain distributions received (or deemed received) by the shareholder with
respect to the shares. All or a portion of any loss realized upon a taxable disposition of Fund shares will be disallowed under the Code&#8217;s
&#8220;wash sale&#8221; rule if other substantially identical shares of the Fund are purchased within thirty days before or after the
disposition. In such a case, the basis of the newly purchased shares will be adjusted to reflect the disallowed loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A repurchase by the Fund of a shareholder&#8217;s
shares pursuant to a repurchase offer generally will be treated as a sale or exchange of the shares by a shareholder provided that either
(i) the shareholder tenders, and the Fund repurchases, all of such shareholder&#8217;s shares, thereby reducing the shareholder&#8217;s
percentage ownership of the Fund, whether directly or by attribution under Section 318 of the Code, to 0%, (ii) the shareholder meets
numerical safe harbors under the Code with respect to percentage voting interest and reduction in ownership of the Fund following completion
of the repurchase offer, or (iii) the repurchase offer otherwise results in a &#8220;meaningful reduction&#8221; of the shareholder&#8217;s
ownership percentage interest in the Fund, which determination depends on a particular shareholder&#8217;s facts and circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a tendering shareholder&#8217;s proportionate
ownership of the Fund (determined after applying the ownership attribution rules under Section 318 of the Code) is not reduced to the
extent required under the tests described above, such shareholder will be deemed to receive a distribution from the Fund under Section
301 of the Code with respect to the shares held (or deemed held under Section 318 of the Code) by the shareholder after the repurchase
offer (a &#8220;Section 301 distribution&#8221;). The amount of this distribution will equal the price paid by the Fund to such shareholder
for the shares sold, and will be taxable as a dividend, i.e., as ordinary income, to the extent of the Fund&#8217;s current or accumulated
earnings and profits allocable to such distribution, with the excess treated as a return of capital reducing the shareholder&#8217;s tax
basis in the shares held after the repurchase offer, and thereafter as capital gain. Any Fund shares held by a shareholder after a repurchase
offer will be subject to basis adjustments in accordance with the provisions of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 102; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Provided that no tendering shareholder is treated
as receiving a Section 301 distribution as a result of selling shares pursuant to a particular repurchase offer, shareholders who do not
sell shares pursuant to that repurchase offer will not realize constructive distributions on their shares as a result of other shareholders
selling shares in the repurchase offer. In the event that any tendering shareholder is deemed to receive a Section 301 distribution, it
is possible that shareholders whose proportionate ownership of the Fund increases as a result of that repurchase offer, including shareholders
who do not tender any shares, will be deemed to receive a constructive distribution under Section 305(c) of the Code in an amount equal
to the increase in their percentage ownership of the Fund as a result of the repurchase offer. Such constructive distribution will be
treated as a dividend to the extent of current or accumulated earnings and profits allocable to it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Use of the Fund&#8217;s cash to repurchase shares
may adversely affect the Fund&#8217;s ability to satisfy the distribution requirements for treatment as a regulated investment company
described above. The Fund may also recognize income in connection with the sale of portfolio securities to fund share purchases, in which
case the Fund would take any such income into account in determining whether such distribution requirements have been satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing discussion does not address the tax
treatment of tendering shareholders who do not hold their shares as a capital asset. Such shareholders should consult their own tax advisors
on the specific tax consequences to them of participating or not participating in the repurchase offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or otherwise
limit the allowance of certain losses or deductions, (ii) convert long-term capital gain into short-term capital gain or ordinary income,
(iii) convert an ordinary loss or deduction into a capital loss (the deductibility of which is more limited), (iv) cause the Fund to recognize
income or gain without a corresponding receipt of cash, (v) adversely alter the characterization of certain complex financial transactions,
and (vi) produce income that will not qualify as good income for purposes of the income requirement that applies to a RIC. The Fund may,
but is not required to, make certain tax elections in order to mitigate the effect of these provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Fund invests in certain pay-in-kind investments,
zero coupon investments, deferred interest investments or, in general, any other investments with original issue discount (or with market
discount if the Fund elects to include market discount in income currently), the Fund must accrue income on such investments for each
taxable year, which generally will be prior to the receipt of the corresponding cash payments. However, the Fund must distribute to shareholders,
at least annually, all or substantially all of its investment company taxable income (determined without regard to the deduction for dividends
paid), including such accrued income, to qualify as a RIC and to avoid federal income and excise taxes. Therefore, the Fund may have to
dispose of its portfolio investments under disadvantageous circumstances to generate cash, or may have to leverage itself by borrowing
the cash, to satisfy these distribution requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 103; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may hold or acquire obligations that are
market discount bonds. A market discount bond is a security acquired in the secondary market at a price below its redemption value (or
its adjusted issue price if it is also an original issue discount bond). If the Fund invests in a market discount bond, it will be required
to treat any gain recognized on the disposition of such market discount bond as ordinary taxable income to the extent of the accrued market
discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Fund invests in options that qualify as
&#8220;section 1256 contracts,&#8221; Section 1256 of the Code generally requires any gain or loss arising from the lapse, closing out
or exercise of such positions to be treated as 60% long-term and 40% short-term capital gain or loss. In addition, the Fund generally
would be required to &#8220;mark to market&#8221; (i.e., treat as sold for fair market value) each such outstanding option position at
the close of each taxable year (and on October 31 of each year for excise tax purposes). If a section 1256 contract held by the Fund at
the end of a taxable year is sold or closed out in a subsequent year, the amount of any gain or loss realized on such sale will be adjusted
to reflect the gain or loss previously taken into account under the &#8220;mark to market&#8221; rules. In addition to most exchange traded
index options, section 1256 contracts under the Code include certain other options contracts, certain regulated futures contracts, and
certain other financial contracts. Section 1256 contracts do not include any interest rate swap, currency swap, basis swap, interest rate
cap, interest rate floor, commodity swap, equity swap, equity index swap, credit default swap, or similar agreement. It cannot be predicted
whether the Fund will invest to any significant extent in section 1256 contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Code contains special rules that apply to &#8220;straddles,&#8221;
defined generally as the holding of &#8220;offsetting positions with respect to personal property.&#8221; For example, the straddle rules
normally apply when a taxpayer holds stock and an offsetting option with respect to such stock or substantially identical stock or securities.
In general, investment positions will be offsetting if there is a substantial diminution in the risk of loss from holding one position
by reason of holding one or more other positions. Under certain circumstances, the Fund may enter into options transactions or certain
other investments that may constitute positions in a straddle. If two or more positions constitute a straddle, recognition of a realized
loss from one position must generally be deferred to the extent of unrecognized gain in an offsetting position. In addition, long-term
capital gain may be recharacterized as short-term capital gain, or short-term capital loss as long-term capital loss. Interest and other
carrying charges allocable to personal property that is part of a straddle are not currently deductible but must instead be capitalized.
Similarly, &#8220;wash sale&#8221; rules apply to prevent the recognition of loss by the Fund from the disposition of stock or securities
at a loss in a case in which identical or substantially identical stock or securities (or an option to acquire such property) is or has
been acquired within a prescribed period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 104; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under Section 988 of the Code, gains or losses
attributable to fluctuations in exchange rates between the time the Fund accrues income or receivables or expenses or other liabilities
denominated in a foreign currency and the time the Fund actually collects such income or receivables or pays such liabilities are generally
treated as ordinary income or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Investment by the Fund in passive foreign investment
companies (&#8220;PFICs&#8221;) could subject the Fund to U.S. federal income tax (including interest charges) on distributions received
from such a company or on the proceeds from the sale of its investment in such a company. A PFIC is any foreign corporation: (i) 75% or
more of the income of which for the taxable year is passive income, or (ii) the average percentage of the assets of which (generally by
value, but by adjusted tax basis in certain cases) that produce or are held for the production of passive income is at least 50%. Generally,
passive income for this purpose means dividends, interest (including income equivalent to interest), royalties, rents, annuities, the
excess of gain over losses from certain property transactions and commodities transactions, and foreign currency gains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Passive income for this purpose does not include
rents and royalties received by the foreign corporation from active businesses and certain income received from related persons. The tax
on PFIC distributions and the sale of interests in PFICs cannot be eliminated by making distributions to Fund shareholders; however, it
can be avoided by making an election to mark such investments to market annually (treating gains as ordinary income) or to treat the PFIC
as a &#8220;qualified electing fund&#8221; (a &#8220;QEF election&#8221;). In the latter case, the Fund will be required to include its
share of the company&#8217;s income and net capital gains annually, regardless of whether it receives any distribution from the company.
The QEF and mark-to-market elections may accelerate the recognition of income (without the receipt of cash) and increase the amount required
to be distributed by the Fund to avoid taxation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may not be able to make a QEF election
due to the difficulty of satisfying the requirements of QEF elections. Making either of these elections therefore may require the Fund
to liquidate other investments (including when it is not advantageous to do so) to meet its distribution requirement, which also may accelerate
the recognition of gain and affect the Fund&#8217;s total return. Dividends paid by PFICs will not be eligible to be treated as &#8220;qualified
dividend income.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may be subject to foreign withholding
or other taxes with respect to income from foreign securities, which could reduce the amount of the Fund&#8217;s distributions. Shareholders
may be able to claim a credit or deduction for foreign taxes if more than 50% of the Fund&#8217;s assets are invested in foreign securities
at the end of a fiscal year and the Fund makes an election to pass through to the shareholders their pro rata share of foreign taxes paid
by the Fund. If this election is made, the Fund may report more taxable income to the shareholders than it actually distributes. The shareholders
will then be entitled either to deduct their share of these taxes in computing their taxable income or to claim a foreign tax credit for
these taxes against their U.S. federal income tax (subject to limitations for certain shareholders). The Fund will provide the shareholders
with the information necessary to claim this deduction or credit on their personal income tax return if the Fund makes this election.
It is not anticipated that the Fund will invest in foreign securities to the extent necessary to meet the above 50% threshold to pass
through the foreign taxes it pays to shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 105; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Convertible debt is ordinarily treated as a &#8220;single
property&#8221; consisting of a pure debt interest until conversion, after which the investment becomes an equity interest. If the security
is issued at a premium (i.e., for cash in excess of the face amount payable on retirement), the creditor-holder may amortize the premium
over the life of the bond. If the security is issued for cash at a price below its face amount, the creditor-holder must accrue original
issue discount in income over the life of the debt. The creditor-holder&#8217;s exercise of the conversion privilege is generally treated
as a nontaxable event. Mandatorily convertible debt (e.g., an exchange traded note or ETN issued in the form of an unsecured obligation
that pays a return based on the performance of a specified market index, exchange currency, or commodity) is often, but not always, treated
as a contract to buy or sell the reference property rather than debt. Similarly, convertible preferred stock with a mandatory conversion
feature is ordinarily, but not always, treated as equity rather than debt. In general, conversion of preferred stock for common stock
of the same corporation is tax-free. Conversion of preferred stock for cash is a taxable redemption. Any redemption premium for preferred
stock that is redeemable by the issuing company might be required to be amortized under original issue discount principles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may invest in preferred securities or
other securities the U.S. federal income tax treatment of which is uncertain or subject to recharacterization by the IRS. To the extent
the tax treatment of such securities or their income differs from the tax treatment expected by the Fund, it could affect the timing or
character of income recognized by the Fund, requiring the Fund to purchase or sell securities, or otherwise change its portfolio, in order
to comply with the tax rules applicable to a RIC under the Code. The Fund&#8217;s investment program and the tax treatment of Fund distributions
may be affected by the IRS interpretations of the Code and future changes in tax laws and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Backup Withholding</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may be required to withhold U.S. federal
income tax from all taxable distributions and redemption proceeds payable to shareholders who fail to provide the Fund with their correct
taxpayer identification number or to make required certifications, or who have been notified by the IRS that they are subject to backup
withholding. The withholding percentage is currently 24%. Corporate shareholders and certain other shareholders specified in the Code
generally are exempt from such backup withholding. Backup withholding is not an additional tax. Any amounts withheld may be credited against
the shareholder&#8217;s U.S. federal income tax liability provided the required information is timely furnished to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 106; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Foreign Shareholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. taxation of a shareholder who is not a U.S.
Common Shareholder (&#8220;foreign shareholder&#8221;) depends on whether the income of the Fund is &#8220;effectively connected&#8221;
with a U.S. trade or business carried on by the shareholder. If a partnership (including an entity treated as a partnership for U.S. federal
income tax purposes) holds Fund shares, the tax treatment of a partner in the partnership will generally depend upon the status of the
partner and the activities of the partnership. A partner in a partnership holding Fund shares should consult its tax advisors with respect
to the purchase, ownership and disposition of Fund shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income not Effectively Connected</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the income from the Fund is not &#8220;effectively
connected&#8221; with a U.S. trade or business carried on by the foreign shareholder, distributions of investment company taxable income
will be subject to a U.S. tax of 30% (or lower treaty rate), which tax is generally withheld from such distributions. Distributions which
are reported by the Fund as &#8220;interest-related dividends&#8221; or &#8220;short-term capital gain dividends&#8221; are currently
exempt from the 30% withholding tax. Interest-related dividends and short-term capital gain dividends generally represent distributions
of interest or short-term capital gains that would not have been subject to U.S. withholding tax at the source if they had been received
directly by a foreign person and satisfy certain other requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Distributions of capital gain dividends (including
any amounts retained by the Fund which are reported as undistributed capital gains) and gains recognized on the sale or other disposition
of our common stock will not be subject to U.S. tax at the rate of 30% (or lower treaty rate) unless the foreign shareholder is a nonresident
alien individual and is physically present in the United States for more than 182 days during the taxable year and meets certain other
requirements. However, this 30% tax on capital gains of nonresident alien individuals who are physically present in the United States
for more than the 182 day period only applies in exceptional cases because any individual present in the United States for more than 182
days during the taxable year is generally treated as a resident for U.S. income tax purposes; in that case, he or she would be subject
to U.S. income tax on his or her worldwide income at the graduated rates applicable to U.S. citizens, rather than the 30% U.S. tax. In
the case of a foreign shareholder who is a nonresident alien individual, the Fund may be required to withhold U.S. income tax from distributions
of net capital gain unless the foreign shareholder certifies his or her non-U.S. status under penalties of perjury or otherwise establishes
an exemption. See &#8220;Tax Matters&#8212;Backup Withholding.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Effectively Connected</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the income from the Fund is &#8220;effectively
connected&#8221; with a U.S. trade or business carried on by a foreign shareholder, then distributions of investment company taxable income
and capital gain dividends, any amounts retained by the Fund which are reported as undistributed capital gains and any gains realized
upon the sale or exchange of shares of the Fund will be subject to U.S. income tax at the graduated rates applicable to U.S. citizens,
residents and domestic corporations. Foreign corporate shareholders also may be subject to the branch profits tax imposed by the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 107; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The tax consequences to a foreign shareholder entitled
to claim the benefits of an applicable tax treaty may differ from those described herein. Foreign shareholders are advised to consult
their own tax advisers with respect to the particular tax consequences to them of an investment in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>FATCA Reporting and Withholding Requirements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under legislation known as &#8220;FATCA&#8221;
(the Foreign Account Tax Compliance Act), the Fund will be required to withhold 30% on income dividends made by the Fund to shareholders
that fail to meet prescribed information reporting or certification requirements. After, December 31, 2018, FATCA withholding also would
have applied to certain capital gain dispositions, return of capital distributions and the proceeds arising from the sale of Fund shares;
however, based on proposed regulations issued by the IRS, which can be relied upon currently, such withholding is no longer required unless
final regulations provide otherwise (which is not expected). In general, no such withholding will be required with respect to a U.S. person
or foreign individual that timely provides the certifications required by the Fund or its agent on a valid IRS Form W-9, W-8BEN or W-8BEN-E,
respectively. Shareholders potentially subject to withholding include foreign financial institutions (&#8220;FFIs&#8221;), such as foreign
investment funds, and non-financial foreign entities (&#8220;NFFEs&#8221;). To avoid withholding under FATCA, an FFI generally must enter
into an information sharing agreement with the IRS in which it agrees to report certain identifying information (including name, address,
and taxpayer identification number) with respect to its U.S. account holders (which, in the case of an entity shareholder, may include
its direct and indirect U.S. owners), and an NFFE generally must identify itself and may be required to provide other required information
to the Fund or other withholding agent regarding its U.S. owners, if any. Such foreign shareholders also may fall into certain exempt,
excepted or deemed compliant categories as established by regulations and other guidance. A non-U.S. entity that invests in the Fund will
need to provide the Fund with documentation properly certifying the entity&#8217;s status under FATCA in order to avoid FATCA withholding.
A foreign shareholder resident or doing business in a country that has entered into an intergovernmental agreement with the U.S. to implement
FATCA may be subject to different requirements provided that the shareholder and the applicable foreign government comply with the terms
of such agreement. Foreign shareholders are encouraged to consult with their tax advisers regarding the possible implications of these
requirements on their investment in Fund shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Tax Considerations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fund shareholders may be subject to state, local
and foreign taxes on their Fund distributions. Shareholders are advised to consult their own tax advisers with respect to the particular
tax consequences to them of an investment in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing discussion is a summary only and
is not intended as a substitute for careful tax planning. Purchasers of Common Shares should consult their own tax advisors as to the
tax consequences of investing in such Common Shares, including under state, local and other tax laws. Finally, the foregoing discussion
is based on applicable provisions of the Code, regulations, judicial authority and administrative interpretations in effect on the date
hereof. Changes in applicable authority could materially affect the conclusions discussed above, and such changes often occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 108; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 8pt"><a href="#toc">Table of Contents</a></h5>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_11"></span>FINANCIAL STATEMENTS </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0pt; text-indent: 0.5in">The audited financial
statements, financial highlights and notes thereto and the independent registered public accounting firm&#8217;s report thereon
appearing in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">Annual Report</a> for the fiscal year ended December 31, 2024 are incorporated herein by reference in this SAI. In addition, any reports and
other documents subsequently filed with the SEC pursuant to Section 30(b)(2) of the 1940 Act and Sections 13(a), 13(c), 14 or
15(d) of the 1934 Act prior to the termination of the offering will be incorporated by reference into this SAI and deemed to be
part of this SAI from the date of the filing of such reports and documents. The information incorporated by reference is considered
to be part of this SAI, and later information that the Fund files with the SEC will automatically update and supersede this information.
The information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this SAI.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0pt; text-indent: 0.5in">Incorporated materials not delivered with the SAI may be obtained, without charge, by calling
<span style="white-space: nowrap">(800)&#160;257-8787,</span> by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#8217;s website (http://www.nuveen.com).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 109; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_12"></span>CUSTODIAN AND TRANSFER AGENT </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The custodian of the
assets of the Fund is State Street Bank and Trust Company, located at One Congress Street, Suite 1, Boston, Massachusetts 02114-2016
(the &#8220;Custodian&#8221;). The Custodian performs custodial, fund accounting and portfolio accounting services. The Fund&#8217;s transfer,
shareholder services and dividend paying agent is Computershare Inc. and Computershare Trust Company, N.A., located at 150 Royall Street,
Canton, Massachusetts 02021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_13"></span>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">PricewaterhouseCoopers LLP (&#8220;PwC&#8221;), an independent registered public accounting firm, provides auditing services to the Fund. The principal business address of PwC is One North Wacker Dr, Chicago, IL 60606.</p>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_14"></span>LEGAL
MATTERS </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Certain
                 legal matters in connection with the offering will be passed upon for the Fund by Stradley Ronon Stevens &amp;
                 Young, LLP, located at 2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp;
                 Young, LLP may rely as to certain matters of Massachusetts law on the opinion of Morgan, Lewis &amp; Bockius LLP.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_15"></span>ADDITIONAL INFORMATION </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A Registration Statement on Form <span style="white-space: nowrap">N-2,</span> including amendments thereto, relating to the Securities of the Fund
offered hereby, has been filed by the Fund with the SEC, Washington, DC. The Prospectus and this SAI do not contain all of the information set forth in the Registration Statement, including any exhibits and schedules thereto. For further information
with respect to the Fund and the Securities offered hereby, reference is made to the Registration Statement. Statements contained in the Prospectus and this SAI as to the contents of any contract or other document referred to are not necessarily
complete and, in each instance, reference is made to the copy of such contract or other document filed as an exhibit to the Registration Statement, each such statement being qualified in all respects by such reference. Copies of the Registration
Statement may be inspected without charge at the SEC&#8217;s principal office in Washington, DC, and copies of all or any part thereof may be obtained from the SEC upon the payment of certain fees prescribed by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 110; Value: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_16"></span>APPENDIX A </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-align: center"><b>Ratings of Investments </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">S&amp;P Global Ratings&#151;A brief description of the applicable S&amp;P Global Ratings, a Division of S&amp;P Global Inc.
(&#8220;S&amp;P&#8221;), rating symbols and their meanings (as published by S&amp;P) follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A S&amp;P issue credit rating is a current
opinion of the creditworthiness of an obligor with respect to a specific financial obligation, a specific class of financial obligations, or a specific financial program (including ratings on medium-term note programs and commercial paper programs).
It takes into consideration the creditworthiness of guarantors, insurers, or other forms of credit enhancement on the obligation and takes into account the currency in which the obligation is denominated. The opinion evaluates the obligor&#8217;s
capacity and willingness to meet its financial commitments as they come due, and may assess terms, such as collateral security and subordination, which could affect ultimate payment in the event of default. The issue credit rating is not a
recommendation to purchase, sell, or hold a financial obligation, inasmuch as it does not comment as to market price or suitability for a particular investor. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issue credit ratings are based on current information furnished by the obligors or obtained by S&amp;P from other sources it considers
reliable. S&amp;P does not perform an audit in connection with any credit rating and may, on occasion, rely on unaudited financial information. Credit ratings may be changed, suspended, or withdrawn as a result of changes in, or unavailability of,
such information, or based on other circumstances. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issue credit ratings can be either long term or short term. Short-term ratings are
generally assigned to those obligations considered short-term in the relevant market. In the U.S., for example, that means obligations with an original maturity of no more than 365 days&#151;including commercial paper. Short-term ratings are also
used to indicate the creditworthiness of an obligor with respect to put features on long-term obligations. The result is a dual rating, in which the short-term rating addresses the put feature, in addition to the usual long-term rating. Medium-term
notes are assigned long-term ratings. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>LONG-TERM ISSUE CREDIT RATINGS </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issue credit ratings are based, in varying degrees, on the following considerations: </p>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 5%">&#160;</td>
<td style="width: 3%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Likelihood of payment&#151;capacity and willingness of the obligor to meet its financial commitment on an
obligation in accordance with the terms of the obligation; </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 5%">&#160;</td>
<td style="width: 3%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Nature of and provisions of the obligation; </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 5%">&#160;</td>
<td style="width: 3%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Protection afforded by, and relative position of, the obligation in the event of bankruptcy, reorganization, or
other arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights. </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issue ratings are an
assessment of default risk, but may incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations are typically rated lower than senior obligations, to reflect the lower priority in bankruptcy, as
noted above. (Such differentiation may apply when an entity has both senior and subordinated obligations, secured and unsecured obligations, or operating company and holding company obligations.) </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">AAA </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated
&#8216;AAA&#8217; has the highest rating assigned by S&amp;P Global Ratings. The obligor&#8217;s capacity to meet its financial commitments on the obligation is extremely strong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 111; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">AA </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated &#8216;AA&#8217; differs from the highest-rated obligations only to a small degree. The obligor&#8217;s capacity to meet its
financial commitments on the obligation is very strong. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated &#8216;A&#8217; is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than
obligations in higher-rated categories. However, the obligor&#8217;s capacity to meet its financial commitments on the obligation is still strong. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">BBB </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated
&#8216;BBB&#8217; exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitments on the obligation. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">BB, B, CCC, CC, and C </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;BB&#8217;, &#8216;B&#8217;, &#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant
speculative characteristics. &#8216;BB&#8217; indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations will likely have some quality and protective characteristics, these may be outweighed by large uncertainties
or major exposures to adverse conditions. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">BB </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated &#8216;BB&#8217; is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing
uncertainties or exposure to adverse business, financial, or economic conditions which could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments on the obligation. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">B </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated
&#8216;B&#8217; is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;, but the obligor currently has the capacity to meet its financial commitments on the obligation. Adverse business, financial, or economic conditions will likely
impair the obligor&#8217;s capacity or willingness to meet its financial commitments on the obligation. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">CCC </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated &#8216;CCC&#8217; is currently vulnerable to nonpayment, and is dependent upon favorable business, financial, and economic
conditions for the obligor to meet its financial commitments on the obligation. In the event of adverse business, financial, or economic conditions, the obligor is not likely to have the capacity to meet its financial commitments on the obligation.
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">CC </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated
&#8216;CC&#8217; is currently highly vulnerable to nonpayment. The &#8216;CC&#8217; rating is used when a default has not yet occurred but S&amp;P Global Ratings expects default to be a virtual certainty, regardless of the anticipated time to default.
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">C </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated
&#8216;C&#8217; is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative seniority or lower ultimate recovery compared with obligations that are rated higher.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">D </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">An obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the D rating category
is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such payments will be made within five business days in the absence of a stated grace period or within the earlier of the stated grace
period or the next 30 calendar days. The D rating also will be used upon the filing of a bankruptcy petition or the taking of similar action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A
rating on an obligation is lowered to &#8216;D&#8217; if its subject to distressed debt restructuring. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Plus (+) or minus (-) </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The ratings from &#8216;AA&#8217; to &#8216;CCC&#8217; may be modified by the addition of a plus (+) or minus (-) sign to show relative standing
within the major rating categories. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">NR </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This indicates that no rating has been requested, that there is insufficient information on which to base a rating, or that S&amp;P does not
rate a particular obligation as a matter of policy. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Short-Term Issue Credit Ratings </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="white-space: nowrap">A-1</span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated <span style="white-space: nowrap">&#8216;A-1&#8217;</span> is rated in the highest category by S&amp;P Global
Ratings. The obligor&#8217;s capacity to meet its financial commitment on the obligation is strong. Within this category, certain obligations are designated with a plus sign (+). This indicates that the obligor&#8217;s capacity to meet its financial
commitment on these obligations is extremely strong. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="white-space: nowrap">A-2</span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated <span style="white-space: nowrap">&#8216;A-2&#8217;</span> is somewhat more susceptible to the adverse effects of
changes in circumstances and economic conditions than obligations in higher rating categories. However, the obligor&#8217;s capacity to meet its financial commitment on the obligation is satisfactory. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="white-space: nowrap">A-3</span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated <span style="white-space: nowrap">&#8216;A-3&#8217;</span> exhibits adequate protection parameters. However, adverse
economic conditions or changing circumstances are more likely to weaken an obligor&#8217;s capacity to meet its financial commitment on the obligation. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">B </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated
&#8216;B&#8217; is regarded as vulnerable and has significant speculative characteristics. The obligor currently has the capacity to meet its financial commitments; however, it faces major ongoing uncertainties that could lead to the obligor&#8217;s
inadequate capacity to meet its financial commitments. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">C </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated &#8216;C&#8217; is currently vulnerable to nonpayment and is dependent upon favorable business, financial, and
economic conditions for the obligor to meet its financial commitment on the obligation. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">D </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A short-term obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the
&#8216;D&#8217; rating category is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such payments will be made within any stated grace period. However, any stated grace period longer than
five business days will be treated as five business days. The &#8216;D&#8217; rating also will
be used upon the filing of a bankruptcy petition or the taking of a similar action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A
rating on an obligation is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Dual Ratings </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">S&amp;P assigns &#8220;dual&#8221; ratings to all debt issues that have a put option or demand feature as part of their structure. The first
component of the rating addresses the likelihood of repayment of principal and interest as due, and the second component of the rating addresses only the demand feature. The first component of the rating can relate to either a short-term or
long-term transaction and accordingly use either short-term or long-term rating symbols. The second component of the rating relates to the put option and is assigned a short-term rating symbol (for example, &#8216;AAA/A-1+&#8217; or
&#8216;A-1+/A-1&#8217;). With U.S. municipal short-term demand debt, the U.S. municipal short-term note rating symbols are used for the first component of the rating (for example, &#8217;SP-1+/A-1+&#8217;). </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Moody&#8217;s Investors Service, Inc.&#151;A brief description of the applicable Moody&#8217;s Investors Service, Inc.
(&#8220;Moody&#8217;s&#8221;) rating symbols and their meanings (as published by Moody&#8217;s) follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Municipal Bonds </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Aaa </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated
&#8216;Aaa&#8217; are judged to be of the highest quality, subject to the lowest level of credit risk. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Aa </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;Aa&#8217;
are judged to be of high quality and are subject to very low credit risk.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations
                                            rated &#8216;A&#8217; are considered upper-medium grade and are subject to low credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Baa </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;Baa&#8217;
are subject to moderate credit risk. They are considered medium grade and as such may possess certain speculative characteristics.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Ba </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;Ba&#8217;
are judged to have speculative elements and are subject to substantial credit risk.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">B </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations
                                            rated &#8216;B&#8217; are considered speculative and are subject to high credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Caa </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;Caa&#8217;
are judged to be of poor standing and are subject to very high credit risk.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Ca </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations
                                            rated &#8216;Ca&#8217; are highly speculative and are likely in, or very near, default, with
                                            some prospect of recovery of principal and interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">C </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Obligations rated &#8216;C&#8217;
are the lowest rated class of bonds and are typically in default, with little prospect for recovery of principal or interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Note:
               Moody&#8217;s applies numerical modifiers 1,2 and 3 in each generic rating classification from &#8216;Aa&#8217; through
               &#8216;Caa&#8217;. The modifier 1 indicates mat the issue ranks in the higher end of its generic rating category; the
               modifier 2 indicates a mid-range ranking; and the modifier 3 indicates that the issue ranks in the lower end of its generic
               rating category.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Short-Term Loans </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">MIG 1 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
superior credit quality. Excellent protection is afforded by established cash flows, highly reliable liquidity support, or demonstrated broad-based access to the market for refinancing. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">MIG 2 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
strong credit quality. Margins of protection are ample, although not as large as in the preceding group. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">MIG 3 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes acceptable credit quality. Liquidity and cash-flow protection may be narrow, and market access for refinancing is
likely to be less well-established. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">SG </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes speculative-grade credit quality. Debt instruments in this category may lack sufficient margins of protection. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">VMIG 1 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
superior credit quality. Excellent protection is afforded by the superior short-term credit strength of the liquidity provider and structural and legal protections. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">VMIG 2 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
strong credit quality. Good protection is afforded by the strong short-term credit strength of the liquidity provider and structural and legal protections. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">VMIG 3 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
acceptable credit quality. Adequate protection is afforded by the satisfactory <span style="white-space: nowrap">short-term</span> credit strength of the liquidity provider and structural and legal protections. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">SG </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This designation denotes
speculative-grade credit quality. Demand features rated in this category may be supported by a liquidity provider that does not have a sufficiently strong short-term rating or may lack the structural or legal protections. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Commercial Paper </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issuers (or supporting
institutions) rated <span style="white-space: nowrap">Prime-1</span> have a superior ability for repayment of senior short-term debt obligations. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issuers (or supporting institutions) rated <span style="white-space: nowrap">Prime-2</span> have a strong ability for repayment of senior
short-term debt obligations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issuers (or supporting institutions) rated <span style="white-space: nowrap">Prime-3</span> have an
acceptable ability for repayment of senior short-term debt obligations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Issuers (or supporting institutions) rated Not Prime do not fall
within any of the Prime rating categories.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Fitch Ratings&#151;A brief description of the applicable Fitch Ratings (&#8220;Fitch&#8221;)
ratings symbols and meanings (as published by Fitch) follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Long-Term Credit Ratings </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Investment Grade </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">AAA </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Highest credit quality. &#8216;AAA&#8217; ratings denote the lowest expectation of credit risk. They are assigned only in case of exceptionally
strong capacity for timely payment of financial commitments. This capacity is highly unlikely to be adversely affected by foreseeable events. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">AA </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Very high credit quality.
&#8216;AA&#8217; ratings denote expectations of very low default risk. They indicate very strong capacity for payment of financial commitments. This capacity is not significantly vulnerable to foreseeable events. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">High credit quality.
&#8216;A&#8217; ratings denote expectations of low default risk. The capacity for payment of financial commitments is considered strong. This capacity may, nevertheless, be more vulnerable to changes in circumstances or in economic conditions than is
the case for higher ratings. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">BBB </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Good credit quality. &#8216;BBB&#8217; ratings indicate that expectations of default risk are currently low. The capacity for payment of
financial commitments is considered adequate, but adverse business or economic conditions are more likely to impair this capacity. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Speculative Grade
</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">BB </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Speculative.
&#8216;BB&#8217; ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists that supports the servicing of
financial commitments. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">B </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Highly speculative. &#8216;B&#8217; ratings indicate that material default risk is present, but a limited margin of safety remains. Financial
commitments are currently being met; however, capacity for continued payment is vulnerable to deterioration in the business and economic environment. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">CCC, CC, C </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">High
                                            default risk. Default is a real possibility. Substantial credit risk. Very low margin for
                                            safety. A &#8216;CC&#8217; rating indicates that default of some kind appears probable. &#8216;C&#8217;
                                            ratings signal a default or default-like process has begun, or for a closed funding vehicle,
                                            payment capacity is irrevocably impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">RD and D </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Restricted default. &#8216;RD&#8217; ratings indicate an issuer that in Fitch&#8217;s opinion has experienced an uncured payment default or
distressed debt exchange on a bond, loan or other material financial obligation, but has not entered into bankruptcy filings, administration, receivership, liquidation, or other formal winding-up procedure, and has not otherwise ceased operating.
&#8216;D&#8217; ratings indicate an issuer that in Fitch&#8217;s opinion has entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up procedure or that has otherwise ceased business and debt is still
outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Short-Term Credit Ratings </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The following ratings scale applies to foreign currency and local currency ratings. A Short-term rating has a time horizon of less than 13
months for most obligations, or up to three years for US public finance, in line with industry standards, to reflect unique risk characteristics of bond, tax, and revenue anticipation notes that are commonly issued with terms up to three years.
Short-term ratings thus place greater emphasis on the liquidity necessary to meet financial commitments in a timely manner. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Fl </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Highest short-term credit quality. Indicates the strongest capacity for timely payment of financial commitments; may have an added
&#8220;+&#8221; to denote any exceptionally strong credit feature. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">F2 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Good short-term credit quality. Good intrinsic capacity for timely payment of financial commitments. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">F3 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Fair short-term credit
quality. The intrinsic capacity for timely payment of financial commitments is adequate. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">B </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Minimal capacity for timely payment of financial commitments, plus heightened vulnerability to near term adverse changes in financial and
economic conditions. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">C </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">High short-term default risk. Default is a real possibility. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">RD </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Restricted Default.
Indicates an entity that has defaulted on one or more of its financial commitments, although it continues to meet other financial obligations. Applicable to entity ratings only. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">D </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Default. Indicates a
broad-based default event for an entity, or the default of a short-term obligation. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Notes to Long-term and Short-term ratings: </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">&#8220;+&#8221; or &#8220;-&#8221;
may be appended to a rating to denote relative status within major rating categories. Such suffixes are not added to the &#8216;AAA&#8217;
Long-term rating category, to categories below &#8216;CCC&#8217;, or to Short-term ratings other than &#8216;FT&#8217;.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">&#8216;NR&#8217; indicates that Fitch Ratings does not rate the issuer or issue in question. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">&#8216;Withdrawn&#8217;: The rating has been withdrawn and the issue or issuer is no longer rated by Fitch. When a public rating is withdrawn,
Fitch will issue a RAC that details the current rating and Outlook or Watch status (if applicable), a statement that the rating is withdrawn and the reason for the withdrawal. A RAC is not required when an issue has been redeemed, matured, repaid or
paid in full. Withdrawals cannot be used to forestall a rating action. Every effort is therefore made to ensure that the rating opinion upon withdrawal reflects an updated view. However, this is not always possible, for example if a rating is
withdrawn due to a lack of information. Rating Watches are also resolved prior to or concurrent with withdrawal unless the timing of the event driving the Rating Watch does not support an immediate resolution. Ratings that have been withdrawn will
be indicated by the symbol &#8216;WD&#8217;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Rating Watch: Ratings are placed on Rating Watch to notify investors that there is a reasonable
probability of a rating change and the likely direction of such change. These are designated as &#8220;Positive&#8221;, indicating a potential upgrade, &#8220;Negative&#8221;, for a potential downgrade, or &#8220;Evolving&#8221;, if ratings may be raised,
lowered or maintained. Rating Watch is typically resolved over a relatively short period. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">A Rating Outlook indicates the direction a
rating is likely to move over a one to two year period. Outlooks may be positive, stable, or negative. A positive or negative Rating Outlook does not imply a rating change is inevitable. Similarly, ratings for which outlooks are &#8217;stable&#8217;
could be downgraded before an outlook moves to positive or negative if circumstances warrant such an action. Occasionally, Fitch Ratings may be unable to identify the fundamental trend. In these cases, the Rating Outlook may be described as
evolving.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="sai780884_17"></span>APPENDIX B </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen Proxy Voting Policies </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen proxy voting guidelines </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen Asset Management, LLC, Teachers Advisors, LLC and TIAA-CREF Investment Management, LLC </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Applicability </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">These Guidelines apply to
employees of Nuveen acting on behalf of Nuveen Asset Management, LLC (&#8220;NAM&#8221;), Teachers Advisors, LLC (&#8220;TAL&#8221;) and TIAA-CREF Investment Management, LLC (&#8220;TCIM&#8221;) (each an &#8220;Adviser&#8221; and collectively referred to as
the &#8220;Advisers&#8221;) </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">I. Introduction </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Our voting practices are guided by our obligations to our clients. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">These Guidelines set forth the manner in which the Advisers intend to vote on proxy matters involving publicly traded portfolio&#160;companies
held in client portfolios, and serve to assist clients, portfolio companies and other interested parties in understanding how the Advisers intend to vote on proxy-related issues. As indicated in these Guidelines, we monitor portfolio companies&#8217;
environmental, social and governance (ESG) practices in an effort to ensure that boards consider these factors in the context of their strategic deliberations. The Guidelines are not exhaustive and do not necessarily dictate how the Advisers will
ultimately vote with respect to any proposal or resolution. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We vote proxies in accordance with what we believe is in the best interest of
our clients. In making those decisions, we are principally guided by advancing long-term shareholder value and may take into account many factors, including input from our investment teams and third-party research. Among other factors, we consider
specific company context, including ESG practices and financial performance. It is our belief that a <span style="white-space: nowrap"><span style="white-space: nowrap"><span style="white-space: nowrap">one-size-fits-all</span></span></span> approach
to proxy voting is not appropriate. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Our proxy voting decisions with respect to shareholder resolutions may be influenced by several
additional factors: (i)&#160;whether the shareholder resolution process is the appropriate means of addressing the issue; (ii)&#160;whether the resolution promotes economic performance and shareholder value; (iii)&#160;whether the resolution
promotes ESG best practices; and (iv)&#160;whether the information and actions recommended by the resolution are reasonable and practical. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Guidelines are implemented by Nuveen&#8217;s Responsible Investing Team (RI Team) and applied in consideration of the facts and
circumstances of the particular resolution. The RI Team relies on its professional judgment informed by proprietary research and reports provided by a various third-party research providers. The portfolio managers of the Advisers maintain the
ultimate decision-making authority with respect to how proxies will be voted, and may determine to vote contrary to the Guidelines if such portfolio manager determines it is in the best interest of the respective Adviser&#8217;s clients to do so. The
rationale for votes submitted contrary to the Guidelines will be documented and maintained. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">II. Accountability and transparency </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Board of directors </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Elect
directors </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We generally vote in favor of the board&#8217;s nominees but will consider withholding or voting against
some or all directors in the following circumstances: </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When we conclude that the actions of directors are unlawful,
unethical, negligent, or do not meet fiduciary standards of care and loyalty, or are otherwise not in the best interest of shareholders. Such actions would include: </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">Egregious compensation practices </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">Lack of responsiveness to a failed vote </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">Unequal treatment of shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 119; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">Adoption of inappropriate antitakeover devices </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When a director has consistently failed to attend board and committee meetings without an appropriate rationale
being&#160;provided </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Independence </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When board independence is not in line with local market regulations or best practices </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When a member of executive management sits on a key board committee that should be composed of only independent directors </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When directors have failed to disclose, resolve or eliminate conflicts of interest that affect their decisions </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Board refreshment </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When there is insufficient diversity on the board and the company has not demonstrated its commitment to adding diverse
candidates </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in">When we determine that director tenure is excessive and there has been no recent board refreshment </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Contested elections </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General
Policy</i>: We will support the candidates we believe will represent the best interests of shareholders. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Majority vote for the election
of directors </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We generally support shareholder resolutions asking that companies amend their governance documents to
provide for director election by majority vote. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Establish specific board committees </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We generally vote against shareholder resolutions asking the company to establish specific board committees unless we
believe specific circumstances dictate otherwise. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Annual election of directors </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We generally support shareholder resolutions asking that each member of the board of a publicly traded operating company
stand for <span style="white-space: nowrap">re-election</span> annually. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Cumulative voting </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We generally do not support proposals asking that shareholders be allowed to cumulate votes in director elections, as
this practice may encourage the election of special interest directors. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Separation of Chairman and Chief Executive Officer </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will consider supporting shareholder resolutions asking that the roles of chairman and CEO be separated when we
believe the company&#8217;s board structure and operation has insufficient features of independent board leadership, such as the lack of a lead independent director. In addition, we may also support resolutions on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-</span></span>case basis where we believe, in practice, that there is not a bona-fide lead independent director acting with robust responsibilities or the company&#8217;s ESG practices or business performance
suggest a material deficiency in independent influence into the company&#8217;s strategy and&#160;oversight. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Shareholder rights </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Proxy access </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General
Policy</i>: We will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis shareholder proposals asking that the company implement a form of proxy access. In making our voting decision, we
will consider several factors, including, but not limited to: current performance of the company, minimum filing thresholds, holding periods, number of director nominees that can be elected, existing governance issues and board/management
responsiveness to material shareholder concerns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">Ratification of auditor </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support the board&#8217;s choice of auditor and believe that the auditor should be elected annually.
However, we will consider voting against the ratification of an audit firm where <span style="white-space: nowrap">non-audit</span> fees are excessive, where the firm has been involved in conflict of interest or fraudulent activities in connection
with the company&#8217;s audit, where there has been a material restatement of financials or where the auditor&#8217;s independence is questionable. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Supermajority vote requirements </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support shareholder resolutions asking for the elimination of supermajority vote requirements. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Dual-class common stock and unequal voting rights </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support shareholder resolutions asking for the elimination of dual classes of common stock or other
forms of equity with unequal voting rights or special privileges. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Right to call a special meeting </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support shareholder resolutions asking for the right to call a special meeting. However, we believe a
25% ownership level is reasonable and generally would not be supportive of proposals to lower the threshold if it is already at that level. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Right to act by written consent </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis
shareholder resolutions requesting the right to act by written consent. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Antitakeover devices (poison pills) </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis
proposals relating to the adoption or rescission of antitakeover devices with attention to the following criteria: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Whether the company has
demonstrated a need for antitakeover protection </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Whether the provisions of the device are in line with generally accepted governance
principles </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Whether the company has submitted the device for shareholder approval </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Whether the proposal arises in the context of a takeover bid or contest for control </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We will generally support shareholder resolutions asking to rescind or put to a shareholder vote antitakeover devices that were adopted without
shareholder approval. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Reincorporation </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will evaluate on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis
proposals for reincorporation taking into account the intention of the proposal, established laws of the new domicile and jurisprudence of the target domicile. We will not support the proposal if we believe the intention is to take advantage of laws
or judicial interpretations that provide antitakeover protection or otherwise reduce shareholder rights. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Corporate political influence
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policies</i>: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">We
will generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s direct political contributions, including board oversight procedures. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">We will generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s charitable
contributions and other philanthropic activities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">We may consider not supporting shareholder resolutions that appear to promote a
political agenda that is contrary to the long-term health of the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"></p>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">We will evaluate on a
<span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis shareholder resolutions seeking disclosure of a company&#8217;s lobbying expenditures. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="white-space: nowrap">Closed-end</span> funds </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We recognize that many exchange-listed <span style="white-space: nowrap">closed-end</span> funds (&#8220;CEFs&#8221;) have adopted particular
corporate governance practices that deviate from certain policies set forth in the Guidelines. We believe that the distinctive structure of CEFs can provide important benefits to investors, but leaves CEFs uniquely vulnerable to opportunistic
traders seeking short-term gains at the expense of long-term shareholders. Thus, to protect the interests of their long-term shareholders, many CEFs have adopted measures to defend against attacks from short-term oriented activist investors. As
such, in light of the unique nature of CEFs and their differences in corporate governance practices from operating companies, we will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis
proposals involving the adoption of defensive measures by CEFs. This is consistent with our approach to proxy voting that recognizes the importance of <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span>
analysis to ensure alignment with investment team views, and voting in accordance with the best interest of our shareholders. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Compensation issues </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Advisory
votes on executive compensation (say on pay) </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis the advisory vote on executive compensation (say on pay). We expect well-designed plans that clearly demonstrate the alignment between pay and performance, and we encourage companies to be
responsive to low levels of support by engaging with shareholders. We also prefer that companies offer an annual <span style="white-space: nowrap">non-binding</span> vote on executive compensation. In absence of an annual vote, companies should
clearly articulate the rationale behind offering the vote less frequently. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We generally note the following red flags when evaluating
executive compensation plans: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Undisclosed or Inadequate Performance Metrics</i>: We believe that performance goals for compensation
plans should be disclosed meaningfully. Performance hurdles should not be too easily attainable. Disclosure of these metrics should enable shareholders to assess whether the plan will drive long-term value creation. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Excessive Equity Grants</i>: We will examine a company&#8217;s past grants to determine the rate at which shares are being issued. We will
also seek to ensure that equity is being offered to more than just the top executives at the company. A pattern of excessive grants can indicate failure by the board to properly monitor executive compensation and its costs. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Lack of Minimum Vesting Requirements</i>: We believe that companies should establish minimum vesting guidelines for senior executives who
receive stock grants. Vesting requirements help influence executives to focus on maximizing the company&#8217;s long-term performance rather than managing for short-term gain. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Misalignment of Interests</i>: We support equity ownership requirements for senior executives and directors to align their interests with
those of shareholders. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Special Award Grants</i>: We will generally not support mega-grants. A company&#8217;s history of such excessive
grant practices may prompt us to vote against the stock plans and the directors who approve them. Mega-grants include equity grants that are excessive in relation to other forms of compensation or to the compensation of other employees and grants
that transfer disproportionate value to senior executives without relation to their performance. We also expect companies to provide a rationale for any other <span style="white-space: nowrap">one-time</span> awards such as a guaranteed bonus or a
retention award. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Excess Discretion</i>: We will generally not support plans where significant terms of awards&#151;such as coverage,
option price, or type of awards&#151;are unspecified, or where the board has too much discretion to override minimum vesting or performance requirements. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Lack of Clawback Policy</i>: We believe companies should establish clawback policies that permit recoupment from any senior executive who
received compensation as a result of defective financial reporting, or whose behavior caused financial harm to shareholders or reputational risk to the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"></p>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">Equity-based compensation plans </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will review equity-based compensation plans on a
<span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis, giving closer scrutiny to companies where plans include features that are not performance-based or where potential dilution or burn rate total is
excessive. As a practical matter, we recognize that more dilutive broad-based plans may be appropriate for human-capital intensive industries and for small- or <span style="white-space: nowrap">mid-capitalization</span> firms and <span style="white-space: nowrap">start-up</span> companies. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We generally note the following red flags when evaluating equity incentive plans:
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Evergreen Features</i>: We will generally not support option plans that contain evergreen features, which reserve a specified
percentage of outstanding shares for award each year and lack a termination date. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Reload Options</i>: We will generally not support
reload options that are automatically replaced at market price following exercise of initial grants. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Repricing Options</i>: We will
generally not support plans that authorize repricing. However, we will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis management proposals seeking shareholder approval to reprice
options. We are likely to vote in favor of repricing in cases where the company excludes named executive officers and board members and ties the repricing to a significant reduction in the number of options. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"><i>Undisclosed or Inappropriate Option Pricing</i>: We will generally not support plans that fail to specify exercise prices or that establish
exercise prices below fair market value on the date of grant. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Golden parachutes </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will vote on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis on
golden parachute proposals, taking into account the structure of the agreement and the circumstances of the situation. However, we would prefer to see a double trigger on all
<span style="white-space: nowrap"><span style="white-space: nowrap">change-of-control</span></span> agreements and no excise tax <span style="white-space: nowrap">gross-up.</span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Shareholder resolutions on executive compensation </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will consider on a <span style="white-space: nowrap"><span style="white-space: nowrap">case-by-case</span></span> basis
shareholder resolutions related to specific compensation practices. Generally, we believe specific practices are the purview of the board. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">III.
Guidelines for ESG shareholder resolutions </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We generally support shareholder resolutions seeking reasonable disclosure of the environmental
or social impact of a company&#8217;s policies, operations or products. We believe that a company&#8217;s management and directors should determine the strategic impact of environmental and social issues and disclose how they are dealing with these
issues to mitigate risk and advance long-term shareholder value. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Environmental issues </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Global climate change </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General
Policy</i>: We will generally support reasonable shareholder resolutions seeking disclosure of greenhouse gas emissions, the impact of climate change on a company&#8217;s business activities and products and strategies designed to reduce the
company&#8217;s long-term impact on the global climate. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Use of natural resources </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s
use of natural resources, the impact on its business of declining resources and its plans to improve the efficiency of its use of natural resources. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Impact on ecosystems </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General
Policy</i>: We will generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s initiatives to reduce any harmful impacts or other hazards to local, regional or global ecosystems that result from
its operations or activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">Animal welfare </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions asking for reports on the company&#8217;s impact on animal
welfare. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Issues related to customers </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Product responsibility </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions seeking disclosure relating to the quality, safety and
impact of a company&#8217;s goods and services on the customers and communities it serves. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Predatory lending </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions asking companies for disclosure about the impact of lending
activities on borrowers and about policies designed to prevent predatory lending practices. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Issues related to employees and suppliers
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Diversity and nondiscrimination </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policies</i>: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We will
generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s nondiscrimination policies and practices, or seeking to implement such policies, including equal employment opportunity standards. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">We will generally support reasonable shareholder resolutions seeking disclosure or reports relating to a company&#8217;s workforce, board
diversity, and gender pay equity policies and practices. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Global labor standards </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions seeking a review of a company&#8217;s labor standards and
enforcement practices, as well as the establishment of global labor policies based upon internationally recognized standards. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Issues
related to communities </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Corporate response to global health risks </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions seeking disclosure or reports relating to significant
public health impacts resulting from company operations and products, as well as the impact of global health pandemics on the company&#8217;s operations and long-term growth. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Global human rights codes of conduct </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General Policy</i>: We will generally support reasonable shareholder resolutions seeking a review of a company&#8217;s human rights standards
and the establishment of global human rights policies, especially regarding company operations in conflict zones or areas of weak governance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Disclosures
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen Asset Management, LLC, Teachers Advisors, LLC, and TIAA-CREF Investment Management, LLC are SEC registered investment advisers and subsidiaries of
Nuveen, LLC </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen proxy voting policy </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen Asset
Management, LLC, Teachers Advisors, LLC and TIAA-CREF Investment Management, LLC </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Applicability </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This Policy applies to Nuveen employees acting on behalf of Nuveen Asset Management, LLC, Teachers Advisors, LLC, and TIAA-CREF Investment
Management, LLC</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Policy purpose and statement </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Proxy voting is the primary means by which shareholders may influence a publicly traded company&#8217;s governance and operations and thus
create the potential for value and positive long-term investment performance. When an SEC registered investment adviser has proxy voting authority, the adviser has a fiduciary duty to vote proxies in the best interests of its clients and must not
subrogate its clients&#8217; interests to its own. In their capacity as fiduciaries and investment advisers, Nuveen Asset Management, LLC (&#8220;NAM&#8221;), Teachers Advisors, LLC (&#8220;TAL&#8221;) and TIAA-CREF Investment Management, LLC
(&#8220;TCIM&#8221;), (each an &#8220;Adviser&#8221; and collectively, the &#8220;Advisers&#8221;), vote proxies for the Portfolio Companies held by their respective clients, including investment companies and other pooled investment vehicles,
institutional and retail separate accounts, and other clients as applicable. The Advisers have adopted this Policy, the Nuveen Proxy Voting Guidelines, and the Nuveen Proxy Voting Conflicts of Interest Policy for voting the proxies of the Portfolio
Companies they manage. The Advisers leverage the expertise and services of an internal group referred to as the Responsible Investing Team (RI Team) to administer the Advisers&#8217; proxy voting. The RI Team adheres to the Advisers&#8217; Proxy
Voting Guidelines which are reasonably designed to ensure that the Advisers vote client securities in the best interests of the Advisers&#8217; clients. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Policy statement </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Proxy voting is a key
component of a Portfolio Company&#8217;s corporate governance program and is the primary method for exercising shareholder rights and influencing the Portfolio Company&#8217;s behavior. Nuveen makes informed voting decisions in compliance with Rule <span style="white-space: nowrap">206(4)-6</span> (the &#8220;Rule&#8221;) of the Investment Advisers Act of 1940, as amended (the &#8220;Advisers Act&#8221;) and applicable laws and regulations, (e.g., the Employee Retirement Income Security Act of 1974,
&#8220;ERISA&#8221;). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Enforcement </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">As
provided in the TIAA Code of Business Conduct, all employees are expected to comply with applicable laws and regulations, as well as the relevant policies, procedures and compliance manuals that apply to Nuveen&#8217;s business activities. Violation
of this Policy may result in disciplinary action up to and including termination of employment. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Terms and definitions </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Advisory Personnel</b> includes the Adviser&#8217;s portfolio managers and/or research analysts. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Proxy Voting Guidelines</b> (<i>the &#8220;Guidelines&#8221;</i>) are a set of <span style="white-space: nowrap">pre-determined</span>
principles setting forth the manner in which the Advisers intend to vote on specific voting categories, and serve to assist clients, Portfolio Companies, and other interested parties in understanding how the Advisers intend to vote on proxy-related
matters. The Guidelines are not exhaustive and do not necessarily dictate how the Advisers will ultimately vote with respect to any proposal or resolution. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Portfolio Company</b> includes any publicly traded company held in an account that is managed by an Adviser. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Policy requirements </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Investment advisers, in
accordance with the Rule, are required to (i)&#160;adopt and implement written policies and procedures that are reasonably designed to ensure that proxies are voted in the best interest of clients, and address resolution of material conflicts that
may arise, (ii)&#160;describe their proxy voting procedures to their clients and provide copies on request, and (iii)&#160;disclose to clients how they may obtain information on how the Advisers voted their proxies. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Nuveen Proxy Voting Committee (the &#8220;Committee&#8221;), the Advisers, the RI Team and Nuveen Compliance are subject to the respective
requirements outlined below under Roles and Responsibilities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Although it is the general policy to vote all applicable proxies received in
a timely fashion with respect to securities selected by an Adviser for current clients, the Adviser may refrain from voting in certain circumstances where such voting would be disadvantageous, materially burdensome or impractical, or otherwise
inconsistent with the overall best interest of clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Roles and responsibilities </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Committee </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The purpose of the Committee is to establish a governance framework to oversee the proxy voting activities of the Advisers in accordance with
the Policy. The Committee has delegated responsibility for the implementation and ongoing administration of the Policy to the RI Team, subject to the Committee&#8217;s ultimate oversight and responsibility as outlined in the Committee&#8217;s Proxy
Voting Charter. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Advisers </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Advisory Personnel maintain the ultimate decision-making authority with respect to how proxies will be voted,
unless otherwise instructed by a client, and may determine to vote contrary to the Guidelines and/or a vote recommendation of the RI Team if such Advisory Personnel determines it is in the best interest of the Adviser&#8217;s clients to do so. The
rationale for all such contrary vote determinations will be documented and maintained. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">When voting proxies for different groups of client accounts, Advisory Personnel may vote proxies held by the
respective client accounts differently depending on the facts and circumstances specific to such client accounts. The rationale for all such vote determinations will be documented and maintained. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Advisory Personnel must comply with the Nuveen Proxy Voting Conflicts of Interest Policy with respect to
potential material conflicts of interest. </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Responsible Investing Team </p>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Performs <span style="white-space: nowrap"><span style="white-space: nowrap">day-to-day</span></span>
administration of the Advisers&#8217; proxy voting processes. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Seeks to vote proxies in adherence to the Guidelines, which have been constructed in a manner intended to align
with the best interests of clients. In applying the Guidelines, the RI Team, on behalf of the Advisers, takes into account many factors, including, but not limited to: </p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Input from Advisory Personnel </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Third party research </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Specific
Portfolio Company context, including environmental, social and governance practices, and financial performance. </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Delivers copies of the Advisers&#8217; Policy to clients and prospective clients upon request in a timely
manner, as appropriate. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">4.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assists with the disclosure of proxy votes as applicable on corporate website(s) and elsewhere as required by
applicable regulations. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">5.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Prepares reports of proxies voted on behalf of the Advisers&#8217; investment company clients to their Boards or
committees thereof, as applicable. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">6.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Performs an annual vote reconciliation for review by the Committee. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">7.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Arranges the annual service provider due diligence, including a review of the service provider&#8217;s potential
conflicts of interests, and presents the results to the Committee. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">8.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Facilitates quarterly Committee meetings, including agenda and meeting minute preparation.
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">9.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Complies with the Nuveen Proxy Voting Conflicts of Interest Policy with respect to potential material conflicts
of interest. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">10.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Creates and retains certain records in accordance with Nuveen&#8217;s Record Management program.
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">11.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Ensures proxy voting service provider makes and retains certain records as required under applicable
regulation. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">12.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assesses, in cooperation with Advisory Personnel, whether securities on loan should be recalled in order to
vote their proxies.</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p></td></tr></table>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Compliance </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Ensures proper disclosure of Advisers&#8217; Policy to clients as required by regulation or otherwise.
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Ensures proper disclosure to clients of how they may obtain information on how the Advisers voted their
proxies. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assists the RI Team with arranging the annual service provider due diligence and presenting the results to the
Committee. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">4.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Monitors for compliance with this Policy and retains records relating to its monitoring activities pursuant to
Nuveen&#8217;s Records Management program. </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Governance </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Review and approval </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This Policy
will be reviewed at least annually and will be updated sooner if substantive changes are necessary. The Policy Leader, the Committee and the NEFI Compliance Committee are responsible for the review and approval of this Policy. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Implementation </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen has
established the Committee to provide centralized management and oversight of the proxy voting process administered by the RI Team for the Advisers in accordance with its Proxy Voting Committee Charter and this Policy. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Exceptions </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Any request for a
proposed exception or variation to this Policy will be submitted to the Committee for approval and reported to the appropriate governance committee(s), where appropriate. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Related documents </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Committee
Charter </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Policy Statement on Responsible Investing </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Guidelines </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Conflicts of Interest Policy and Procedures </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Nuveen proxy voting conflicts of interest policy and procedures </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Applicability </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This Policy applies to employees
of Nuveen (&#8220;Nuveen&#8221;) acting on behalf of Nuveen Asset Management, LLC (&#8220;NAM&#8221;), Teachers Advisors, LLC (&#8220;TAL&#8221;) and TIAA-CREF Investment Management, LLC (&#8220;TCIM&#8221;), (each an &#8220;Adviser&#8221; and collectively
referred to as the &#8220;Advisers&#8221;) </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Policy purpose and statement </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Proxy voting by investment advisers is subject to U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) rules and regulations, and for
accounts subject to ERISA, U.S. Department of Labor (&#8220;DOL&#8221;) requirements. These rules and regulations require policies and procedures reasonably designed to ensure proxies are voted in the best interest of clients and that such procedures
set forth how the adviser addresses material conflicts that may arise between the Adviser&#8217;s interests and those of its clients. The purpose of this Proxy Voting Conflicts of Interest Policy and Procedures (&#8220;Policy&#8221;) is to describe how
the Advisers monitor and address the risks associated with Material Conflicts of Interest arising out of business and personal relationships that could affect proxy voting decisions. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen&#8217;s Responsible Investing Team (&#8220;RI Team&#8221;) is responsible for providing vote recommendations, based on the Nuveen Proxy
Voting Guidelines (the &#8220;Guidelines&#8221;), to the Advisers and for administering the voting of proxies on behalf of the Advisers. When determining how to vote proxies, the RI Team adheres to the
Guidelines which are reasonably designed to ensure that the Advisers vote proxies in the best interests of the Advisers&#8217; clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Advisers may face certain potential Material Conflicts of Interest when voting proxies. The procedures set forth below have been reasonably
designed to identify, monitor, and address potential Material Conflicts of Interest to ensure that the Advisers&#8217; voting decisions are based on the best interest of their clients and are not the product of a conflict. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Policy statement </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Advisers have a fiduciary
duty to vote proxies in the best interests of their clients and must not subrogate the interests of their clients to their own. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Enforcement </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">As provided in the TIAA Code of Business Conduct, all employees are expected to comply with applicable laws and regulations, as well as the
relevant policies, procedures and compliance manuals that apply to Nuveen&#8217;s business activities. Violation of this Policy may result in disciplinary action up to and including termination of employment. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Terms and definitions </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Advisory Personnel</b>
includes the Advisers&#8217; portfolio managers and research analysts. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Conflicts Watch List (&#8220;Watch List&#8221;)</b> refers to a
list maintained by the RI Team based on the following: </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The positions and relationships of the following categories of individuals are evaluated to assist in
identifying a potential Material Conflict with a Portfolio Company: </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">i.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The TIAA CEO </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">ii.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Nuveen Executive Leadership Team </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">iii.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">RI Team members who provide proxy voting recommendations on behalf of the Advisers, </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">iv.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Advisory Personnel, and </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">v.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Household Members of the parties listed above in Nos. 1(i)&#150;1(iv) </p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The following criteria constitutes a potential Material Conflict: </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 5%">&#160;</td>
<td style="width: 3%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Any individual identified above in 1(i)&#150;1(v) who serves on a Portfolio Company&#8217;s board of directors;
and/or </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 5%">&#160;</td>
<td style="width: 3%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Any individual identified above in 1(v) who serves as a senior executive of a Portfolio Company.
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">In addition, the following circumstances have been determined to constitute a potential Material Conflict:
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">i.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Voting proxies for Funds sponsored by a Nuveen Affiliated Entity (i.e., registered investment funds and other
funds that require proxy voting) held in client accounts, </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">ii.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Voting proxies for Portfolio Companies that are direct advisory clients of the Advisers and/or the Nuveen
Affiliated Entities, </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">iii.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Voting proxies for Portfolio Companies that have a material distribution relationship* with regard to the
products or strategies of the Advisers and/or the Nuveen Affiliated Entities, </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">iv.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Voting proxies for Portfolio Companies that are institutional investment consultants with which the Advisers
and/or the Nuveen Affiliated Entities have engaged for any material business opportunity* and </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 5%; vertical-align: top; text-align: left">v.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Any other circumstance where the RI Team, the Nuveen Proxy Voting Committee (the &#8220;Committee&#8221;), the
Advisers, Nuveen Legal or Nuveen Compliance are aware of in which the Adviser&#8217;s duty to serve its clients&#8217; interests could be materially compromised.</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p></td></tr></table>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">In addition, certain conflicts may arise when a Proxy Service Provider or their affiliate(s), have determined
and/or disclosed that a relationship exists with i) a Portfolio Company ii) an entity acting as a primary shareholder proponent with respect to a Portfolio Company or iii) another party. Such relationships include, but are not limited to, the
products and services provided to, and the revenue obtained from, such Portfolio Company or its affiliates. The Proxy Service Provider is required to disclose such relationships to the Advisers, and the RI Team reviews and evaluates the Proxy
Service Provider&#8217;s disclosed conflicts of interest and associated controls annually and reports its assessment to the Committee. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Household Member</b> includes any of the following who reside or are expected to reside in your household for at least 90 days a year:
i)&#160;spouse or Domestic Partner, ii)&#160;sibling, iii)&#160;child, stepchild, grandchild, parents, grandparent, stepparent, and <span style="white-space: nowrap">in-laws</span> (mother, father, son, daughter, brother, sister). </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Domestic Partner</b> is defined as an individual who is neither a relative of, or legally married to, a Nuveen employee but shares a
residence and is in a mutual commitment similar to marriage with such Nuveen employee. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Material Conflicts of Interest (&#8220;Material
Conflict&#8221;)</b> A conflict of interest that reasonably could have the potential to influence a recommendation based on the criteria described in this Policy. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Nuveen Affiliated Entities</b> refers to TIAA and entities that are under common control with the Advisers and that provide investment
advisory services to third party clients.<sup><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">&#134;</span></sup> TIAA and the Advisers will undertake reasonable efforts to identify and manage any
potential TIAA-related conflicts of interest. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Portfolio Company</b> refers to any publicly traded company held in an account that is
managed by an Adviser or a Nuveen Affiliated Entity. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Proxy Service Provider(s)</b> refers to any independent third-party vendor(s) who
provides proxy voting administrative, research and/or recordkeeping services to Nuveen. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Proxy Voting Guidelines (the
&#8220;Guidelines&#8221;)</b> are a set of <span style="white-space: nowrap">pre-determined</span> principles setting forth the manner in which the Advisers generally intend to vote on specific voting categories and serve to assist clients, Portfolio
Companies, and other interested parties in understanding how the Advisers generally intend to vote proxy-related matters. The Guidelines are not exhaustive and do not necessarily dictate how the Advisers will ultimately vote with respect to any
proposal or resolution. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"><b>Proxy Voting Conflicts of Interest Escalation Form (&#8220;Escalation Form&#8221;)</b> Used in limited
circumstances as described below to formally document certain requests to deviate from the Guidelines, the rationale supporting the request, and the ultimate resolution. </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 2%; vertical-align: top; text-align: left"><b>*</b></td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Such criteria is defined in a separate standard operating procedure. </b></p></td></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 2%; vertical-align: top; text-align: left"><b><sup><span style="font-size: 6.5pt">&#134;</span></sup>&#160;</b></td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Such list is maintained in a separate standard operating procedure. </b></p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Policy requirements </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Advisers have a
fiduciary duty to vote proxies in the best interests of their clients and must not subrogate the interests of their clients to their own. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The RI Team and Advisory Personnel are prohibited from being influenced in their proxy voting decisions by any individual outside the
established proxy voting process. The RI Team and Advisory Personnel are required to report to Nuveen Compliance any individuals or parties seeking to influence proxy votes outside the established proxy voting process. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The RI Team generally seeks to vote proxies in adherence to the Guidelines. In the event that a potential Material Conflict has been
identified, the Committee, the RI Team, Advisory Personnel and Nuveen Compliance are required to comply with the following: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Proxies are
generally voted in accordance with the Guidelines. In instances where a proxy is issued by a Portfolio Company on the Watch List, and the RI Team&#8217;s vote direction is in support of company management and either contrary to the Guidelines or the
Guidelines require a case by case review, then the RI Team vote recommendation is evaluated using established criteria<sup><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">&#135;</span></sup> to determine
whether a potential conflict exists. In instances where it is determined a potential conflict exists, the vote direction shall default to the recommendation of an independent third-party Proxy Service Provider based on such provider&#8217;s benchmark
policy. To the extent the RI Team believes there is a justification to vote contrary to the Proxy Service Provider&#8217;s benchmark recommendation in such an instance, then such requests are evaluated and mitigated pursuant to an Escalation Form
review process as described in the Roles and Responsibilities section below. In all cases votes are intended to be in line with the Guidelines and in the best interests of clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The Advisers are required to adhere to the baseline standards and guiding principles governing client and personnel conflicts as outlined in
the TIAA Conflicts of Interest Policy to assist in identifying, escalating and addressing proxy voting conflicts in a timely manner. </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 2%; vertical-align: top; text-align: left"><b><sup><span style="font-size: 6.5pt">&#135;</span></sup>&#160;</b></td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Such criteria is defined in a separate standard operating procedure. </b></p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Roles and responsibilities </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting
Committee </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Annually, review and approve the criteria constituting a Material Conflict involving the individuals and
entities named on the Watch List. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Review and approve the Policy annually, or more frequently as required. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Review Escalation Forms as described above to determine whether the rationale of the recommendation is clearly
articulated and reasonable relative to the potential Material Conflict. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">4.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Review RI Team Material Conflicts reporting. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">5.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Review and consider any other matters involving the Advisers&#8217; proxy voting activities that are brought to
the Committee. </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Responsible Investing Team </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Promptly disclose RI Team members&#8217; Material Conflicts to Nuveen Compliance. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">RI Team members must recuse themselves from all decisions related to proxy voting for the Portfolio Company
seeking the proxy for which they personally have disclosed, or are required to disclose, a Material Conflict. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Compile, administer and update the Watch List promptly based on the Watch List criteria described herein as
necessary. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">4.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Evaluate vote recommendations for Portfolio Companies on the Watch List, based on established criteria to
determine whether a vote shall default to the third-party Proxy Service Provider, or whether an Escalation Form is required. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">5.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">In instances where an Escalation Form is required as described above, the RI Team member responsible for the
recommendation completes and submits the form to an RI Team manager and the Committee. The RI Team will specify a response due date from the Committee typically no earlier than two business days from when the request was delivered. While the RI Team
will make reasonable efforts to provide a two business day notification period, in certain instances the required response date may be shortened. The Committee reviews the Escalation Form to determine whether a Material Conflict exists and whether
the rationale of the recommendation is clearly articulated and reasonable relative to the existing conflict. The Committee will then provide its response in writing to the RI Team member who submitted the Escalation Form. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">6.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Provide Nuveen Compliance with established reporting. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">7.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Prepare Material Conflicts reporting to the Committee and other parties, as applicable. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">8.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Retain Escalation Forms and responses thereto and all other relevant documentation in conformance with
Nuveen&#8217;s Record Management program.</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p></td></tr></table>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">Advisory Personnel </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Promptly disclose Material Conflicts to Nuveen Compliance. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Provide input and/or vote recommendations to the RI Team upon request. Advisory Personnel are prohibited from
providing the RI Team with input and/or recommendations for any Portfolio Company for which they have disclosed, or are required to disclose, a Material Conflict. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">From time to time as part of the Adviser&#8217;s normal course of business, Advisory Personnel may initiate an
action to override the Guidelines for a particular proposal. For a proxy vote issued by a Portfolio Company on the Watch List, if Advisory Personnel request a vote against the Guidelines and in favor of Portfolio Company management, then the request
will be evaluated by the RI Team in accordance with their established criteria and processes described above. To the extent an Escalation Form is required, the Committee reviews the Escalation Form to determine whether the rationale of the
recommendation is clearly articulated and reasonable relative to the potential Material Conflict. </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Compliance
</p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Determine criteria constituting a Material Conflict involving the individuals and entities named on the Watch
List. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">2.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Determine parties responsible for collection of, and providing identified Material Conflicts to, the RI Team
for inclusion on the Watch List. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">3.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Perform periodic reviews of votes where Material Conflicts have been identified to determine whether the votes
were cast in accordance with this Policy. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">4.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Develop and maintain, in consultation with the RI Team, standard operating procedures to support the Policy.
</p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">5.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Perform periodic monitoring to determine adherence to the Policy. </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">6.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Administer training to the Advisers and the RI Team, as applicable, to ensure applicable personnel understand
Material Conflicts and disclosure responsibilities. </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">7.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assist the Committee with the annual review of this Policy. </p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Legal </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">1.</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Provide legal guidance as requested. </p></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt">Governance </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Review and approval </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">This Policy will be reviewed at least annually and will be updated sooner if changes are necessary. The Policy Leader, the Committee and the
NEFI Compliance Committee are responsible for the review and approval of this Policy. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Implementation </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen has established the Committee to provide centralized management and oversight of the proxy voting process administered by the RI Team
for the Advisers in accordance with its Proxy Voting Committee Charter and this Policy. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Exceptions </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Any request for a proposed exception or variation to this Policy will be submitted to the Committee for approval and reported to the
appropriate governance committee(s), where appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Related documents </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Committee Charter </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Policy Statement on Responsible Investing </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Policy </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">Nuveen Proxy Voting Guidelines </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">TIAA Conflicts of Interest Policy</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in"></p>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



 <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">PART C&#8212;OTHER INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Item 25: Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">Contained in Part A:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">For the fiscal years ended December 31, 2024, December 31,
2023, December 31, 2022, December 31, 2021 and December 31, 2020 are incorporated in Part A by reference to the Registrant&#8217;s December
31, 2024 <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">Annual Report</a> (audited) on
Form N-CSR, as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) via EDGAR Accession No. 0001193125-25-049467 on March 7, 2025.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Contained in Part B:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Financial Statements are incorporated in Part B by reference
to the Registrant&#8217;s December 31, 2024 <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">Annual
Report</a> (audited) on Form N-CSR, as filed with the SEC  via EDGAR Accession
No. 0001193125-25-049467 on March 7, 2024.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">Exhibits:</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a.</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312514305175/d772175dex991.htm">Registrant&#8217;s Declaration of Trust dated August 5, 2014. Filed on August 12, 2014 as Exhibit 1 to the Registrant&#8217;s Registration Statement on Form N-14 (File No. 333-198062) and incorporated herein by reference</a>.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1266585/000119312524063442/d777056dex99b.htm">Amended and Restated By-Laws of Registrant dated February 28, 2024 is incorporated herein by reference to Exhibit b to Nuveen Municipal High Income Opportunity Fund&#8217;s Registration Statement on Form N-2 (File Nos. 333-277778 and 811-21449), as filed with the SEC via EDGAR Accession No. 0001193125-24-063442 on March 8, 2024</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">c.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">d.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">e.</td><td><a href="ex99-e.htm">Terms and Conditions of the Dividend Reinvestment Plan is filed herewith</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">g.1</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-g1.htm">Investment Management Agreement between the Registrant and Nuveen Fund Advisors, LLC dated November 7, 2014. Filed as Exhibit g.1 of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 811-22988 as filed with the SEC via EDGAR Accession No. 0001999371-25-006696) on May 27, 2025 and incorporated herein by reference</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">g.2</td><td><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-g2.htm">Renewal and Amendment of Investment
                                                                Management Agreement between the Registrant and Nuveen Fund Advisors, LLC dated August 1, 2019. Filed as Exhibit g.2 of the
                                                                Registrant&#8217;s Registration Statement on Form N-2 (File No. 811-22988 as filed with the SEC via EDGAR Accession No.
                                                                0001999371-25-006696) on May 27, 2025 and incorporated herein by reference</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">g.3</td><td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-g3.htm">Continuance and Amendment of Investment Management Agreement between the Registrant and Nuveen Fund Advisors, LLC dated May 1, 2024. Filed as Exhibit g.3 of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 811-22988 as filed with the SEC via EDGAR Accession No. 0001999371-25-006696) on May 27, 2025 and incorporated herein by reference</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">g.4</td><td><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-g4.htm">Investment Sub-Advisory Agreement between Nuveen Fund Advisors, LLC and Nuveen Asset Management, LLC dated November 7, 2014. Filed as Exhibit g.4 of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 811-22988 as filed with the SEC via EDGAR Accession No. 0001999371-25-006696) on May 27, 2025 and incorporated herein by reference</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>




<!-- Field: Page; Sequence: 133; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin: 0">&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">g.5</td><td><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-g5.htm">Continuance and Amendment of Investment Sub-Advisory Agreement between Nuveen Fund Advisors, LLC and Nuveen Asset Management, LLC dated April 30, 2024. Filed as Exhibit g.5 of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 811-22988 as filed with the SEC via EDGAR Accession No. 0001999371-25-006696) on May 27, 2025 and incorporated herein by reference</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">h.1</span></td><td><span style="font-size: 10pt">Not
                                            applicable.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">h.2</span></td><td style="text-align: justify"><span style="font-size: 10pt">Not
                                            applicable.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">i.</td><td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1777482/000199937124009186/ex99-i1.htm">Nuveen/TIAA-CREF Funds Board Voluntary Deferred Compensation Plan for Independent Directors and Trustees, effective January 1, 2024, is incorporated herein by reference to Exhibit (i) (1) to Nuveen Enhanced High Yield Municipal Bond Fund Registration Statement on Form N-2 (File No. 333-231722 and 811-23445), as filed with the SEC via EDGAR Accession No. 0001999371-24-009186 on July 29, 2024</a>.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 55.45pt; text-indent: -13.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">j.1</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/892992/000119312516598771/d193684dex99j1.htm">Amended and Restated Master Custodian Agreement dated July 15, 2015 between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit j.1 of the Nuveen California AMT-Free Quality Municipal Income Fund on Form N-2 (File No. 333-184971), as filed with the SEC on November 16, 2017</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">j.2</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/892992/000119312516598771/d193684dex99j2.htm">Appendix A, dated April 14, 2016, to the Amended and Restated Master Custodian Agreement dated July 15, 2015 between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit j.2 of the Nuveen California AMT-Free Quality Municipal Income Fund Registration Statement on Form N-2 (File No. 333-211531), as filed with the SEC on May 23, 2016</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">j.3</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1195738/000119312517345678/d266913dex99j2.htm">Appendix A, dated August 1, 2017, to the Amended and Restated Master Custodian Agreement between the Registrant and State Street Bank and Trust Company dated July 15, 2015. Filed on November 16, 2017 as Exhibit j.2 of the Nuveen California AMT-Free Quality Municipal Income Fund Registration Statement on Form N-2 (File No. 333-184971) and incorporated herein by reference</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">j.4</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1380786/000119312522314076/d403340dex99g3.htm">Amendment and Revised Appendix A, effective September 8, 2022, to the Amended and Restated Master Custodian Agreement between the Registrant and State Street Bank and Trust Company dated July 15, 2015 is incorporated herein by reference to Exhibit g.3 to Post-Effective Amendment No. 81 to Nuveen Investment Trust V&#8217;s Registration Statement on Form N-1A (File Nos. 333-138592 and 811-21979), as filed with the SEC via EDGAR Accession No. 0001193125-22-314076 on December 29, 2022</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.5in">&#160;</td>
  <td style="width: 0.25in">j.5&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1074952/000199937125010856/ex99-j8.htm" style="-sec-extract: exhibit">Amendment to the Amended and Restated Master Custodian Agreement, effective February 20, 2024, is incorporated herein by reference to Exhibit (j) (8) to Nuveen California Quality Municipal Income Fund's Registration Statement on Form N-2 (File No. 333-289350 and 811-09161), as filed with the SEC via EDGAR Accession No. 0001999371-25-010856 on August 7, 2025</a>.</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
    <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>j.6&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1074952/000199937125010856/ex99-j9.htm" style="-sec-extract: exhibit">Amendment to the Amended and Restated Master Custodian Agreement, effective December 11, 2024, iis incorporated herein by reference to Exhibit (j) (9) to Nuveen California Quality Municipal Income Fund's Registration Statement on Form N-2 (File No. 333-289350 and 811-09161), as filed with the SEC via EDGAR Accession No. 0001999371-25-010856 on August 7, 2025</a>.</td>
  </tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.1</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1793129/000119312520174170/d820867dex99k1.htm">Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and ComputerShare Inc. and ComputerShare Trust Company, N.A. is incorporated herein by reference to Exhibit k.1 to the Nuveen Dynamic Municipal Opportunities Fund Registration Statement on Form N-2 (File No. 333-234592), as filed with the SEC via EDGAR Accession No. 0001193125-20-174170 on June 19, 2020</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.2</span></td><td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1774342/000119312521092969/d60524dex99k2.htm">First Amendment, dated September 7, 2017, to the Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and ComputerShare Inc. and ComputerShare Trust Company, N.A. is incorporated herein by reference to Exhibit k.2 to Nuveen Municipal Credit Opportunities Fund&#8217;s Registration Statement on Form N-2 (File Nos. 333-254678 and 811-23440), as filed with the SEC via EDGAR Accession No. 0001193125-21-092969 on March 25, 2021</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.3</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1774342/000119312521092969/d60524dex99k3.htm">Second Amendment, dated February 26, 2018, to the Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and ComputerShare Inc. and ComputerShare Trust Company, N.A. is incorporated herein by reference to Exhibit k.3 to Nuveen Municipal Credit Opportunities Fund&#8217;s Registration Statement on Form N-2 (File Nos. 333-254678 and 811-23440), as filed with the SEC via EDGAR Accession No. 0001193125-21-092969 on March 25, 2021</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.4</span></td><td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1774342/000119312521092969/d60524dex99k4.htm">Third Amendment, effective May 11, 2020, to the Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and ComputerShare Inc. and ComputerShare Trust Company, N.A. is incorporated herein by reference to Exhibit k.4 to Nuveen Municipal Credit Opportunities Fund&#8217;s Registration Statement on Form N-2 (File Nos. 333-254678 and 811-23440), as filed with the SEC via EDGAR Accession No. 0001193125-21-092969 on March 25, 2021</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.5</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/883618/000119312523132482/d501638dex99k5.htm">Amended and Restated Schedule A, effective March 28, 2023, to the Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and ComputerShare Inc. and ComputerShare Trust Company, N.A. is incorporated herein by reference to Exhibit k.5 to Nuveen Select Tax-Free Income Portfolio&#8217;s Registration Statement on Form N-2 (File Nos. 333-271575 and 811-06548), as filed with the SEC via EDGAR Accession No. 0001193125-23-132482 on May 2, 2023</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">k.6</span></td><td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/883618/000119312523132482/d501638dex99k6.htm">Rule 12d1-4 Investment Agreement between RiverNorth Funds as Acquiring Funds and Nuveen CEFs as Acquired Funds, dated January 19, 2022 is incorporated herein by reference to Exhibit k.6 to Nuveen Select Tax-Free Income Portfolio&#8217;s Registration Statement on Form N-2 (Files Nos. 333-271575 and 811-06548), as filed with the SEC via EDGAR Accession No. 0001193125-23-132482 on May 2, 2023</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.5in">&#160;</td>
  <td style="width: 0.25in">k.7</td>
  <td><a href="https://www.sec.gov/Archives/edgar/data/1074952/000199937125010856/ex99-k6.htm" style="-sec-extract: exhibit">Amended and Restated Schedule A, effective June 30, 2023, to the Transfer Agency and Service Agreement dated June 15, 2017 between the Registrant and Computershare Inc. and Computershare Trust Company, N.A. is incorporated herein by reference to Exhibit (k) (6) to Nuveen California Quality Municipal Income Fund's Registration Statement on Form N-2 (File No. 333-289350 and 811-09161), as filed with the SEC via EDGAR Accession No. 0001999371-25-010856 on August 7, 2025</a>.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>k.8</td>
  <td><a href="https://www.sec.gov/Archives/edgar/data/1074952/000199937125010856/ex99-k8.htm" style="-sec-extract: exhibit">Rule 12d1-4 Investment Agreement between First Trust CEF Income Opportunity ETF and Nuveen CEFs as Acquired Funds dated August 31, 2023 is incorporated herein by reference to Exhibit (k) (8) to Nuveen California Quality Municipal Income Fund's Registration Statement on Form N-2 (File No. 333-289350 and 811-09161), as filed with the SEC via EDGAR Accession No. 0001999371-25-010856 on August 7, 2025.</a></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">l.1</td><td><a href="ex99-l1.htm">Opinion of Stradley Ronon Stevens &amp; Young, LLP is filed herewith</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">l.2</td><td><a href="ex99-l2.htm">Consent of Morgan, Lewis &amp; Bockius LLP is filed herewith</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">m.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">n.</td><td><a href="ex99-n.htm">Consent of PricewaterhouseCoopers LLP is filed herewith</a>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">o.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">p.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">q.</td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">r.1</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1635073/000119312524051051/d670852dex99pi.htm">Code of Ethics and Reporting Requirements of Nuveen, as amended January 1, 2024. As filed with the SEC via EDGAR Accession No. 0001193125-24-051051 on February 29, 2024, as Exhibit p.i. to Nushares ETF Trust&#8217;s Registration Statement on Form N-1A (File Nos.333-212032 and 811-23161) and incorporated by reference herein</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">r.2</span></td><td><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1635073/000119312524051051/d670852dex99pii.htm">Code of Ethics for the Independent Trustees of the Nuveen Funds, TIAA-CREF Funds and TIAA-CREF Funds, dated January 1, 2024. As filed with the SEC via EDGAR Accession No. 0001193125-24-051051 on February 29, 2024, as Exhibit p.ii. to Nushares ETF Trust&#8217;s Registration Statement on Form N-1A (File Nos.333-212032 and 811-23161) and incorporated by reference herein</a>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">s.</td><td style="text-align: justify"><a href="ex99-s.htm">Calculation of Filing Fees Table is filed herewith</a>.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 379.65pt 0pt 41.95pt; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">t.</td><td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125006696/ex99-t.htm">Powers of
                                                                                 Attorney are incorporated herein by reference to Exhibit (t) to the Registrant&#8217;s Registration Statement on Form N-2 (File No.
                                                                                 811-22988 as filed with the SEC via EDGAR Accession No. 0001999371-25-006696) on May 27, 2025</a>.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 379.65pt 0pt 41.95pt; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Item 26: Marketing Arrangements.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Item 27: Other Expenses of Issuance and Distribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 84%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%; text-align: left">Printing and Engraving Fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">10,000</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Legal Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">50,000</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounting Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">6,750</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Exchange Listing Fees</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">2,500</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">SEC Registration Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">15,310</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Miscellaneous Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">440</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-size: 10pt">85,000</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Item 28: Persons Controlled by or Under Common Control.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Item 29: Number of Holders of Securities.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in">As of July 31, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 84%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Title of Class</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Number of Record Holders</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 85%">Common Shares, $0.01 par value</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">18,086</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,086</td><td style="text-align: left">&#160;</td></tr>
  </table>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item&#160;30: Indemnification. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Section&#160;4 of Article XII of the Registrant&#8217;s Declaration of Trust provides as follows: </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Subject to the exceptions and limitations contained in this Section&#160;4, every person who is, or has been, a Trustee, officer, employee or
agent of the Trust, including persons who serve at the request of the Trust as directors, trustees, officers, employees or agents of another organization in which the Trust has an interest as a shareholder, creditor or otherwise (hereinafter
referred to as a &#8220;Covered Person&#8221;), shall be indemnified by the Trust to the fullest extent permitted by law against liability and against all expenses reasonably incurred or paid by him in connection with any claim, action, suit or
proceeding in which he becomes involved as a party or otherwise by virtue of his being or having been such a Trustee, director, officer, employee or agent and against amounts paid or incurred by him in settlement thereof. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">No indemnification shall be provided hereunder to a Covered Person: </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">(a)</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">against any liability to the Trust or its Shareholders by reason of a final adjudication by the court or other
body before which the proceeding was brought that he engaged in willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office; </p></td></tr></table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">(b)</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">with respect to any matter as to which he shall have been finally adjudicated not to have acted in good faith
in the reasonable belief that his action was in the best interests of the Trust; or </p></td></tr></table> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">(c)</td>
<td style="text-align: left; vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">in the event of a settlement or other disposition not involving a final adjudication (as provided in paragraph
(a)&#160;or (b)) and resulting in a payment by a Covered Person, unless there has been either a determination that such Covered Person did not engage in willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in
the conduct of his office by the court or other body approving the settlement or other disposition or a reasonable determination, based on a review of readily available facts (as opposed to a full trial-type inquiry), that he did not engage in such
conduct: </p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 9%">(i) by a vote of a majority of the Disinterested Trustees acting on the matter (provided that a majority of the
Disinterested Trustees then in office act on the matter); or </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 9%">(ii) by written opinion of independent legal counsel. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The rights of indemnification herein provided may be insured against by policies maintained by the Trust, shall be severable, shall not affect
any other rights to which any Covered Person may now or hereafter be entitled, shall continue as to a person who has ceased to be such a Covered Person and shall inure to the benefit of the heirs, executors and administrators of such a person.
Nothing contained herein shall affect any rights to indemnification to which Trust personnel other than Covered Persons may be entitled by contract or otherwise under law. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Expenses of preparation and presentation of a defense to any claim, action, suit or proceeding subject to a claim for indemnification under
this Section&#160;4 shall be advanced by the Trust prior to final disposition thereof upon receipt of an undertaking by or on behalf of the recipient to repay such amount if it is ultimately determined that he is not entitled to indemnification
under this Section&#160;4, provided that either: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">(a) such undertaking is secured by a surety bond or some other appropriate security or
the Trust shall be insured against losses arising out of any such advances; or </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; margin-left: 0.5in">(b) a majority of the Disinterested Trustees acting on the
matter (provided that a majority of the Disinterested Trustees then in office act on the matter) or independent legal counsel in a written opinion shall determine, based upon a review of the readily available facts (as opposed to a full trial-type
inquiry), that there is reason to believe that the recipient ultimately will be found entitled to indemnification. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">As used in this
Section&#160;4, a &#8220;Disinterested Trustee&#8221; is one (x)&#160;who is not an Interested Person of the Trust (including anyone, as such Disinterested Trustee, who has been exempted from being an Interested Person by any rule, regulation or order
of the Commission), and (y)&#160;against whom none of such actions, suits or other proceedings or another action, suit or other proceeding on the same or similar grounds is then or has been pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As used in this Section&#160;4, the words &#8220;claim,&#8221; &#8220;action,&#8221; &#8220;suit&#8221;
or &#8220;proceeding&#8221; shall apply to all claims, actions, suits, proceedings (civil, criminal, administrative or other, including appeals), actual or threatened; and the words &#8220;liability&#8221; and &#8220;expenses&#8221; shall include without
limitation, attorneys&#8217; fees, costs, judgments, amounts paid in settlement, fines, penalties and other liabilities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">The trustees and
officers of the Registrant are covered by joint errors and omissions insurance policies against liability and expenses of claims of wrongful acts arising out of their position with the Registrant and other Nuveen funds, subject to such
policies&#8217; coverage limits, exclusions and retention. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Section&#160;8 of the Distribution Agreement Relating to <span style="white-space: nowrap"><span style="white-space: nowrap">At-the-Market</span></span> offerings, filed as Exhibit h.1 to this Registration Statement, provides for each of the parties thereto, including the Registrant and the underwriters, to
indemnify the others, their trustees, directors, certain of their officers, trustees, directors and persons who control them against certain liabilities in connection with the offering described herein, including liabilities under the federal
securities laws. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Insofar as indemnification for liability arising under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that, in the opinion of the SEC, such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Item&#160;31:
Business and Other Connections of Investment Adviser and Sub-Adviser.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen
Fund Advisors, LLC (&#8220;Nuveen Fund Advisors&#8221; or the &#8220;Adviser&#8221;) manages the Registrant and serves as investment
adviser or manager to other open-end and closed-end management investment companies and to separately managed accounts. The principal
business address for all of these investment companies and the persons named below is 333 West Wacker Drive, Chicago, Illinois 60606.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
description of any other business, profession, vocation or employment of a substantial nature in which the directors and officers
of Nuveen Fund Advisors who serve as officers or Trustees of the Registrant have engaged during the last two years for his or
her account or in the capacity of director, officer, employee, partner or trustee appears under &#8220;Management of the Fund&#8221;
in the Statement of Additional Information. Such information for the remaining senior officers appears below:&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            and Position with Nuveen Fund Advisors</b></span></p></td>
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
    Business, Profession, Vocation or</b><br/>
    <b>Employment During Past Two Years</b></span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oluseun
    Salami, Executive Vice President and Chief Financial Officer</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Vice President (since 2020) NIS/R&amp;T, Inc.; Senior Vice President and Chief Financial Officer (since 2020), Nuveen Alternative
    Advisors LLC Executive Vice President (since 2024) and Chief Financial Officer (since 2020), formerly, Senior Vice President (2020-2024),
    TIAA-CREF Asset Management LLC; formerly, Senior Vice President and Chief Financial Officer (2020-2023), Teachers Advisors, LLC and
    TIAA-CREF Investment Management, LLC; Executive Vice President (since 2022), formerly, Senior Vice President (2020-2022), and Chief
    Financial Officer (since 2020), Nuveen, LLC; Executive Vice President and Chief Financial Officer (since 2022), Nuveen Investments,
    Inc.; Executive Vice President (since 2021), formerly, Senior Vice President, Chief Financial Officer (2018-2021), Business Finance
    and Planning (2020)&#160;Chief Accounting Officer (2019-2020), Corporate Controller (2018-2020), Teachers Insurance and Annuity Association
    of America; formerly, Senior Vice President, Corporate Controller, College Retirement Equities Fund, TIAA Board of Overseers, TIAA
    Separate&#160;Account&#160;VA-1,&#160;TIAA-CREF&#160;Funds,&#160;TIAA-CREF Life Funds (2018-2020).</span></td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Megan
    Sendlak, Managing Director and Controller</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director and Controller (since 2020) of Nuveen Alternatives Advisors LLC, Nuveen Asset Management, LLC, Nuveen Investments, Inc.,
    Teachers Advisors, LLC and&#160;TIAA-CREF Investment Management, LLC; Managing Director (since 2019) and Controller (since 2020),
    formerly, Assistant Controller (2019-2020), of Nuveen Securities, LLC; Managing Director and Controller (since 2020), formerly, Vice
    President and Corporate Accounting Director (2018-2020) of Nuveen, LLC; Managing Director and Controller (since 2021), formerly,
    Vice President and Assistant Controller (2019-2021), of NIS/R&amp;T, INC.; formerly, Vice President and Controller of NWQ Investment
    Management Company, LLC and Santa Barbara Asset Management, LLC (2020-2021); Vice President and Controller of Winslow Capital Management,
    LLC (since 2020).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 52%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 47%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nathaniel
    T. Jones, President</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Managing Director, Head of Public Product of  Nuveen; has previously held various positions with Nuveen.</span></td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Erik
    Mogavero, Managing Director and Chief Compliance Officer</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Formerly
    employed by Deutsche Bank (2013-2017) as Managing Director, Head of Asset Management and Wealth Management Compliance for
    the Americas region and Chief Compliance Officer of Deutsche Investment Management Americas.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen
Asset Management LLC (&#8220;Nuveen Asset Management&#8221;) currently serves as&#160;sub-adviser&#160;to the Fund and as an investment
adviser or&#160;sub-adviser&#160;to certain other&#160;open-end&#160;and&#160;closed-end&#160;funds and as investment adviser
to separately managed accounts. The address for Nuveen Asset Management is 333 West Wacker Drive, Chicago, Illinois 60606. See
&#8220;Investment Adviser,&#160;Sub-Adviser&#160;and Portfolio Managers&#8221; in Part B of the Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Set
forth below is a list of each director and officer of Nuveen Asset Management, indicating each business, profession, vocation
or employment of a substantial nature in which such person has been, at any time during the past two fiscal years, engaged for
his or her own account or in the capacity of director, officer, partner or trustee.&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            and Position with Nuveen Asset Management</b></span></p></td>
    <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
    Business Profession, Vocation or</b><br/>
    <b>Employment During Past Two Years</b></span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    T. Huffman, President</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and President (since 2024), formerly, Executive Vice President (2020-2024) of Nuveen, LLC; formerly, Executive
    Vice President (2020-2023) of Nuveen Securities, LLC; President, Nuveen Investments, Inc. (since 2020), Teachers Advisors, LLC and
    TIAA-CREF Investment Management, LLC (since 2019); Senior Managing Director (since 2019) of Nuveen Alternative Advisors LLC; Senior
    Managing Director (since 2022) and Chairman (since 2019) of Churchill Asset Management LLC.</span></td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart
    J. Cohen, Managing Director and Head of Legal</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director and Assistant Secretary (since 2002) of Nuveen Securities, LLC; Managing Director (since 2007) and Assistant Secretary (since
    2003) of Nuveen Fund Advisors, LLC; Managing Director, Associate General Counsel and Assistant Secretary (since 2023) of Nuveen Alternatives
    Investments, LLC and (since 2019) of Teachers Advisors, LLC; Managing Director, Assistant Secretary (since 2019) and Assistant General
    Counsel (since 2023), formerly, General Counsel (2019-2023) of TIAA-CREF Investment Management, LLC; Vice President and Assistant
    Secretary (since 2008) of Winslow Capital Management, LLC; formerly, Vice President (2007-2021) and Assistant Secretary (2003-2021)
    of NWQ Investment Management Company, LLC; formerly Vice President (2007-2021) and Assistant Secretary&#160;(2006-2021)&#160;of Santa
    Barbara Asset Management, LLC.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 12pt; width: 52%"><span style="font: 10pt Times New Roman, Times, Serif">Travis
    M. Pauley, Managing Director and Chief Compliance Officer</span></td>
    <td style="vertical-align: bottom; font-size: 11pt; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt; width: 47%"><span style="font: 10pt Times New Roman, Times, Serif">Regional
    Head of Compliance and Regulatory Legal (2013-2020) of AXA Investment Managers.</span></td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Megan
    Sendlak Managing Director and Controller</span></td>
    <td style="vertical-align: bottom; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Managing
    Director and Controller (since 2020) of Nuveen Alternatives Advisors LLC, Nuveen Investments, Inc., Nuveen Fund Advisors,
    LLC, Teachers Advisors, LLC and TIAA-CREF Investment Management, LLC; Managing Director (since 2019) and Controller (since
    2020), formerly, Assistant Controller (2019-2020), of Nuveen Securities, LLC; Managing Director and Controller (since 2020),
    formerly, Vice President and Corporate Accounting Director (2018-2020) of Nuveen, LLC; Managing Director and Controller (since
    2021), formerly, Vice President and Assistant Controller (2019-2021), of NIS/R&amp;T, INC., formerly, Vice President and Controller
    of NWQ Investment Management Company, LLC and Santa Barbara Asset Management, LLC&#160;(2020-2021);&#160;Vice President and
    Controller of Winslow Capital Management, LLC (since 2020).</span></td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item&#160;32: Location of Accounts
and Records. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Fund Advisors, LLC, 333 West Wacker Drive, Chicago, Illinois 60606, maintains the Fund&#8217;s Declaration of Trust, <span style="white-space: nowrap">By-Laws,</span> minutes of trustee and shareholder meetings, and contracts of the Registrant and all advisory material of the investment adviser. Nuveen Asset Management, LLC, in its capacity as <span style="white-space: nowrap">sub-adviser,</span> may also hold certain accounts and records of the Fund. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">State Street Bank and Trust
Company, One Congress Street, Suite 1, Boston, Massachusetts 02114-2016, maintains all general and subsidiary ledgers, journals, trial balances, records of all portfolio purchases and sales, and all other required records not maintained by Nuveen
Fund Advisors or Nuveen Asset Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item&#160;33: Management Services. </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Not applicable. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><b>Item&#160;34:
Undertakings.</b></p><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">1.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Not applicable.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">2.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Not applicable.</span></td></tr>
</table><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">The Registrant undertakes:</span></td></tr>
</table><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">a.
Not applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">b.
that, for the purpose of determining any liability under the Securities Act, each post-effective amendment to this registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of those
securities at that time shall be deemed to be the initial bona fide offering thereof;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">c.
to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">d.
that, for the purpose of determining liability under the Securities Act to any purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(1)
if the Registrant is relying on Rule 430B:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(A)
Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as
of the date the filed prospectus was deemed part of and included in the registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(B)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (x), or (xi) for the purpose of providing the information
required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale
of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and
any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement
relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by
reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with
a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date;
or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(2)
if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424 under the Securities Act as part of a registration
statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in
reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede
or modify any statement that was made in this registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&#160;</p>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution
of securities:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or
sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser
and will be considered to offer or sell such securities to the purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(1)
any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant
to Rule 424 under the Securities Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(2)
free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to
by the undersigned Registrants;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(3)
the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the
offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned
Registrant; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(4)
any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">The Registrant undertakes
    that:</span></td></tr>
</table><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">a.
for the purpose of determining any liability under the Securities Act, the information omitted from the form of prospectus filed
as part of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant
under Rule 424(b)(1) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was
declared effective; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">b.
for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities
at that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">5.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">The undersigned Registrant
    hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s
    annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference
    into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein,
    and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
</table><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">6.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">Insofar as indemnification
    for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of
    the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of
    the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
    unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
    of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any
    action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
    being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
    submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
    expressed in the Act and will be governed by the final adjudication of such issue.</span></td></tr>
</table><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">7.</span></td>
    <td style="font-size: 11pt"><span style="font: 10pt Times New Roman, Times, Serif">The Registrant undertakes
    to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt
    of a written or oral request, any prospectus or Statement of Additional Information. Additionally, the Registrant undertakes
    to only offer rights to purchase common and preferred shares together after a post-effective amendment to the Registration
    Statement relating to such rights has been declared effective.</span></td></tr>
</table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Part C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



 <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0px"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this Registration Statement on Form
N-2 to be signed on its behalf by the undersigned, thereunto duly authorized, in this City of Chicago, and State of Illinois, on the
15th day of August, 2025.</p>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


<tr>

    <td style="width: 50%">&#160;</td>
<td style="width: 50%; margin-left: auto"/></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td>&#160;</td>
<td style="vertical-align: top; margin-left: auto">NUVEEN GLOBAL HIGH INCOME FUND</td></tr>
<tr style="font-size: 1pt">
    <td>&#160;</td>
<td style="height: 16px; margin-left: auto"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td>&#160;</td>
<td style="vertical-align: top; margin-left: auto"> <p style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt">/s/ Mark L. Winget</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td>&#160;</td>
<td style="vertical-align: top; margin-left: auto"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Mark L. Winget</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt">Vice President and
Secretary</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt; text-indent: 0.5in">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed
below by the following persons in the capacities and on the date indicated. </p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


<tr>

<td style="width: 35%"/>

<td style="vertical-align: bottom; width: 1%"/>
<td style="width: 43%"/>

<td style="vertical-align: bottom; width: 2%"/>
<td style="width: 18%"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><b>Signature</b></td>
<td style="vertical-align: bottom; padding-bottom: 1pt">&#160;&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><b>Title</b></td>
<td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><b>Date</b></td></tr>


<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/
                                MARC CARDELLA</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt">Mark Cardella</p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Vice President and Controller<br/>(Principal Financial and Accounting Officer)</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top; white-space: nowrap; text-align: center">August 15, 2025</td></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/
                                DAVID&#160;J. LAMB</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt">David J. Lamb</p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Chief Administrative Officer<br/>(principal executive officer)</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top; white-space: nowrap; text-align: center">August 15, 2025</td></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Thomas J. Kenny*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Terence J. Toth*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Joseph A. Boateng*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top; text-align: center">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Michael A. Forrester*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>



<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top; text-align: center">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Amy B. R. Lancellotta*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Joanne T. Medero*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Albin F. Moschner*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">John K. Nelson*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Loren M. Starr*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Matthew Thornton III*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Margaret L. Wolff*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
<tr style="font-size: 1pt">
<td style="height: 16px"/>
<td colspan="2" style="height: 16px"/>
<td colspan="2" style="height: 16px"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top">Robert L. Young*</td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: top; text-align: center">Chair of the Board and Trustee</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"/></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>


<hr style="background-color: Black; margin: 0pt auto 0pt 0; width: 15%; height: 1px"/>
<p style="margin-top: 0; margin-bottom: 0"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="padding-top: 3pt; width: 2%; vertical-align: top; text-align: left">*</td>
<td style="padding-top: 3pt; text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The powers of attorney authorizing Mark L. Winget, among others, to execute this Registration Statement, and Amendments thereto, for the
Trustees of the Registrant on whose behalf this Registration Statement were filed as Exhibit t. to the Registrant&#8217;s Registration Statement
on Form N-2 (File No. 333-287584) filed on May 27, 2025.</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p></td></tr></table>

<!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>EXHIBIT INDEX </b></p> <p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 100%; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 5%"/>

<td style="vertical-align: bottom; width: 5%"/>
<td style="width: 90%"/></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><b>EXHIBIT</b></td>
<td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap"><b>EXHIBIT NAME</b></td></tr>


<tr style="font-size: 1pt">
<td style="height: 8px"/>
<td colspan="2" style="height: 8px"/></tr>

  <tr style="vertical-align: top">
    <td><a href="ex99-e.htm">e.</a></td>
    <td>&#160;</td>
    <td><a href="ex99-e.htm">Terms and Conditions of the Dividend Reinvestment Plan</a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="ex99-l1.htm">l.1</a></td>
    <td>&#160;</td>
    <td><a href="ex99-l1.htm">Opinion of Stradley Ronon Stevens &amp; Young, LLP</a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="ex99-l2.htm">l.2</a></td>
    <td>&#160;</td>
    <td><a href="ex99-l2.htm">Consent of Morgan, Lewis &amp; Bockius LLP</a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="ex99-n.htm">n</a></td>
    <td>&#160;</td>
    <td><a href="ex99-n.htm">Consent of PricewaterhouseCoopers LLP</a></td></tr>

<tr style="vertical-align: top">
<td><a href="ex99-s.htm">s.</a></td>
    <td>&#160;</td><td><a href="ex99-s.htm">Filing Fee Exhibit</a></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
    <td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
    <td>&#160;</td><td>&#160;</td></tr>
</table>



<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>

    <!-- Field: /Page -->



</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(E)
<SEQUENCE>3
<FILENAME>ex99-e.htm
<DESCRIPTION>TERMS AND CONDITIONS OF THE DIVIDEND REINVESTMENT PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin: 0"><A HREF="jgh-n2a_052725.htm">Nuveen Global High Income Fund N-2A</A></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.(e)</B></FONT></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NUVEEN CLOSED-END FUNDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Opt-Out w/ Discount-Premium Feature)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Terms and Conditions of the Automatic Dividend
Reinvestment Plan</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Dividend Reinvestment Plan (&#8220;Plan&#8221;)
for the Nuveen Closed- End Funds set forth on Exhibit A attached hereto (each, a &#8220;Fund&#8221;) provides for reinvestment of Fund distributions
to shareholders, consisting of income dividends, returns of capital and capital gain distributions paid by the Fund, on behalf of all
common shareholders that have not opted out of participation in the Plan, by providing express written and duly executed notice to the
Fund or by telephone notice satisfying such reasonable requirements as Computershare Inc. and Computershare Trust Company, N.A., collectively
(&#8220;Computershare&#8221;) and the Fund may agree, that they elect not to participate in the Plan (&#8220;Participants&#8221;), by Computershare
the Plan Agent, in accordance with the following terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&#8239;&#8239;&#8239;Computershare will act as Agent for Participants
and will open an account for each Participant under the Dividend Reinvestment Plan in the same name as the Participant&#8217;s shares are registered,
and will, for each Participant, automatically reinvest each Fund distribution to shareholders as of the first record date for a distribution
to shareholders following the date on which the Participant becomes a shareholder of record. In the case of shareholders who hold shares
for others who are the beneficial owners, Computershare will administer the Plan on the basis of the number of shares certified from time
to time by the record shareholder as representing the total amount registered in the record shareholder&#8217;s name and held for the
account of beneficial owners who are Participants. In the case of shareholders that elect not to participate in the Plan but rather elect
to receive all distributions of income dividends, returns of capital and/or capital gains in cash, such shareholders can send instructions
to the Agent, as dividend paying agent, in writing, by telephone or by internet as detailed in the Fund&#8217;s prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&#8239;&#8239;&#8239;Whenever the Fund declares a distribution payable
in shares or cash at the option of the shareholders, each Participant shall take such distribution entirely in shares and Computershare
shall automatically receive such shares, including fractions, for the Participant&#8217;s account, except in circumstances described in Paragraph
3 below. Except in such circumstances, the number of additional shares to be credited to each Participant&#8217;s account shall be determined
by dividing the dollar amount of the distribution payable on the Participant&#8217;s shares by the greater of net asset value or 95% of current
market price per share on the payable date for such distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.&#8239;&#8239;&#8239;If on the payment date for a distribution,
the net asset value per Common Share is equal to or less than the market price per Common Share plus estimated per share fees (which include
any applicable brokerage commissions Computershare is required to pay), Computershare shall receive newly issued Common Shares including
fractions, from the Fund for each Participant&#8217;s account. Should the net asset value per Fund share exceed the market price per share [plus
estimated per share fees, shortly before payment date for such distribution (the &#8220;Valuation Date&#8221;), for a distribution payable
in shares or in cash at the option of the shareholder, or should the Fund declare a distribution payable only in cash, each Participant
shall take such distribution in cash and Computershare shall apply the amount of such distribution to the purchase on the open market
of shares of the Fund for the Participant&#8217;s account. Such Plan purchases shall be made as early as the Valuation Date, under the supervision
of the investment adviser. If the Common Shares start trading at or above net asset value before the Plan Agent has completed its purchases,
the Plan Agent may cease purchasing Common Shares in the open market, and may invest the uninvested portion in new shares at a price equal
to the greater of net asset value per Common Share on the last purchase date or 95% of the market price on that date. Computershare shall
complete such Plan purchases or share issuance no more than 30 days after the Valuation Date, except where temporary curtailment or suspension
of purchases and issuance is necessary to comply with applicable provisions of federal securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.&#8239;&#8239;&#8239;For the purpose of this Plan, the market price
of the Fund&#8217;s shares on a particular date shall be the last sale price on the Exchange where it is traded on that date, or if there is
no sale on such Exchange on that date, then the mean between the closing bid and asked quotations for such shares on such Exchange on
such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5.&#8239;&#8239;&#8239;Open-market purchases provided for above may
be made on any securities exchange where the Fund&#8217;s shares are traded, in the over-the-counter market or in negotiated transactions and
may be on such terms as to price, delivery and otherwise as Computershare shall determine. Participants&#8217; funds held uninvested by Computershare
will not bear interest, and it is understood that, in any event, Computershare shall have no liability in connection with any inability
to purchase shares within 30 days after the Valuation Date as herein provided, or with the timing of any purchase affected. Computershare
shall have no responsibility as to the value of the Fund&#8217;s shares acquired for Participants&#8217; accounts. Computershare may commingle all
Participants&#8217; amounts to be used for open-market purchase of Fund shares and the price per share allocable to each Participant in connection
with such purchases shall be the weighted average price of all Fund shares purchased by Computershare as Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6.&#8239;&#8239;&#8239;Computershare may hold each Participant&#8217;s shares
acquired pursuant to this Plan, together with the shares of other Participants, in non-certificated form in Computershare&#8217;s name or that
of its nominee. Computershare will forward to each Participant any proxy solicitation material and will vote any shares so held only in
accordance with proxies returned to the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&#8239;&#8239;&#8239;Computershare will confirm to each Participant
each acquisition made for the Participant&#8217;s account as soon as practicable but not later than 60 days after the date thereof. Although
a Participant may from time to time have an undivided fractional interest (computed up to six decimal places) in a share (&#8220;fractional
shares&#8221;) of the Fund within the operation of the Plan, and distributions on fractional shares will be credited to the Participant&#8217;s
account no fractional shares will be transferred. In the event of termination of a Participant&#8217;s account under the Plan, Computershare
will either (a) continue to hold the Participant&#8217;s Common Shares in book-entry form, or (b) transfer a whole number of Common Shares
to an intermediary of the investor&#8217;s choosing, in either case disbursing to the investor an amount of cash equal to the value of
any such fractional shares valued at the then-current market value of the Fund&#8217;s Common Shares at the time of termination, less any applicable
fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8.&#8239;&#8239;&#8239;Any stock dividends or split shares distributed
by the Fund on full and fractional shares held by Computershare for a Participant will be credited to the Participant&#8217;s account. In the
event that the Fund makes available to its shareholders rights to purchase additional shares or other securities, the shares held for
each Participant under the Plan will be added to other shares held by the Participant in calculating the number of rights to be issued
to that Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.&#8239;&#8239;&#8239;Computershare&#8217;s service fee for handling reinvestment
of distributions pursuant hereto will be paid by the Fund. Participants will be charged a per share fee (currently $0.02) on all open
market purchases. Per share fees include any applicable brokerage commissions Computershare is required to pay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.&#8239;Each Participant may terminate his account
under the Plan by notifying Computershare of his intent so to do, such notice to be provided either in writing duly executed by the Participant
or by telephone or through the internet in accordance with such reasonable requirements as Computershare and the Fund may agree. Such
termination will be effective immediately if notice is received by Computershare prior to any distribution record date for the next succeeding
distribution. If Computershare receives the Participant&#8217;s notice of withdrawal on or after a distribution record date, Computershare,
in its sole discretion, may either distribute such distributions in cash or reinvest them in Common Shares on behalf of the withdrawing
Participant. If such distributions are reinvested, the Agent will process the withdrawal as soon as practicable, but in no event later
than five business days after the reinvestment is completed. The Plan may be terminated by the Fund or Computershare upon at least 90
days prior notice. Upon any termination, Computershare will continue to hold the Participant&#8217;s Common Shares in book-entry form
mail to the Participant a cash adjustment for any fractional shares valued at the then-current of the Fund&#8217;s Common Shares less any applicable
fees. If any Participant elects in advance of such termination to have Computershare sell part or all of his shares, Computershare is
authorized to deduct from the proceeds a $2.50 fee plus a per share fee (currently $0.02) incurred for the transaction. Per share fees
include any applicable brokerage commissions Computershare is required to pay. Computershare will sell such Common Shares through a broker-dealer
selected by Computershare within 5 business days of receipt of the request. The sale price will equal the weighted average price of all
Common Shares sold through the Plan on the day of the sale, less applicable fees listed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11. These terms and conditions may be amended
or supplemented by Computershare or the Fund at any time or times but, except when necessary or appropriate to comply with applicable
law or the rules or policies of the Securities and Exchange Commission or any other regulatory authority, only by mailing to each Participant
appropriate written notice at least 90 days prior to the effective date thereof. The amendment or supplement shall be deemed to be accepted
by each Participant unless, prior to the effective date thereof, Computershare receives notice of the termination of such Participant&#8217;s
account under the Plan in accordance with the terms hereof. Any such amendment may include an appointment by Computershare in its place
and stead of a successor Agent under these terms and conditions. Upon any such appointment of any Agent for the purpose of receiving distributions,
the Fund will be authorized to pay to such successor Agent, for each Participant&#8217;s account, all dividends and distributions payable on
Common Shares of the Fund held in the Participant&#8217;s name under the Plan for retention or application by such successor Agent as provided
in these terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. The automatic reinvestment of distributions
to shareholders does not relieve Participants of any federal, state or local taxes which may be payable (or required to be withheld on
distributions to shareholders). Participants will receive tax information annually for their personal records and to help them prepare
their federal income tax return. For further information as to tax consequences of participation in the Plan, Participants should consult
with their own tax advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13. Computershare shall at all times act in good
faith and agree to use its best efforts within reasonable limits to insure the accuracy of all services performed under this Agreement
and to comply with applicable law, but assumes no responsibility and shall not be liable for loss or damage due to errors unless such
error is caused by its negligence, bad faith or willful misconduct or that of its employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. These terms and conditions shall be governed
by the laws of the Commonwealth of Massachusetts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 8%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NUW</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 92%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen AMT-Free Municipal Value Fund (f/k/a Nuveen Municipal Value Fund 2)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NBB</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Taxable Municipal Income Fund (f/k/a Nuveen Build America Bond Fund)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JCE</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Core Equity Alpha Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIAX</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Dow 30 Dynamic Overwrite Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JGH</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Global High Income Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NMS</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Minnesota Municipal Income Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JLS</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Mortgage and Income Fund (f/k/a Nuveen Mortgage Opportunity Term Fund)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JMM</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Multi-Market Income Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QQQX</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen NASDAQ 100 Dynamic Overwrite Fund.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPI</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Preferred Securities &amp; Income Opportunities Fund (f/k/a Nuveen Preferred and Income Term Fund)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JRI</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Real Asset Income and Growth Fund</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BXMX</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen S&amp;P 500 Buy-Write Income Fund (f/k/a Nuveen Equity Premium Income Fund-JPZ)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPXX</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen S&amp;P 500 Dynamic Overwrite Fund (f/k/a Nuveen Equity Premium and Growth Fund-JPG)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(1)
<SEQUENCE>4
<FILENAME>ex99-l1.htm
<DESCRIPTION>OPINION OF STRADLEY RONON STEVENS & YOUNG, LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin: 0"><A HREF="jgh-n2a_052725.htm">Nuveen Global High Income Fund N-2A</A></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.(l)(1)</B></FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 70%"><IMG SRC="ex99l1001.jpg" ALT="" STYLE="height: 24px; width: 180px"></TD><TD STYLE="text-align: justify; width: 30%">2005 Market Street<BR>
Suite 2600<BR>
Philadelphia, PA 19103<BR>
T: 215.564.8000</TD>
</TR></TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nuveen Global High Income Fund<BR>
333 West Wacker Drive<BR>
Chicago, Illinois 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Registration Statement on Form N-2</U></B></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">We have acted as
counsel to Nuveen Global High Income Fund (the &ldquo;Fund&rdquo;), a Massachusetts business trust, in connection with an offering
with the registration of (i) common shares, $0.01 par value per
share (&ldquo;Common Shares&rdquo;), (ii) preferred shares (&ldquo;Preferred Shares,&rdquo; and collectively with Common Shares,
&ldquo;Capital Stock&rdquo;), and (iii) subscription rights to purchase Common Shares (&ldquo;Rights,&rdquo; and collectively with
Capital Stock, &ldquo;Securities&rdquo;), in any combination with a maximum aggregate dollar offering price of up to $100,000,000,
pursuant to a registration statement on Form N-2 to be filed on or about the date hereof (the &ldquo;Registration Statement&rdquo;)
with the U.S. Securities and Exchange Commission under the Investment Company Act of 1940 (the &ldquo;Investment Company Act&rdquo;)
and the Securities Act of 1933 (the &ldquo;Securities Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">This opinion is furnished
in accordance with the requirements of Item 25.2(l) of Form N-2 under the Investment Company Act and the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">In this connection, we have
examined originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate and other records, certificates
and other papers as we deemed it necessary to examine for the purpose of this opinion, including the Fund&rsquo;s Declaration of Trust
(the &ldquo;Declaration&rdquo;) and Amended and Restated By-Laws (the &ldquo;By-Laws&rdquo;), actions of the Board of Trustees of the
Fund (the &ldquo;Board&rdquo;) authorizing the registration of the Securities, and the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">In our examination, we have
assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified, conformed or
photostatic copies and the authenticity of the originals of such copies. As to any facts material to the opinions expressed herein that
we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives
of the Fund and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">We have assumed the following
for purposes of this opinion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Securities will be issued in accordance with the Declaration and By-Laws, each as is in existence as of the date of this opinion, and
that the Board will take all actions and pass all resolutions necessary to authorize, issue and sell the Securities, and that the specific
terms of the Securities will be determined in accordance with all Board resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stradley Ronon Stevens &amp; Young, LLP</B>
&nbsp;|&nbsp; <B>stradley.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chicago &nbsp;|&nbsp; Los Angeles &nbsp;|&nbsp; New York &nbsp;|&nbsp; Philadelphia
&nbsp;|&nbsp; Washington, D.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nuveen Global High Income Fund</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">333 West Wacker Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago, Illinois 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Securities will be issued against payment therefor as described in the Prospectus, including the applicable Prospectus Supplement, and
the Statement of Additional Information relating thereto included in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">Based upon the foregoing,
we are of the opinion that when the Securities are issued and sold after the Registration Statement has been declared effective and the
authorized consideration therefor is received by the Fund, (i) any Rights so issued and sold will be a binding obligation of the Fund
under the laws of Massachusetts, and (ii) any Capital Stock, including those Common Shares underlying Rights, so issued and sold will
be legally issued, fully paid and non-assessable by the Fund, except that, as set forth in the Registration Statement, shareholders of
the Fund may under certain circumstances be held personally liable for obligations of the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">In rendering the foregoing
opinion, we have relied upon the opinion of Morgan, Lewis &amp; Bockius LLP expressed in their letter to us dated August 15, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">We hereby consent to the
use of this opinion as an exhibit to the Registration Statement of the Fund and we further consent to reference in the Registration Statement
of the Fund to the fact that this opinion concerning the legality of the issue has been rendered by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: justify">Very truly yours,</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="padding-bottom: 1pt; width: 50%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 25%">/s/ Stradley Ronon Stevens &amp; Young, LLP</TD>
               <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 25%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">Stradley Ronon Stevens &amp; Young, LLP</TD>
               <TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(2)
<SEQUENCE>5
<FILENAME>ex99-l2.htm
<DESCRIPTION>CONSENT OF MORGAN, LEWIS & BOCKIUS LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin: 0"><A HREF="jgh-n2a_052725.htm">Nuveen Global High Income Fund N-2A</A></P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.(l)(2)</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><IMG SRC="ex99l2_001.jpg" ALT="A black background with a black square&#10;&#10;AI-generated content may be incorrect." STYLE="height: 36px; width: 217px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nuveen&nbsp;Global High Income Fund</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">333 West Wacker Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chicago, Illinois 60606</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RE:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nuveen&nbsp;Global High Income Fund</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">We have acted as special Massachusetts counsel to
Nuveen&nbsp;Global High Income Fund, a Massachusetts business trust (the &ldquo;Fund&rdquo;), in connection with the Fund&rsquo;s&nbsp;
registration statement on Form&nbsp;N-2&nbsp;to be filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on
or about August 15, 2025 (the &ldquo;Registration Statement&rdquo;), with respect to an offering with a maximum aggregate dollar offering
price of up to $100,000,000 of the Fund&rsquo;s (i)&nbsp;common shares of beneficial interest, $.01 par value per share (the &ldquo;Common
Shares&rdquo;) including Common Shares to be issued upon exercise of any Subscription Rights (as defined below), (ii) subscription rights
to purchase Common Shares (&ldquo;Subscription Rights&rdquo;), which may be issued under one or more subscription rights certificates,
agreements or other instruments (each, a &ldquo;Rights Instrument&rdquo;), and (iii)&nbsp; preferred shares of beneficial interest, $.01
par value per share (the &ldquo;Preferred Shares,&rdquo; and collectively with the Common Shares, and the Subscription Rights, the &ldquo;Securities&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">In connection with the furnishing of this opinion,
we have examined the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a certificate
dated as of a recent date of the Secretary of the Commonwealth of Massachusetts as to the existence of the Fund;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a copy
of the Fund&rsquo;s Declaration of Trust, dated August 5, 2014, as filed with the office of the Secretary of the Commonwealth of Massachusetts
on August 6, 2014 (the &ldquo;Declaration&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a certificate
executed by the Secretary of the Fund, certifying as to the Declaration, the Fund&rsquo;s&nbsp;By-Laws,&nbsp;certain resolutions adopted
by the Fund&rsquo;s Board of Trustees at a meeting held on May 20-21, 2025 (the &ldquo;Prior Resolutions,&rdquo; and together with the
Declaration and the&nbsp;By-laws,&nbsp;the &ldquo;Existing Governing Instruments&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a printer&rsquo;s
proof of the Registration Statement received on August 8, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">In such examination, we have assumed the genuineness
of all signatures, including electronic signatures, the conformity to the originals of all of the documents reviewed by us as copies,
the authenticity and completeness of all original documents reviewed by us in original or copy form and the legal capacity and competence
of each individual executing any document. We have also assumed that the Registration Statement, when filed with the Commission, will
be in substantially the form of the printer&rsquo;s proof referenced in subparagraph (d)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">We understand that the Securities to be registered
under the Registration Statement will be offered on an immediate, delayed or continuous basis in reliance on Rule 415 under the Securities
Act of 1933 (the &ldquo;1933 Act&rdquo;). In this regard, we have presumed for the purposes of our opinions below that in connection with
any such offering of the Common Shares pursuant to the Registration Statement (a &ldquo;Common Offering&rdquo;), any offering of Preferred
Shares pursuant to the Registration Statement (a &ldquo;Preferred Offering&rdquo;) and any offering of Subscription Rights pursuant to
the Registration Statement (a &ldquo;Rights Offering&rdquo; and in each case, a &ldquo;Securities Offering&rdquo;), each of the applicable
following conditions (collectively, the &ldquo;Required Conditions&rdquo;) shall have occurred prior to the issuance of the Securities
referred to therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99l2_002.jpg" ALT="" STYLE="height: 82px; width: 381px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nuveen Global High Income Fund</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 2 of 4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(i) the Fund will file with the Commission a prospectus
supplement pursuant to Rule 424 under the 1933 Act relating to such Securities Offering (each, an &ldquo;Offering Supplement&rdquo;) and
that each such Offering Supplement will identify and describe (a)&nbsp;the number of Securities to be offered pursuant to such Securities
Offering, (b) the terms, rights and preferences of such Securities, including without limitation, with respect to any Preferred Offering,
any voting powers, redemption provisions, dividend provisions, rights upon termination, any exchange or conversion rights, limitations
on exercise or transfer or receipt of rights and any other relative, participating, optional or other special rights, qualifications,
limitations or restrictions thereof, (c)&nbsp;any agents or underwriters involved in the sale of the Securities pursuant to such Securities
Offering (the &ldquo;Distributors&rdquo;), (d) the applicable purchase price of the Securities offered in the Securities Offering or the
basis on which such amount may be calculated, (e)&nbsp;any applicable fee, commission or discount arrangement between any Distributor
named in the Offering Supplement and the Fund, or among such one or more Distributors, or the basis on which such amount may be calculated,
(f)&nbsp;any other material terms of any agreement by and between the Fund and any such Distributor relating to the conditions under which
the Securities will be issued and sold (in each case, a &ldquo;Distribution Agreement&rdquo;) and (g)&nbsp;any other specific terms of
the Securities Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(ii) if not taken in the Prior Resolutions, the Board
of Trustees or the Executive Committee of the Board of Trustees, acting pursuant to delegated authority (the &ldquo;Trustees&rdquo;) will
have taken, by resolution (the &ldquo;Subsequent Resolutions,&rdquo; such Subsequent Resolutions and the Prior Resolutions referred to
herein as the &ldquo;Resolutions&rdquo;), all appropriate action as contemplated by the Existing Governing Instruments and any statement
of preferences or similar instruments relating to the Fund&rsquo;s then outstanding preferred shares, if any, as in effect at the time
of the issuance of the Securities (a &ldquo;Subsequent Preferred Statement&rdquo;) in the exercise of their fiduciary duty (a)&nbsp;to
authorize the issuance of the number of Securities to be offered pursuant to such Securities Offering and the applicable purchase price
of such Securities, (b)&nbsp;to appoint the Distributors and authorize the entering into, by the Fund, of the Distribution Agreements,
(c)&nbsp;to authorize any applicable fee, commission or discount arrangement between the Distributors and the Fund, and (d)&nbsp;to authorize
any other actions, including the entering into of such other agreements as may be considered appropriate or necessary in connection with
such Securities Offering (the &ldquo;Offering Actions&rdquo;), and in each case as described in the Offering Supplement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(iii) without limiting the foregoing, with respect to
a Preferred Offering, (a) the Trustees will have taken all actions, by resolution, to authorize the terms and conditions, execution and
filing of the Fund&rsquo;s statement establishing and fixing the rights and preferences of the Preferred Shares and any applicable supplements
or appendices thereto with respect to such Preferred Shares (the &ldquo;Operative Preferred Statement&rdquo;) and the entering into of
agreements with any service providers or other agents with respect to such Preferred Shares consistent with such Operative Preferred Statement;
(b) such Operative Preferred Statement shall provide that the Preferred Shares covered by such Statement shall rank on a parity with shares
of each other series of the Fund&rsquo;s preferred shares, if any, as to the payment of dividends by the Fund and as to the distribution
of assets upon dissolution, liquidation or winding up of the affairs of the Fund; (c) that the issuance of such Preferred Shares will
not violate any restrictions or limitations on the amount of leverage that may be incurred and the asset coverage that must be maintained
by the Fund pursuant to any Subsequent Preferred Statement, and that any other requirements for the issuance of additional Preferred Shares
by the Fund set forth in such Subsequent Preferred Statements shall have been met; and (d) the Operative Preferred Statement will have
been duly executed and filed with the office of the Secretary of the Commonwealth of Massachusetts and the Clerk of the City of Boston;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(iv) that with respect to a Rights Offering, the Trustees
will have duly authorized and the Fund will have prepared and, if applicable, duly executed and delivered any subscription rights or similar
agreements or certificates (collectively, the &ldquo;Rights Instruments&rdquo;), and such Rights Instruments will have been authorized,
executed and delivered by the other parties thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(v) if applicable, the Fund will have duly entered into
such Distribution Agreements, and will have duly taken all of the other Offering Actions in accordance with the Existing Governing Instruments,
the Subsequent Preferred Statements (if any), the Operative Preferred Statement, the Rights Instruments, and the Resolutions (collectively,
the &ldquo;Governing Instruments&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(vi) that the Trustees, a majority of whom will have
been independent for the purposes of Massachusetts law at the time of taking such action, will have acted in a manner consistent with
their fiduciary duties as required under applicable Massachusetts law and that the activities of the Fund have been and will be conducted
in accordance with the Governing Instruments and applicable Massachusetts law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(vii) that no event has occurred that would cause a termination
of the Fund;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(viii) that the required consideration for the Securities
is paid in accordance with the terms, conditions, requirements and procedures set forth in the Governing Instruments and the Distribution
Agreements and that the Securities are otherwise issued in accordance with the terms, conditions, requirements, limitations and procedures
set forth in the Governing Instruments, the Distribution Agreements and Massachusetts law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nuveen Global High Income Fund</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 3 of 4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(ix) that, with respect to the Securities, (a)&nbsp;there
will be no changes in applicable law between the date of this opinion and any date of issuance or delivery of any Securities, and (b)&nbsp;at
the time of delivery of any Securities, all contemplated additional actions shall have been taken and the authorization of the issuance
of the Securities will not have been modified or rescinded; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(x) that the Fund&rsquo;s Governing Instruments will
be in full force and effect and the Existing Governing Instruments will not have been modified, supplemented or otherwise amended in any
manner that would affect the issuance of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">This opinion is based entirely on our review of the
documents listed above and such investigation of law as we have deemed necessary or appropriate. We have made no other review or investigation
of any kind whatsoever, and we have assumed, without independent inquiry, the accuracy of the information set forth in such documents.
We have further assumed that there are no other documents that are contrary to or inconsistent with the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">As to all matters of fact (including factual conclusions
and characterizations and descriptions of purpose, intention or other state of mind), we have relied entirely upon the certificate referred
to in subparagraph (c) above and the disclosures of the Fund in the Registration Statement, and have assumed, without independent inquiry,
the accuracy of those disclosures and that certificate. The opinion in paragraph (1) below as to the existence of the Fund relies entirely
upon and is limited by the certificate described in subparagraph (a) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This opinion is limited solely to the laws of the Commonwealth
of Massachusetts as applied by courts located in such Commonwealth, without regard to choice of law (except for tax, antitrust, commodities,
derivatives, insurance, energy, utilities, intellectual property, disclosure, environmental, national security, anti-money laundering,
foreign trade, foreign investment, national emergency, economic or public health emergency, anti-terrorism, securities, or blue sky laws
of any jurisdiction, as to which we express no opinion in this letter), and we express no opinion as to the laws of any other jurisdiction.
We have not conducted any special review of statutes, rules or regulations for purposes of this opinion, and our opinions are in any event
limited to such laws, rules and regulations as in our experience are normally applicable to the proposed Securities Offerings. No opinion
is given herein as to the choice of law or internal substantive rules of law which any tribunal may apply. In addition, to the extent
that the Fund&rsquo;s Governing Instruments refer to, incorporate or require compliance with the Investment Company Act of 1940, as amended,
or any other law or regulation applicable to the Fund, except for the internal substantive laws of the Commonwealth of Massachusetts,
as aforesaid, we have assumed compliance by the Fund with such Act and such other laws and regulations. Further, we express no opinion
with respect to, and we assume no responsibility for, any offering documentation relating to the Fund, including the Registration Statement
and any Offering Supplement, any Securities Offering or the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with our opinion below with respect to
the binding obligation under Massachusetts law of the Rights Instruments:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(a)&nbsp;We have assumed without any independent investigation
that (i) each party to the Rights Instruments other than the Fund, at all times relevant thereto, is validly existing and in good standing
under the laws of the jurisdiction in which it is organized, and is qualified to do business and in good standing under the laws of each
jurisdiction where such qualification is required generally or necessary in order for such party to enforce its rights under such Rights
Instruments, (ii) each party to the Rights Instruments other than the Fund at all times relevant thereto, had and has the full power,
authority and legal right under its certificate of incorporation, certificate of formation, partnership agreement, by-laws, limited liability
company agreement and other governing organizational documents, and the applicable corporate, limited liability company, partnership,
or other enterprise legislation and other applicable laws, as the case may be, to execute and deliver the various Rights Instruments,
and to perform its obligations under the Rights Instruments, (iii) each party to the Rights Instruments, other than the Fund, has duly
authorized, executed, and delivered each of the Rights Instruments to which it is a party, and (iv) the Rights Instruments are valid and
binding obligations of each party thereto other than the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(b)&nbsp;We have assumed without any independent investigation
that the Rights Instruments are valid and binding obligations of the Fund to the extent that laws other than those of the Commonwealth
of Massachusetts are relevant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(c)&nbsp;The enforcement of any obligations of the
Fund or any other person, whether under any of the Rights Instruments or otherwise, may be limited by bankruptcy, insolvency, reorganization,
moratorium, marshaling or other laws and rules of law affecting the enforcement generally of creditors&rsquo; rights and remedies (including
such as may deny giving effect to waivers of debtors&rsquo; or guarantors&rsquo; rights); and we express no opinion as to the status under
any fraudulent conveyance laws or fraudulent transfer laws of any of the obligations of the Fund or any other person, whether under any
of the Rights Instruments or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nuveen Global High Income Fund</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 4 of 4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(d)&nbsp;We express no opinion as to the availability
of any remedy of specific performance or equitable relief of any kind and no opinion as to the enforceability of any particular provision
of the Rights Instruments relating to remedies after default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(e)&nbsp;The enforcement of any rights may in all
cases be subject to an implied duty of good faith and fair dealing and to general principles of equity, including, without limitation,
concepts of materiality and reasonableness (regardless of whether such enforceability is considered in a proceeding at law or in equity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(f)&nbsp;We express no opinion as to the enforceability
of any particular provision of the Rights Instruments relating to or constituting (i) waivers of rights to object to jurisdiction or venue,
or consents to jurisdiction or venue, (ii) waivers of rights to (or methods of) service of process, or rights to trial by jury, or other
rights or benefits bestowed by operation of law, (iii) waivers of any applicable defenses, setoffs, recoupments, or counterclaims, (iv)
exculpation or exoneration clauses, indemnity clauses, and clauses relating to releases or waivers of unmatured claims or rights, (v)
submission to binding arbitration or mandatory negotiation, (vi) provisions that attempt to modify or waive, or have the effect of modifying
or waiving, any statute of limitations, or (vii) the imposition of a penalty or the payment of any premium, liquidated damages, or other
amount which may be held by any court to be a &quot;penalty&quot; or a &quot;forfeiture.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(g) We express no opinion concerning the determination
that a court of competent jurisdiction may make regarding whether the Trustees would be required to redeem or terminate, or take other
action with respect to the Subscription Rights at some future time based on the facts and circumstances existing at that time, and our
opinion addresses the Subscription Rights and the Rights Instruments in their entirety and it is not settled whether the invalidity of
any particular provision of a Rights Instrument or the Subscription Rights issued thereunder would result in invalidating such rights
in their entirety and our opinion is so qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 85.7pt">(h)&nbsp;To the extent applicable, we have assumed
without any independent investigation that each party to the Rights Instruments has agreed that such Instruments may be electronically
signed, and that any electronic signatures appearing on such Instruments are the same as handwritten signatures for the purposes of validity,
enforceability and admissibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">We understand that all of the foregoing assumptions,
qualifications and limitations are acceptable to you. Based upon and subject to the foregoing, please be advised that it is our opinion
that, assuming the Required Conditions have been met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Fund has been formed and is validly existing under the Fund&rsquo;s Declaration and the laws of the Commonwealth of Massachusetts as a
voluntary association with transferable shares of beneficial interest commonly referred to as a &ldquo;Massachusetts business trust.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 42.85pt">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Securities, when issued, sold and delivered in accordance with the terms, conditions, requirements and procedures set forth in the Governing
Instruments, and following the due adoption by the Trustees of the Resolutions, will be validly issued, fully paid and nonassessable,
except that, as set forth in the Registration Statement, shareholders of the Fund may under certain circumstances be held personally liable
for its obligations, and the Rights Instruments will constitute valid and binding obligations of the Fund under the laws of the Commonwealth
of Massachusetts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">This opinion is given as of the date hereof and we
assume no obligation to update this opinion to reflect any changes in law or any other facts or circumstances which may hereafter come
to our attention. We hereby consent to the reference to our name in the Registration Statement and in the prospectus forming a part thereof
under the heading &ldquo;Legal Matters&rdquo; and to the filing of this opinion as an exhibit to the Registration Statement. In rendering
this opinion and giving this consent, we do not concede that we are in the category of persons whose consent is required under Section&nbsp;7
of the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">/s/ Morgan, Lewis &amp; Bockius LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 30.6pt">MORGAN, LEWIS&nbsp;&amp; BOCKIUS LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(N)
<SEQUENCE>6
<FILENAME>ex99-n.htm
<DESCRIPTION>CONSENT OF PRICEWATERHOUSECOOPERS LLP
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin: 0"><A HREF="jgh-n2a_052725.htm">Nuveen Global High Income Fund N-2A</A></P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.(n)</B></P>

<p style="font: 10pt Georgia, Times, Serif; margin: 0; color: red"><b>&nbsp;</b></p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal"><u>CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</u></font></p>

<p style="font: bold 10pt/95% Georgia, Times, Serif; margin: 0; text-align: center; color: red">&nbsp;</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0">We hereby consent to the incorporation by reference in this Registration Statement
on Form N-2 of Nuveen Global High Income Fund of our report dated February 27, 2025, relating to the financial statements and financial
highlights which appears in Nuveen Global High Income Fund&rsquo;s Certified Shareholder Report on Form N-CSR for the year ended December
31, 2024. We also consent to the references to us under the headings &ldquo;Independent Registered Public Accounting Firm&quot; and &ldquo;Financial
Highlights&rdquo; in such Registration Statement.</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0">/s/ PricewaterhouseCoopers LLP</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0; text-align: left; color: red"><b>&nbsp;</b></p>

<p style="font: 10pt Georgia, Times, Serif; margin: 0">Chicago, Illinois</p>

<p style="font: 10pt Georgia, Times, Serif; margin: 0">August 15, 2025</p>

<p style="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Georgia, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%">&nbsp;</td><td style="width: 33%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0; color: red"><b>&nbsp;</b></p>

<p style="font: 10pt/95% Georgia, Times, Serif; margin: 0; color: red"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</p>
<p style="margin: 0">&#160;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>7
<FILENAME>ex99-s.htm
<DESCRIPTION>FILING FEE IXBRL
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:nghif="http://nuveen.com/20250813">
<head>
     <title>FEE EXHIBIT</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_028_FFD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_nghif_nuveen.com_20250813 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250813_20250813 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001615905 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000003" name="dei:EntityCentralIndexKey">0001615905</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-08-042025-08-04" id="xdx2ixbrl0009" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-08-042025-08-04" id="xdx2ixbrl0010" name="ffd:SubmissnTp">N-2/A</ix:nonNumeric>
  <ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2025-08-042025-08-04_1" id="xdx2ixbrl0015" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="From2025-08-042025-08-04_1" id="xdx2ixbrl0016" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2025-08-042025-08-04_2" id="xdx2ixbrl0027" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="From2025-08-042025-08-04_2" id="xdx2ixbrl0028" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-13</xbrli:startDate>
        <xbrli:endDate>2025-08-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-042025-08-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-04</xbrli:startDate>
        <xbrli:endDate>2025-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-042025-08-04_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-04</xbrli:startDate>
        <xbrli:endDate>2025-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-042025-08-04_2">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>2</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-04</xbrli:startDate>
        <xbrli:endDate>2025-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000044"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0; text-align: right"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0; text-align: left"></p>

<p style="margin: 0"><a href="jgh-n2a_052725.htm">Nuveen Global High Income Fund N-2A</a></p>

<p id="xdx_98D_effd--FeeExhibitTp_dxL_c20250804__20250804_zMsWCPx7vgUk" title="::XDX::EX-FILING%20FEES" style="margin: 0; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl0009">Exhibit 99.(s)</span></b></p>

<p style="margin: 0; text-align: right"><b>&#160;</b></p>

<p style="font: bold 10pt/24.5pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">Calculation
of Filing Fee Tables </p>

<p style="font: bold 10pt/24.5pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">Form
<span id="xdx_90D_effd--SubmissnTp_dxL_c20250804__20250804_zyrobTVDQif4" title="::XDX::N-2%2FA"><span id="xdx_905_effd--FormTp_c20250804__20250804_znKqPr2mfzjc"><span style="-sec-ix-hidden: xdx2ixbrl0010"><ix:nonNumeric contextRef="From2025-08-042025-08-04" id="Fact000011" name="ffd:FormTp">N-2</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">(Form Type)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529"><span id="xdx_905_edei--EntityRegistrantName_c20250804__20250804_zVsniFRP6iHg"><ix:nonNumeric contextRef="From2025-08-042025-08-04" id="Fact000012" name="dei:EntityRegistrantName">Nuveen Global High Income Fund</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">(Exact Name of Registrant as Specified
in its Charter)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #202529">Table 1: Newly Registered and
Carry Forward Securities</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<table cellspacing="0" cellpadding="0" id="xdx_30F_101_z3Ve1qdz1sBd" summary="xdx: Document - Offerings" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border: black 1pt solid; vertical-align: top; width: 7%">&#160;</td>
    <td id="xdx_484_effd--OfferingSctyTp_zhLWCvLNJFG6" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.55pt; padding-left: 8.55pt; text-align: center; text-indent: -5.95pt"><b>Security</b><b> Type</b></td>
    <td id="xdx_489_effd--OfferingSctyTitl_zrcZ38Ox8f39" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 14.8pt; padding-left: 17.2pt; text-align: center"><b>Security</b><b> Class Title</b></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.2pt; padding-left: 2.25pt; text-align: center; text-indent: 1.35pt"><b>Fee</b><b> Calculation</b><b> or Carry Forward Rule</b></td>
    <td id="xdx_48B_effd--AmtSctiesRegd_pid_z3910cpXPNjj" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.8pt; padding-left: 4.95pt; text-align: center; text-indent: 3.55pt"><b>Amount Registered</b></td>
    <td id="xdx_489_effd--MaxOfferingPricPerScty_pid_z2qCpiW38Hdf" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-top: 0.05pt; padding-right: 1.3pt; padding-left: 2.65pt; text-align: center; text-indent: 1.7pt"><b>Proposed Maximum Offering</b><b> Price Per Unit</b></td>
    <td id="xdx_48F_effd--MaxAggtOfferingPric_pid_zvDAioY0muL3" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 19%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.05pt 0 1.05pt; text-align: center; color: #202529"><b>Maximum
    Aggregate Offering</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.65pt; text-align: center; color: #202529"><b>Price</b></p></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 14.95pt; padding-left: 16.95pt; text-align: center; text-indent: 2.4pt"><b>Fee Rate</b></td>
    <td id="xdx_481_effd--FeeAmt_pid_zY7Lg4pfzZ28" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.35pt; padding-left: 2.75pt; text-align: center; text-indent: 1.7pt"><b>Amount of Registration Fee</b></td>
    <td id="xdx_48E_effd--CfwdFormTp_znIfGXPEQluh" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 5%; padding-top: 0.05pt; padding-right: 0.45pt; padding-left: 2.2pt; text-align: center; text-indent: 1.35pt"><b>Carry Forward</b><b> Form Type</b></td>
    <td id="xdx_48C_effd--CfwdPrrFileNb_zNJBcPjU8pBd" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 7%; padding-top: 0.05pt; padding-right: 7.1pt; padding-left: 8.95pt; text-align: center; text-indent: 1.35pt"><b>Carry Forward</b><b> File</b><b> Number</b></td>
    <td id="xdx_485_effd--CfwdPrrFctvDt_z795yxevkcv" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 5%; padding-top: 0.05pt; padding-right: 2.1pt; padding-left: 3.4pt; text-align: center; text-indent: 1.6pt"><b>Carry Forward Initial effective</b><b> date</b></td>
    <td id="xdx_488_effd--CfwdPrevslyPdFee_zpkscGtIrB5j" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-top: 0.65pt; padding-right: 7.9pt; padding-left: 7.15pt; text-align: center; text-indent: 1.7pt"><b>Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward</b></td></tr>
  <tr style="vertical-align: top">
    <td colspan="13" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 0.05pt; padding-left: 6.65pt; text-align: center"><b>Newly Registered Securities</b></td></tr>
  <tr id="xdx_41B_20250804__20250804__ffd--OfferingAxis__1_ztwUswjCuD1a" style="vertical-align: top">
    <td id="xdx_989_effd--PrevslyPdFlg_dbF_c20250804__20250804__ffd--OfferingAxis__1_zu0WvWW3tbA1" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 0.75pt"><ix:nonNumeric contextRef="From2025-08-042025-08-04_1" format="ixt:booleanfalse" id="Fact000023" name="ffd:PrevslyPdFlg">Fees to Be Paid</ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.1pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_1" id="Fact000013" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_1" id="Fact000014" name="ffd:OfferingSctyTitl">Common Shares, $0.01 par value per share, and Preferred Shares</ix:nonNumeric></td>
    <td id="xdx_986_effd--FeesOthrRuleFlg_dbT_c20250804__20250804__ffd--OfferingAxis__1_fKDEp_zlsysaClIomd" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_1" format="ixt:booleantrue" id="Fact000024" name="ffd:FeesOthrRuleFlg">457(o)<sup id="xdx_F23_zMfJAyuVRpkl">(1)</sup></ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.15pt; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl0015">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl0016">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 0.05pt; padding-left: 1.05pt; text-align: center">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-08-042025-08-04_1" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">98,987,589.81</ix:nonFraction><sup id="xdx_F28_zlaz0P0M6uhc">(1)</sup></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.5pt; text-align: center">0.0001531</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">$<ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-08-042025-08-04_1" id="Fact000018" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">15,155.00</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 0.75pt; padding-right: 4.4pt; padding-left: 13.6pt; line-height: 88%; text-indent: 1.1pt">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.1pt; text-align: center">Other</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; text-align: center">Rights to purchase Common Shares<sup>(2)</sup></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.15pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 0.05pt; padding-left: 1.05pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.5pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td></tr>
  <tr id="xdx_41A_20250804__20250804__ffd--OfferingAxis__2_zVgbwnnURsmc" style="vertical-align: top">
    <td id="xdx_98B_effd--PrevslyPdFlg_dbT_c20250804__20250804__ffd--OfferingAxis__2_z99zH0uHlGvk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 0.75pt"><ix:nonNumeric contextRef="From2025-08-042025-08-04_2" format="ixt:booleantrue" id="Fact000035" name="ffd:PrevslyPdFlg">Fees Previously Paid</ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.1pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_2" id="Fact000025" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_2" id="Fact000026" name="ffd:OfferingSctyTitl">Common Shares, $0.01 par value per share, and Preferred Shares</ix:nonNumeric></td>
    <td id="xdx_98E_effd--FeesOthrRuleFlg_dbT_c20250804__20250804__ffd--OfferingAxis__2_fKDMp_zO1yXLlyavza" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; text-align: center"><ix:nonNumeric contextRef="From2025-08-042025-08-04_2" format="ixt:booleantrue" id="Fact000036" name="ffd:FeesOthrRuleFlg">457(o)<sup id="xdx_F21_zai8CfyzF7Da">(3)</sup></ix:nonNumeric></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.15pt; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl0027">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl0028">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.05pt; text-align: center">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-08-042025-08-04_2" id="Fact000029" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">1,012,410.19</ix:nonFraction><sup id="xdx_F23_z37ZX1e1gKHj">(3)</sup></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.5pt; text-align: center">0.0001531</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">$<ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-08-042025-08-04_2" id="Fact000030" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">155.00</ix:nonFraction><sup id="xdx_F21_zEJq7C9W2Rml">(3)</sup></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 0.75pt; padding-right: 0.8pt; padding-left: 8.25pt; text-align: center; line-height: 88%; text-indent: -0.05pt">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.1pt; text-align: center">Other</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; text-align: center">Rights to purchase Common Shares<sup>(2)</sup></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.15pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.05pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.5pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="13" style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 6.65pt; text-align: center"><b>Carry Forward Securities</b></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 0.75pt">Carry Forward Securities</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.1pt">Equity</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.9pt; text-align: center">Common Shares, $0.01 par value per share</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.15pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.05pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.5pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.8pt; text-align: center">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.25pt; text-align: center; line-height: 8.7pt">&#8212;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.5pt; text-align: center">&#8212;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 44.15pt"><b>Total Offering Amounts</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td id="xdx_986_effd--TtlOfferingAmt_pip0_c20250804__20250804_zhz0e61MDUKf" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.05pt; text-align: center">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="From2025-08-042025-08-04" id="Fact000037" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USD">100,000,000.00</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td id="xdx_98D_effd--TtlFeeAmt_pid_c20250804__20250804_zXkaM52Acine" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="From2025-08-042025-08-04" id="Fact000038" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">15,310.00</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 39.95pt"><b>Total Fees Previously</b><b> Paid</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td id="xdx_988_effd--TtlPrevslyPdAmt_c20250804__20250804_zBPQlHg8Hvrf" style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">$<ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="From2025-08-042025-08-04" id="Fact000039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155.00</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 56.05pt"><b>Total Fee Offsets</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td id="xdx_985_effd--TtlOffsetAmt_d0_c20250804__20250804_z0pLFAiDG5H" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="From2025-08-042025-08-04" id="Fact000040" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td colspan="4" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3.3pt; text-align: center"><b>Net Fee Due</b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td id="xdx_987_effd--NetFeeAmt_pid_c20250804__20250804_zHbmXIb0xxld" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="From2025-08-042025-08-04" id="Fact000041" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">15,155.00</ix:nonFraction></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">&#160;</td></tr>
  </table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F00_zvSb6BwYXJ22" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/><td id="xdx_F1E_zk4bBIUw3by1" style="text-align: justify"><ix:footnote id="Footnote000042" xml:lang="en-US"><span id="xdx_90C_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__1_zmrVZlcK5fq5"><ix:nonNumeric contextRef="From2025-08-042025-08-04_1" escape="true" id="Fact000043" name="ffd:OfferingNote">Estimated pursuant to Rule 457(o) under the Securities Act of 1933 (&#8220;Securities Act&#8221;) solely
for purposes of determining the registration fee. The proposed maximum offering price per security will be determined from time to time
by the Registrant in connection with the sale by the Registrant of the securities registered under this Registration Statement. </ix:nonNumeric></span></ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/><td style="text-align: justify">No separate consideration will be received by the Registrant. Any shares
issued pursuant to an offering of rights to purchase Common Shares, including any shares issued pursuant to an over-subscription privilege
or a secondary over-subscription privilege, will be shares registered under this Registration Statement. </td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_zjEcbdg1hFmb" style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"/><td id="xdx_F1C_zhp1l12ZH7o6" style="text-align: justify"><ix:footnote id="Footnote000044" xml:lang="en-US"><span id="xdx_90F_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__2_zl7tPczkyXac"><ix:nonNumeric contextRef="From2025-08-042025-08-04_2" escape="true" id="Fact000045" name="ffd:OfferingNote">The Registrant previously paid $155.00 in filing fees in reliance on Rule 457(o) under the Securities
Act in connection with the initial filing of this Registration Statement on May 27, 2025. The proposed maximum offering price per security
will be determined from time to time by the Registrant in connection with the sale by the Registrant of the securities registered under
this Registration Statement. </ix:nonNumeric></span></ix:footnote></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; visibility: hidden"><span id="xdx_90B_effd--OffsetTableNa_c20250804__20250804_zPzYvETMQVX1"><span id="xdx_901_effd--CombinedProspectusTableNa_c20250804__20250804_zs8I8fMBkx93"><ix:nonNumeric contextRef="From2025-08-042025-08-04" id="Fact000046" name="ffd:OffsetTableNa"><ix:nonNumeric contextRef="From2025-08-042025-08-04" id="Fact000047" name="ffd:CombinedProspectusTableNa">N/A</ix:nonNumeric></ix:nonNumeric></span></span><span id="xdx_901_effd--RegnFileNb_c20250804__20250804_zrZt90yvNWjc"><ix:nonNumeric contextRef="From2025-08-042025-08-04" id="Fact000048" name="ffd:RegnFileNb">333-287584</ix:nonNumeric></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>

    <!-- Field: /Page -->




<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbObP+guHTrEKTJEvC0uk+LWjLT+PZJvad0QQyAk53w5QgxERitdI8NpUeRwwKatlUMosEJGc0bvSNebBPws8KKtY2Vct/7AlDyDnpmGkfL3znnXFssE5Gwox8N4AnKUxHPYb0Xw1VMylS7ROK1qUKaEPVPLGp3iV//hoJ5kqHl1SUdkq8kkEIWyl98QyyiGHd3Vg/hqIc9TEQy6CkTGdGu9a/l0aL4kLGtsfJzt6X8HH85ASmE= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>jgh-20250815.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaSGCbP9w5dzSelBtm9zHfnqLyYtWg8a5i62B352QbkB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:jgh="http://nuveen.com/20250815" elementFormDefault="qualified" targetNamespace="http://nuveen.com/20250815">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20250815_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20250815_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20250815_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="jgh_BorrowingsOutstandingMember" name="BorrowingsOutstandingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>jgh-20250815_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#AddressTypeOnly" roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:loc xlink:type="locator" xlink:href="jgh-20250815.xsd#jgh_BorrowingsOutstandingMember" xlink:label="loc_jghBorrowingsOutstandingMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_jghBorrowingsOutstandingMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>jgh-20250815_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="jgh-20250815.xsd#jgh_BorrowingsOutstandingMember" xlink:label="jgh_BorrowingsOutstandingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jgh_BorrowingsOutstandingMember" xlink:to="jgh_BorrowingsOutstandingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jgh_BorrowingsOutstandingMember_lbl" xml:lang="en-US">Borrowings Outstanding [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jgh_BorrowingsOutstandingMember" xlink:to="jgh_BorrowingsOutstandingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jgh_BorrowingsOutstandingMember_doc" xml:lang="en-US">Borrowings Outstanding [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>jgh-20250815_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2Cover" roleURI="http://xbrl.sec.gov/cef/role/N2Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" order="100" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:loc xlink:type="locator" xlink:href="jgh-20250815.xsd#jgh_BorrowingsOutstandingMember" xlink:label="loc_jghBorrowingsOutstandingMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_jghBorrowingsOutstandingMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>nuveenlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nuveenlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ ,\# 2(  A$! Q$!_\0
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M@4"/N&BOD[]CG]M6[_:B\7:_I4VD0Z=#IMF+I&CA*,W[Q5P297_O>@K,^/\
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M'U&UOQK]S_A+\;M)^(_P/T_XA;TAM&L#=7:!O]2R)N=#[BO@S_@K'\"_[/\
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M5^J= ;,_.W_@D?J'B'3;#X@^'=6M;JWT^)[.ZM%G0J%=O/$F,^H6/\J^6O\
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M.@_%[PQJ&G645G/?Z61<>2@17*2-AB!W^8\^PKZL_P""6W_)K=C_ -A"Z_\
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M'([=^?>NYM;.WL8_+MH([>/KLB0*/R%10Z38V]TUS%9V\5PWWIDB4.?J<9I
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6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>jghcover001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 jghcover001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  > .4# 2(  A$! Q$!_\0
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M?H/_  4'_:)_9F\::9H'Q[\*MKNF.0635]/2"]\K(#/!,@"28ZX(;/&2,YH
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M!P5P >V* .'_ .":O_)B/[1O_7.__P#3;70?\$/?^1<^*O\ U]V/_H$M<_\
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?!\3S>/?$LD?AS5W1M3N2&6QE((\UO]FBOZ:J* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex99l1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99l1001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  > .4# 2(  A$! Q$!_\0
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M?H/_  4'_:)_9F\::9H'Q[\*MKNF.0635]/2"]\K(#/!,@"28ZX(;/&2,YH
M^XOVS_VZO#_[,OPOL[S3VBU+QOK]H)M&TF0\QJZ@BXF'4(N>G\1&!W(H?L:_
MMP>!OBK\/_A[X9U_Q_;:M\5]4M2MY8-;NDLEP-[LORQB,81<\'&!7RY_P5D^
M&/P\U'X2>%?C-X<T]W\0>*M1M5?57NYG\VU:U=D01,Y1 -J\*HQ@U[I_P3S_
M &0OA/;?!SX4_%J+PMM\?&Q:[.J_;K@_O6,D;-Y7F>7]PD8VX_&@#Z(C_:\^
M#CQ>+9&^(&DP+X4G^S:S]H=HC:R;V3;AE!<[D8?)GD5M_##]H;X=_&/PEJOB
M?PEXHL]3\/Z7,UO>ZBVZ"*!U17;<9 N %93GIS7XO?##]G[3?VFO^"A'C;P/
MK6H76GZ)+K^L7MXUF0)9(XIY#L4D$ DD#)!QSQ7KW_!1OP5HO['/PB\,?!CX
M:S:G9>'O%FH7&O:R;NZ\V2X,20Q1Q;@!\A(W%?5%H ^Y-3_X*9_LZZ7XB_LA
M_'T<[!]C7EO9S26RGO\ O O(]QD5Z1I'[6?PA\0>.-#\'Z5X\TK4_$6MPI<:
M?9V;--YZ,C."'52H.U&."01CD5\I?!'_ ())?""Z^#&C2>,%U36/%.JV$5U/
MJ=M?-"ML\B!@L*#Y<+D#+ALX_"OC;]F?X2R? G_@J'X;\!27@U :'KES;QW6
M,&6,V<KQL1V)5ER/7- '[.?%?XU>!_@=X>&M^.?$EEX=T]VV1M=/\\S?W409
M9S] <=Z^0/VA/V_O@=\9OV<?BKX:\.^,H_[;NO#UY%:VE];26YN7\LX6,L,$
MGL,Y-?(?Q5T75_V\O^"DVJ^ M7UB>PT#3-2NM+A5#G[-9V>[S?*4\;Y"C-D]
MV&<X KZ'_:R_X)6_"KPG\!/$?B3P$NI:+XA\.Z?)?AKF]:XCO4B7<Z2!ONL5
M!P5P >V* .'_ .":O_)B/[1O_7.__P#3;70?\$/?^1<^*O\ U]V/_H$M<_\
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?!\3S>/?$LD?AS5W1M3N2&6QE((\UO]FBOZ:J* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex99l2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99l2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D -D# 2(  A$! Q$!_\0
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MC#XIZ?X.\466A76G75Q-=HCK)$RA5W.5&<G/:N]KYO\ CA_R5_P__P!<+?\
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MYW8%?5=<]X?\"^&?"TS3:-H]O:S,-IE&7?'IN8D@5T- !1110 4444 %%%%
M!1110!SNN> _"WB.X^T:MHEI<S]Y=I1S]64@G\:N:'X8T/PU T.C:9;62O\
M?,2?,WU;J?Q-%% &M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex99l2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99l2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !1 7T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#],_&OQ"\*
M_#72HM3\7^)M'\*Z;+,+:.\UN_BLX7E*LPC#R,H+%4<[<YPI/8U%XH^)GA#P
M0=*_X2+Q7HF@?VM)Y6G_ -J:C#;?;'X^6'>P\P_,O"Y^\/6OD3_@K5HUMXC^
M"WPQTF]#-9W_ ,1M+M9@C;6*/;7BM@]C@GFOD#X\>$OB:8/AA<?$NRO[%/A_
MXSTOX?Z!-=0R1+JT$<EQ)+J*[U&\2QPV*!P6#>2QSDF@#]GZ*_+OXE_%SQW-
M\.OVG?B3J'CWQ'X9\=^ ?&\&E^'-(M-9EM[.SM$NHUA5[$,(+D31NY+2QOY@
MCR.,BNU\,W?Q!^+O[9'QFL;[QSXY\.Q>&-%T#Q!:>$=#U=H;1KW^S[:5[1XV
M5R(GE9@Z1E"^X[B3C !^A]%?DMX<^)?C/5?@_P#LS?$JX^)7B^Z\7>.OB8+7
M7D3Q)>)9M;"_>/[*MDDH@CBVHAV+&.'Q]T@5N?$G]H?7;F_T_P"(/PYOO%>B
MZ/:_%L>&I]0U[QU>W3ZFTA>:XM?[%96M8;5!*$C*N'5(X_EW$D 'ZFT5^3_Q
M:^('CB#PQ^V/XLM_B)XSM-4\"^+M.A\.Q6OB*[BMK!)=06*1! L@1T*';L<,
MHQPH).?T2^&_QW\->,]>L_!8U4W7CN#0;/6M3L8;*?R[>.:-&5FFV>4I8OD)
MOW$<@8!H [*?QSX;M?%]MX4F\0:5#XIN;8WD&B27L:WLL + RK 6WLF4<;@,
M?*>>#6Y7Q'X[_P"4NWPZ_P"R;R_^E%_57X[^)/B1\1_VS[_X4:7J$VEZ3#X*
M;4=$M(_%][X9%S<R2!)+P3V<$LER\1R%@?" 1NV#\V0#[FJO?WT&EV-S>7+^
M5;6\;32O@G:B@DG Y/ /2OR\^*OQ2^,7[-5]X1N/%'Q'F\8:WXK\":UX4B;0
M-4FN-,.OV]TT5O/$I"*MRJM;QN^U6\Q)03R<V_@WX\^)_B7XP^'_ (4ZSXZ\
M376H_".Q\4R^)]0BU&YC_MHB3;827#;\RKB2)D#Y( /?=0!^B'PG^+?A/XX>
M"+/Q?X)U7^VO#MX\D<%Y]FEM][1N4<;)45QAE(Y';BNPK\I/AAXQ^.7C;]FK
MX,^+=/UC6OB1HFDQ:WJ/BOP_!X[DT/6;R-;FZC@N)KXR"<V\83 16Y:,#!&"
MOV=\'?BMHWB?]AT>/[2Q\5:EH[>'M3U!].UG4&O=6D$9N#);K<M\TO*,D4C?
M,R",GDF@#USPO\9OA_XW\0W6@>'/'/AK7]=M5=[C2]+U>WN;F%48*Y>)'+*%
M8A22."0#UKH=?\0:7X4T:[U?6]2L]'TFS0RW-_?SI!! @ZL\CD*H]R:_$?P9
MXZ\1_LX^$O@_\3+;1-,U:%;&_MOAI>37\;V=E-<7TRWUKK+ P%Y$BN)=LJM&
MBG&5(W>5^HO[=+RR?L6?%)YVB:9M <NT!)C+97)7/;/2@#T[P5\;_AU\2M5E
MTSPAX^\+^*M2BA-S)9Z)K-M>3)$&53(4C=B%#.@W8QE@.XKM:_*7P%)KGPV^
M*W[''B_4A9>-=2U?X?S:3X?TC1;1[";3PEFIC>Z)EF-T"MS*I(\E<J7"J5(.
MAX!^,/Q M/A-^SQ\48O'7B+7/B1XU^(<VBZ_H=UJ\LEE/:-=3Q26XTXL88-B
M1PD-'&A3S<YY7 !^I5<5\(OC+X/^/'@R'Q9X&UC^W- EFDMTN_LTUOET.'&R
M5$;@]\8KY4_9#N[[X]>'O%/Q!^)/C[Q3HWC'3_'OV%M+M/$UQI]CI9@N;=8-
M--DCK;NLIVPL)(V>7S2 V]MU?(?_  3[\=:]>>(_@QX"\4Z]KO@7X;W5QJMU
MHSZ+J$MHGB;55E7=;7,T4B,L: H!$?O,0#D2K@ _67X3?&KP9\<=&U75?!&L
M_P!MV&EZE+I%W-]EFM_*NHU1GCQ*B$X$B'< 5.>"<&NWK\DO#OQJ^(TOP:\$
M:G-X\\4/++\?O[%N;Q]8N2SV)CC(M'<OS#]X^43MZ\=:]!\4^+OC%\0_B;^U
M9X4^'/CRZ.JVOB+0++2-*FU_[,[0F"]>[L]-ED?9;3N("Q*;2!"Y/*Y !^EE
M%?+G[#GQ-C\?K\2=/N-"\6>%M?\ #NLKIFJZ)XC\6S>)8+2=%92MM>3,S')4
M[TR5!QCK7&_!#Q_XHU;X4_MAW=]XDU>\N]"\9^*K729[B^EDDT^&&#,,=NQ;
M,2(>55,!>V* /M6BOSY^*/Q)\7VW_!-'X4>([?Q-XB_X2/4)=#2[U.QU6:'4
M;L22@2*;@2*Y+C@DN,YY(ZU]'?LM>#O'_A67Q_-XM?7++PWJ.L+<>&M"\3ZU
M_:^IZ=;")5D$MSYT^5=QN5/.DVC/(+&@#WBBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Q?%7@GP[XZM;.V\2:!I?B&WL[I+
MZVAU6SCN4@N$!"3('4A9%#, PY&XX/--\5>!O#?CJ"RA\2^']*\0PV-RMY:Q
MZK91W*V\Z@A98Q(IVN 3AA@C)YK<HH Y'5_@_P" _$'B^U\5ZIX)\.ZEXIM&
MC>WUR[TF"6]A:,YC*3LA=2IY4@\=JU+#P3X=TKQ/J?B2RT#2[/Q%JB1QW^KP
M6<:7=VJ*%199@N]PJJH 8G   Z5M44 ?)]G^PE!JWQ0\'>,/%FK>$[J?PWJI
MUTR^%O!,.B7^KWX</%/?W2SR>;M;<Y5$C#,Q)["O<;W]GSX6ZEKUQKEW\-?"
M%UK5Q<"[FU*?0;5[F6<-N$K2&/<7W<[B<YYS7?T4 <?>?!WP#J%GX@M+KP/X
M<N;7Q%,ESK,$VDV[IJ<J/O22Y4IB9E;Y@SY(/(YJE\.?@KX<^&'BCQKXATE9
MY-6\6WD%U?3W'E_NXX($@MK:((BA88D4[%.2-[?,<C'>T4 <5XU^"'PZ^)6J
MQ:GXO\ ^%_%6I10BVCO-;T:VO)DB#,PC#R(Q"AG<[<XRQ/<U%J7P&^&>L^&M
M+\.W_P ._"E]X?TIG;3])N=$MI+2S+DES%$4*QEB23M R2<UW5% ''?\*:\
M?V/H6D_\(-X;_LK09_M6DV/]D6_D:=-N+^9;ILVQ/N);<@!R<]:T+/X>>%=/
MU[6-<M?#.CVVM:S&(M3U*&PB2YOD P%GD"[I   ,,3Q70T4 >;WO[-7PBU+3
M]/L+OX5^";JQTY'CLK:;P[9O%:J[EW6-3'A SLS$+C)))Y->@V5E;Z;9P6EI
M!%:VEO&L4,$"!(XT48554<     =,5/10!YS'^S;\)(6U)H_A;X+1M3C,5\5
M\/6@-VAD60K+^[^<&1$?#9^95/4"NE7X>>%4\&?\(@OAG1U\)^2;?^P181"Q
M\HG)C\C;LVYYQC%=#10!Q'@OX&_#CX;ZL^J>$OA_X6\+:F\)MWO=%T6VLYFB
M)!*%XT4E254D9QE1Z59TSX0> ]%\8W'BW3_!/AVP\5W+2/-KMMI,$=]*S_?+
M3J@<EN^3SWKKJ* .*U/X(?#K6O&2>+]0\ ^%[_Q8DT-RNO7.C6TE\LL0412"
M=D+AD"(%;.5VKC&!40^!'PT&@:?H8^'GA0:)IUT;ZRTW^Q+;[-;7!ZS1Q[-J
M.?[R@'WKNJ* .,?X*_#R3PO>^&F\!^&6\.7MT;ZZT@Z/;FTN+@D$S/#LV-)E
M5^<@GY1SQ6:W[.'PE;3;G3C\+O!AT^Z>"2>T/A^T\J5H$9(&=/+PQC21U0D?
M*'8# )KT6B@#&\)>"_#W@#18]'\,:%IGAS2(F9X]/TBSCM;=&8Y8B.,!02>2
M<<URTW[.WPIN-?N]=E^&7@Z76[N66>XU)] M#<S22[O-=Y/+W,S[VW$G+;CG
M.37H5% 'F^G?LT_"'1UE6P^%7@FR64H9!;>';.,.48.A.(QG:P##T(!'(KTB
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* .;\>?$/0/AIHL>J>(;U[6WFN([.WBM[:6ZN;J=SA(8((5>6:0X)V1JQPK-
MC"DA_@;Q[H?Q'T/^UM NWNK19Y+65)[:6VGMYHVVR1302JLD4BGJCJK#(.,$
M5QGQL\-Z_/KGP^\7^'M%/B>X\)ZO+=W&B1310W-S!/9SVKM;O,Z1"5//#XD=
M R"1=P)&?);SX Z[\1-9CUSQ1X1B33?$7Q%B\1:EX7U":WG^Q:=#HDFGI]I"
M2-%*TCQQ.\<;2+B;:=P#&@#ZNKF/B%\2- ^%NAPZMXBN+J"TGNXK&%;'3[B^
MGFGE;;'&D-O&\CLQX "FOC+Q;^R_X\U;X?\ PYTC6=!\0ZMHVB:!?:6-$\+W
M6A_;--NS<9MIXY-15HHP+<*BSV\BSPE5V_>;'TI^T#\,]3^)O@WP;HUK!>W
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M>HZ==6MO/#<P7DZNLLDSI]F4RP(Z2;.6 45]/4 %%%% !1110 4444 %%%%
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MOQ:QXJT>/5]$TR;5[K0UU&W&H?9XXRY80,ZMR ,$X!)'/-1Z+^T%\-M<\/\
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M=<GD\8^*K\W,A190L0G>WNY9-QG<[G?Y BJJD$;0#I_$'QLG\,>/M%\,ZAX
M\416^M:F-*T_7$ETQ[2XE\IY2PC6\-SL6.*1F)AR C$C S5'3/VD-&6X\01^
M*/#OB'P FCZ+_P )"\GB*" BXT\,ZO-&+::9@RE1F*0)+^\0!"<@;MMX&U74
M?C-=>+M:EM)-+TS3AIWAVTMY'9XC,0][<3!E"B1C'#&FW=M2-SN_?,J^-O\
M CXC_$?PC\2],^(6F^$HM>\7:3)9CQ!I^MW-^D.QMUI9K:/8P".T0L[-^]=V
M9F)W;\H ?0/@;Q3>>,=!34KWPQK'A*1W(2PUW[-]I*8!#D032JH.?NLP<$'<
MHKH:\C_9X^$E]\*K'Q2UWI>@^&(=;U-+ZW\+^%9&?2]*5;6"!EA)AAR9'A:9
ML1(-TA&&(+MZY0 4444 %%%% !1110 4444 %?%'_!0;]K;5/@?K?A+P9I-]
M?Z%#J\9OM7UK2H8Y;Z"T#E ELLN$\QBK9+= !@C.:^UZ^<?VQ_V-=)_:MT'3
MG&I'0?%&E!ULM1,?F1O&V"T4JY!*Y ((.5.>#DB@:/E+5/VH-7_99^*'@NPB
M^(?C;XB6&MV]CJ>J6'B]()(DL;I-R&"56,BSIGE?N'IS7Z2>(O%>E>%%TYM5
MNOLHU"]BTZV/EN_F7$IQ&GR@XR1U. .Y%?%7@;_@G=XA\0_%3P[XR^+_ (IT
MC6XO#UI9V5GI6@VTB1W$=JH6 3.X' P"P .[ID"OH?X[?L\6WQ@U/PWJ":EK
M-G=6&K65S<I;^)]3L(#;1.S/Y<-O,L:S_-Q(%5_]L8% ,['QO\6-&\ ^)_!^
M@ZE;ZG+?>*;\Z=8R6MA));)((WD/FSX$<?RQMA2V]N2JL%8K=^(?Q L/AOH"
M:E>VUYJ,UQ<Q6-EINFQ"2ZO;J5ML<,09E7<Q_B=E10&9V55+#SGXO?#+QC?-
M\+[;P-8Z3J=AX2UI-7G?Q3XDO4N91';SP+%YIMKEY21<,QDD?/R 8;=E8/C=
M\'_%'QCTN>UU?2?!GB&QT7Q-9ZQH&BZMYWV74+5+?RIH=0+12A7+37)1DC=1
MMARI.Z@1V/BOXU:;X%T[P?/XAT+7M,O?$^I6NE6]@+);EK2XGE2)5N9H'>WB
M ,@))E.[!";R,54\9_&RX\#>+]+T:_\ A[XIFT[4]5M=(M=?M9=,>SDEG( 8
M1F\%SL3+ESY&56*1L%1D^:ZK\"/'^C?!+X<^#_#EOX:U&_T'Q!;:_=1ZCJ]Q
M9VMJD-_]LCL;5DM)2\2 _9T9DCVI$C;.=B^K/X'UGQ!\7=.\3ZZUBNBZ%IIC
MT>PMI7E<7\^5NKF0LB@;8@L46,G;+.3C<  "3XM_%A_A-H[:HW@_Q!XHL8+2
MYO[V?1/L:)8V\"JTCRO=7$"]&R%4LQVN0,*:J>*?C_X5\+:UX,TIOM^I7WBJ
M:V2UCLK8_P"BQ7&1#/<[RODH[*553^\8K)M1A%*4YCXD^$/BCX[\"-HE[H'P
M^UV[N9K[][=7UW:III$Q_LV\@/V>9FN(XRK/@Q$2J#'(HP1C^./V1['Q#J/A
M#6;75]7F\1V6M:3J.N:A/XCU*VCU%;2!86E%M%,81.RQQ_,$4_>RW)R >I^'
M?BWHOBCXF^*/ UG;:I'J_AVSM+R\FO+"2WMW6X>=$$+2!3+C[.Y+H#'R '9@
MX7'^+?QLN/A%%+>77P^\4:_HD2P^9J^CRZ9Y*R22")(A'/>13/(79 %2-MQ=
M0N2<5AZ5X(^(6G_M$>-?&0T[PRGA_5]!LM(LI#K%P]VCVCW<L<DD'V14P[7>
MUE68E1'D%BV!K3^!O&'C76/AO/XQET1;+0;5=5UBUTEYC'=ZXL:I'Y2R+D6L
M3-/(N]BY<0$A3'E@!^I?'*70OB'I'A;5O /B?2X-6OI[*RUZ:73)+*410R3-
M,5CO&N$BV1$[WA7!9 P4L!6-H'[5WA;7/"FN:])H^OZ5!I^F6>M6MK?V\*SZ
MK97C.EE-;*DK#]_)&R*DIC=6*^8L88$]#'\-+_Q!\2_$WB3Q-):R6;:;_8.@
M6UG(S-:V<@5[N9RR#;--*(U(7<H2UAYR6%>,:+^RIXPN? NIZ=KUWH$>L:?X
M8T'PUH36%S/)!<C2;E[J*XN2T2M#YTGE*T:"7RU5B'E)P #Z$^''Q#M?B/HM
MU>PZ=?Z+>V-[-IU_I.J"+[397$9&8Y##))&<JR."CL"KJ<]0.KKSOX+>!-7\
M&:=XFOO$"6$&O>)=<GUN]M-+N9+FVMF9(H4CCEDCC:3$<$9+&-/F+8& "?1*
M "BBB@ HHHH **** .7\4_$+3O"7BGP;H-Y#=27GBJ_GT^R>!%,<<D5I/=,9
M26!"F.W<#:&.XJ, 9(P8OV@O EO8:Y?:YX@L/"5EI&KW&BS7/B*]@LHY)X2@
M<QL\F"N9$ )P>>0,BH/C+X!U_P 3:IX$\2>%ETVZU[PCK$FI0Z=K%U):VM['
M+97-G)&TT<4K1,%N=ZL(W!,>TCYMR\!HG[.7B$ZGHNM:P^AMJG]LZ_KE_;P2
M2RQ6TFH6SP1102/&#)L1@K2%8]P+D(,[: .S^)7[3G@?X3RHWB'48+:PDFTF
M)-0&H60B(U">2**0JTXD6)!%)*\C(%\M'9#(4<+V5K\4?!E]XCT_P_;>+M"N
M->U&T74++2HM2A:ZNK9E++/'$&W/&54D.H((!.>*^:+3]DGQUIGAS1/)U#0+
MO6M&\.>!;*".:[G2"YOM"O9+FX5Y! S)%*&"I($9LY+(,<]!:_LU^)C\:M0\
M6:C;6&HV.KZQ;^('N?\ A,=6ADT>Y%C':R)#8)&+6[*K%B.XD\I@KX9"$4$
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M0LB@;8@L46,G;+.3C<  "3XM_%A_A-H[:HW@_P 0>*+&"TN;^]GT3[&B6-O
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L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 15, 2025</div></th>
<th class="th"><div>Aug. 08, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001615905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Amendment No.
1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333-287584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">811-22988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreEffectiveAmendmentNumber', window );">Pre-Effective Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nuveen Global High
Income Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333
West Wacker Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Chicago<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">60606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">257-8787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">From
time to time after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_806_ecef--ShareholderTransactionExpensesTableTextBlock_gL1STETTB-KEUBN_zfr3YikU5WP9" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr>
    <td style="vertical-align: top; font-size: 8pt; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Sales Charge (<span id="xdx_908_ecef--BasisOfTransactionFeesNoteTextBlock_c20250815__20250815_zUmr8miBFnN4">as a percentage of offering price</span>)</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecef--SalesLoadPercent_dp_c20250815__20250815_fKg_____zHFbg2t210La" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%<sup>*</sup></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan Fees <sup>(1)</sup></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecef--DividendReinvestmentAndCashPurchaseFees_pid_c20250815__20250815_fKDEp_zoBMXZWwQQv5" style="vertical-align: bottom; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 8pt"><span id="xdx_F01_zEew5cxfgfga" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 8pt"><span id="xdx_F14_ztv84zaBcaUg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; visibility: hidden; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F07_zv5AhwnVBhBk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span id="xdx_F1E_zBU8j1Hux776" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</span></td>
</tr></table>


<div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</span></td>
</tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_808_ecef--AnnualExpensesTableTextBlock_gL1AETTB-TRF_zd9gQnXIjXKl" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; font-weight: bold; text-align: right; padding-bottom: 1pt; padding-left: 10pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Shares<sup>(2)</sup></b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Annual Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 75%; text-align: left">Management Fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_ecef--ManagementFeesPercent_dp_c20250815__20250815_fKDIp_z4WY5nEwWFV7" style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest and Other Related Expenses <sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250815__20250815_fKDIpKDMp_z0GP7Ja2P4lb" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Expenses <sup>(4)</sup></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecef--OtherAnnualExpensesPercent_dp_c20250815__20250815_fKDIpKDQp_z8xgw44rdMv7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Annual Expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 2.5pt">&#160;</td><td id="xdx_986_ecef--TotalAnnualExpensesPercent_dp_c20250815__20250815_fKDIp_znclkbIxkkTi" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.73%</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<div><p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F0C_zBCKezzeMNL" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span id="xdx_F1D_z2ROwh85iCug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F01_z9TJ0NzsGamk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span id="xdx_F1E_zenYffoi5l82" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#8217;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#8217;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F0C_zgvO4dJ2lWT" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span id="xdx_F11_z9V72rAVYfOh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecef--OtherExpensesNoteTextBlock_c20250815__20250815_zdvSowkrm1ab">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.</span></span></td>
</tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">2.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">3.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_804_ecef--ExpenseExampleTableTextBlock_zMNIvguq0kzh" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example
</b></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following example illustrates the expenses, including the transaction fee (referred to as the &#8220;Maximum Sales Charge&#8221; in
the Shareholder Transaction Expenses table above), if any, that a common shareholder would pay on a $1,000 investment that is held
for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the
Fund and that the Fund&#8217;s Annual Expenses, as provided above, remain the same. The example also assumes a 5% annual return.
Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less
than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 1%">$</td><td id="xdx_989_ecef--ExpenseExampleYear01_c20250815__20250815_z22VtpbOXPA7" style="text-align: right; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250815__20250815_zNE7pnry5Iyb" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98D_ecef--ExpenseExampleYears1to5_c20250815__20250815_zkAIFZhvLVw7" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_988_ecef--ExpenseExampleYears1to10_c20250815__20250815_zguNRQS9wNkk" style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
</table>



<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not
be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80A_ecef--PurposeOfFeeTableNoteTextBlock_zrbQarXoWuf8" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the table below and the Examples below are to help you understand all fees and expenses that you, as a Common Shareholder,
would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable
to Common Shares, and not as a percentage of total assets or Managed Assets.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">as a percentage of offering price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_800_ecef--InvestmentObjectivesAndPracticesTextBlock_zHvGdh4Snm44" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objective and Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221;
as such investment objective and investment policies may be supplemented from time to time, which is incorporated by reference herein,
for a discussion of the Fund&#8217;s investment objective and policies.</span></p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80A_ecef--RiskFactorsTableTextBlock_zgI7h8CAncd8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_9"></span>RISK
 FACTORS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                            is inherent in all investing. Investing in any investment company security involves risk,
                                            including the risk that you may receive little or no return on your investment or even that
                                            you may lose part or all of your investment. Please refer to the section of the Fund&#8217;s
                                            most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
                                            Objective, Investment Policies and Principal Risks of the Fund&#151;Principal Risks of
                                            the Funds,&#8221; as such principal risks may be supplemented from time to time, which is
                                            incorporated by reference herein, for a discussion of the principal risks you should consider
                                            before making an investment in the Fund. Any additional risks applicable to a particular offering
                                            of Securities will be set forth in the related prospectus supplement.</span></p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_805_ecef--EffectsOfLeverageTextBlock_zyCmkKFzT6E3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Effects of Leverage </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a>
on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks of the Fund&#151;Effects of Leverage,&#8221; as such may be supplemented from time to time, which is incorporated by
reference herein, for a discussion of the effects of leverage.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_801_ecef--SharePriceTableTextBlock_zdWh8ptpiHr3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_4"></span>TRADING AND NET ASSET VALUE INFORMATION </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 9pt; text-indent: 0.5in"><span style="font-size: 10pt">The
following table shows for the periods indicated: (i) the high and low sales prices for Common Shares reported as of the end of
the day on the NYSE, (ii) the corresponding NAV per share, and (iii) the premium/(discount) to NAV per share at which the Common
Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in
relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount
to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might
be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of
such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion
of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of
these actions, or that share repurchases or tender offers will actually reduce market discount.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_484_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuCHvqTmVXa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_487_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBB8e1Uf9PXd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_48D_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBc5J9RZspIb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_48B_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8NmHmx9pI1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDutwyfxEyp" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_481_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z21wOlRowup7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Closing Market Price per</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">NAV per Common Share on</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Premium/(Discount) on</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Share</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left">Fiscal Quarter Ended</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td></tr>
  <tr id="xdx_419_20250401__20250630_zM9lTEaGmH3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left">June 2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">11.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.53</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">12.89</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(3.92</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(10.94</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_419_20250101__20250331_zHWKXhKyUCs" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.94</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.67</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_410_20241001__20241231_zUmRX5EZHbK1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.02</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.96</td><td style="text-align: left">)%</td></tr>
    <tr id="xdx_418_20240701__20240930_z0lIAUAyXFvl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.09</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.83</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41F_20240401__20240630_zJHsfptO6WNi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.40</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.16</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_411_20240101__20240331_zdvtip8DnOt8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.92</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.96</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.37</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9.19</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_411_20231001__20231231_zDvjGFQx3mF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8.52</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13.98</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_414_20230701__20230930_zGHPN2PYxPv9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.13</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12.19</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_417_20230401__20230630_zSdPY0UAoHp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.53</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.25</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41F_20230101__20230331_zfU4zFoXq7j7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.67</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.86</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.23</td><td style="text-align: left">)%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">The
net asset value per Common Share, the market price, and percentage of premium/(discount) to net asset value per Common Share on
August 8, 2025, $<span id="xdx_90D_eus-gaap--NetAssetValuePerShare_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU4lu6AhTKg8">13.90</span>,
$<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeyPXPR4uDRg">13.34</span>
and <span id="xdx_90D_ecef--LatestPremiumDiscountToNavPercent_dp_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zl1icWeTPzj1">(4.03)</span>%,
respectively. As of August 8, 2025, the Fund had <span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zjXU7y2alWX5">23,177,393</span>
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_801_ecef--CapitalStockTableTextBlock_zBFtFcuzIDH9" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="toc780884_15"></span>DESCRIPTION OF SHARES </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Common Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
Declaration of Trust authorizes the issuance of an unlimited number of Common Shares. The Common Shares have a par value of $0.01 per
share and, subject to the rights of holders of any Preferred Shares, have equal rights to the payment of dividends and the distribution
of assets upon liquidation. The Common Shares when issued, are fully paid and, subject to matters discussed in &#8220;Certain Provisions
in the Declaration of Trust and By-Laws,&#8221; non-assessable, and have no preemptive or conversion rights or rights to cumulative voting.
A copy of the Declaration of Trust is filed with the SEC as an exhibit to the Fund&#8217;s registration statement of which this Prospectus
is a part.&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span id="xdx_90D_ecef--SecurityVotingRightsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zChXo54FbiDf">Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#8217;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.</span> <span id="xdx_907_ecef--SecurityDividendsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsp5KmGlzEGe">Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#8220;&#151;Preferred Shares&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Common Shares
are listed on the NYSE and trade under the ticker symbol &#8220;JGH.&#8221; The Fund intends to hold annual meetings of shareholders
so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such
listing. The Fund does not issue share certificates.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unlike open-end funds, closed-end funds like the Fund do not provide
daily redemptions. Rather, if a shareholder determines to buy additional Common Shares or sell shares already held, the shareholder may conveniently do so by trading on the exchange through a broker or otherwise. Common shares of closed-end
investment companies may frequently trade on an exchange at prices lower than NAV. Common shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and have during other periods traded at
prices lower than NAV. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), call protection, dividend stability, portfolio credit quality, NAV, relative demand for and supply of such shares in the market, general market
and economic conditions, and other factors beyond the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than NAV in the future. The Common Shares are designed primarily for long-term
investors, and investors in the Common Shares should not view the Fund as a vehicle for trading purposes. See &#8220;Repurchase of Fund Shares; Conversion to Open-End Fund.&#8221; </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Preferred Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund&#8217;s Declaration of Trust authorizes the issuance of an unlimited number of Preferred
                                         Shares in one or more classes or series, with rights as determined by the Board of Trustees,
                                         by action of the Board of Trustees without the approval of the Common Shareholders. The Fund currently has no Preferred Shares outstanding. The discussion below generally describes the rights of the
                                         holders of Preferred Shares, although the terms of any Preferred Shares that
                                         may be issued by the Fund may be the same as, or different from, the terms described
                                         below, subject to the applicable Statement, applicable law and the Declaration of Trust.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>







<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Under
                                            the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred
                                            Shares if, immediately after the issuance of Preferred Shares, the asset coverage ratio would
                                            be less than 200%. See &#8220;Use of Leverage.&#8221; Additionally, the Fund will generally
                                            not be permitted to purchase any of its Common Shares or declare dividends (except a dividend
                                            payable in Common Shares) or other distributions on its Common Shares unless, at the time
                                            of such purchase or declaration, the asset coverage ratio with respect to such Preferred
                                            Shares, after taking into account such purchase or distribution, is at least 200%. Preferred
                                            Shares issued by the Fund have priority over the Common Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">For so long as any Preferred Shares are outstanding, the Fund will not:
(1) declare or pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares) in respect of the Common Shares, (2) call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares,
or (3) pay any proceeds of the liquidation of the Fund in respect of the Common Shares, unless, in each case, (A) immediately thereafter, the Fund shall be in compliance with the 200% asset coverage limitations set forth under the 1940 Act after
deducting the amount of such dividend or other distribution or redemption or purchase price or liquidation proceeds and (B) all cumulative dividends and other distributions of shares of all series of Preferred Shares of the Fund due on or prior to
the date of the applicable dividend, distribution, redemption, purchase or acquisition shall have been declared and paid. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p id="xdx_843_ecef--SecurityDividendsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zm6RpaeqHXCk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Dividends and Distributions and Priority of Payment</i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund issues Preferred Shares, the Fund&#8217;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p id="xdx_84C_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWlL7ZRXLuTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Liquidation Preference </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p id="xdx_84D_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zoIdSC74EcR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Voting Rights </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the election of the Fund&#8217;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#8217;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#8217; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#8217;s trustees until all dividends in arrears have been paid or declared and set apart for payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>





 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#8217;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#8217;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#8217;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#8217;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#8220;Investment Restrictions&#8221; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p id="xdx_84C_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zTYhDHWW3yQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Redemption, Purchase and Sale of Preferred Shares </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.</p>

<p id="xdx_855_zRG6NWYQWhU" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_802_ecef--OutstandingSecuritiesTableTextBlock_zei1WqnakaNe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The following
provides information about the Fund&#8217;s outstanding Common Shares and Preferred Shares as of August 8, 2025:</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Title of Class</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Authorized</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount&#160;Held<br/>by&#160;the&#160;Fund&#160;or<br/>for
    its Account</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%"><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zNOrXQo0Js73">Common Shares</span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_908_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSUQBH3uM0Fc">0</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zOOS0BO3oyAi">23,177,393</span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zPfdigaMtJOi">Preferred Shares</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zFEKBtmf8Lx7">0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zw1nn6RIxOKg">0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333
                                            West Wacker Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Chicago<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">60606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mark
L. Winget<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jgh_BorrowingsOutstandingMember', window );">Borrowings Outstanding [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000,000<span></span>
</td>
<td class="nump">$ 159,000,000<span></span>
</td>
<td class="nump">$ 149,200,000<span></span>
</td>
<td class="nump">$ 175,200,000<span></span>
</td>
<td class="nump">$ 175,200,000<span></span>
</td>
<td class="nump">$ 175,200,000<span></span>
</td>
<td class="nump">$ 164,800,000<span></span>
</td>
<td class="nump">$ 170,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,335<span></span>
</td>
<td class="nump">$ 3,424<span></span>
</td>
<td class="nump">$ 3,636<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 3,118<span></span>
</td>
<td class="nump">$ 3,455<span></span>
</td>
<td class="nump">$ 3,513<span></span>
</td>
<td class="nump">$ 3,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.48<span></span>
</td>
<td class="nump">$ 12.80<span></span>
</td>
<td class="nump">12.72<span></span>
</td>
<td class="nump">$ 12.42<span></span>
</td>
<td class="nump">$ 12.18<span></span>
</td>
<td class="nump">$ 11.96<span></span>
</td>
<td class="nump">10.40<span></span>
</td>
<td class="nump">$ 11.17<span></span>
</td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="nump">$ 10.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00<span></span>
</td>
<td class="nump">13.42<span></span>
</td>
<td class="nump">13.38<span></span>
</td>
<td class="nump">13.38<span></span>
</td>
<td class="nump">13.05<span></span>
</td>
<td class="nump">12.92<span></span>
</td>
<td class="nump">12.24<span></span>
</td>
<td class="nump">11.99<span></span>
</td>
<td class="nump">11.39<span></span>
</td>
<td class="nump">12.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.89<span></span>
</td>
<td class="nump">13.57<span></span>
</td>
<td class="nump">13.82<span></span>
</td>
<td class="nump">13.33<span></span>
</td>
<td class="nump">13.12<span></span>
</td>
<td class="nump">13.17<span></span>
</td>
<td class="nump">12.09<span></span>
</td>
<td class="nump">12.72<span></span>
</td>
<td class="nump">12.42<span></span>
</td>
<td class="nump">12.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.53<span></span>
</td>
<td class="nump">$ 13.97<span></span>
</td>
<td class="nump">$ 13.94<span></span>
</td>
<td class="nump">$ 13.95<span></span>
</td>
<td class="nump">$ 13.51<span></span>
</td>
<td class="nump">$ 13.51<span></span>
</td>
<td class="nump">$ 13.38<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
<td class="nump">$ 12.73<span></span>
</td>
<td class="nump">$ 13.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.92%)<span></span>
</td>
<td class="num">(3.94%)<span></span>
</td>
<td class="num">(4.02%)<span></span>
</td>
<td class="num">(4.09%)<span></span>
</td>
<td class="num">(3.40%)<span></span>
</td>
<td class="num">(4.37%)<span></span>
</td>
<td class="num">(8.52%)<span></span>
</td>
<td class="num">(7.13%)<span></span>
</td>
<td class="num">(10.53%)<span></span>
</td>
<td class="num">(6.86%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.94%)<span></span>
</td>
<td class="num">(5.67%)<span></span>
</td>
<td class="num">(7.96%)<span></span>
</td>
<td class="num">(6.83%)<span></span>
</td>
<td class="num">(7.16%)<span></span>
</td>
<td class="num">(9.19%)<span></span>
</td>
<td class="num">(13.98%)<span></span>
</td>
<td class="num">(12.19%)<span></span>
</td>
<td class="num">(14.25%)<span></span>
</td>
<td class="num">(14.23%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.25<span></span>
</td>
<td class="nump">15.88<span></span>
</td>
<td class="nump">15.55<span></span>
</td>
<td class="nump">16.38<span></span>
</td>
<td class="nump">13.65<span></span>
</td>
<td class="nump">16.91<span></span>
</td>
<td class="nump">15.99<span></span>
</td>
<td class="nump">13.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.79<span></span>
</td>
<td class="nump">$ 16.63<span></span>
</td>
<td class="nump">$ 16.97<span></span>
</td>
<td class="nump">$ 18.14<span></span>
</td>
<td class="nump">$ 16.01<span></span>
</td>
<td class="nump">$ 18.51<span></span>
</td>
<td class="nump">$ 17.82<span></span>
</td>
<td class="nump">$ 16.05<span></span>
</td>
<td class="nump">$ 19.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.03%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityDividendsTextBlock', window );">Security Dividends [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#8220;&#151;Preferred Shares&#8221; below.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#8217;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,177,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityDividendsTextBlock', window );">Security Dividends [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_843_ecef--SecurityDividendsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zm6RpaeqHXCk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Dividends and Distributions and Priority of Payment</i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund issues Preferred Shares, the Fund&#8217;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84D_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zoIdSC74EcR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Voting Rights </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the election of the Fund&#8217;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#8217;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#8217; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#8217;s trustees until all dividends in arrears have been paid or declared and set apart for payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>





 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#8217;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#8217;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#8217;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#8217;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#8220;Investment Restrictions&#8221; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityLiquidationRightsTextBlock', window );">Security Liquidation Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84C_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWlL7ZRXLuTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Liquidation Preference </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PreferredStockRestrictionsOtherTextBlock', window );">Preferred Stock Restrictions, Other [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84C_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zTYhDHWW3yQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Redemption, Purchase and Sale of Preferred Shares </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Preferred Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="22"></td></tr>
<tr><td colspan="22"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#8217;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#8217;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_90A_ecef--OtherExpensesNoteTextBlock_c20250815__20250815_zdvSowkrm1ab">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Aggregate Amount Outstanding: Aggregate amount outstanding represents the principal amount outstanding or liquidation preference as of the end of the relevant fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Asset Coverage Per $1,000: Asset coverage per $1,000 is calculated by subtracting the Fund&#8217;s liabilities and indebtedness not represented by senior securities from the Fund&#8217;s total assets, dividing the result by the aggregate amount of the Fund&#8217;s senior securities representing indebtedness then outstanding (if applicable), plus the aggregate of the involuntary liquidation preference of the outstanding preferred shares, if applicable, and multiplying the result by 1,000.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PreferredStockRestrictionsOtherTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph b<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PreferredStockRestrictionsOtherTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityDividendsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityDividendsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityLiquidationRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityLiquidationRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesCvgPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 3<br> -Subparagraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesCvgPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jgh_BorrowingsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jgh_BorrowingsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
<th class="th"><div>Aug. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001615905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nuveen Global High Income Fund<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">333-287584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">N-2/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th" colspan="2">
<div>Aug. 04, 2025 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Shares, $0.01 par value per share, and Preferred Shares<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 98,987,589.81<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 15,155.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated pursuant to Rule 457(o) under the Securities Act of 1933 (&#8220;Securities Act&#8221;) solely
for purposes of determining the registration fee. The proposed maximum offering price per security will be determined from time to time
by the Registrant in connection with the sale by the Registrant of the securities registered under this Registration Statement. <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Shares, $0.01 par value per share, and Preferred Shares<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,012,410.19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 155.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The Registrant previously paid $155.00 in filing fees in reliance on Rule 457(o) under the Securities
Act in connection with the initial filing of this Registration Statement on May 27, 2025. The proposed maximum offering price per security
will be determined from time to time by the Registrant in connection with the sale by the Registrant of the securities registered under
this Registration Statement. <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_90C_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__1_zmrVZlcK5fq5">Estimated pursuant to Rule 457(o) under the Securities Act of 1933 (&#8220;Securities Act&#8221;) solely
for purposes of determining the registration fee. The proposed maximum offering price per security will be determined from time to time
by the Registrant in connection with the sale by the Registrant of the securities registered under this Registration Statement. </span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_90F_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__2_zl7tPczkyXac">The Registrant previously paid $155.00 in filing fees in reliance on Rule 457(o) under the Securities
Act in connection with the initial filing of this Registration Statement on May 27, 2025. The proposed maximum offering price per security
will be determined from time to time by the Registrant in connection with the sale by the Registrant of the securities registered under
this Registration Statement. </span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 100,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">155.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">15,310.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 15,155.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>42</ContextCount>
  <ElementCount>101</ElementCount>
  <EntityCount>2</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="jgh-n2a_052725.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex99-s.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ex99-s.htm">
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ex99-s.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>jgh-20250815.xsd</File>
    <File>jgh-20250815_def.xml</File>
    <File>jgh-20250815_lab.xml</File>
    <File>jgh-20250815_pre.xml</File>
    <File doctype="N-2/A" isN2Prospectus="true" isUsgaap="true" original="jgh-n2a_052725.htm">jgh-n2a_052725.htm</File>
    <File doctype="EX-FILING FEES" original="ex99-s.htm">ex99-s.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nuveenlogo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="36">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="123">http://xbrl.sec.gov/cef/2025</BaseTaxonomy>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>29
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "jgh-n2a_052725.htm": {
   "nsprefix": "jgh",
   "nsuri": "http://nuveen.com/20250815",
   "dts": {
    "schema": {
     "local": [
      "jgh-20250815.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "jgh-20250815_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "jgh-20250815_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jgh-20250815_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "jgh-n2a_052725.htm"
     ]
    }
   },
   "keyStandard": 79,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 1,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 38,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 197,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2025": 123,
    "http://xbrl.sec.gov/dei/2025": 37,
    "http://fasb.org/us-gaap/2025": 36
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-15",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jgh-n2a_052725.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-15",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jgh-n2a_052725.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "jgh_BorrowingsOutstandingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nuveen.com/20250815",
     "localname": "BorrowingsOutstandingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings Outstanding [Member]",
        "documentation": "Borrowings Outstanding [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r194",
      "r197",
      "r199",
      "r204"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r201",
      "r202",
      "r203",
      "r209",
      "r213",
      "r214"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r3",
      "r4",
      "r6",
      "r7",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r195",
      "r196",
      "r198",
      "r200",
      "r205",
      "r206",
      "r207",
      "r210",
      "r211",
      "r212"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r195",
      "r196",
      "r198",
      "r200",
      "r205",
      "r206",
      "r207",
      "r210",
      "r211",
      "r212"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r169"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r169"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r166",
      "r167",
      "r168"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r69",
      "r70",
      "r72",
      "r73",
      "r76",
      "r94"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r166",
      "r167",
      "r168"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r5",
      "r195",
      "r197",
      "r208"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r90",
      "r91",
      "r92",
      "r93",
      "r213",
      "r214"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r142",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r143",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r194",
      "r197",
      "r199",
      "r204"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    }
   }
  },
  "ex99-s.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex99-s.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2024q2": 6,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 29,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-08-042025-08-04",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-08-042025-08-04",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2025-08-042025-08-04_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-08-042025-08-04_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-08-042025-08-04",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-08-042025-08-04",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99-s.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>30
<FILENAME>0001999371-25-011457-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001999371-25-011457-xbrl.zip
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M<D4,NZV #'/%PG8Z,BK-4R3=@8!9FSOX/8V^--08@&5!E!SK.MCEVEMC/7Z
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M/M:XLD/_S9?\OU_TWX/]+U!+ P04    " "#> ];!6T!]8P*  "X+   "P
M &5X.3DM;#$N:'1M[5IK;]-*&OX>*?]A-GL.*I*3)BD%VJ:1T@M0*92J"0?Q
M:36Q)_& 8YN9<=L<[8_?YYVQ'2=-*7#*PAZVB#;QS+SW^[CW:OQZV*_7>J].
M!R?XR^BG-SX;#T_[O6WW%ZO;^7+OZ,W)>S8:OQ^>'C:F26SV6:>=&C:6<Z'9
MN;AFE\F<QYY[X+&14'+:P$$<_4>SR5Y($07[[#*+1/."SP1K-ON]D[,_"I!S
MKF8R;IHD!>!N:@Y8_F22&)/,]]D./;N6@0D)<_OWQLIQHJBIY9\"B[1QDJA
M* ?N*.+^1P:83">1#,K% K);[Q3KC?ZC>*+3@]XVX/?SWQ46ME=X( ;!XL4J
M'_NL#?H&[-7EZ8O#QH=9V(R[_%_MW>ZS[FXK-/-&_SR[$B)F+Z-DPB/V2LY"
M=A;[R5RP%UD<L/-F=]#;'@#]1?].! 6=ZUN,N#%-'LD9MBE +H7IR'KQYGR\
M(K<IG\MHL?]Y71ZPJHRA>D ZZI_>A'(B#=O;:VU%C[<ZCWO;1R":4'P;[7=O
M&0^.AJ?L^'0XO!B<G)R=OSQLM!OV^^AB<%Q\_TH++<W,6DI[@]VU;]O=^+)
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M_*R*OE'QOA3Z/GD.:@@#;H2B6PE$@;VO##:"K1C2]GA=,*L35L6]9&8$0+<
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M[2U-\FU2>$3=4]27#^^>,NR!IQ-=@/ND#YP[RX@'D><0\"3?J:2(>P?ZO^G
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MV<SIGYMY?'H??V\X_R)Q_E7C_PM02P,$%     @ @W@/6T:M_>CF P  @@P
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M^R [B'V'WZL?*KLLKOV&6']4V&^/_P%02P,$%     @ @W@/6ZT;9H&.$P
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MH#=4C9L0/MG7T8B,F]"M*"I7V[::2K:1"2'C?  XH1EPVUP\5 DMD=HHE.O
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M5#A52<NS<?.PD_T:RH&_5Z\'_O>+3C<:0LIH(FS:(O *+\NRS"]H-!J^^UI
MGR"G/<F+&/M^(6?&;+XF*_ E)2H)E9/7P8AI-^MKPY!G$?8?+6#4FFBP1_>#
MVE3%7I%\ET&)'*ZA3]PP0_U[9"I));80O-PVE-!?+H9+Z5M_7\" :8AMH(8-
M%!S80.]S<X?U@'O$(DU]/#NNQAQ7[N17+?8*9(+Q9[&;ZD7O5Y)OUH[4+QA
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M/PBF]:"23WF4KL41488C:T_04+BJN'5EY<YY0E;,B2H]X+<:P>^4^SW<7,2
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MD8'I5?IK5/*"I?//=-W2=(O0SVN\RMT20U1CAJ@O/T0[>HAF=>DAFN6X(83
MK\NOJRDN-^+RRVS&('OY98I8[3AB"+':6GZ(UO.'B*97DB$JT?1*-$0T@1(-
M$4V11$-$LW^B(6K/'Z+^_"$:SQ\BCK7:RP\1QUK+#U&-8ZT$0\2Q5H(AXE@K
MP1!QK)5@B#C62C!$'&LE&"*.M1(,$2?XVH%RK%[U558%EA?[_;@+I_!^+I?[
M.*H[Q8%1$2M*JC+4]@25#*P/PE@RAHI6M/3)GE">>!_T=,O2Q_2S_/Y'26"E
M8O\#VFM^_T;JJ430!P(O[0WJ@K3_<7=4A]F$CQ-GL@%\NR>T)Y9P SJS*9R3
MJ7"ECR6MP#XH"->@+@Z6@N&#X >]#Y/BE>&__R,VRA\^[DY@XG7.^]&<2)I_
MNN) &BOJP]ZB&>FSIO)(]@218;:WWS%S T4ELC!5K)%@C8CPO71=@C?ZML$*
MK$N:+!S?]T>2-B0"WCH5$R\@ OR_8P]MTQ+$>D% )?WC;@\(@=#M;SE6'-*^
MEO6$5[*.A1A8)CSE=7ALF>OT+>&*#!73,J@4$\[U$B<;G9$7N>ZVRR*M,5\L
M'M,;ZPEP.UQ8X*K;[;O5]+VZ^H\'\K_WQ\9($[^-8,JG5?,6Q=F*VMZ\^?UJ
MM5JLM)KU5BU<3-LETNN@UZEV1TP+S0<YD!PP\,.2-&MSFGD#\/>![(LH^._Q
M/]5[_>3WR?WPZ12L^"DX'XK\?DL4BY5*N]5:DIR!ROQ7MDJ*E]*0UMOWU]+W
M4U"L1)"PBI]-%=D:(<K+[_*!UWNZ 2<Q>_U E?JW HPAF+JJR!\$_J4S$OM>
M]+[W$Q-IZ0A$/-3YW[XE[ ;6,"LGD1^2\&MM[8*R$A#\W\]/;XZ/<M<WG9OC
MZT5[,>GBUG\*.(N[/C[\?G5Z<WI\G>N<'PG'OPZ_=,X_'PN'%]^^G5Y?GUZ<
MOYZU_I1 K=6&EJX5<D>EPQ(H*/5:>\Z)'@![%NB0NC<R0MN,;T-XLZ^KNK$G
M?#:D!]AGL*^&AFYK<C'PN=-$0YS<NUNX4G^WG$:\N_]$N&?(V5@E.7O[)Q=7
MWX0 6:<CQ2)%^*1/L$?(U) F#N$]X5\-'-@@?+G4I3UF(D7^W9_6SW_U(ZE_
M^8Q#NSI[: ?GIET_8D6\3](_G;,^6O1VTR>JBDC"MF5YN%SC[Q-)EIW?&=/1
M'Q/O3]^!X0*#M[$]0;(MW3T:@%U5:6("F9R?W*<-QKOX>)Y>\2P#%VS)N^P?
M!Z8[8EA*7U(=SF!+=B&HO:.<[#W//V\W\(N/NS@J#)U\A1,XB(H]@TBWV)--
MD6$-TIVNR/G]>= !?5:M$(7XO,;YW.DLXU>-7*].-,.7?US\/CGL76J#6B*&
M9QW1/N65>VNOI^LJD33LF1/:"9%];R*A0^9M-VN-#XNVA27/13YCC321[6RJ
MEYH_H.>Z^!+@)" &O6>'[C+Z0!#;U>J>'^+(/>!7R_Q+<HZ4^N3>V5>P<W&P
M3_E*/OJI#=MDWM9H\JUQ:9#CP8#T+>6.N+V>HK?$I'[1.#EK7NN/X@JV1* _
M4R14B[?"F]L#@*>BBZB<BRF\]@EABC?F47S>=4^9DE]?:C<7?TGMIY_]C87D
M=>YZXA*2[DG[MK74OFUMXKY-AU=A\]1>D%E??+/HIN7M%B&P6Y[-7)6EF*NR
M8N9RIZ[FYS!:_CGW3JIB<U69_KQ:VZJ$S4?]]\EL^Z>C&[?F& #]JE7TF5#_
M7+/+W\C@@%17H LT%]D&_0!F&O*3->0(Z[&K*=?*;UI37L66.XG;<GY"+5#"
MOXQ^?/MQT+YK_3E8P<9KS=UXD6!FVV]9\CM6-Q=U1\3L&\HD7LJ*-^KGIOI7
M_ZC7?[KFW8YLY^N;.[\?4(5R8;@/$K'M7,=1_Y^;J[\?SLGMTV\2&&65E$<7
M7RTB/YYE("JDX"^T(>X+83\,IWYULFS@Q499O'V+"3FO_E.F?_!!QWT5:%1=
M6W+!'ECB.__BA6?;S2.]=_,,YW':$+-*.TP$G .<%LW+^N/TNO%YW'^\EI_.
MRQ%N[.#<^?USVM!>^*SJ/4D5O@#&<Z=:7Q\3X<1&W7B./S0*L]L147%\#QBB
MW=11&?%0(DBF<#TA?8SREP5%HUK,$>FK$M=RX.D;PS:M>!];XDVZL@-I(W;]
MQB!G3AS01I%LM5*R$I:2ZUG*MCB?W7"K&-LF$Z&\ASC_YPR(($;+\-_RP>A;
MSU9..[=/E^&561D> 0"-2<K]!&5%^ E;&2Y@1X9R1\+R6W#HTS-P<X:6>12U
MS$/X\<*XT:<Q2N3T\DS^?-S_?=!J/7V1$:[;F>GS^X<CT*B'>LRA5)@Q24>N
MAUY4+XQ+0[]3M'[,Z=O\]G@O?[VZ_*PE.WU]UZ"B2?J8'&61"4R%JR-::-6U
MV%6'@,SOGZJPV77%C%G[S-)K44M'"Z6D_J-,#G4Y9N':OS]_-!_NA]_[SU [
MZK'K"D"0WV^4X7]/#*';$FG"%YX#S>'2 %HJ$U"SCN])WZ96XHO!0.G#@#OL
M#@'C6 8A5D% OB\PJTI! (0)B+'WKP A45K*=JXDXJ!PW)Y(O8Y!I/B-)AE?
M_FGU1\?36N_I&RW@]?+/F=_?:97+[V.VUHS@=Z3%F=Z7U,N1KLV-SWSXI_WC
M[Y_G]_U1X^F@!VRPX7GS^Y5ZL]AJMIJO6SAX-X___D^K(C8_F+D;HI()8D)P
M) ((#=5&=XB U*5R(-7=4TVT]C2PG6S&%\@+V)X%A7=RV1% \"QLM4MBF+JF
M$376T-"=51.(HUEBS!PFHO.'#FP35$U0R=C8+-^\^RB?_3NZ[C1^M3KS8_=B
M$_MA\&[DV"&1$; >1RTPO_]-,FYS9R7A)VP78BTG/"+,0]LA/8#\/T!Y\.5D
M+_YS"72EA0QH6M UZ1O$DHR'5X22\(ZH/.GN]OQM41\?U7N/E:M)?[YQ_=G;
MHIW@@IB$519>)E_761S!.H=/N \_GW$FQR(9]<]./A_/5Z^>RSC5<AJ7[AE=
MLOW42_?S,7=F7S8/QU^_7M](J6,NT<V^&F%X3^MFWWG:S?[YV+4F4M_LG)Q/
M?LPW#3R;+^,M7D\W'\PD%F^)5$*U)I'4QF.=8VM9HP)Z-3I#U F R1&2.] J
MYF@#FV4OWQP/Q[8;[)^O]27TDZ9W=BO[A_H$(_&3;!5:@F \MC4XX&@=!<'2
M][ *PCQ5>+.8?_791A$)1H$$I*391A]9&%8X9ZA:"2<3+4@^FGE^-0.]?-C8
M2C3=8SRTKTO"I6U,5#@+CLU_;05K9/D.S?4'-$7:9Q: L1Y\_:D353@J@;PP
M#(48>H:QI3CLI"2<@"(2AFZ#-M5V:H68"VX9DJR2AX4GWI6NT?!<<D?@A/MO
M:0RH^!O4H&%!.#N[?#V7]PKH6KFOKJI[7OI9@N=MQ2)"LUQ>QSK%M:PS(C&^
MC+>@P/JV7Q9M+1]F&W-V8]9S:)@GEKL[V;ZL-%[3QKP<*:HD$W4R4J1"[I)H
MFOF@WDF:(@EB6RQ7LRVZ*1QY.)(F\.C"'8JVE$/;4HGQNG:D*(HL5.R;KADZ
M68>I;#U;D-NJ"XG, (X!5D!S8N0NY?JJ$Y>_I=[BSF1BZ/?*6+)\%D4LP^T8
M0HC69QE<-%9)G^@FD>&&V%-!D[\8#&!8;;B7Y@YX*;=YR*+NU)?S(0C1<C'P
M(^5BX*#D6E+)C7XS(@PUT3$RI]7#X5]_?M<J"8L9! SA@:C(IT&7WT=S?,X"
MC( D%^B_TL#B"7K$S5:6.1]8(]@(T8E]I4496 &.2)J@\N)VW%4;/Q4-W>[P
M2:FN:*MD9\=!=$2KJ&ORA7&*.PCD_151W'RF2U72+C3U(9I]O\H_ZG\V*L?R
M.%D]IH@TP(&DFJ$\P&JP/LU2</H*#$3'M!V.2/\6E*9[01E0YM;A+<'TZJ#V
M",90&92W81H9"Z!2=C\!H 7)(/P)'44=?#VQ#=/&I!#8-S*'4= -0>%0PE >
MF,($X#1+:1ZCL=(Q8))=.3LY6:5'1)4>"% )77>*9NNVZ1P*,3ST</EU<M.H
M7%G)LO&62B6M!F*,Y\"V*'^4'84!YL$\Y:7Y9JJH*CSB<@U\*0DR@P>YI>]"
M!)++A+<4#<92%0DD-SZ,E1>%FEAG<$15%_)RIJM580<#!2OE#\&OZ8?BA_<%
M08=W<0!D!N\1!SB8NX_14GTJV6G%8,GC;3\_,W"0J4OK._'7)B);7=(G ZQ5
M ^>I\7 ](NK@1)5B&/EH^NOGS8_?YLGI[Q4PLAO#"Q#MA0%:R+TAJ>=P)?PK
M<9;EQ[CIYN?[Y=IGHA%#4H53#1ZT&5MT2A5D7$F88$$33T60W"Q>Y#%BZ>OA
MC/5*N[H37>$L^_M$UTX4N"$,:XU*3"SW].!\7)^>/6IW]56<EH%0Z1C DAZ/
M:3#*P7)L@M+(HG(RUR,TL]1[V(9%" .Z"J^ N:]&N1\$)BD;E1WR/E9.EE)U
M9V\(3SHG<$>6%42\I'J+=MFA)E9[,5<1N!(<_%:^ES\KJ^#.0%3N0A 7\FF2
MF_L\GH[G2CV>XUDE?8?I$L$2NT?@"T=W$"07/8'3.?!%'[N T3/;]TPB4&8W
MC5C=Z2VW:5:U9U(V])Q:.:#RQ#%24 E#&<"5)50K"TF;G3YE& EOTA-#P2LO
M,,][(6W+WH9H.>WP6?9S1#26S4[D:Z8$MF+L%^I0FM3^&9OGE<HJA$8[\DB+
MA&^AQ)C"6Z!QL]=\U/9O SX:LS>T=OKOF:WC->R$0<['SP6!L3@N;:"KJC[%
MW0!,OO=:F=RI'@,CN'R$]C$X"2X-<J? Q8MI23$E<!KJY%3^??(+JT.GSN>U
M0(CU0A 7LOH-BKC_&SS:_I_O;).)J0PU&!I/0 UP&C+P#9C"QB=5'_B!-V?$
M_QM]4OZ_5ZEHE><H6J!XQNA7#U_TWNFMKG[]EBS+?TD6$A?I5PA9<K7JQJ\N
M,398K*E0_M&8.0$%2Z1Z/D?3B'#,H(\MPMX1HZ!I-*#9$=Y$,E3LY>IQ>9Q>
MIS-H3%;QA4$_"XMB[@6KW5-1!D>+SD;<8PO#*%Y$>$MLUS\L\0^GP6N\+CM7
MDW/]VNX!OC6DPB%M-85\&:-<7,G-?PZ^GI^>M9]=_#QJQP3R!^(@6T[6+G&?
M"-X9 CNA/V<G)&/\7)J,GSJ?OV(&=Q+ZC^]'2D^Q3'1% &GE:,8V^\.Z.C):
MXG E1T&P2DH(HG4PM/S:&3J"DU>FW:0>^P"*?R([ 9'Z(VH]H==GWRT"%,/^
M2#* [6"Z1P $,>[5*IBY2ZQ0 5SO9:+,_0)7KK/G4$4#P[$F8S6\>!>!]->M
M?:[U__IUMX)ZQ;6:WT4P![;E?%U+_O'F$=A$19B)%@44=OKL W0:]7EA7\I#
M(%A\?K*H0L "KZ.9"!1?T6#7 38[I-\1]OXUGD4GG#N=',HC<D=4?>*K3AK/
MH"/IQ\G7S]5RXT>RGGI+GDQU/X?.AV_A.>6\+OC>=VD<SWK82U:FQM219 I$
MA7.$W6EZ]#"Q50E_E_#HZSDSR+X9G-$HU^:BN199[/VKO/HV.6_1$(P[29TO
M[J;MO^[./W^MB"<KX:: 2S0,4:H>!&=P+M?FR#QJ.9G+FI0-Q](MT&$" .FR
MTD\$BT% YX)SU^2*C<D%*-6^*M5^L3I7HL[PYFLYE*.<]7_9DDJ+M,;SZ%5]
M\%G\8CY.;U?08:O6C//:!R!;>""CK]U]0]CYU_W1;XOQ&6"6\MW[?&&ODB&"
M93E^$E7]JNE3[9I(IJX1^=0T[;C29>>6TI+^'CYJ7WHA"+&H0U&Y+XX4&9:Q
M)\!4%>6^9ZA [-9L=QM&/IR[2"<7G-D%-KVP(^'Q,E#PH]X#OT*5Z['WIU=)
MJ6#GYF/@?0!H^-G0I]:(BZV8RJG5"KDTS^Y/K&>'W$0=,!$E<R*!6WC6.&\)
M[#5/38F@OECI%2O1]'?;LWNA7C57T_5_Z>BWS]=!_"'6J&-LA%;"L;WXV#S%
M*#TA!OM8,D_&G'Z"N&<.,8#[U@D,-;QZWWY54=.I6+7A_*4FB7M4*(F\&!@<
MRJ36<G[P4RL%ZI/J@QO8@ER!'AGX!MTOZ+4&]I"TO@(B7.KW=1OC!(=HZM!D
MR9"I=QL#\Y+$(X0]G<T=Z?U.Y?W. ?5WKM_7^0*ASU15@!$.R>#".)#[GMDB
M7E50AB=WC8?'._%N%?;H>MFO*\2"ME#64+1XK+OCCT@U?%><14HBY4X5M5@:
M)BI6A+ZD$F0Z80R+'2'G 1IIQ4E?3,6\ VJSBF*\VDR"-/%V,R(Y'S=AJ!X(
M2VH%-N=E@6#,LFGW1SQCQ*#_FGBO'DL/>-?6@'=,$]1A&C>/@=""8IEA3S1*
M.Q69U ^$.9)4E=J?X:XUL T:R^R/)X0+ELG:,P#+8G2_12?GX3\D#F0V+@U'
M9+DOX<B@G*)1&6S(-"R;"NQ0R(@4$S*"*' 7,Q^ F7BD "HE,Q<:'0WJ[N'O
M!446 %0K['V=@;9 Z2$36.X8U)# YEV=1=O?<2;W\;^*1>%$(:J\1S6@XJ4$
M"RD6]S_*REU4GE#L*>*K.),/O,TW.'W[0(7]C(F&3K6E4#TF]GW%^]Z_)_S
MP_C[_&_?"G8#2W@)'.+<'V"H?VU,^X(9/P@7M,.2N8=3<A:@T*$R$(&G("I\
MJ/(#UH@ K$&%3QIYH;.I?8NPP$@QLR1?)9 >@2,-*X&H4^G!3+P:]NW<>?U\
MX&.!43W@<(I5IR,S8IE EX21@;K%?RR]#U*9UG.B^9AHS[3,C[L2 #*J(R_$
M]J2/VS8Q^E(JFM?J$Z'S7DG.);QZ!YWK8^'RZN+Z\OCPYOMUN%'1,Q(3D^$\
MHN,?$DX9@VIO]#_E-=IO2=6'>NGW9)@'G@4%\NSB\P5J#D)R6.>H1%$Y:-55
MYJCW]O\ $5THL_\<W,_RQXJ!P*,2C]^19, 4$2RP'C N85\3 ]3SW$M#<H5\
MB-7ML-X7LS OQ-%S66^6ZLW5+G)^(S,A@AN?L\3UM]:+TA>JX1*43SP60DKA
M,T99;5&,D"$A0(1U3IQNU6F%7L:<A%56?Y)^C!GW?)&SW"WXN7L'KP[<7H@?
M.'9"],@[43(%FINJ"<IX#)=[#!;/^9)3\2;'LU9IGBH:T01L0Z&C6<#P@FW@
M&YXX.I;NE;$]%J3AT"!#O,/(6/O1\,6'&DJ?JC/V!*6/_W0HH($,19#)1)!C
M[0P()B^O=>(*T]#SKI2=>06N3[L O&GWW%:D[$2FDG 2+0F=89G(+/#1Z%4,
M"UNRBYOZD*,H"+Z*SX2A*0@S^;H>@'CIU!X0#SU%HQI-20!.8!3%VQO%(QW7
M)'!_I'=%;Z"<K!@ CTHOVGY*.4LS8'K\"HU!('6 9:B^-(77V7?\4YE(*KH;
MT<6)98!]%VH*BB^J?&#H8X$7DZ!%)0K^X27_6OAU&3 \)M9(ETVVN(FAXQ7>
M I8S[<E$91=D UB/WFDQ.TM[\#@H:+:D:3TR;2W;(SF*#X^[W3XI!>KEA[&5
M/JK3!;H2M,#1I"K7Q^_B87;]B')%8^8]RC; W@8UB.';WM YEXLHIQ>$ 2&,
ML7G^(NXJQ:3&74$R#+S)C^D,8TDF3L:C;I*%$/&P-Y9"3K,FIR.E/V(XD,9T
M FZ Z4MJGYD"DV"<ZP@NXBFJ34*MA3POTPO9"S!^#M9JTWL+A8O9SHG15Z@C
MFT69T=&%'5B%-PB;\;T;-\A3UXDQ9LEOMO.>!U4)G9J,R7WDR4D]W6;\"B)7
M0\0I'#\>$WO[R>.G BS0%9M8: +G/4(#CM*SZ7[DFS6ZK,-+W\'6W7%Q#8<@
M[SF+)Y]3J\R5B#1J%:[D0%_J(X>-YL4"P302VUN"KR@'C^GQQ*K39LG_D-[[
MS>UQ"CL9F-\%)AOA,:MBJ <R!G"-P<;'<Y>.:>!NTZC54\])L T,:C\,BD^Z
MDV 3* 2GL&+FIAO<]UH4I-2R2(:N)(1Y89>@N75@JS&U1S(F38]),8(Z=^F*
M4SQ=AX1*+=?%1\4J^NRBA"[*&\OD$A5T+Q21<'S[3QI/E%'>89&Y[FC,5(W\
M@(K-2+=56;C5]*G +&"<5]@1B%H#>X(&P%D2=4:C[V=@6[:!GV%1$.#7$G<4
MT4AJS7_>PGBZ"E^!WF3>FKXCEIJJZ8=PUIIZ7Z&+=C/X PQLLW, ]Y$!>[2$
M12YA]0@9[E_!1"T63SJ5;K,'W39\3,\>YRL!G&'-7R/7AX,'>!YU'ZIB,%!"
MY&#C>4>+'\\*K^'B49-B;"$).:9S8^F6J@.8>*K0H]ZO4S(5)N0M*,'/[FD3
ML/LU6^56J]9MY^&F;MZR'8/>0]V@]C]'">W!UM<TJA5I.31_"F*MY _%#O/Z
M,GN+,O9,0'<F/U*7'TQG<FQ!6&Y*1?<M+R=$Z$A_Z\:M< T<<>LY?OQ7N_._
MKX_=$!!ZJ&&Q6<H1AO.,I6#')H=GS(=Q3W?W01 &8'_^SI^?OSBJ#AT5#];
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M HJ .#+I*T"S C]^84Z3>]>6I@G?)KYCG59+Q\IIJ(9@A9)0%1-_.5.G%,Z
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MA?*UYJC+C4PSAF57GJ(9;T(X8 II<"GG!FZ6W%VHIH:WY=STVTS91=QT9(Q
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M #+>I$4#7&\@7L2!&R(C0':8P$<]Q38TYV4\VKAN196?X AA=^-[KBS1.D_
MPVAYA*_0)OR-AR+05^"T#?[N>@FLD4^= 'U1Y07;G0)<,4>PPY4T10 U2C/
MHSN@,S G [WNN9\[AG*XS+&3R%$>?&:?@6UQ4_H4Q"LS=2M &<GPV_??EX0#
MPHKGSEE90&OPUQ(!U8FF.)KN>8W[68J!+"X@C*N5+OZXFCZK.[@O<UAS'%:<
M<(B^!:< /+[NP1D3.X0HB?,_XXCAV#3;]&L:GA<N-W=MGDLN,1 ]?NU0#%HA
MQ@S6$9B."(O!0HU4G^;&R.=^Z)"H3I00BR1S:PQ[J9M +@_/;K5\Q)MI.L1Q
M9J([*2Q'%?>.T(,UYQSC0= I[RFIDK<4 )&9-0/7+'?@$;]',%=2@56_1C@
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MZ%HIB=N@]&\UCG<J<#O-]LZKHRMHXF*V=U:MBK>J&8Y7KHLWYOH2%AHM-E2
MO34_]XUN2>KV1G?.3=.+W&&54@6Y4-;M'J)WHU<GPFFQJ<'(VU![X14PP-KC
M!E;- .NL:;#U],=KP%LPC6PT$5XWBY5+[;E&FK>6\/*ZJ8VVUK=@D]MH(BR3
M4[7UG%8M5=<>HK+1"'GE]'XKUOZ-)L*;D"R5DKAV^]Y&(^1-4!W.DW)&];=&
M=;@ S]=77X&=>:NRK,^(:0I'BFD92L^F*=;8]MI?DWBDJ]CZ.LN\S@#/ ,\
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M:X5:N;I,I\775,P@10QR9YZE"QV82QH2G\ENIY]VE/E;LOYF@&> 9X!G@&>
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M\Y0'3F F8 I1;.8!&F,L69_RRKVUI]EC6;=DTE?&DIH7^ _FIWRQFA=,0 O
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MRN"'36ARN6'N1?*U<Z/P72G81:$(? V7!>?>4&37DCV\.C@'34CU]ZOZX:M
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M/W__Z_+WR<>C? EM<^X8%1CQW<M:O7*UOM@*8[X;);&M268+X8+F)9G;]QD
MH;A]\ZU^2'LZK\:WY);>'@@?Q=O->O=#VM)%U+?EMG7G]FCM0*D'>VNUK0OH
M8DONZNT1Q5$ION]=G;ODY8X5JR4W?2'+?$[%ZF8Q/4N;NO_M7X&6M.3N+V21
MS[/[.\W=92[ 3,VHA?H0_#_1C+;;FZ@9?1R>_;5S_']?=WYOWXDCKCK)5V&7
M]M"O*^)_2*QR/D5I>Z/=8JI1G9GFI9J5> ^V;O;C/*0]G4M16GY+5^('V%LO
MW7-N16GY;;T]5&U[27GR<"AU];MZ>SA5V-7]^R;6!Z$H+;_I"UFG\XCJ[69K
MF2-89T5I^=U?R)"=9_?WFK5XP@LJ2F55:9\4I-:>4I5:!QBS;,6GAQ\/)W^=
M7,5WZ44Z#T?%]Z4@M?84M;0.%G ^[J[$/O\^%:1EMW0%QOGFNCGG%E"0EMW6
ME03&#^JZ3SS<;9U?05IV5U<0Z-XB>*(?44%:=M,7LDKG5)!N#JQ^;PK2LKN_
MD $[S^[O-O>7N0 S/4DGK!1M:_6(4KI^>YWW1\7[W3_?1??D25)I7-^'DK2M
M*6:1".WN2FSSVB;)#W=/YU62EMS2%1CFF\W:[F</=TL749*6W-:5!(9WVFNU
MK0LH24ONZ@IBPUO-]@_J15IRT_<6LDSG"[=M+Q.>7W,E:<G=7\B(G<^+U%Z!
M%\E5DMJL&K6UDD2)2+VK(AKMOTK>%_OWDHGT?:A&;4TGBX1E]U9@E6_.DU_X
MD/9T7M5HR2U=2>[Y4B[;!T2F,X3XDMNZFD3R[U8U6G)75Q -!M7HA\Q$6G[3
M5Y[BO=W<NDTNS)JJ1DON_LKSM0\(VOP.5*,MG8FTQ9E(KZ[^^?7D?[]L#4]V
MOT$FTH(@]@]14=K28=FMQ<*R>RNPS#>;F^N=W['B+5V!6=Y:SB9\0&0Z3:0O
MO:W[CR'AN]C5E42%EXKRK+VBM/RFKSQE>[^Y\Z-E(BV_^RM/V<8 _C)\9::F
MM$WZD4Y$VN)$I%]??WBW^>'O+Q^N#NXM$>F[T(]45'9KL:CL_@K,\W;SX+[Y
MX[WH1\MNZ0IL\_;]V^;WIA\MNZTKB 9O-@^^3T?2\KNZDH#PO9<5/!#]:-E-
M7WFF]EZS?9M4F/74CY;=_95G:F-*Q,H]27NL%6UK_8@RD<Y['_YN?3Q,7X^6
MT8]NDXGT?6A)VYID%@G+'JS -F\WM[Y/+6G)+5V!8=YJ[JY7<M<B6M*2V[J2
MP/#>?2<6WYN6M.2NKB V_ UJ"QZ*EK3DIJ\\71L8QAR(9-^=FK3D]J\\7[N]
MW=Q<AE_?G+"]I7.1MC@7J?]Q^^M)^M>_>__LW4LNTO>A'+4UH2P2F#U8B6&^
M^QWF(BV_I2NPREO+X6P\(#*=(<:7W-;5I&FOE\ZY@'*TY*ZN!,)K^[Y#[ ]%
M.5IJTS=;*T_3WFWNWR91>$UUHR5W?^5IVJ@;K:*83?>>OYLNITZS6[M%FW?O
M7[SSKRD*7<DWEVG]>6,?SB0LN,>U?Q7$X[#2@$8U&Z3^&]1HDSM@COA.8#_<
MM#^E"^9-8_MIXAV.!^.\\/<;! S:\/_C]C$_:+WZ%.H^1^_"@KJ&_X'#P:VD
M43Y%IY^Z^')KO[5O-45:LG'2Q^UXO'MX>?'[8'^:2)37?ZZ=CLLE[.Z[,+MY
M><-J"N;KTJ.($AM>99M?6MML>OFN>&_#R8>_/IQMCU^=#6[:6S.'E6SH:FKE
MZ_0+VE /KT0-Y7+K+]@K%#$S&WY9N[RZ_8[;4??/\.+#UW_:LX7@33.<!@B(
M9[#$:=Q%$7U5\CV3P_FIX4FGUN@JC"=-_Y#Z[)8YCVZ%>AE4SU+U>'P_+O(B
MH+[ YV%WG$7%Y%U:O [C'M/)W9SC/W]]W)ML!O&??^W,4M-OFMR*3W&Y' 5U
MGS:W&NV]O<;609W*PI?*;2J<FM61!-+2)?>#T2B.NM3@%<1.Z;6^_Y^MS<U&
MN[7=V-G9+76%E4]+XW2GM7E[Z]/7[)_]\W\^GF\//W2U#VAY!4#]X\X;@(MZ
M=T,K]!W3"OWUL7_R\=VK]>]UCBJ-/^]_=-LC(!^_%U%/Y'X4]AI^-T[SL$=M
MD&%JH.%0&^1J1V0_"P=1#CL<]H"\L3MQL<C7VP?;+?^P6UB-E:^Q W@V"!+8
M26I:'OAO@<2#[N48Z!P(O3/.HR3,<[_ ]LK8O5RXV YRL?;V_%_'&P3K@/5T
M0Z?=<PI:&K4&SW'X=^F5Y+AM\Q=N:DJ^P Q  8QQ_WIV%W:SDWX^&7;2V,?O
M;+9>_/;KZR;]V'[A@Z3JAQGNNUQR6,WS-///T-Q;8 I1GH^Q7?K$,'_LV0U<
M*_4[]NP"/V>&&L''PB_=RR 9A,T2>=_VIGC_=9C15+6G#8PW!*DX0FLN&X<E
MMKSW9*9(@!5<(*>\@*%?QL#;GSA<K[4Y5=)5W@2%+FK_^6\2? [>A4OTSK[-
M+8>-C./T&F;GC;+T*NI1%W661R@5@P[(BVIK>UN(N'("+T25KFHTA9_YK!Y\
M/W$3?)C'QV4U1YSQ^#=]F_P3BS1\E.<6[N,&!!85,1FVI*>572@KZ3,W?Q/*
M.?O,'0Y1:_]O)WO^R^&XN$PS%"+EJ=?,LW8#ZEUK#WGA_$U4=FD+.A/^!7
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M04C54A')7-8ER(.,%R?)>7I @^&749CDR@F+E-!)LR2T*XQ@$3&>SN!R_DG
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MF2"S[?-G3?]EV WPG1DK<W*F[6X?<.M"X&]!KB^RRK:MF]G4E/,JY[:M\QJ
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MB*;7F U1QU)*!#]USIII]X()T SB!MMX->E(]_5S<!4^6!M):FGM<AM3/TL
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M=\L[FJP^EKF'=S/WF+*2&[C'C3.U9^C9O(;F6=H//!4K_^B(6OH4H4[F@3^
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M0AAU1883[\TK?<'@(D- \7U^\(5?RR;7H_KN4/K7SYUY^8H<AF^=%GO_7ZG
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M-/NI!HSWBGJT:!P[ZK/E!VR"?!4(6JK6EVZ6E,) E@,";M27][,X=S>+%+0
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M'A.=$VV%6SQC7KAUKM78G/;6-/2<3%44@A9@:6N:.5F+M2[<ZML81U)EX)Y
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MXUY3S(M30C3(P_PS$*<!D='//N:<5(BP"D,AW8<&:0HJ>X![HJA(>G4LA,A
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M!XS20EI7VA$$"B;EVB%K#%.CI([,LC)[65S(I-<5J'51M$J6A@^-AV9"NAK
M,U%+>SHJU1;[D/R#FU#@)C1+P;HHUR4LI-"+5VV<X) YS+,7PM%J?QHUW&V
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M 7?N<=E@-.Q0<FO D%L8$,FE\JA:CF5RSZ1Q%=9\N:W(>3.0?.D4]*;@,";
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MSQ"UQ+]X/P<NR?L/Q^\VCM^]4L D--B/U4S7]U7YR(V5%Y0^KKI;EG..=,R
M[KBVN1>:"%;%8H:34?G)0L R&7$SYM)8]S0!+A'TZD#%:"*$F:\T5\PT7V@>
M@L9/2BFCZG&!DU0%!7 #$QV8RZE;?$SUZ&GF@"ER02[B),(SH,P_I4#+0E-1
M.=_C+#%54YV)MI2>-?QWAW\TL&5-K.K:*2%'?QL#/F0G@'1)LZ(/.AAL,^QJ
MM-CA_#L.>!1.4C?9<BR=>@PN-M'0"Z80B;WLN*4-?\"P.7J+%^GW"_^%W31)
MAU&7ZMXC8T"QV),C:/HO0Z8C)3#[,RD["A?H:^G[) S[F;:^F=:"@DD%3+;T
M6HE@.IHY!"X6T2S1^M4WS7]#=G8UK+*5)!&TAJA0 -@<3]&I"F2TD0Z";2:"
MSV$B%V[<78R#(&!#K+NG)A,#^*X:LG$9".Q'J8&.<W=5%USN[4T%^8OQ#RXN
MUSI4+24B-]#]-JA0;$0.>+?.I"%4^YE34Q>[LSZEB$I?;LMWHX$[B2Y$FD\I
MFYE:YK;05(1U6[ I7: +#.?DU ]VDHXE/E?4T261#4:/1'6AC#XJI5OT7'(K
M'3L5?P$W8C4'QIB'UM;)!.!%HF2A3'5XBK2:*TY"O5]A?;K 5MKI]1AR#>>J
MO8^*:A6O$:SS?QTE3!5V0%D6Y#ZT2]^>\K<4*@L*L,6Z2F-F=01#]-@9A<)+
M+DE4.'7O6JP],]#^)9U :G.!-R>#<('>Z@1*0^%023-_]S>HG<3N\I +GKG@
M2CY!$$2"Q4U.^P'C/Y&@$/(-%FFO'I-V,2!7>Y3S+H-1%:<3V%B;7ZJ0%R9^
MCU(N\96T^FG;U5BDF[/ARWR6+,@+*_$^B)W"T&Z:%YJC:P+LI%E"%=A\0 LT
M6B^C"M!LRA5^4G<09L!TAQ32QR<Y_TIU&64KZ31A;!80E0M<P/0F);GA:L54
M##SK>B[F[K2+@JUZZ!H5V0%95CW)IZ74+L #\IKZ7E4.J21:-H[)!P*W@\*G
MSZ0,%B9'@H^2&W!R.._A:+$8(TB*;*"22G+C_W=*;:D@5(UM"S^E8Y'^S 6A
MO%$+-KLWHUL8UT.Q.1"TV_HH9=[QK!$Q)&><)_4^M:Y=H,'[B*Z65AE*_+]/
M.1:GB!4@L3=*,=+I)L@18IH*(8LK1K' !!!Q2[@R <-I/[_MDE+H;=8V-6;<
M@H44\&(RPE0C/,-D0)PQ8; :F,\8JUPTU+9.3E%6X_O5S(!Z;UT2G+(.SW)6
M$1@F!*D ']CH@QT@QLFXD'_I6AZ"Y69H;\V.YY_ 4(,U3:M )MYH<0"$8<,P
MR"QE<P$:F,'/.)U+(\JA[-$I04&N'&# MQ$,7F-IX:5:X  T<D),U@O:=P[0
M'XG)419>!?"%9+#>&N)+BA,L:!5VN=;,REK7RKO:O3J$ +9E"1.JWGA=:!HU
M!@7Q2F.(QEC!"3I.@!9BU8%"87E.H6#X^FSQC!25.RW6 B^)6=@T2 >C(='?
M(J!LME:M[5M,EX7_2H:VA;985\.G5!RR=-SN:$W_)6'F\PCY8I3A#M6@I <[
M35WO@:@1XK_6/HZ@M)&5(U[8DV(A[Y,#0\STN<$-*-0@AZ*][8N9IW@@CU'>
M4I2W_1CEQ2COWF.4=[$H[S>,$1WH&-'%X5_^V\.+B^.S\_6/YZP MG5Z"B[(
M.1#V[*4AHUEEO",X0<&EY,IIGX^',"(#>U(Z;$V(N^E_8$3$/&0[]?SPE$,$
M@I5)C3_UE]!801TRS;2LR4*"<1/=/;U.J$,H:8SB3<6?NZ$7=!!1&[]AH<U)
M;FN#,1:X2U7:1=^$M!F5&ZQ4T2%Y2&@.%H PYZH3U*DLVM1O27M3MC:#+YXS
M*!O\EEX, ZH60%G%?<;J>V5FRG'MCJ3"3_)]@P&L-"CO;CJ] +FL2E3-I$22
M\!@)49!^G&2&#F$Z+ I ]2>,\8YHLAXG-A? 9PO50^CL]$ARML_'';"Z1]CR
MZ:U2(DZ1?R2$AL+)@4=I+W3M9?45"K;CR,IRH;'MKD$8L\^!B//^1,-L.G D
MN@DS)\"EXTP.EQURV#M*,@4))<0"BN='+!AMT6"U \L=I>E_$$Q&SP'^)ML/
M+I-^$Z,@^BUQ*2))LS=$IXI;=FVU5V_3?R6A15"4@Z@W#=;>J\/N"[Z(KX!&
MXWBH"O7D.F9I=3:D-EE7Y&A6"J&\C-N"3:B!:V3%!NJ0_S][;][<MK&E#__?
MGP*5M_(KN8I2+'G)XIE4R4MR->/8+LNYMV;^@TA00DP"' "4S'SZM\_:IQL
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MF/Q_QSIVK_P>[3]Y1D(@&\*U3.QOWZA @7RCT@^_+=OW;;QH\-BAQTG_87@
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MR,SIROSIRK>=+K^PU$MN](#-Q:WQ!P0@3[#;)YC50,*A<N[%TM(/O!1DD7]
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M:+FN2H+CT6:UO%^X+F'_J/>N;J#@EW2TSBPOA26W)\_X4#Q!_Z#(9Z0P@[#
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M<?G4O\";W.64L7LA>A-&3A1?E,A!1X&W[DGVM,EGF^QI7<TTQ JV5KHK_*@
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M1EJ(ISB4UBT9U$J"ER)[B,!%?HYV>N9_L2#I;3)\(9H67/V&H:[HX'!(TVM
M=!1G6H&G'K<-B:4N&]6[&A:WUD)%VL]W?3[2>HMJ-E'SN<LUG]'I A%JE[GW
MJQK5S_FJ!$S/GP/4'_(<NXQ@EQ$3%2>IG=I:8"D"B3-U/?.7K_06'/!^H]LO
M:6C\:P0IAE(K-O%LJS<"X[8M5IQ!@-5_0P<9X1L0@00?Y\DD!:[QP[W9*W81
MPZ9G%&XF6B9*(4LK.5@.J,&34K$0+JXM1&+J]Z/@\(!;%/F,0"(P:Z%&PF%
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M5CS'",:.$+!@+[(:0V,(4)G= _"'8QPC631+<2<46&/G@81+0_.R 3A^7EP
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MA,&F[O4W]9Y'*81'O?J,5A8/K)=K[T.*'@/:.M##9>4UR9_AE;".X.)5G5-
M*><3>JL+"7>3;TB H]YF+.'DH\B6(C=*=502IF.\A^U1P(S_#19+4<X!?*#4
M1 *Y(HG;<+/2AI:<5\'L$<C5$A&,R/P6-N'::^DH-FY"4SJ"3,IV_;GU0J@K
MU-AA/%54[ 3Q5C:YR6DNVT!A2YRP#;;ZJ!BU00;9H9B1B\W$#<B'M@A(UL$3
M8*GX(_[<%/N+IGO)45D!S/(Q% V/^N)V"3^M@8'*1U(IUQ=7R-I!H0IJ5@>
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M\XDI5 ',SA1#^]W9A!*.5 &O(1B:+^,>(T"YL&F$44>0%CJ- N;!<V-*1='
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M:D &/X#@UE N8B,?R@^A?9\0,AU/RAL8<ATQ_\BXOBOM+D$-N*S.[@Y%A%2
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M7.G0:WQ RRC%$Q_RF*;".+&8TN##*]@TY5A=PR"P7X*_2QHZ3M[E!,A1%>"
MD1GK[Q"!]>4NH.(]G)V7+5:Y%@MHGB!EG=32$D/%;3<LGN6!'(VD+6[KU1F:
MN40DWL$9.]56YI$CR3#!P2V'P5_4: 'AND-@3.F]HEY#B=@T["'8]L*[2*X.
M*#?F%& .$+^J(W*!"P*N< ;4\)->MB,G.$*ON-"+1@8#V]G6$RBNVBJKUB![
M>B\9D2X#\B-3^0&DD>565Y\% S91H HR#&#[!6ZN^H[L:N]PV]^A&!T"P:%'
MO$/F'YDT$QKD<&^*>U\U5.6'.ZC*YX2J/+B#JGRL1X[IMU_5O7%71*DD7XM
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M0RJ5H/K!7%L5(LSAPKLCT5@VPA)HV2MARE*FTA2<>^;'@NW&Y.(6M&&Y)9?
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M[A[4Y.=='D(1>]ESA'X+RPJ1/<#C(2J!SA[+=5YUTFV)/6%LB6(FTAT&08P
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M"[^:+T"A&:.YP^#4-X*=-TT>6J^X+QL[-'D2RB$T*>JV%V=)X>I&$(@9@GX
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MQA%@!YB-=O2)X@TJ*P7/46 SR&Q1SC4A$U[%15$0M0 OH\3<A8#^";Z%R1)
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M8BGSASMN== $G%?"&R7!!Q0^K0NK*$!AY&P3VZVG]O4X >YA%!*#\"8BK95
M4 IQ:%E\.I8' J]'IAWQ1-(*X&(B4*T<G]>@3<E^D-2@0DEXI<3#UC@(I]'^
MV!</^PL.+F*5PY'#QFY.&./.$)XZYFX+L$2J'SRJSQ@?B>TH['<5=%3-YZ *
MX)Z*>+UH&X3DFZPROGV?2IW*8A(/0QI@#NX^/Z;(3]OF0XF$8MC51:/0G@S-
M3)0SR?"L1>F91L.OBUBBR6?1)4%- 9+FO)A-;<+?)?LU1]RC024T+"62$B\[
M+17U.C%TKG:],K]>?BH,@W077H;<N2*+>%4&KU#@"H6@LM/ ^LD0<MA?L46
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MO>@-_$U%QH!K)'3RRG<2HD%&M?%NB1/UFQR? F<J.RW3#-!KG6V71##1KZ#
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M>Z-B)H\9WJX ]"_)OY#$ )%8E&&84NC*6?ERED@ 6UO+(81D8S*"(PKF;4Z
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MNRWYDLW?.$M=0;3LDMHN7=H/3K_,=K4W?%VJ,'I2:',\\A0%"%0F<.VXR=_
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M.V5Z-O@7='/PYZ%3ZQX:'54*+V'0::3IZE)6_&+&^?%5<IW0'S[]-_I9")!
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M(^Q$ISL (B'C7&@F29C2C[P67J-PO8<.F=MWAL'B\5M@)LQN[+5J4%N<58>
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M.CQT_ZMWD7R:C?B_YUS]04]\C.))?P;L'7^\PKXT3.G;VJJU+GXU>ORJ3E+
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M:)N71X%/)>@CXQ'5;XM+,R_KS2SB0SLPT.!P;20QC=6CL+ ]6<NM"9*Q7SA
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MO$M[$H(?:T-+DY-2^$HZ$:.Q6*,AM.L.LZ2=2??K1I=1]H^^@4EV#[^+2:X
M8-?6Q\5]8P+2'PQ;SOQB8JZ_N"EXW@I0>8?Q5]Z?)ME4>P/-%\41LAG&<1">
MIEC:DYE[(V1U\X(H3>'@-\E6>$<6M\&EH _E$5ZR_=GA;XJINY\^F7UH7K(T
M];D-]FB-Z'4ZY_%/][.XADG< E1^,3,AY6RE"=72&KZ"==WO\=X*!GZE5W\T
MA4%N4!"[3'['ZS[\CM?V\U%GKUMI8.!>KKM<G37(]:>^D:RS?\BRQ+T>_XS&
M\2")BN]XZ?O?\=I^/CG<ZQP?2F9&\PU9C_CY8>^04I&^XX5VO^.U_;P'-^;D
M=.&-^2[OP\(6.YN)/Y6)/PV[P4FF?#(;NK$9[FO=>]_QVGX^/3CM["W6B;Y+
M#K^Q&C8W9$4=:.^T<[A8!]I8#1NK86,U6#?FH'-Z\N/)E!]+^?YF)_XTK(:F
M$HPGLZ\;X^&^UGWZ':_MYVZW<W*\B3AL;(>-[= 2D=OK''0WIL/&=+C'A1X$
MNZ?'W_'Z?M[KG!S\>$+EQ]+!O]F)/PWC09=C/IG-W%@,][7NW>]X;3_O_A"\
M?&,@;.[#'>_#QA[8V .;4(*Q!78/.B>[FU#"]ZU4?[,3?QK6@ $ >#*[N3$'
M-NQ]E8SLDV4)V=\E=]_8!QO[8&,?/(4;\P/8!S_2_=!(Z%5@"@%O:$:Q^+^U
M/ZI7X[I:O"R>5'>/=LO!![D%^LC?LZ*,1W-J$*-/0D;;Q5ZOM4_WZ(7V&()@
M8C>WJB&B_(=TL^(C,(,VSF7Q4%R5S!T^"2JV!M/?\=YE::1@G$)^GO%VBL@
M5^ (Q:S_=S3@!H&IZ;*$C8CZ(>*Q9:D_C7("PT@'V//,+,/[3QLNQ?.]>X ,
MN1VN3J] &+:;5($)A?WL<^3Y-"%&S6^ #)EH*) :DD>]LRZC@2#XR#1#?!0$
M-D)HD4&6CI)X4$I'6=2UB]*/OL0(*WHSQGXX3;!B_-^B^F)!>"QB4.Q"&\?)
MS^AX&$$+B4:#8=F]][94$T;^O>=;U?;4?[$#^Z!F;V:.&\& 5%' R/%?PLD4
M=\X\HYIJ65.R)L$XG.I9/@3/E_Y=JDVPM1B%&JBA.1^87C[6,6+H1( W-?;;
M$FQ$;Y#$D6PG_-.<*X&_",0R(G/!MA-0C.FA6]FQCO^*\0T1@I)'M4<C.E!4
M8.]SKA _A_Z,NA(3OFHXB0R!! C0E6>AX%-.QW&2%=ET/"?RS0FO*+!($CL3
MPTA%(,#UGR,-5.8CNZ'3]02R-?H"W\URI#OLMPS+ZT=ZH@+IIOYIKX?0=B=Q
M"E_AB.5J]X@[M3TP;5CG[^E^:WA%I \@PJE%;A-L.B[$'1(..@!I@_WLY!X:
M)",!%PIU4\%A[;?Z,A--FK<Z+V26#&^8AGFIH& M]HR;V#8))(.85S3((T*9
M-&?AJ7-PV)G"4&I@HOVYA=%&&)$(I8$3AK6,PL_\2Y VM;U YEAA-].$U ,;
MH([:?8<#!3;7P+WLB>*BPAR;IM"V]A5"<WA]C>!-M'?2Y<)P)J_E=?4G0;^:
MQ*7;%];E9=B%6YZGF:D7(^HU@BTCA&B(JL@L8;!W0F F;*:"">,&5@(G"M_1
M@\@AZ.R3" <9SFACU3S"SR%L*G.QH&&^;?/TKBWND\V2H9^'N&L6)?A-E/"8
M%[+6Z!#Q%0EI7TD@ J8=$G>"G095*B(.)3*>R- S= ./#/*XC[N(V@)H0,@Q
MBQ5WD!2EP3B.X)>C,,X-4#@IORL.$DXR@0(6R4((P7X).]?Q7]I70TA$M^%%
MEN_BDL]9$S0$A[2.IUC&Z0QN-O ,PH &^_=ZG,U 24$1H="W$1<-(1;170C3
MI.O3LO$:*'@X*ZGC<9]5'I@&+9@0*,V2.OY%PSV@R8YF2-W\2\1 U7H0WY%X
MR@B?HM3Q7;F)DP2%CFH.2G#RL/]P^$#$)2A/XY!N$)R(%WXF/&;X,AZ0(ALC
M$VFX5[*]]<'YA(B].G,RJ'&XR\L;VL+T=G!ZJIEMP\R0^&[ 2'J4_J3_&?]^
M9DD8PMJS^/U$X^S9LH\VG^B)*&W2CU--\RBB@$R3,&<4<02!9KM08=L6BN!P
M/^$76_$V6\6A-P@+Y-[IK/@-/M:?$^CR#K"BB2/LPILP'_Y&;X&'U=/6>65D
M&(1((Z.8%%21%R!PTL<# EV, WJPP0&MF\;WAP-ZNL$!Y:-YPCB@SPT/88;4
MJYO26AK9#"=&\8Y\@OJ-L+8\FY),T C4GFJRTCJB*$DVKPFJ[7:D0QHB_R>%
MYGO3D(U*TBF4-?4HRA/R=<U,J?F=W_/J_@C8L AHAZ#TJ?<V&QVT7:@]^(8C
MLYH:%\8OQ$VF%8,OL#]C\6DG'*(?RU66;:ZMK4TR(M/!&+?2UXJI/XG"@D"W
M627"7A=9P883ZE$I.7;PQ=3X&P>BCI5X.MFP\+=FU$?1/6*O>L1 XMBB)2X8
MQC_*M\$,%FQ[>&T!RWV;Y8CQ790T.$+"4UN<]4ZT1HM-$Q5D:[MU&DT0NUM$
M-\5CZ1%OVH5TZRUN)<!%(I\ID3OXA*.2-A_WF?J<D[?# _5MQC"_9 ;2K]#P
M]*_AE(DX'3H6Q1JAPM'JGXF5K7B)<KB8R\ NP<^$H^^\)"SY2=8P12<B+1:G
MN$,4H%J6,"40\KZZ,\Z<5KI.,#RZ#;:*;4]YB, V;R0J4-QSM93*'%0OR<K(
M^-'51:_GM!%CX/B;<99$C\7:/E04.D\4NG;=M8G(JFHA>3#;K$YJ\$0$)SU6
M8$%H2>$+E+LH\-^\.5,]IG"'C5G'=B+V0T@BL5S0 4?F?X8J:I0CVR"G]$CW
M%= >1^'&,F-$WZ>_>&;J9 0:VRAC,Z]. YK"6$;!!*S&<#A=[%R'UB/8R#/;
M$\[H^8]QX.2^I 4:YIMFGFKU@AT!E)N:N'!4CI'!TBTN,Z,1+';>:0><N@L5
M-'(GT"#6/CH0'HO=OL7N+JTN,1'Y@Q+)!GOD3,$N0CI>ZD!#+MD4ND"WRW)[
M=_D3!I!=QY+8-+;[F-E^>G285 ^+?+'D5<5 5Z@[F>#'U"%GA+9&,@_J"T$/
MI'8.3;"UQ#2I!,6FV%V#Q(356LBKN\CLAAZ!N PHLE.@Z,]@-X=Q,9A17R,&
MAG^DZU.!OJ^OFCW.V&A#+.:JYH3-@3.2&+,4;";8!,W5L#UK:G,*]V7$A_0)
MM;'7(HH^%9;7CK@3W5=Q!2D^ISQA#:^'ES6<-DC#<?B99%W]2]U3+;3\LYXE
M:O$ 8:N >R!U85\ELV5:VC9=E]@=LR$<-%\4UK$>GV1#L#$>A<V@!Z]I;?@0
M]B^BMJZ+?.-S%0("^L*(D?*34N2MZ0X'9'L(6CK^*LU*\LQA1T*DK_ 3^P\Q
M5AU: C-T7RL.<QS,<<F"\,:LK^DL'XS18D-C+4RT*UYU)X+QM<80F@ *"A,@
M?>)&'-ZP^]4M<EB'PVQ:1HZO6MK$TN2PL9CL8\53S.W4:C?V43C)7U4N'*;D
M"+:\OEIAD7FV[XH6RRI,V,^S3Q&U% +)31H,.X@]*S@CYQ34?-;45@_]TF5&
MO*3JG%9:N!FJX[_.;K!#4] :QW.C].U+$>I6)RCZMX1WF_2,(DJB@?:8TKH+
M%?CK1\!_N/>4Z"]Q3C]E_[EQO%K,A8>@1J-,EF"I1$LFC$$WG D,0]KL<LF-
M#;**&$DQ3*-L5@1*<CO1,\6@M2Y5S770#*&,)MC-*\<^@Z!6PR(]%A_D6F$/
MN=M*=.[+X(L.%H,F% (,U'8#J>6QDD=VH)4Z)#O3>Y1[=8D]J?U;_%%1HTH&
MCVE^F$?7LT2UZNH5'! JE+.3=@%]95J#1G$EO\GR^:WFDF,X*B>Z@KTHL&68
MFI[%OZ=XUTMEFJ38EHQ$)#!:/ 1+>)318)S&,-/B5M/@9K6&#+DYF7D3WPOG
M$749*:;VA7@)-]RLT,2MYK',"._X+^.45=.P,=;*>CC%R>%T[1M\JWE4Y8\5
MH@],S-,V^'?8-+2TMY'I>$Y>.PI_WFH6=760",2PU"IWY+>UV1_&=KC#F31:
M%D\U"G2XB0*M,0ITM+N) CWM*-!9NYN"^IP:7P6RF.6Z"TC)'<INQ<91I+5X
MJ@D\I<J*.>(HLTYBJ)&M^*Q2QU$'*[220H9;4<PL_WVM';#E,G#Z)F-2UZP/
M2U;Q!]!_/F.6EMW%E+JHR_><!4+*3A&EV(Q3OOA[AO_Z!59,R8CD#\0?XJ,>
M2;8;V3RROY1OS5D@]O[4"G:.>>4D4?M1&K$#\D4TB LE:)5 56)%=^767=ZI
MH^>7N<\^!(RF8>OV@OY^$\9DGN- L!>T,^:5@^QSE(8L*[@/.+WNLUE[SK]&
M>[N?A?DPH-;PJ&S0N=**\;"SY#/+ -CJ:_1T<JMNU_71[!Y3[D6EV$CNI+5G
M5BZ9VXC5R?@$(H>9#\F5V^"7PBP4,EXHR4A<,?!UROT)*;2 !D)"Z4?4#I;U
M%3)V]&RE*WEHL@\CE?%,)@(9!W+^39(652?L.S\*!U%A:RG5M"5+CL?E"M./
M2S7Y@J<,K <-H8+&5,[G$6S0(,9P+AIT@64PF&/2043M!<!]]X9Q87V EHAE
M)#VJBK^*;T"9G10\BKEWO7$7B&:$-]5*<@.QCHW3I3-E"5*/*->0,=X%O!M\
M=)972:C.,H.9%X!=D&;^]2RD2%G$)\?! FLR>-9HP0\DGXS"&S#*W'A$\)R4
M.F=(B)3;1W%FM1V!I*WIP([MU:7H%^C+J#,B?X*-S/-PSIXDU>A8=8<F@LNC
M4JPAR_BU]OTZPX;RGN0M8M]LT]<8&%PRO,&/*";$?<)!?YL5L#*)W70H(D%9
MYLA11GDV85\H6C/PW\ 8N.*60)X MC12&#TMOB]AN04H@V[N+;%5>I*L)\G$
MJRU$N'!,=WD0HL\&=L48D0$H(M<<?*!P4DBQ"$_-ABTPI"V6Y=IAQR]R&8P6
MI[;$A"W\16QX8GTI<57)"X6IM)QWH"*:E5-WKA5=P;GDX\_(_C'3%HN:N9&Z
M-K+9$MVO)#A304@;_=%=0C,Y1I\?BGPB([RXF&NON(*^VXX-B^Q"'JB*(%0Y
M>*>:C2SK+,ES57 ?W3Y.,J?0YO!1[NF5ZP^PZ*S]4!N.4^N*M+BJEZ%2Q*+T
M#>,>HCQ<3Y^@M<^#.!_,)D494N11JU%\YY12Z9X'*87D$QA0#3XE$K/+.L)Y
MV,/+#2*/.K5#CYDCZ0=TXWLZ92)\I 6@?O:<\06NN(: 9:"O31&7NJ1^=@/2
MN1C'4R#_$1$@NK(]K</8+Q[-2F+^N&%@":)Z2GD\%CU6;H/0E>0SZ&1@7](S
M^!6\,:L?;(N#L:JST_Y:'JCHRR"*AE)Y@6HDCD'I()2P[P'CB-+"J(S.+N76
M!I(G#6-9%Z;8PBS-;"AF?!2H*;*?3JX4C:6NM'V3837X\2>LCN!:-BY26L3)
ML"0D&H?)J.K8;-P2\H=:D0]4EZ89\VV;L1+G(OT\LA1Q/3^_C[$J2EVRYU^7
M-OVYY8?4LR+C(X9; &)R6&&E][90G S?>[5>]$V"J/.H1*]B? 7NY-02\%/#
M//26H)3C7=DR>H($1_F+;;9,6U<#1X\T760)1XCSB/W6PRB:H"[,E5Q@  IK
M2'!4#F^J$+1+G(I@+=&*.ZY)41E^MA>XD%W':9.T)P)U=\:BX<=*]:%Z+,KM
M+VA!VK-:+TJ2++/FFMC6<E"V:0=<&<!OV J=/%(@H6(&? +CCQ]G<&;=HW"G
MNQ5N;^UM\[6@L;NG^P>8<;'MJ^E:I"HA:,H88X$LF21H$G+.SA#=:3FF(5Y'
M]^26O-5F/WS3^F6]Z=N\AKR4.GA#Q8/9KWHP5ZBP=ROI6_J@WUL[\ELT@]=]
MI/?:'+9+EMOD2*W-AM;V@@GQ(Q(B$O$YUQM=&GWFN75GN-NW_YYNCA UDOR:
M>GNO!.^17_>W]G8/@KW]DV#O\'![77!2FJ"/CY\U],1^"%P0<Z>>K0' ZVZC
MVZ1&$O%^5KB'[GY$-G@$^(RVC5B)'/_"R3Q03\4GAD7S,&^Y7X)[-")[NHSN
MB;?@60.0X@]+4NMF5@J-_8FQD VC^DX8U1,$^-RPI]L14@,R626I9"4S5PUN
M&;;^XJR;HTW6S3JS;KJ;K)LGEG7C'#$9_YQ*$P__ZZ<BC(]/=D].#O[O\4^J
M2.?L_8MS__U+__SJ]<79I<\V_J-$B-#%$#2"=BUP(\L7EB?#Q \XPU&*]/ K
MBH:IV+S"N< P?3:DTXK*<3PHO"UT> @ VYE\=4Y?*?0U#D5$1<&^VX2@D\9Q
MGQ(I5*KY2.&94$5>&B5V%+K9=1G4H[3\ZS!Q_/GT>JZEB730"/-6R _)T:(2
MD[$Y/QU=_$YQ12C^=16%#3QW9KC[^CO848'?X%@'AWVM+!,W7$05/-6<A@+K
MJG7&BU7\@YD-G()C[PZ=/OE<I:0RX"HN3'#'PJM1)A$Z9R"]T9+VDTI&/@5+
M&_;1JT!2Z9];439\B4L#G&JO8BX-CN'*KRT?OH_4"W/'ZH:T8>@.JNI)9"UD
M^4Q, :4)[]EQ2I6Q8><0>!1%Y><;Z^FHHBRE0T^P/'K(I?(FS;C4]U7%XX89
MR+>.?X67FT"O,--!@6<US'T08@#(Q_IVJEY%U0*I:YC=I$D6#E5N _[T_,6K
MWD?_10@2A.)<O'>7YV=6%@%&32,$W>H7,<8CX:\W-QW8B<YU]AF3I#P%!,EI
MVM-YR\0DZI7U\183EA$5I$_#N;H==BQG.)LFL=3[4')U?[Y"[F*T,PGC1!5;
M8+X]I8F7[D^)40ZC 08I8=Z_<F0"-^JGWSFS,$Y'V?^GUJB&>PCVO9J4.=%2
MYL/']__]/_X_WU]=O'OE?WC_YN+LXOS1A0TGH$>)P%F%LW*<44D*W+8F,82?
M?\[*R,/,QUCBUM9=&X-BH6)9?#F0%S:.- X97'.6I]8,!$_00;0T<ZD*OXZW
M .#2R<[D))HY""S4P>)BC,D4".$XF_B8]3 ,\Z&)PMMA46<4LT&5Z+YG3>HQ
MLN\O!%V!8 $^<Y03TY!2R=UE*#Y$\,1_,GS4%ZD\"KE$B?90/68P*_A!D^P1
M,F*$57Z@ZIC:2[,H&PCIQE=T$Z<"+$H9@:KV4!WG!WKG/WG/7\UBH \,S@=6
MOB (=TH]  I#5 T]A-\TQ <^?(L6G:^=O.P+!;]@_>B#3A(,D/7WIE-,Z?WB
M/V>I%!?^9>_B4<Z];<=S3$F5(F 0)!*-I0Q8IND1J&Z48%-X^KI)#2M#KC &
MYE#?'SXXRK4EU*%_T0/X^30K0M+L'*!ADPUM0.WT2_V_9\-K5E\YR=.=T:R$
MF_\OAN')9IA4 ,I&).G+5-JCWY*.B8+X%:'A&!%&I5$\4<&23)(03E!ED?$L
ML&!D.E$(*HV2N7$^]##1=BXWP,!((V:$G:,#>T?E@ZC J1F;S!J3E;U#A=FD
M01K@$0552R'Y/@M2A=?)AVM7;CO;U/&?6\@J!-O(:%!RQ+1D'ND:[Y#FS,MN
M6<.1X&>I1U?8SH!&I2/%D3'M(YES\NYG=2)N"G>A8%T<M?9)W1J=R&T2T\E@
MBC%?#I_ 4Y)LS,"S4H<U8F=15)(NISFSX^8<?*(U(.D$G0;JFFEI,U3U"(IN
M%:UJ=,&,5,SK<>FY1TO;_!P+!\A<D1D1E9DZ LIJRT8N*N$@030?J:!5  3V
MI$ -5D6Q9*A]D2Q5MF$\3F*'KS%%A^"]PP3U!/6K&K0AJ9.,!C[)TKC,<H%0
ME!K,H<*)P:2B1 ";G;2AQJW%#3&5"8R/06<IE<=YEK 8DJI;E7IHCJ)J!;K;
MH.6__IHS@QD]7.6Z>^Z%?0Q:9Z 9!L;MBX: >;2<Z6G2V5.[D(-WJ_!">[N^
M8K>VHLYU)ZCNF*N@V3N%!@J3[X0RGBAY,U0U03*)S[J2FBGI#MX3J9=&WJES
M,;<)OROF:EE9?Y;[]GN]S,60X 38N:IV)SJCFE"IN2V*;!!;"#T-OR7!R@ A
MG-A':H5U)'%A;@0K:"!+O'$\*2+,(,Q]A&C!O]*U#*F4094S*0E#_,B^RZ+_
M-4SG44I(X]]!&D6D;WWA.M98W)@7EMC'I%1&I!]G-_X<9#D#G'_.!(R"-$QF
M1 Q;;Y9GV2H6<)B%<<>OZ^[M #,JQX*^RGAB+.G^F*41?[R_2S!G#%N=1"H'
MUQN >+N.2%<>H$1HO!Z.\/T8X0Q1D+^$5?KO=C[\M])UG3<HG 3" J]<)F/V
M\^S&93G]]9=?T 60TI,=.-I?HG1G5OR"?#0:[L""=LBK(<(D]ZI.!<N78(UG
MS.T'H)'5[.Q38V>__WCU$LSK]_[5Q]Z[R][9U<7[=Y=^[]T+__G']_\X_]A[
M=?Y89O>EX\ORBMD4JV0*"_+A.1?[M;$K8@*NMFYNN9T(39(WHMHU3?!VCCDI
M>5X:76=EK.4\J\I4M</-$*9A;*##7,P9%UR>"K&4[HMP,@@MR=AJ5PZ  7IV
MLL$G3%P?8\I%H8H8^>7AG/4PXT$P8"+HN"7EI3 ZD0.?QD5>(-FTFD-/*D?C
M(&2#WD7(AROMO;\Z\_N2/,\(';1P>Q:S8B8>1M+ "'L /F>5A&I1:<W66TD6
MY)]V9M/*'LAT\*6""C) =&_T1_:U@Y<A_VG=.SPVJS!8@HC5==>J6LA7W*9I
MC[A@AU!(D,W@*UV'K_8#H4N4P5/0@5]]4(E#%H:JA@BV*F7_J*QC$GXB1S6\
MM&G^L4 :Q1HL6T/)B*73BLZ>@65TK8T^=DRR=8&P77')11L:0(4K0B4*H96=
M2A49SM9DTB,8&CD7;W+4CL5O4B#G4U>"YBX:N'Y4O)Y/%G/A>!/]76?T=V\3
M_7WPZ._M[LB')MU/%3;*[1\:SL;:<VIX =>.UYFV#LT8-J@9G6CR=OFI "-S
M'0QB^HJ#%LOP*;C"R%"YA0)5"<-H[8^-BDD4<A>9AN7IZDMGC31CT2PNW-(H
MA%VUJM$RVQZRBK5<#SX6GTT%8$ 7=VL_;/?T8!<K1QZEQN:"I,RRGA\2$R@S
MCRO\E<?*'($IA'$+)!4$)"D0[0"0= [:$\E'+*%#^,<$X0!($@XC=K8$9OM,
M)38\H:)V>32=E:;SCU(%/T=4N28:G%9%>&!TSD4X!F')._C/GKO:CO\*AVK:
M!Z9![D"G4!'ZT?(-Q@)I7#0!V"$J@KXC2/V.SSCP1[,\C8NQ\<3:OMXMWC"$
M51O FO >D;=3O,(4Y!!?IR#=XZ*S23S 78-+ G8]]?["_2M(=E@^7%VMOB#6
MY#-1X;6:9D6A@)=9:PI5I9/ 9Z?.Y+G-W<(7ZQY:=$MEESK^94Q 9O1FBBF#
MS2"^2#S/]ND:U>DF]?2.@BZ(6Q%(6!Y>.2W9U]:PY;)8;!*@8/M@YV<(L ?R
M@=!H4V29RV:  Z0$D,"Q_86WI:^N!IYTU=:ABX/[;>/>Z<I-*P,A6*I15IHM
M,9V*<DY6UC5YGV8$E%+35^F&@J2^SE28!"<?H+9(Z&_,QOI.M3*'5915(<Y9
MNS;[D>$CK!"F7VLGZ=2N*U3AU %(-57@HTH-JU6W;#(T2@4NI#  [-9E5GZ%
MV)_R>\Y?<EHWFFZ2JED?F==AZ>[N,I!>3P&-MZ3UZ(98<RJ$15P0) N8,F'E
M&#.< 7 9[\*!9$5S7/J6NE%S)@E/KU;A1>B0DT8:1NS:U.F+A:HT&I B[04*
M5C6#(D0^JXL;73%C,?=EIIDT%/*HZ92TENH),*F#6*O!V-5/?/,3A@UP4"),
MI,*1<\A:KEG69'589LM9W^<VG0KU@7*7$+4Y2K*I.*&U#X/#D4W@Q':$HWT>
M:(0+1B]#9"#D=IA0$TP[!*<8AV2@H?(WM/0>,P-NFJ>ANZL3TKV=9!,]R\%R
MPWWL-#30\GR:;#C<2;)29<"08TB:5!8"38!EP;1+-J*^[8HV%=5T;7_#4;;B
MSS+/.G:C&W .,;D,KX<%@DM[-,1@$J(LB')MR,9:<0P**)([ZAC*M:/1+OIV
MR*("3J%U7=,C*U)\F$*5-M*N\C]4>Z(QGI8!4V)!Q7%0:Y)6Q(\#*LR.#!8K
MJAWD;M%]+)5:[S;OL%F=\>YF)@^C 0*'E0!\ FF_ZC,TF84*S\P:V=;\VR2B
M9T-:SLH;3''W,:AAXT\91LP -ZL,["?HH%)M@JOP)ZH%11I%0ZQ%UUS8;-'C
MP-?.^DAPDMN*Q&1)$]/)1O?_\_C<#6=41J%PTRO2&&!QE%C!_A02!9P,639!
MB;2Y/NON2:4<)6'!^ 8H"0I4-:E_S*]-.WC7R@-64U:KI6=7SU>U2$<OQ*^8
M>)6M6FFO?YISE0;^]J??J9E[?OMIH"MFA[TS,8D.&/!S%@_=[NIMU?QNL0;U
M%[_KCY87R__;+OWQN],ORM>VL$JG'EIYKLB-7WYF:,[[ #1GRM]77H55!'/'
M UA>=W770R*GH2IV/WEF^]+NN2[!H>5N5"V3VH&/?OK])=W8U4& J>\2!R6K
MR"![[/A;Z:0:JL!;Z/56A5(R*&[KSU\W4D-9F)KQ'HR^%^R>'MW+7!O+X.^5
M:311LZI-74RHWPAQ+J#)_5O0Y/T1XOU3WT^_GQP??MV4[H?(ULH8OWUZ._AN
MZ.WX</^^Z4V"4?Y#1RQ?F*0;5E"]12=H16R'H/&RE3=W5&%,5)!>(X0S2/4$
MG,4L+DWE8EUGA+9[_PL.!Y+LU02%R8C>C)>6V\U6Q'%,:>H$?LCX18SPM=O?
MZ7)(P[,C-(P4-U+>"XX)B6^U-O(*E@RB[]5_J)W@#._L.7TF':/*V$$"25TT
MF,TJ B/E#:'4T0GRG]GN-@[AX7;_6@,&6R&\?0L&O5*@^YZ P6IA=K+Q;J12
MO0\[^9.H][^\H!-A=F#&:WA^0>7^'=Y^04>E7GM'0+#:BQJ"_JO<\*)!8-79
M6*NAU-,T:F#!IK_?JH''TC\/L8[7YH;=[^29U+[=C9%+<MMV/1^X(>56V S8
MN*TVQ"'[)< C;9K"70!)A._L'SQKNCG/06 FX;SPS[C#0Y5%R*\/%N.FJ7<<
M+W['AS=G+>/OKS3^:>/P/R_Z"=B+C0I6-SC<.PQ.3X\7_G@I2-KJ!]6"1]2P
M6^\^($W%_;!8R#A7&<"_[-UV#-F?VSV]'QP>[ 4'Q\>/1>3U73@#I0%'F?JO
MDJP/6L%;1I7V+])!YVX;:X:$,1YD7TE!VOMM/;NZ,D6^I>HU_[(,TR2:^_\>
M3L#P.,ONN(ON: ^RC=U@;^\HV#]]-/(4H;4'0JLW+;,B*,*TV"%YY7*8K]M,
MQ<11&^4<DS>&X_X A/KG\TL;%.4.BS?CO**+WGOU0/SSX'@OZ!YWGP[__ M-
M(?\E*$^9M:?!W3?5'E"QD*=%FQJORWN,K&Y_&:K7R2:O>YUYW?N;O.[;YG4_
MC4*P[JZN!+OJ_;?_MG=U=?[Q\K'JO33843]*LAO*/*$ZYEFABK[$N^?]V;GL
M^*-H2*FKV*D.4S_"+ZH,!3/-HCRU2PEU899*,@NLY@C4SH0Z8<1V==<9-\ZZ
M),BFCO]<>ASABY+PIO!"*A7&S*TOG*0ZPE(8+M4*L-32+\:4^"*@!UQ]B3^7
M7#4_[*LV)/BITYHA&U4R]RQ@=70K4O->M3?>,(LDV7:64W4DEZ2IS#;IA6M:
MEX>473>-I Z\93]#DP:D>WLD$6:WX&CV]@@^@6>WJA @"Y-CYF2%=_P_.<G?
M=-U(L215:GFM<T<P,"0YW% ",^'IUE\O71O(C^L1#6V;?$C\-3[&AR P7-0
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M*],:B.T\DJPRG'2GD@^71]S)3C(@V\4?"DF#1**2)=22FO.OOO7KYL(XR$$
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MTFUX<D.=) MNN^24>906D<QW0"6/ES [L/($ZE5A,,UO<*,Y+3,NLDPA1%S
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M;6FWG-.,3P.K7-3N740,9]Z3K-=M+MOT]ZT=FH3<=$BX)L8E8PJAJVC>,XV
MY:^<P^8_>Y=CT4[M1^%XFJ%#IQUX]1FXK^I_X>F45W(K _ 4(XSF\0\)=LK=
MS**+/":+%U8*62=2J0^9XWW(PQYHC-;&>E&46!-J&ZL"# [BW,%4")\*W#NX
M9;*>_8'P6240/XD(%C1*QR A$S*Y=K2==A8V1T"@!-U6XTMO<J';P,TM-S-W
M/ 5*K0YOP= 55"ZHI:Z;NA/?DOZ*,)C$VD,'PP,.TBR?\0!HT,1]$)F*8.G@
M*S5T*371<@8DZK:URHGO:7C!#NC67&!2#T1496(6;HS4^7+69<XH.!Y!+?Y$
M95K>*?"@*P4/4BP@*;XP748A3 UFQM/8O"8@S"6V+<-KW2NTP%#ZB.NP[D1\
MGE)7-M2JQHYP0GNAY7D,FA$;#>YR*A#[I<?.Y/"9(0O,5J53%&FO<VZVU_?4
M8#3(;7.<!':ZW&GBV(B58<JS2E2J828BFYBQ1R4<7!,G#SMM;8MV:A.ETH>G
MVC#J4A0_Z[Y%[0S:ZA74T''@J+0D =&V4_@(WGT1UY*DC=W(RY:XC</--M1>
M&+;*U2%1Q> J37+"/2[P@V5P^+&;P3FK<@PZ+8/ %U8G*0NK1,;<!:>)<,T6
M8V36'8?FU@W(:^+"CE0P[Y9?TN[ZNRD$Z4JNBH8,$78+V:B5^27T)1/'!)0J
M-#Z> /?1GS/94Z8R6I4@S^XZR/.809ZC=9!G-8(\?WB8FJ/#6G5!C5@YJ--Z
MC*?54.B=M.*7W0@FM'+;72'#M>-Z46C"U.Y3X9UI*\T%(/,X+=QNZDZ[+[#4
MTHR ^+&PAM3:L%_;-EBUUTH3$=P[E".I<7741C''FJ)ZLS$Z'*Q'[?CL=9)F
M]<J?NWU]9FV^&G_S/"H*A#WI_%NK*+ -O94L[^/;LQ/;;HIY3DUFW<GM+DJG
M.T0PQA.3H_XE^M;M-70!G9=:]"6)'92J5-'(W%/.HY1IR0E9YFEY"$8V\9/(
MPDVOK0Q:FN&?*;-_@,VZ\X!-5"^O:_+>#A&#%X+0^=4,D;;VI8B#)%B:O'72
M_]L\_85C#5X'%*MAAAL$?)N"-M,7S\F HL%0O&1+27/:>/@K$9:.FW]GJ'V\
M4=/\.!WJW1Y'0>W2<8WI*,3:GJ*ML;4O#=PK&LR+2V1#*SGUR1>^;/ 4%1Z)
M$1>$*%.![>/IMA$S"6%C.KJ^@4!!* I 27D7$T"_;:@G4JS/7B]\O&'Q#'!*
MPC !S3X7D.F2V%I742TMVTAZN3'"TC9V]^B;#%)"GD:W*!<+V_Z<'R7D%CR3
MMFZ-7ET.#:,!W%;II+V<>$R,&!4^@@:8I?C2)! "*;0U%I*:?FW9/Q)0DLQ%
M2=E=[T'8%UN@&1K(:^;?383/$B*]H.,(GV"ZIM9.I9>A).$IH(N?BU_&I-@-
M8G > T:V!2=%$6%SX?\Z?6N&:<N#!.L,4X\^M:VS]3IGMO91+:6,U*("2-,Z
M "V3]V[V:K29?I\R5<-E2:G2430((JWV5^5.G2[Q^Y@[._\"MMR&S+8%S1#&
M<P@6/6?"6]PWA0XH7J"&?< L^$LAZQ:,LA--=O-( Y^$OE9)Q?@ Y05[]IK%
M2SXJ08X8G81ABD)7]@+I6L]>\7B,)04,*Q-P@=98>2!6^+7[$% /[WGS<1VQ
M13S9]2X57R'-C-GMU87 99H*04;<@NQQCBP*Z24&I.4A+4I"C!;92_K:&/G=
MRF(A,$+Q-I34].4Q:)%'IN=#6W@!8IHYE[A6;3-\XW,O@=2Q'G29BTRS@1L;
M#00UVBP-B'Y7XNJ7Q>EQAOM?:9M=EL*X&3?6XQ15DMYNHR^ZWFP_.^2A/FFJ
MMZ9^XP&/02F0(9OV&M2).=(TA8?FI*R?#(B'GHPYBDG<%V#;M;Y=S-&(ND7B
M;F"OK?EI@1Q()B,W3@J,04D_(:=P'W5 43\DT9:$2W+N4.G4SRJ0NM26V.B?
M1K;+MO]-]78R @2 G6I>AC#5:%0'63'_GTQ(:WZ^-IJ(5(!Q2IU>\&RI^"4U
MN.-*5!MN[VQ15:@R:)E<?+E58+)8#&"M2M&&25X?)EL&*@+.M*@XP(\"]Y&W
M:PC^PMD/3B=?KWN2UTW%@;/29PO-0V,. U,[D:1(T\C6HND0;3^&:Y2-(.-[
M1;Z=@B .#SOCEH)=%UK)@N=)PV9P9O5X*A!Z+:QKS=&U"G\M..]]!!T"M,>Q
MQH0V&LAY7'!% 4M^8"3?,:)EX4N.9-10DJL2;-U;!UL?,=AZL+4.MJY&L/6$
M2R;(5!K%@Y+S(^2<)9@&<JL$-4F-3)QQH'$']<"DQ8#DI"-TN/61&AX!4R"9
M2I5&01D[+N:WK<6<V-8@1IW'!ZHB%O@Y!@6G2#VL-"6XW$@A>?$LJ68*$R*5
MCLFN!F_F.!H:&P6T$4\_6K*E&+("0&?%G.4;RF*#)NT,ZU;_CB761&_DQNGD
M:"9CXS$B4*XQYM".V8RO%4_HC''!8!Q@O*('@QIZT 8C6D>(RR0MR?V'VT8<
M#DR,75)=1!SP93*-+RBH9J-Z3HDV=7S48YV2BNC6I."19"1EP[H0OH@W+Y [
M(ZV#@/! (Y/@]/,'G;XZ)3)6Y=(L([K)8$(#CA?BD6-8+YC=UG+;TG$M14R1
M5JT9L"(C9AQJ/HV<40C40&XXQ0ARG7(\DX[@Z16\N.?/B0&!H8M277,^D^VI
MD(A,226:\)[+Z,;KY:1TW1F<&Q94SI-*Q\*93/BULW;!&,93,2#"[OJ%XT8U
M('NQ.1H7D.%(![&J^P,:ZW2E_ -E8"JB6>R%V)+"-"K8#$]N?B;M\<)!S5DL
M+K.+.-A<U1'2HI(?%O##- F/E\<S>I+8WBAR2A^%\9H9-1BKA8X&L5$.2HBS
M"-4+>R<%VVSZ'? N>?ZF-2J=A;)F)5CLPEO@F)IP_R)CW2MJ-55Y56K;G+KN
MK0?T8$F2Y3O[=$X-9JU-&TB&PW\%XY+<\8I%+F/"> ZZ2R9"YS\!$X7#6D",
ML-CL'SM1CC*9<;5K8(;L!.@<'(SW)!8VC1]IN,T6Q8HB<?USMVXS%/WE5=O8
M+H4!,?_/".2EK@QY'@8>8AL;<3V0C[FTCE)[$6MVD4<SFPRMSSUW2_7Z &HX
M@.;-3@92OI-- #*F[IN+DJ8L!W<FXB]F+@QXX32ZDI _HSV?6>$@\>#^"NY!
M-0__M#&<Y\AVZT:H7!VJH2E/)02.2N#TRW3JLH/6TB:>MI>,JEIY]69G6!*/
MO5L9^&0]>_&3>1LD.=<$#LO X!X9E60Z2::5=@S6J+#Y*E16YD+>DOA62UM@
M6DDX\JT.^W6]B_: EC]P0GB\[YP?>!R"A8,;V][]!YZG"SND^A!GO^[?&$6F
MP=LH#AQT:HZ:%:<]M#EN'FOHC?77QL]LO*+6U8;/;FVW0'=@GE>DABU6-$XX
M[A/4 C)&"2TZ7!1&<>TR=SKKYH9QT"+AMNAC,""38F(!C'BVK$CP8G\=O'C,
MX$5_';SHA/G]K000W53!<SOS2 FYK9)\<D,\$%0-DL(*F@TF#';)Q&M]94=(
M)H<)UBW-L!@?BY@R*3$F54@N8W;)4S*VM!!!O$@>?Z,?%L*<$_:EFQ2?4@&%
MD&9EM7*RCNCD8^:@%FQRKZ[SRKMV@*FSD@H$AT"RUVY@FF?K$>:^BD+B]CCC
M:;0-<&P#)X3HZ'/4EB4TB'@,X_JC$9KEO-C_0CT"7?K+&L6.M(:W[;?<%)V2
MBJD/T',):MF>7D"=_MS,WC->>MPAIXZ\GJB\/C>%<.:![WQJ7M$$S>T9U+=G
M>-?MV:([ZMURR ^]@7XB:"%=U5& K,(C=K;^0=A\Y*$7%C.*'L4O-6F,%WJ1
M0V/A60NREBSVVR$QU5A$G>+1GZTA46S.?W$_+$/-G9LH]X*JUL8M^%YC6@>N
M[8LCP,]W;5PR9\]NVY=KP:N]^E^L5\ %\EUF!RFVH)B% 4K, D2*ANC +(>:
M75!:SMI'A))'+#+0.+&D(Y%I8\2W&Z2KH9$G(E\5.\YL\M<*U8;O='3$LO%$
MS;P7+*L]%8/(\7@PND%%@*Y4"\#&%?J(JE\=/%:MQS7.-J]ZL^!_8>=4E"18
M8R]@ZR%MZH+B"(=I1+I0!\" I\I>UZ*2.)J;9BG(,3G: 9BI5&FL_;09I@9^
M_>2Z0-\ ^V3(AI#3_8^4O,/SDN#_VBZ&(]?]PVWNT3&J3#C-@SL3T Y;%OCB
M&7CBZ7(!P5#P:TGYI;6]!C/A?$I8_Q0.0A"3XNT^)O _!G\O'R252S $J==,
M8M/];"Z.-<&H,<M&/&9<C&QF]6YS&"R=P[:LD*$RY:DP!EZ+8?>:!Q&5@MJ<
M<( 30QW*&R B&*@(.D_)O-;$5UD^'5TE(W/>BJ!>P(E9T;BX2,0/<M(SAPG&
M\S%NXZ8^5,6KY*-N5R8A22.UB;68^=%2>:@A>98&R.J!L<9A4(>FWK3Q)%B%
M+.QV^K 9,+U.S&".^X*%++!IS,O$^5]5?NW'F^$0@KG$:$D14$[/)&7.8\,/
M\!G&_I[@N72T]K=?-R.<SP^;Y]JL/X*]^M"V:NO^Z3'F[![F*D4W%S0)??@C
M5PKAK\VI*T72UIUL:2W4TF*JQ<BN[_I[*+) -0^/<X1HBS(9NAE8[O/ME3[4
MP\6*\/6'1["'/$JY]':LOFLRFQ-MB<SJ*O58.%C'3!\S9KJ]CIFN!N#KLX3$
MZC3,[8:*8GH#![6*#F(:TYYFN(VK9#38=DU*@?/D>DI0^94IKL>J!>SZ\K;Y
M6L9E-QO1!V639CK.FV!UC;Q)%X=EK-.16Q^JYBXAK)^9C?'V^//)<?B)#B8.
MJXY<RPE^8SV6YV9S<$7X-+Y("D[6AU]2% (;V:&OUU UD3FK6!T+'Q6:ER>(
M:D@(X74\+%_>4 %F+&PT\#,#H+/N.K6%KG>/<I'@Y+5H5IGPT@ZYA)M6S,VR
M9;F?)_8#(>$QXB5[X9MX&,^8A*P7;F_U#WLAK[\;I:&CF7RD@,(Z[ ?R?C*E
MM'Z[3T/\TFMI#-5>EV@RZPV^.:U8=(+-KP-3:&BP=]0!I(@]+(9"^VPBW%28
M<'%B'M.GD"%E@F_2$ZV14B:^%AM3&HGO$XP)D>6^5C/_UG5Y8=!&&.Y08,]+
M'^Z69LTW-R2JKJ3$ .9(6.!4L3AN.&?_.>$L8V.7S<<2V)=X73%SRAG Z966
MW!'P$@ZL$<$*WB)8\L^-HQ[\X_#7TP]X,?]IX[2G35O)?/<K<\)YAN<4$[(X
M]IXWYU(YJ=]C*=(2(1.B,6L6Z^W;,U. +RL8%7ISX"AG+/>4VF5T1.UC]45T
M6+G%_1_>OCTM; WH9RU)=$?+/BSM'@*<PG"<< 5A:\D("IC=+O7V+4HU;37E
M1[.(*08G*5BMY$L*:1N")3FF2)@!)-<\=?;93HHLC;#.7CH],*/[<OS)RV;]
M5BD ".7GTP5E >_IT6?B%B8KY_E=C.WCPFDN ,3HKM2*RE_H-9Q^>ME3+C!<
MBOJ\ZI<K'7/4'NGP-F4K+$.S7RKV?*6G"VD3< TN3;1.!X^SAP%LHD^@3A<M
MEI#CZ8PCJIIQU"@'-'H!A]?B46B;(@[ER,'H2QE?9'G"+39L2(0VK:N$#'E4
M>(%5FW!:8>K0Q%XT64H85<LTZAUE01K[<^=#F4;9L$)IC10;!4IH>BU*Q=2E
M\HMLJUDWYL.GC4O/SSNK<0IM!L>MAJ6)>N%447,3$P!@5B@4TEP^<X(31MF,
M46BW(?S] M'L*7W*M&T3<H@A0[]S2K\*>(!-AY4MU=C6-W-UK-_+MY;7MGE?
M:P#KM]J1-;&4<3ZCF!SK.DNMN- 2!JLUJY!7PS6&752:9PU;*:?S63MPX1R8
M T.K\ *_^%@+SWR3^!EGBZD!O-A^*4J<Q#6>FP7<H&QH$6'<H#&2X(&['[@,
M'UQP9Q:W";"MG?'MSE=X+^<K^-Z=KSOV;1+FR=D,JR@Y/9..@D0I2:AAD_8=
M1_8[YE[DZH8\QG;2E!N91FE*,,J/ OC("PXC6+#0+7LT$9\HMR!N+)4)J4KS
M)5)8WCO<]A%\,KA2Z!QEBKH&+8=6-QKKY8(YPMDPWH&C6MM[M/;<L[,7_@5C
MX5Y(53G)F,8=+9 1]A)#*L62R6%\U#B>X=)11OC/D:D (Q39>#,\L>!Q9SCV
M!8SJ!U,$Q(-!L!;@#_,)\\.CED^T+9PI_4WM^N0-5#849D-P:58E+GJXCHL^
M9EQTYWN(BSYQ9/0;-L7B0=#/VK;*H^Y#>OBW?DY_^?=X,DM6T3]ATZ'C^5\_
M%5%R<+AU>+C[?_M]' W^XI>W9Q^./YR<';\+SS\??SY]?_KA\WEH+*9O'>WA
M728?S]&H8GR_<?@#.F.DNY4- TR2B\D4Z_$*B1&4L9#CD,<PDKPE0SK%'80C
M@;R*>07.V%"=8PIC)?G,^#[BLM/#X(""4R!FQ]^Q6<S%1I(G93DO?G[UZNKJ
M:K.(AYO@$[PZAN,:V9Y>Q2.PTE_!.1.]ZN_W]XZV]EYM;6WU^T<[_>V][;VM
MW:/=_8-7HZ/^_OY>?Y0.BWQS4LY^^N68&*4DT(N;PO#=N<0D;$;4PH3;N\)W
M8G)Y&H5G%U1+3NFCX! ^/SZK$2Q'J3**T!Q+$9^ZDX73A0 K)))I;&MGPO/3
M$Z\SLFV:^V+P\L6V:9O;/]K=PO L+=FYDASU=UY$+WOXKR'^:Q=+YOI[+T;.
M;3N[=)O7T8M;8QFP-?Z(6D:Z$3IO/FH308_AJ> DJ>D./&#X+S]5KK LR )\
MXF692DT\'?7.]-F)X](=K]!D\:"8E1M]&4/"51\)FQ:(+<R]I_KT'[A A;]
M-"=@V61X R.0JCE]#=LJ&*V,*9Y G(SFR4Q-YKY*:._)8^]Q 25!>)A;;HA5
M^.16$S](K[F+KN)! =M>(Z_U+]Q\>EUTYBZ)6GL\NE$\A4V=>^(.\B ^6C;@
MF>B9!FW,$-K#A<5)1L ?ZV3YFJL)?/H&FD9PEJ?951[-?_KEQ>'6UDL^EK?W
M#C8.#PX/>J*Q\4%76.J)3K\3"X,9W]G9"?]$%.B?8$6!.+S)$S0]3R:PO!=9
M+SS#UV<)-G>!_])*>:".QH*\0+4F6BVM+N,XW1QFLY??;*_>8T7HE>$-!NS1
MVH!]3 -V]WLP8+_)?)6EN;W]&CZN_7I+>V_;V'LG?YQ__OW-V?&'\/C#F_#S
MI^,/YV]//X7'OX'A]W!VWPU6:HOA!\YRF8V22(_NP'((NY S0J7"/W-,L/X:
MI=Q_Y'..*883AH%Q/*)D?IC?4XP<I!?4-IMO@P%7J-O 3/HU@Y?"A[R'ET7#
M284M)XIP:[O?W]W8WNKO<W99$DPG.D(GR81Q"3-P(14IS+=,>]PRW;$T<;2V
MZ:7SBR+.+['=<TM!/='Y@D70"]QXM-X@)3]":SB/KFT*!.;KA/C6L#@(K4$X
MU3;I>O_'M>G[L'F\Z4UB?V\+EOP:4R$RA<$)&'9M,P=S1X?#-XO]P_@Y.T;N
MSSZ\.?UX"O\ ,?]T^MO9^>?33Z=OPH]__/KN["0\/CGY_8\/G\\^_!:^/?OT
M/M"-\-B?4><S1CJ@*[0VP'(HXI,,DS5%^.[=1\MA?G5B$Z@44[V#C].SB65R
MM%S!<VT)%D+A*P$WPZ1KM $][$H8" H8;K /(- 3:W.X!L<[-C7$8%@1J=@U
M4O'N]+?C=\'[X\\@#=;M?>)5EX[P=&9Y_YG&%S#Y,\9),WLBH6M-=Z56%P>Y
M^!0NH>XBJ4^P&\\1@CN-K^$34HSKEDC05(3_'LWFKYOO_S\@.Q<]%#]/'6QO
M;>W!QB>:)%^E;N]O;?7"CY-D&H&5/)\D$?PM3M/B>GH9I4FT>>\!"+^EM,2R
MV5B='!!(7Q5-HRN-[V;S)!6?\'V67^#2O8NO$GDK' +#+TE%N^QA'(V'$=(]
M(Z3';]Z<?3[[_</QN_#LP]O?/X&XPM^Z.JP1=W8AT75:00G/X&P3TN1FY^;#
MQK9Q9IS:8'C*2/M942"GQ_SICJ-S[M#T6,,@H#T@ 8X!G&"80Z;*- Y+>+AN
MQP/N@<XJ)O!X.LK>2!/[CWE&^:U*<4_B\$M'/_%UM7%W67.%0?IPUY43#1>U
MSY:;2\% 2_QUD@P2"144PTD\DL9Q-!&4+D86BG+B._E!6T*.O4&)@7DSYL^2
M%V8@?)L\H'W(F_:/A>?QTSV+9LUDG.@6I;W&3S:4:+8234(D8>[T"]-.6,I'
MFE"5 >;X.5!!:!;JS(F((T10+/FR83:_-M&9)0-@N8F8D)"79OGD])S6HR9B
M"3*(ZVO9[$5L9+VHJY;$B62\R-0R=Z3;?5E@MYK$&N"#A7O*CS5H@0"(N#$B
M[6&>(3TY!?Y\Z>])'PE]O[2KQZ6B@ P'1,?U0(>-(&!,R50[@"&J-?BJJ\>(
MB7) D;(MX;8'BB?<39'=)J#0WUH'%!XSH+"W#B@\SX#"OK5./J);=?:_P^,G
MLTB:8_Q$5@*IK3.GWT%')M(Y&98?P]^FV0#3-SPX$*F]_NOC<) G\5AJ(^9N
MLL+!&[0_ 30T]4-07LS:5>C=!^HGRN^LKYBS(55<SP;9U$"ZL8-V'*4T>2^B
M@OU&!2K*,UZ"*IE.LZOBY[ #[^C8?";3:0IONGP.06P$%!XXACX=]G3E%1IC
M[+TR"HEH8K.\!:,M?&=#)\]H.65[[@7#:<3/:[N2Z=Y:'Z>$B [>-U?1!6<&
MQEO-F+F!N&_E<MOA"7EY\3'1/,[-;U\2 7Q)Q/ ,577A;PNGXJ**<HSB$"(V
M+:J<L+'&%N)0%A[?/.%Q.D'C2DU]<JS,)[,XV1$H\)C>K3VG#$*Z=B\QXYM^
M>FR$ZU+&V"PLDN2N+IT:-=CY%8Y/@?V@_PLS29_G]BUQNW;/9HFH!NZLC%8H
MEGE4 M AKF=L[50P<M-BU.F0+8E.SK Z<YILP&2Z+"-N:PQ!!E73,L$,DC&)
MQ&+FAJO96#MQ2UZP7<B))"I *H<9NDF1:3EA.("0!926C\I8H@4R##\L9O))
MV 1<&V3Q<TLQUX4#F=FIB6\U*94W;TRR[51<,6HLRS?##E3M67.Z&--H0&6B
M'#PGS?+YB0TJ@L7='@>V'%A5#S<YIGW!)"@%,[SR/BL"+%%!Q;UI[C S*U%A
MJIW#F%M;'(?<(6_)11A[^ 79<!@Q@SH%0#*LYV_@)+P$;7CB3XBR)Q+R;(1"
M75#,<,3$E#"$41YQC141-2""$'>^P<+1=?#6RRB9JB!DXUX@'<',F^DZ,_4\
M85[7Z\TNCI!6(9'LM/0OP:HAVO*&0(?^AF!90Z;CB)=+@EE@JWNEAL2R1^<D
M<++W+BV/MAV/IS&V79+]9AJ7(9*=F>R='NW8X9MZ$;J/%^FQE-,SI/CFU<%*
M)<O<L;._1^PG;(78XZ=^JBSZ8BJ)"*I"&Z:-$%X>W^><G8.?*E3D=.K9!MO.
ME[$R%%&D0YYJI'A /?\H*>H#UC"UG!K."^E.A;BH1U\5%77UUF'P0S;#]_8X
M#AA@1/.@ZUV_X;%EFPS==[]_^&WC\^FG]^'9^?D?I^')I],W9Y_#3\>8NWA
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MZX)LU<=FLB9LXH*@%*4<%X1)U&=).KT^'.<8V@S_G"33F)/3?CX(E(+((O$
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M<BZ(DL?P$U&>!>T>;C:Z_'5<F8"GH/<YSI@7/@3)42C036I:.%(BSU[( TN
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MX_=:V;AP3?3:S\?O3 N(6Z^3N?GDS+PI?$%DFQ);@U_2^^)<HXY$1)5-,0#
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M'+J3^229P@Z=@#Y(ADZ\LI-]]R<GZHVA[VBM98@&AEI3O\B0*1-F=- &5E1
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M$#"1\2H4T<.TG M.[/@*-V&;DO(.4C-)L_@BVE!9.V[("+A:)=IZVLS)*(2
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M(E.D)84CW$H5VTY ,9-#Y=3333.])G!>GLW@D:,UA=XM!K4@[G]3:<#ANC2
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MZ JG?T,QER+V];) +_. ^\=&K7A:1<+.IC"5#5\ZF@CH8?(G6'T&][,)$M4
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M9^96C!S95IQY]KZJJN?9U?O9NC&/P%4%Q?<68N_G"+-I<U.;C.$V]NP2[=E
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M=MYNMW#\((#5='U]*MC5R<A2.SE,P0N"7V'/<4UA[6 K%50A\&Y@OK"9\/?
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MJ]@#[ZHF+*@M^T3+9!2+TTCZQ%3(G2P."2-1)=BW@.^,#0%O 'O,&\7>=.R
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M_I3-!O6ZQ/M&P12.OH"+)^!50\UL\ 5_ZJNN-;@NMXJQ*&KB^G":$[P<@=8
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MG@VUOWV'=Z()(>+@ME5#_18^MT.CMHB:K'KSL90B<2VC!NA[.W/ 1M+TR_:
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M8=*6ZY=R0=BZ6N<1H]C!U(]1F1EWY])-64YI& 5!=(/4]*/)) U5UTG9:EH
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MD2'6<_&S.U27@1>:%_(4%IY!T&$J@G9GD3GHKW_*;L!_ ?MA$(#A]#D*R8K
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M/R35 !E5YQF)\YI=9U\2,":/NQI;?;]?KC*QCGBI'A:0(**@GF&^] 94@=+
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M3Y$M1NCI34+BT>>4K+!O&X4371_ D"UQW<;%5J.+3(!/4USX-"^/7.7,6 W
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M>#DY+6PQ+FAT;5!+ 0(4 Q0    ( (-X#UMC^)D.LQP  '-\   +
M      "  =T?  !E>#DY+6PR+FAT;5!+ 0(4 Q0    ( (-X#UM&K?WHY@,
M ((,   *              "  ;D\  !E>#DY+6XN:'1M4$L! A0#%     @
M@W@/6ZT;9H&.$P  N(,   H              ( !QT   &5X.3DM<RYH=&U0
M2P$"% ,4    " "#> ];G(902%T#  !!#0  $               @ %]5
M:F=H+3(P,C4P.#$U+GAS9%!+ 0(4 Q0    ( (-X#UN5K^Q7! ,  +40   4
M              "  0A8  !J9V@M,C R-3 X,35?9&5F+GAM;%!+ 0(4 Q0
M   ( (-X#UN\2+!'X@(  .L/   4              "  3Y;  !J9V@M,C R
M-3 X,35?;&%B+GAM;%!+ 0(4 Q0    ( (-X#UN"F_4#M (  )4,   4
M          "  5)>  !J9V@M,C R-3 X,35?<')E+GAM;%!+ 0(4 Q0    (
M (-X#UL0VW+<?>D" &[!$P 2              "  3AA  !J9V@M;C)A7S U
M,C<R-2YH=&U02P$"% ,4    " "#> ];S!K(Y6,2   2$P  #@
M    @ 'E2@, ;G5V965N;&]G;RYJ<&=02P4&      L "P": @  =%T#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>jgh-n2a_052725_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jgh="http://nuveen.com/20250815"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jgh-20250815.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
        </entity>
        <period>
            <startDate>2025-08-15</startDate>
            <endDate>2025-08-15</endDate>
        </period>
    </context>
    <context id="From2025-08-152025-08-15_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-15</startDate>
            <endDate>2025-08-15</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-08</instant>
        </period>
    </context>
    <context id="From2025-08-082025-08-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-08</startDate>
            <endDate>2025-08-08</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_BorrowingsOutstandingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jgh:BorrowingsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2025-08-082025-08-08_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-08</startDate>
            <endDate>2025-08-08</endDate>
        </period>
    </context>
    <context id="From2025-08-152025-08-15_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-15</startDate>
            <endDate>2025-08-15</endDate>
        </period>
    </context>
    <context id="From2025-08-152025-08-15_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-15</startDate>
            <endDate>2025-08-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-15" id="Fact000003">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2025-08-15" id="Fact000004">N-2/A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-15" id="Fact000005">0001615905</dei:EntityCentralIndexKey>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2025-08-15" id="xdx2ixbrl0048">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityFileNumber contextRef="AsOf2025-08-15" id="Fact000011">333-287584</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="AsOf2025-08-15" id="Fact000012">811-22988</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType contextRef="AsOf2025-08-15" id="Fact000013">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement contextRef="AsOf2025-08-15" id="Fact000014">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment contextRef="AsOf2025-08-15" id="Fact000015">true</dei:PreEffectiveAmendment>
    <dei:PreEffectiveAmendmentNumber contextRef="AsOf2025-08-15" id="Fact000016">1</dei:PreEffectiveAmendmentNumber>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2025-08-15" id="Fact000017">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2025-08-15" id="Fact000018">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:AmendmentDescription contextRef="AsOf2025-08-15" id="Fact000019">Amendment No.
1</dei:AmendmentDescription>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2025-08-15" id="Fact000020">1</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-15" id="Fact000021">Nuveen Global High Income Fund</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-15" id="Fact000022">333 West Wacker Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-15" id="Fact000023">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-15" id="Fact000024">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-15" id="Fact000025">60606</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-15" id="Fact000026">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-15" id="Fact000027">257-8787</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2025-08-152025-08-15_dei_BusinessContactMember"
      id="Fact000028">Mark L. Winget</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2025-08-152025-08-15_dei_BusinessContactMember"
      id="Fact000029">333                                             West Wacker Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="From2025-08-152025-08-15_dei_BusinessContactMember"
      id="Fact000030">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2025-08-152025-08-15_dei_BusinessContactMember"
      id="Fact000031">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2025-08-152025-08-15_dei_BusinessContactMember"
      id="Fact000032">60606</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2025-08-15" id="Fact000033">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2025-08-15" id="Fact000034">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2025-08-15" id="Fact000035">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2025-08-15" id="Fact000036">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="AsOf2025-08-15" id="Fact000037">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="AsOf2025-08-15" id="Fact000038">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2025-08-15" id="Fact000039">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="AsOf2025-08-15" id="Fact000040">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="AsOf2025-08-15" id="Fact000041">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="AsOf2025-08-15" id="Fact000042">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="AsOf2025-08-15" id="Fact000043">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2025-08-15" id="Fact000044">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2025-08-15" id="Fact000045">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2025-08-15" id="Fact000046">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2025-08-15" id="Fact000047">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-15" id="Fact000049">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2025-08-15" id="Fact000050">false</cef:NewCefOrBdcRegistrantFlag>
    <us-gaap:SharePrice
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000051"
      unitRef="USDPShares">13.34</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000052"
      unitRef="USDPShares">13.90</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000053"
      unitRef="USDPShares">13.34</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">13.90</us-gaap:NetAssetValuePerShare>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000055"
      unitRef="Shares">23177393</cef:OutstandingSecurityNotHeldShares>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2025-08-15" id="Fact000057">&lt;p id="xdx_80A_ecef--PurposeOfFeeTableNoteTextBlock_zrbQarXoWuf8" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the table below and the Examples below are to help you understand all fees and expenses that you, as a Common Shareholder,
would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable
to Common Shares, and not as a percentage of total assets or Managed Assets.&lt;/span&gt;&lt;/p&gt;

</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2025-08-15" id="Fact000060">&lt;p id="xdx_806_ecef--ShareholderTransactionExpensesTableTextBlock_gL1STETTB-KEUBN_zfr3YikU5WP9" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; font-size: 8pt; width: 75%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder
    Transaction Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maximum
    Sales Charge (&lt;span id="xdx_908_ecef--BasisOfTransactionFeesNoteTextBlock_c20250815__20250815_zUmr8miBFnN4"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecef--SalesLoadPercent_dp_c20250815__20250815_fKg_____zHFbg2t210La" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend
    Reinvestment Plan Fees &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecef--DividendReinvestmentAndCashPurchaseFees_pid_c20250815__20250815_fKDEp_zoBMXZWwQQv5" style="vertical-align: bottom; font-size: 8pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 8pt"&gt;&lt;span id="xdx_F01_zEew5cxfgfga" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 8pt"&gt;&lt;span id="xdx_F14_ztv84zaBcaUg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; visibility: hidden; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F07_zv5AhwnVBhBk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F1E_zBU8j1Hux776" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment
                                         account.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;


&lt;div&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment
                                         account.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2025-08-15" id="Fact000061">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000062"
      unitRef="Ratio">0.0100</cef:SalesLoadPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000063"
      unitRef="USD">2.50</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2025-08-15" id="Fact000068">&lt;p id="xdx_808_ecef--AnnualExpensesTableTextBlock_gL1AETTB-TRF_zd9gQnXIjXKl" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 8pt; font-weight: bold; text-align: right; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    a Percentage of Net Assets&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Attributable
    to&lt;/b&gt;&lt;/span&gt;&lt;br/&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common Shares&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Annual Expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 75%; text-align: left"&gt;Management Fees&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecef--ManagementFeesPercent_dp_c20250815__20250815_fKDIp_z4WY5nEwWFV7" style="width: 12%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.18%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest and Other Related Expenses &lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250815__20250815_fKDIpKDMp_z0GP7Ja2P4lb" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.41%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other Expenses &lt;sup&gt;(4)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecef--OtherAnnualExpensesPercent_dp_c20250815__20250815_fKDIpKDQp_z8xgw44rdMv7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.14%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Annual Expenses&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecef--TotalAnnualExpensesPercent_dp_c20250815__20250815_fKDIp_znclkbIxkkTi" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.73%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;div&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0C_zBCKezzeMNL" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F1D_z2ROwh85iCug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F01_z9TJ0NzsGamk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F1E_zenYffoi5l82" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#x2019;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#x2019;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#x2019;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#x2019;s adviser and sub-advisor(s).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0C_zgvO4dJ2lWT" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F11_z9V72rAVYfOh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecef--OtherExpensesNoteTextBlock_c20250815__20250815_zdvSowkrm1ab"&gt;Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#x2019;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#x201c;Investment Objective and Policies&#x2014;Other
                                         Investment Companies&#x201d; in the SAI.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000069"
      unitRef="Ratio">0.0118</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000070"
      unitRef="Ratio">0.0241</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000071"
      unitRef="Ratio">0.0014</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2025-08-15"
      decimals="INF"
      id="Fact000072"
      unitRef="Ratio">0.0373</cef:TotalAnnualExpensesPercent>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2025-08-15" id="Fact000076">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#x2019;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#x201c;Investment Objective and Policies&#x2014;Other
                                         Investment Companies&#x201d; in the SAI.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2025-08-15" id="Fact000078">&lt;p id="xdx_804_ecef--ExpenseExampleTableTextBlock_zMNIvguq0kzh" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Example
&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following example illustrates the expenses, including the transaction fee (referred to as the &#x201c;Maximum Sales Charge&#x201d; in
the Shareholder Transaction Expenses table above), if any, that a common shareholder would pay on a $1,000 investment that is held
for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the
Fund and that the Fund&#x2019;s Annual Expenses, as provided above, remain the same. The example also assumes a 5% annual return.
Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less
than the hypothetical 5% return shown in the example.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3
    Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5
    Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10
    Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecef--ExpenseExampleYear01_c20250815__20250815_z22VtpbOXPA7" style="text-align: right; width: 23%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250815__20250815_zNE7pnry5Iyb" style="text-align: right; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;123&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecef--ExpenseExampleYears1to5_c20250815__20250815_zkAIFZhvLVw7" style="text-align: right; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecef--ExpenseExampleYears1to10_c20250815__20250815_zguNRQS9wNkk" style="text-align: right; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The example should not
be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2025-08-15"
      decimals="0"
      id="Fact000079"
      unitRef="USD">47</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2025-08-15"
      decimals="0"
      id="Fact000080"
      unitRef="USD">123</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2025-08-15"
      decimals="0"
      id="Fact000081"
      unitRef="USD">201</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2025-08-15"
      decimals="0"
      id="Fact000082"
      unitRef="USD">404</cef:ExpenseExampleYears1to10>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">13.37</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">12.79</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">16.63</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000087"
      unitRef="USDPShares">16.97</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000088"
      unitRef="USDPShares">18.14</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000089"
      unitRef="USDPShares">16.01</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2017-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">18.51</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2016-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">17.82</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2015-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">16.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2014-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000093"
      unitRef="USDPShares">19.46</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000095"
      unitRef="USDPShares">13.84</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">13.37</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">12.79</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">16.63</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000099"
      unitRef="USDPShares">16.97</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000100"
      unitRef="USDPShares">18.14</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000101"
      unitRef="USDPShares">16.01</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2017-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">18.51</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2016-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">17.82</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2015-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">16.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000106"
      unitRef="USDPShares">12.84</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000107"
      unitRef="USDPShares">12.20</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000108"
      unitRef="USDPShares">11.25</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">15.88</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000110"
      unitRef="USDPShares">15.55</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000111"
      unitRef="USDPShares">16.38</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000112"
      unitRef="USDPShares">13.65</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2017-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">16.91</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2016-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000114"
      unitRef="USDPShares">15.99</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2015-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000115"
      unitRef="USDPShares">13.74</us-gaap:SharePrice>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2024-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">104000000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000118"
      unitRef="USD">119000000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000119"
      unitRef="USD">127000000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">159000000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000121"
      unitRef="USD">149200000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000122"
      unitRef="USD">175200000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000123"
      unitRef="USD">175200000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000124"
      unitRef="USD">175200000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000125"
      unitRef="USD">164800000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_BorrowingsOutstandingMember"
      decimals="-3"
      id="Fact000126"
      unitRef="USD">170500000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2024-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000128"
      unitRef="USDPShares">4085</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000129"
      unitRef="USDPShares">3605</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000130"
      unitRef="USDPShares">3335</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000131"
      unitRef="USDPShares">3424</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000132"
      unitRef="USDPShares">3636</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000133"
      unitRef="USDPShares">3400</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000134"
      unitRef="USDPShares">3118</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000135"
      unitRef="USDPShares">3455</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000136"
      unitRef="USDPShares">3513</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_BorrowingsOutstandingMember"
      decimals="INF"
      id="Fact000137"
      unitRef="USDPShares">3196</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SharePriceTableTextBlock contextRef="AsOf2025-08-15" id="Fact000141">&lt;p id="xdx_801_ecef--SharePriceTableTextBlock_zdWh8ptpiHr3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&lt;span id="toc780884_4"&gt;&lt;/span&gt;TRADING AND NET ASSET VALUE INFORMATION &lt;/b&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 9pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;The
following table shows for the periods indicated: (i) the high and low sales prices for Common Shares reported as of the end of
the day on the NYSE, (ii) the corresponding NAV per share, and (iii) the premium/(discount) to NAV per share at which the Common
Shares were trading as of such date. The Fund&#x2019;s Common Shares have historically traded both at premiums and discounts in
relation to the Fund&#x2019;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount
to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might
be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of
such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion
of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of
these actions, or that share repurchases or tender offers will actually reduce market discount.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_484_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuCHvqTmVXa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_487_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBB8e1Uf9PXd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_48D_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBc5J9RZspIb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_48B_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8NmHmx9pI1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDutwyfxEyp" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_481_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z21wOlRowup7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Closing Market Price per&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;NAV per Common Share on&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Premium/(Discount) on&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date of Market Price&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date of Market Price&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"&gt;Fiscal Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20250401__20250630_zM9lTEaGmH3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; text-align: left"&gt;June 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;13.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;11.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;13.53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;12.89&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;(3.92&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;(10.94&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20250101__20250331_zHWKXhKyUCs" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;March 2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.94&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.67&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20241001__20241231_zUmRX5EZHbK1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;December 2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.02&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.96&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
    &lt;tr id="xdx_418_20240701__20240930_z0lIAUAyXFvl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;September 2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.83&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20240401__20240630_zJHsfptO6WNi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;June 2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20240101__20240331_zdvtip8DnOt8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;March 2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.37&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20231001__20231231_zDvjGFQx3mF6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;December 2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8.52&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13.98&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20230701__20230930_zGHPN2PYxPv9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;September 2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.13&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20230401__20230630_zSdPY0UAoHp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;June 2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.65&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10.53&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.25&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20230101__20230331_zfU4zFoXq7j7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;March 2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.23&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;The
net asset value per Common Share, the market price, and percentage of premium/(discount) to net asset value per Common Share on
August 8, 2025, $&lt;span id="xdx_90D_eus-gaap--NetAssetValuePerShare_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU4lu6AhTKg8"&gt;13.90&lt;/span&gt;,
$&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeyPXPR4uDRg"&gt;13.34&lt;/span&gt;
and &lt;span id="xdx_90D_ecef--LatestPremiumDiscountToNavPercent_dp_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zl1icWeTPzj1"&gt;(4.03)&lt;/span&gt;%,
respectively. As of August 8, 2025, the Fund had &lt;span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zjXU7y2alWX5"&gt;23,177,393&lt;/span&gt;
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556.&lt;/span&gt;&lt;/p&gt;

</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000142"
      unitRef="USDPShares">13.00</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000143"
      unitRef="USDPShares">11.48</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000144"
      unitRef="USDPShares">13.53</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000145"
      unitRef="USDPShares">12.89</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000146"
      unitRef="Ratio">-0.0392</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000147"
      unitRef="Ratio">-0.1094</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000148"
      unitRef="USDPShares">13.42</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000149"
      unitRef="USDPShares">12.80</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000150"
      unitRef="USDPShares">13.97</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000151"
      unitRef="USDPShares">13.57</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000152"
      unitRef="Ratio">-0.0394</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000153"
      unitRef="Ratio">-0.0567</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000154"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000155"
      unitRef="USDPShares">12.72</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000156"
      unitRef="USDPShares">13.94</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000157"
      unitRef="USDPShares">13.82</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000158"
      unitRef="Ratio">-0.0402</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000159"
      unitRef="Ratio">-0.0796</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000160"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000161"
      unitRef="USDPShares">12.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000162"
      unitRef="USDPShares">13.95</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000163"
      unitRef="USDPShares">13.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000164"
      unitRef="Ratio">-0.0409</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000165"
      unitRef="Ratio">-0.0683</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000166"
      unitRef="USDPShares">13.05</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000167"
      unitRef="USDPShares">12.18</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000168"
      unitRef="USDPShares">13.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000169"
      unitRef="USDPShares">13.12</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000170"
      unitRef="Ratio">-0.0340</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000171"
      unitRef="Ratio">-0.0716</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000172"
      unitRef="USDPShares">12.92</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000173"
      unitRef="USDPShares">11.96</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000174"
      unitRef="USDPShares">13.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000175"
      unitRef="USDPShares">13.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000176"
      unitRef="Ratio">-0.0437</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000177"
      unitRef="Ratio">-0.0919</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000178"
      unitRef="USDPShares">12.24</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000179"
      unitRef="USDPShares">10.40</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000180"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000181"
      unitRef="USDPShares">12.09</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000182"
      unitRef="Ratio">-0.0852</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000183"
      unitRef="Ratio">-0.1398</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000184"
      unitRef="USDPShares">11.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000185"
      unitRef="USDPShares">11.17</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000186"
      unitRef="USDPShares">12.91</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000187"
      unitRef="USDPShares">12.72</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000188"
      unitRef="Ratio">-0.0713</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000189"
      unitRef="Ratio">-0.1219</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000190"
      unitRef="USDPShares">11.39</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000191"
      unitRef="USDPShares">10.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000192"
      unitRef="USDPShares">12.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000193"
      unitRef="USDPShares">12.42</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000194"
      unitRef="Ratio">-0.1053</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000195"
      unitRef="Ratio">-0.1425</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000196"
      unitRef="USDPShares">12.62</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000197"
      unitRef="USDPShares">10.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000198"
      unitRef="USDPShares">13.55</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000199"
      unitRef="USDPShares">12.44</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000200"
      unitRef="Ratio">-0.0686</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000201"
      unitRef="Ratio">-0.1423</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000202"
      unitRef="USDPShares">13.90</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000203"
      unitRef="USDPShares">13.34</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000204"
      unitRef="Ratio">-0.0403</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000205"
      unitRef="Shares">23177393</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecuritiesTableTextBlock contextRef="AsOf2025-08-15" id="Fact000207">&lt;p id="xdx_802_ecef--OutstandingSecuritiesTableTextBlock_zei1WqnakaNe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The following
provides information about the Fund&#x2019;s outstanding Common Shares and Preferred Shares as of August 8, 2025:&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Title of Class&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&#160;Held&lt;br/&gt;by&#160;the&#160;Fund&#160;or&lt;br/&gt;for
    its Account&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt;Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%"&gt;&lt;span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zNOrXQo0Js73"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_908_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSUQBH3uM0Fc"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zOOS0BO3oyAi"&gt;23,177,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_908_ecef--OutstandingSecurityTitleTextBlock_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zPfdigaMtJOi"&gt;Preferred Shares&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--OutstandingSecurityHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zFEKBtmf8Lx7"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--OutstandingSecurityNotHeldShares_c20250808__20250808__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zw1nn6RIxOKg"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      id="Fact000208">Common Shares</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000209"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000210"
      unitRef="Shares">23177393</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember"
      id="Fact000211">Preferred Shares</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-08-082025-08-08_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000213"
      unitRef="Shares">0</cef:OutstandingSecurityNotHeldShares>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2025-08-15" id="Fact000215">&lt;p id="xdx_800_ecef--InvestmentObjectivesAndPracticesTextBlock_zHvGdh4Snm44" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Objective and Policies &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Please
refer to the section of the Fund&#x2019;s most recent &lt;a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm"&gt;annual report&lt;/a&gt; on Form N-CSR entitled &#x201c;Shareholder Update&#x97;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#x97;Investment Objective&#x201d; and &#x201c;&#x97;Investment Policies,&#x201d;
as such investment objective and investment policies may be supplemented from time to time, which is incorporated by reference herein,
for a discussion of the Fund&#x2019;s investment objective and policies.&lt;/span&gt;&lt;/p&gt; </cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:EffectsOfLeverageTextBlock contextRef="AsOf2025-08-15" id="Fact000217">&lt;p id="xdx_805_ecef--EffectsOfLeverageTextBlock_zyCmkKFzT6E3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Effects of Leverage &lt;/b&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;Please refer to the section of the Fund&#x2019;s most recent &lt;a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm"&gt;annual report&lt;/a&gt;
on Form N-CSR entitled &#x201c;Shareholder Update&#x97;Current Investment Objective, Investment Policies and Principal Risks of the Fund&#x97;Effects of Leverage,&#x201d; as such may be supplemented from time to time, which is incorporated by
reference herein, for a discussion of the effects of leverage.&lt;/p&gt;

</cef:EffectsOfLeverageTextBlock>
    <cef:RiskFactorsTableTextBlock contextRef="AsOf2025-08-15" id="Fact000219">&lt;p id="xdx_80A_ecef--RiskFactorsTableTextBlock_zgI7h8CAncd8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="toc780884_9"&gt;&lt;/span&gt;RISK
 FACTORS &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk
                                            is inherent in all investing. Investing in any investment company security involves risk,
                                            including the risk that you may receive little or no return on your investment or even that
                                            you may lose part or all of your investment. Please refer to the section of the Fund&#x2019;s
                                            most recent &lt;a href="https://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm"&gt;annual report&lt;/a&gt; on Form N-CSR entitled &#x201c;Shareholder Update&#x97;Current Investment
                                            Objective, Investment Policies and Principal Risks of the Fund&#x97;Principal Risks of
                                            the Funds,&#x201d; as such principal risks may be supplemented from time to time, which is
                                            incorporated by reference herein, for a discussion of the principal risks you should consider
                                            before making an investment in the Fund. Any additional risks applicable to a particular offering
                                            of Securities will be set forth in the related prospectus supplement.&lt;/span&gt;&lt;/p&gt; </cef:RiskFactorsTableTextBlock>
    <cef:CapitalStockTableTextBlock contextRef="AsOf2025-08-15" id="Fact000221">&lt;p id="xdx_801_ecef--CapitalStockTableTextBlock_zBFtFcuzIDH9" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;span id="toc780884_15"&gt;&lt;/span&gt;DESCRIPTION OF SHARES &lt;/b&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Common Shares &lt;/b&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The
Declaration of Trust authorizes the issuance of an unlimited number of Common Shares. The Common Shares have a par value of $0.01 per
share and, subject to the rights of holders of any Preferred Shares, have equal rights to the payment of dividends and the distribution
of assets upon liquidation. The Common Shares when issued, are fully paid and, subject to matters discussed in &#x201c;Certain Provisions
in the Declaration of Trust and By-Laws,&#x201d; non-assessable, and have no preemptive or conversion rights or rights to cumulative voting.
A copy of the Declaration of Trust is filed with the SEC as an exhibit to the Fund&#x2019;s registration statement of which this Prospectus
is a part.&#160;&lt;/p&gt;

&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;span id="xdx_90D_ecef--SecurityVotingRightsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zChXo54FbiDf"&gt;Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#x2019;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.&lt;/span&gt; &lt;span id="xdx_907_ecef--SecurityDividendsTextBlock_c20250815__20250815__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsp5KmGlzEGe"&gt;Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#x201c;&#x97;Preferred Shares&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The Common Shares
are listed on the NYSE and trade under the ticker symbol &#x201c;JGH.&#x201d; The Fund intends to hold annual meetings of shareholders
so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such
listing. The Fund does not issue share certificates.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;Unlike open-end funds, closed-end funds like the Fund do not provide
daily redemptions. Rather, if a shareholder determines to buy additional Common Shares or sell shares already held, the shareholder may conveniently do so by trading on the exchange through a broker or otherwise. Common shares of closed-end
investment companies may frequently trade on an exchange at prices lower than NAV. Common shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and have during other periods traded at
prices lower than NAV. &lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), call protection, dividend stability, portfolio credit quality, NAV, relative demand for and supply of such shares in the market, general market
and economic conditions, and other factors beyond the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than NAV in the future. The Common Shares are designed primarily for long-term
investors, and investors in the Common Shares should not view the Fund as a vehicle for trading purposes. See &#x201c;Repurchase of Fund Shares; Conversion to Open-End Fund.&#x201d; &lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Preferred Shares &lt;/b&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The
                                         Fund&#x2019;s Declaration of Trust authorizes the issuance of an unlimited number of Preferred
                                         Shares in one or more classes or series, with rights as determined by the Board of Trustees,
                                         by action of the Board of Trustees without the approval of the Common Shareholders. The Fund currently has no Preferred Shares outstanding. The discussion below generally describes the rights of the
                                         holders of Preferred Shares, although the terms of any Preferred Shares that
                                         may be issued by the Fund may be the same as, or different from, the terms described
                                         below, subject to the applicable Statement, applicable law and the Declaration of Trust.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;/p&gt;







&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;Under
                                            the 1940 Act, the Fund is not permitted to issue &#x201c;senior securities&#x201d; that are Preferred
                                            Shares if, immediately after the issuance of Preferred Shares, the asset coverage ratio would
                                            be less than 200%. See &#x201c;Use of Leverage.&#x201d; Additionally, the Fund will generally
                                            not be permitted to purchase any of its Common Shares or declare dividends (except a dividend
                                            payable in Common Shares) or other distributions on its Common Shares unless, at the time
                                            of such purchase or declaration, the asset coverage ratio with respect to such Preferred
                                            Shares, after taking into account such purchase or distribution, is at least 200%. Preferred
                                            Shares issued by the Fund have priority over the Common Shares.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;For so long as any Preferred Shares are outstanding, the Fund will not:
(1) declare or pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares) in respect of the Common Shares, (2) call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares,
or (3) pay any proceeds of the liquidation of the Fund in respect of the Common Shares, unless, in each case, (A) immediately thereafter, the Fund shall be in compliance with the 200% asset coverage limitations set forth under the 1940 Act after
deducting the amount of such dividend or other distribution or redemption or purchase price or liquidation proceeds and (B) all cumulative dividends and other distributions of shares of all series of Preferred Shares of the Fund due on or prior to
the date of the applicable dividend, distribution, redemption, purchase or acquisition shall have been declared and paid. &lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_843_ecef--SecurityDividendsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zm6RpaeqHXCk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Dividends and Distributions and Priority of Payment&lt;/i&gt;&lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;If the Fund issues Preferred Shares, the Fund&#x2019;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84C_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWlL7ZRXLuTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Liquidation Preference &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. &lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84D_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zoIdSC74EcR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Voting Rights &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. &lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In connection with the election of the Fund&#x2019;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#x2019;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#x2019;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#x2019; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#x2019;s trustees until all dividends in arrears have been paid or declared and set apart for payment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;/p&gt;





 &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#x2019;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#x2019;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#x2019;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#x201c;Investment Restrictions&#x201d; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. &lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84C_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zTYhDHWW3yQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Redemption, Purchase and Sale of Preferred Shares &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.&lt;/p&gt;

&lt;p id="xdx_855_zRG6NWYQWhU" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</cef:CapitalStockTableTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_CommonStockMember"
      id="Fact000222">Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#x2019;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityDividendsTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_CommonStockMember"
      id="Fact000223">Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#x201c;&#x97;Preferred Shares&#x201d; below.</cef:SecurityDividendsTextBlock>
    <cef:SecurityDividendsTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember"
      id="Fact000226">&lt;p id="xdx_843_ecef--SecurityDividendsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zm6RpaeqHXCk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Dividends and Distributions and Priority of Payment&lt;/i&gt;&lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;If the Fund issues Preferred Shares, the Fund&#x2019;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; </cef:SecurityDividendsTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember"
      id="Fact000228">&lt;p id="xdx_84C_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWlL7ZRXLuTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Liquidation Preference &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. &lt;/p&gt; &lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; </cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember"
      id="Fact000230">&lt;p id="xdx_84D_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zoIdSC74EcR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Voting Rights &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. &lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;In connection with the election of the Fund&#x2019;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#x2019;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#x2019;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#x2019; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#x2019;s trustees until all dividends in arrears have been paid or declared and set apart for payment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;/p&gt;





 &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#x2019;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#x2019;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#x2019;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#x201c;Investment Restrictions&#x201d; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. &lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; </cef:SecurityVotingRightsTextBlock>
    <cef:PreferredStockRestrictionsOtherTextBlock
      contextRef="From2025-08-152025-08-15_us-gaap_PreferredStockMember"
      id="Fact000233">&lt;p id="xdx_84C_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zTYhDHWW3yQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;i&gt;Redemption, Purchase and Sale of Preferred Shares &lt;/i&gt;&lt;/p&gt;
&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.&lt;/p&gt;

</cef:PreferredStockRestrictionsOtherTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000062"
          xlink:label="Fact000062"
          xlink:type="locator"/>
        <link:footnote id="Footnote000064" xlink:label="Footnote000064" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000062"
          xlink:to="Footnote000064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000063"
          xlink:label="Fact000063"
          xlink:type="locator"/>
        <link:footnote id="Footnote000065" xlink:label="Footnote000065" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment
                                         account.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000063"
          xlink:to="Footnote000065"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000069"
          xlink:label="Fact000069"
          xlink:type="locator"/>
        <link:footnote id="Footnote000073" xlink:label="Footnote000073" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000073"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000070"
          xlink:label="Fact000070"
          xlink:type="locator"/>
        <link:footnote id="Footnote000074" xlink:label="Footnote000074" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#x2019;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#x2019;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#x2019;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#x2019;s adviser and sub-advisor(s).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000073"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000074"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnote id="Footnote000075" xlink:label="Footnote000075" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_90A_ecef--OtherExpensesNoteTextBlock_c20250815__20250815_zdvSowkrm1ab">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#x2019;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#x201c;Investment Objective and Policies&#x2014;Other
                                         Investment Companies&#x201d; in the SAI.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000073"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000075"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000072"
          xlink:label="Fact000072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000072"
          xlink:to="Footnote000073"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000117"
          xlink:label="Fact000117"
          xlink:type="locator"/>
        <link:footnote id="Footnote000138" xlink:label="Footnote000138" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Aggregate Amount Outstanding: Aggregate amount outstanding represents the principal amount outstanding or liquidation preference as of the end of the relevant fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000117"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000118"
          xlink:label="Fact000118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000118"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000119"
          xlink:label="Fact000119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000119"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000120"
          xlink:label="Fact000120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000120"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000121"
          xlink:label="Fact000121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000121"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000122"
          xlink:label="Fact000122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000122"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000123"
          xlink:label="Fact000123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000123"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000124"
          xlink:label="Fact000124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000124"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000125"
          xlink:label="Fact000125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000125"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000126"
          xlink:label="Fact000126"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000126"
          xlink:to="Footnote000138"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000128"
          xlink:label="Fact000128"
          xlink:type="locator"/>
        <link:footnote id="Footnote000139" xlink:label="Footnote000139" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Asset Coverage Per $1,000: Asset coverage per $1,000 is calculated by subtracting the Fund&#x2019;s liabilities and indebtedness not represented by senior securities from the Fund&#x2019;s total assets, dividing the result by the aggregate amount of the Fund&#x2019;s senior securities representing indebtedness then outstanding (if applicable), plus the aggregate of the involuntary liquidation preference of the outstanding preferred shares, if applicable, and multiplying the result by 1,000.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000128"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000129"
          xlink:label="Fact000129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000129"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000130"
          xlink:label="Fact000130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000130"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000131"
          xlink:label="Fact000131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000131"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000132"
          xlink:label="Fact000132"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000132"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000133"
          xlink:label="Fact000133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000133"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000134"
          xlink:label="Fact000134"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000134"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000135"
          xlink:label="Fact000135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000135"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000136"
          xlink:label="Fact000136"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000136"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000137"
          xlink:label="Fact000137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000137"
          xlink:to="Footnote000139"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>ex99-s_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-08-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <context id="From2025-08-042025-08-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
        </entity>
        <period>
            <startDate>2025-08-04</startDate>
            <endDate>2025-08-04</endDate>
        </period>
    </context>
    <context id="From2025-08-042025-08-04_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-04</startDate>
            <endDate>2025-08-04</endDate>
        </period>
    </context>
    <context id="From2025-08-042025-08-04_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-04</startDate>
            <endDate>2025-08-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-13" id="Fact000003">0001615905</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="From2025-08-042025-08-04" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:SubmissnTp contextRef="From2025-08-042025-08-04" id="xdx2ixbrl0010">N-2/A</ffd:SubmissnTp>
    <ffd:AmtSctiesRegd
      contextRef="From2025-08-042025-08-04_1"
      id="xdx2ixbrl0015"
      unitRef="Shares"
      xsi:nil="true"/>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2025-08-042025-08-04_1"
      id="xdx2ixbrl0016"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ffd:AmtSctiesRegd
      contextRef="From2025-08-042025-08-04_2"
      id="xdx2ixbrl0027"
      unitRef="Shares"
      xsi:nil="true"/>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2025-08-042025-08-04_2"
      id="xdx2ixbrl0028"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ffd:FormTp contextRef="From2025-08-042025-08-04" id="Fact000011">N-2</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="From2025-08-042025-08-04" id="Fact000012">Nuveen Global High Income Fund</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="From2025-08-042025-08-04_1" id="Fact000023">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2025-08-042025-08-04_1" id="Fact000013">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-08-042025-08-04_1" id="Fact000014">Common Shares, $0.01 par value per share, and Preferred Shares</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-08-042025-08-04_1" id="Fact000024">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-08-042025-08-04_1"
      decimals="INF"
      id="Fact000017"
      unitRef="USD">98987589.81</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="From2025-08-042025-08-04_1"
      decimals="INF"
      id="Fact000018"
      unitRef="USD">15155.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="From2025-08-042025-08-04_2" id="Fact000035">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2025-08-042025-08-04_2" id="Fact000025">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-08-042025-08-04_2" id="Fact000026">Common Shares, $0.01 par value per share, and Preferred Shares</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-08-042025-08-04_2" id="Fact000036">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-08-042025-08-04_2"
      decimals="INF"
      id="Fact000029"
      unitRef="USD">1012410.19</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="From2025-08-042025-08-04_2"
      decimals="INF"
      id="Fact000030"
      unitRef="USD">155.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="From2025-08-042025-08-04"
      decimals="INF"
      id="Fact000037"
      unitRef="USD">100000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="From2025-08-042025-08-04"
      decimals="INF"
      id="Fact000038"
      unitRef="USD">15310.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="From2025-08-042025-08-04"
      decimals="0"
      id="Fact000039"
      unitRef="USD">155.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="From2025-08-042025-08-04"
      decimals="0"
      id="Fact000040"
      unitRef="USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="From2025-08-042025-08-04"
      decimals="INF"
      id="Fact000041"
      unitRef="USD">15155.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-08-042025-08-04_1" id="Fact000043">Estimated pursuant to Rule 457(o) under the Securities Act of 1933 (&#x201c;Securities Act&#x201d;) solely
for purposes of determining the registration fee. The proposed maximum offering price per security will be determined from time to time
by the Registrant in connection with the sale by the Registrant of the securities registered under this Registration Statement. </ffd:OfferingNote>
    <ffd:OfferingNote contextRef="From2025-08-042025-08-04_2" id="Fact000045">The Registrant previously paid $155.00 in filing fees in reliance on Rule 457(o) under the Securities
Act in connection with the initial filing of this Registration Statement on May 27, 2025. The proposed maximum offering price per security
will be determined from time to time by the Registrant in connection with the sale by the Registrant of the securities registered under
this Registration Statement. </ffd:OfferingNote>
    <ffd:OffsetTableNa contextRef="From2025-08-042025-08-04" id="Fact000046">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="From2025-08-042025-08-04" id="Fact000047">N/A</ffd:CombinedProspectusTableNa>
    <ffd:RegnFileNb contextRef="From2025-08-042025-08-04" id="Fact000048">333-287584</ffd:RegnFileNb>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000042" xlink:label="Footnote000042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_90C_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__1_zmrVZlcK5fq5">Estimated pursuant to Rule 457(o) under the Securities Act of 1933 (&#x201c;Securities Act&#x201d;) solely
for purposes of determining the registration fee. The proposed maximum offering price per security will be determined from time to time
by the Registrant in connection with the sale by the Registrant of the securities registered under this Registration Statement. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_90F_effd--OfferingNote_c20250804__20250804__ffd--OfferingAxis__2_zl7tPczkyXac">The Registrant previously paid $155.00 in filing fees in reliance on Rule 457(o) under the Securities
Act in connection with the initial filing of this Registration Statement on May 27, 2025. The proposed maximum offering price per security
will be determined from time to time by the Registrant in connection with the sale by the Registrant of the securities registered under
this Registration Statement. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
